0001638833-18-000020.txt : 20181109 0001638833-18-000020.hdr.sgml : 20181109 20181109161605 ACCESSION NUMBER: 0001638833-18-000020 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 68 CONFORMED PERIOD OF REPORT: 20180930 FILED AS OF DATE: 20181109 DATE AS OF CHANGE: 20181109 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Surgery Partners, Inc. CENTRAL INDEX KEY: 0001638833 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062] IRS NUMBER: 473620923 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-37576 FILM NUMBER: 181173269 BUSINESS ADDRESS: STREET 1: 310 SEVEN SPRINGS WAY STREET 2: SUITE 500 CITY: BRENTWOOD STATE: TN ZIP: 37027 BUSINESS PHONE: 615-234-5900 MAIL ADDRESS: STREET 1: 310 SEVEN SPRINGS WAY STREET 2: SUITE 500 CITY: BRENTWOOD STATE: TN ZIP: 37027 10-Q 1 a2018q310-qfiling.htm 10-Q Document
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
________________________________________________________________
Form 10-Q
(Mark One)
x
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2018
or
o    TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Commission file number:  001-37576
Surgery Partners, Inc.
(Exact name of registrant as specified in its charter)
Delaware
 
47-3620923
(State or other jurisdiction of
incorporation or organization)
 
(I.R.S. Employer
Identification No.)

310 Seven Springs Way, Suite 500
Brentwood, Tennessee 37027
(Address of principal executive offices and zip code)
(615) 234-5900
(Registrant’s telephone number, including area code) 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes  x  No  o
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes  x No  o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. 
Large accelerated filer o
 
Accelerated filer x
Non-accelerated filer o
 
Smaller reporting company o
 
 
Emerging growth company o
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes o  No  x
As of November 8, 2018, there were 48,891,520 shares of the registrant’s common stock outstanding.
 


SURGERY PARTNERS, INC.
FORM 10-Q
TABLE OF CONTENTS

 
 
Page
 
 
 
 
 
 
Item 1.
 
 
 
Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited)
 
 
 
Notes to Condensed Consolidated Financial Statements (Unaudited)
 
 
 
Item 2.
Item 3.
Quantitative and Qualitative Disclosures About Market Risk
Item 4.
 
 
 
 
 
 
Item 1.
Item 1A.
Risk Factors
Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds
Item 3.
Defaults Upon Senior Securities
Item 4.
Mine Safety Disclosures
Item 5.
Other Information
Item 6.
Exhibits



PART 1 - FINANCIAL INFORMATION
Item 1.  Financial Statements
SURGERY PARTNERS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited, amounts in thousands, except shares and per share amounts)
 
 
Successor
 
 
September 30,
2018
 
December 31,
2017
ASSETS
 
 
 
 
Current assets:
 
 
 
 
Cash and cash equivalents
 
$
79,123

 
$
174,914

Accounts receivable, less allowance for doubtful accounts of $3,416 and $2,026, respectively
 
286,260

 
288,023

Inventories
 
44,360

 
44,951

Prepaid expenses and other current assets
 
53,575

 
55,337

Total current assets
 
463,318

 
563,225

Property and equipment, net of accumulated depreciation of $49,534 and $19,680, respectively
 
420,013

 
398,536

Intangible assets, net
 
55,607

 
58,908

Goodwill
 
3,372,606

 
3,346,838

Investments in and advances to affiliates
 
80,785

 
74,282

Long-term deferred tax assets
 
126,660

 
132,319

Other long-term assets
 
39,675

 
48,665

Total assets
 
$
4,558,664

 
$
4,622,773

 
 
 
 
 
LIABILITIES AND STOCKHOLDERS' EQUITY
 
 
 
 
Current liabilities:
 
 
 
 
Accounts payable
 
$
76,979

 
$
84,710

Accrued payroll and benefits
 
41,563

 
49,625

Other current liabilities
 
122,938

 
109,944

Current maturities of long-term debt
 
54,106

 
58,726

Total current liabilities
 
295,586

 
303,005

Long-term debt, less current maturities
 
2,118,567

 
2,130,556

Other long-term liabilities
 
247,311

 
222,480

 
 
 
 
 
Non-controlling interests—redeemable
 
317,541

 
299,316

Redeemable preferred stock - Series A, 310,000 shares authorized, issued and outstanding at both September 30, 2018 and December 31, 2017; redemption value of $350,893 and $330,806, respectively
 
350,893

 
330,806

 
 
 
 
 
Stockholders' equity:
 
 
 
 
Preferred stock, $0.01 par value, 20,000,000 shares authorized, no shares issued or outstanding
 
—

 
—

Common stock, $0.01 par value, 300,000,000 shares authorized, 48,891,520 shares issued and outstanding at September 30, 2018; 48,687,136 shares issued and outstanding at December 31, 2017
 
489

 
487

Additional paid-in capital
 
671,252

 
695,560

Accumulated other comprehensive loss
 
(1,389
)
 
—

Retained deficit
 
(99,280
)
 
(41,316
)
Total Surgery Partners, Inc. stockholders' equity
 
571,072

 
654,731

Non-controlling interests—non-redeemable
 
657,694

 
681,879

Total stockholders' equity
 
1,228,766

 
1,336,610

Total liabilities and stockholders' equity
 
$
4,558,664

 
$
4,622,773

See notes to unaudited condensed consolidated financial statements.


1

SURGERY PARTNERS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited, amounts in thousands, except shares and per share amounts)
 
 
Successor
 
 
 
Predecessor
 
Successor
 
 
 
Predecessor
 
 
Three Months Ended September 30,
 
September 1 to September 30,
 
 
 
July 1 to August 31,
 
Nine Months Ended September 30,
 
 
 
January 1 to August 31,
 
 
2018
 
2017
 
 
 
2017
 
2018
 
 
 
2017
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenues
 
$
443,932

 
$
132,258

 
 
 
$
174,079

 
$
1,306,076

 
 
 
$
748,615

Operating expenses:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Salaries and benefits
 
131,441

 
41,784

 
 
 
61,240

 
395,196

 
 
 
241,149

Supplies
 
120,123

 
35,028

 
 
 
48,078

 
355,701

 
 
 
193,322

Professional and medical fees
 
34,902

 
11,254

 
 
 
14,229

 
107,294

 
 
 
57,931

Lease expense
 
21,629

 
6,858

 
 
 
9,203

 
64,910

 
 
 
36,503

Other operating expenses
 
26,194

 
8,000

 
 
 
11,022

 
78,590

 
 
 
43,267

Cost of revenues
 
334,289

 
102,924

 
 
 
143,772

 
1,001,691

 
 
 
572,172

General and administrative expenses
 
19,478

 
7,777

 
 
 
12,601

 
69,729

 
 
 
46,797

Depreciation and amortization
 
16,945

 
3,330

 
 
 
7,599

 
49,379

 
 
 
30,124

Provision for doubtful accounts
 
11,555

 
3,690

 
 
 
4,834

 
25,788

 
 
 
16,297

Income from equity investments
 
(1,861
)
 
(712
)
 
 
 
(896
)
 
(6,283
)
 
 
 
(3,148
)
Loss on disposals and deconsolidations, net
 
12,631

 
333

 
 
 
114

 
15,875

 
 
 
1,715

Transaction and integration costs
 
7,099

 
2,983

 
 
 
2,343

 
23,771

 
 
 
5,584

Loss on debt refinancing
 
—

 
—

 
 
 
18,211

 
—

 
 
 
18,211

Gain on litigation settlement
 
—

 
—

 
 
 
—

 
—

 
 
 
(3,794
)
Gain on acquisition escrow release
 
—

 
—

 
 
 
(1,000
)
 
—

 
 
 
(1,000
)
Other (income) expense
 
(1,207
)
 
7

 
 
 
(3
)
 
(3,601
)
 
 
 
(307
)
Total operating expenses
 
398,929

 
120,332

 
 
 
187,575

 
1,176,349

 
 
 
682,651

Operating income (loss)
 
45,003

 
11,926

 
 
 
(13,496
)
 
129,727

 
 
 
65,964

Gain on amendment to tax receivable agreement
 
—

 
1,098

 
 
 
15,294

 
—

 
 
 
15,294

Interest expense, net
 
(37,159
)
 
(15,883
)
 
 
 
(18,147
)
 
(107,368
)
 
 
 
(68,929
)
Income (loss) before income taxes
 
7,844

 
(2,859
)
 
 
 
(16,349
)
 
22,359

 
 
 
12,329

Income tax expense (benefit)
 
5,825

 
(211
)
 
 
 
(20,718
)
 
10,905

 
 
 
(18,089
)
Net income (loss)
 
2,019

 
(2,648
)
 
 
 
4,369

 
11,454

 
 
 
30,418

Less: Net income attributable to non-controlling interests
 
(23,000
)
 
(6,492
)
 
 
 
(8,813
)
 
(69,418
)
 
 
 
(42,087
)
Net loss attributable to Surgery Partners, Inc.
 
(20,981
)
 
(9,140
)
 
 
 
(4,444
)
 
(57,964
)
 
 
 
(11,669
)
Less: Amounts attributable to participating securities
 
(8,245
)
 
(18,199
)
 
 
 
—

 
(23,973
)
 
 
 
—

Net loss attributable to common stockholders
 
$
(29,226
)
 
$
(27,339
)
 
 
 
$
(4,444
)
 
$
(81,937
)
 
 
 
$
(11,669
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net loss per share attributable to common stockholders
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Basic
 
$
(0.61
)
 
$
(0.57
)
 
 
 
$
(0.09
)
 
$
(1.71
)
 
 
 
$
(0.24
)
Diluted (1)
 
$
(0.61
)
 
$
(0.57
)
 
 
 
$
(0.09
)
 
$
(1.71
)
 
 
 
$
(0.24
)
Weighted average common shares outstanding
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Basic
 
48,037,634

 
48,314,746

 
 
 
48,146,611

 
48,020,369

 
 
 
48,121,404

Diluted (1)
 
48,037,634

 
48,314,746

 
 
 
48,146,611

 
48,020,369

 
 
 
48,121,404

(1) The impact of potentially dilutive securities for all periods presented was not considered because the effect would be anti-dilutive in those periods.

See notes to unaudited condensed consolidated financial statements.



2

SURGERY PARTNERS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(Unaudited, amounts in thousands)
 
 
Successor
 
 
 
Predecessor
 
Successor
 
 
 
Predecessor
 
 
Three Months Ended September 30,
 
September 1 to September 30,
 
 
 
July 1 to August 31,
 
Nine Months Ended September 30,
 
 
 
January 1 to August 31,
 
 
2018
 
2017
 
 
 
2017
 
2018
 
 
 
2017
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income (loss)
 
$
2,019

 
$
(2,648
)
 
 
 
$
4,369

 
$
11,454

 
 
 
$
30,418

Other comprehensive income, net of tax:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Derivative activity
 
(1,389
)
 
—

 
 
 
—

 
(1,389
)
 
 
 
—

Comprehensive income (loss)
 
$
630

 
$
(2,648
)
 
 
 
$
4,369

 
$
10,065

 
 
 
$
30,418

Less: Comprehensive loss attributable to non-controlling interests
 
(23,000
)
 
(6,492
)
 
 
 
(8,813
)
 
(69,418
)
 
 
 
(42,087
)
Comprehensive loss attributable to Surgery Partners, Inc.
 
$
(22,370
)
 
$
(9,140
)
 
 
 
$
(4,444
)
 
$
(59,353
)
 
 
 
$
(11,669
)
See notes to unaudited condensed consolidated financial statements.



3

SURGERY PARTNERS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
(Unaudited, amounts in thousands, except shares)
 
 
 
 
 
 
 
Accumulated Other Comprehensive Loss
 
 
 
 
 
 
 
Common Stock
 
Additional
Paid-in Capital
 
 
Retained Deficit
 
Non-Controlling Interests—
Non-Redeemable
 
Total
 
Shares
 
Amount
 
Successor
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance at December 31, 2017
48,687,136

 
$
487

 
$
695,560

 
$
—

 
$
(41,316
)
 
$
681,879

 
$
1,336,610

Net (loss) income
—

 
—

 
—

 
—

 
(57,964
)
 
48,890

 
(9,074
)
Equity-based compensation
—

 
—

 
6,303

 
—

 
—

 
—

 
6,303

Preferred dividends
—

 
—

 
(23,973
)
 
—

 
—

 
—

 
(23,973
)
Other comprehensive loss
—

 
—

 
—

 
(1,389
)
 
—

 
—

 
(1,389
)
Issuance of restricted and unrestricted shares
512,948

 
5

 
(5
)
 
—

 
—

 
—

 
—

Cancellation of restricted shares
(151,746
)
 
(1
)
 
(1,126
)
 
—

 
—

 
—

 
(1,127
)
Repurchase of shares
(156,818
)
 
(2
)
 
(1,980
)
 
—

 
—

 
—

 
(1,982
)
Acquisition and disposal of shares of non-controlling interests, net (1)
—

 
—

 
(3,527
)
 
—

 
—

 
(15,566
)
 
(19,093
)
Distributions to non-controlling interests—non-redeemable holders
—

 
—

 
—

 
—

 
—

 
(57,509
)
 
(57,509
)
Balance at September 30, 2018
48,891,520

 
$
489

 
$
671,252

 
$
(1,389
)
 
$
(99,280
)
 
$
657,694

 
$
1,228,766

(1)
Includes post acquisition date adjustments.

See notes to unaudited condensed consolidated financial statements.



4

SURGERY PARTNERS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited, amounts in thousands)
 
 
Successor
 
 
 
Predecessor
 
 
Nine Months Ended September 30,
 
September 1 to September 30,
 
 
 
January 1 to August 31,
 
 
2018
 
2017
 
 
 
2017
 
 
 
 
 
 
 
 
 
Cash flows from operating activities:
 
 
 
 
 
 
 
 
Net income (loss)
 
$
11,454

 
$
(2,648
)
 
 
 
$
30,418

Adjustments to reconcile net income to net cash provided by operating activities:
 
 
 
 
 
 
 
 
Depreciation and amortization
 
49,379

 
3,330

 
 
 
30,124

Non-cash interest (income) expense, net
 
(1,041
)
 
(130
)
 
 
 
4,874

Equity-based compensation
 
6,303

 
1,683

 
 
 
3,697

Loss on disposals and deconsolidations, net
 
15,875

 
333

 
 
 
1,715

Loss on debt refinancing
 
—

 
—

 
 
 
18,211

Gain on amendment to tax receivable agreement
 
—

 
(1,098
)
 
 
 
(15,294
)
Deferred income taxes
 
9,464

 
(465
)
 
 
 
(18,703
)
Provision for doubtful accounts
 
25,788

 
3,690

 
 
 
16,297

Income from equity investments, net of distributions received
 
(186
)
 
(203
)
 
 
 
489

Changes in operating assets and liabilities, net of acquisitions and divestitures:
 
 
 
 
 
 
 
 
Accounts receivable
 
(23,665
)
 
(2,795
)
 
 
 
8,837

Other operating assets and liabilities
 
5,683

 
(2,919
)
 
 
 
(12,947
)
Net cash provided by (used in) operating activities
 
99,054

 
(1,222
)
 
 
 
67,718

 
 
 
 
 
 
 
 
 
Cash flows from investing activities:
 
 
 
 
 
 
 
 
Purchases of property and equipment
 
(26,618
)
 
(1,840
)
 
 
 
(18,773
)
Payments for acquisitions, net of cash acquired
 
(55,213
)
 
(1,163
)
 
 
 
(725,853
)
Proceeds from divestitures
 
18,031

 
—

 
 
 
70

Other investing activities
 
(2,811
)
 
—

 
 
 
—

Net cash used in investing activities
 
(66,611
)
 
(3,003
)
 
 
 
(744,556
)
 
 
 
 
 
 
 
 
 
Cash flows from financing activities:
 
 
 
 
 
 
 
 
Principal payments on long-term debt
 
(94,880
)
 
(3,609
)
 
 
 
(1,164,237
)
Borrowings of long-term debt
 
62,759

 
—

 
 
 
1,805,966

Payments of debt issuance costs
 
—

 
(4
)
 
 
 
(58,591
)
Proceeds from preferred stock issuance
 
—

 
—

 
 
 
310,000

Payments of stock issuance costs
 
—

 
—

 
 
 
(18,347
)
Payments of preferred dividends
 
(7,810
)
 
—

 
 
 
—

Distributions to non-controlling interest holders
 
(80,091
)
 
(6,444
)
 
 
 
(50,343
)
Payments related to ownership transactions with non-controlling interest holders
 
(483
)
 
30

 
 
 
(1,518
)
Repurchase of shares
 
(1,982
)
 
—

 
 
 
—

Principal payments on financing lease obligations
 
(4,622
)
 
(253
)
 
 
 
(796
)
Other financing activities
 
(1,125
)
 
—

 
 
 
(789
)
Net cash (used in) provided by financing activities
 
(128,234
)
 
(10,280
)
 
 
 
821,345

Net (decrease) increase in cash, cash equivalents and restricted cash
 
(95,791
)
 
(14,505
)
 
 
 
144,507

Cash, cash equivalents and restricted cash at beginning of period
 
175,229

 
214,521

 
 
 
70,014

Cash, cash equivalents and restricted cash at end of period
 
$
79,438

 
$
200,016

 
 
 
$
214,521

See notes to unaudited condensed consolidated financial statements.


5
SURGERY PARTNERS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)


1. Organization, Basis of Presentation and Significant Accounting Policies
Organization
Surgery Partners, Inc., a Delaware corporation, acting through its subsidiaries, owns and operates a national network of surgical facilities and ancillary services. The surgical facilities, which include ambulatory surgery centers ("ASCs") and surgical hospitals, primarily provide non-emergency surgical procedures across many specialties, including, among others, gastroenterology ("GI"), general surgery, ophthalmology, orthopedics and pain management. The surgical hospitals also provide services such as diagnostic imaging, laboratory, obstetrics, oncology, pharmacy, physical therapy and wound care. Ancillary services are comprised of a diagnostic laboratory, multi-specialty physician practices, urgent care facilities, anesthesia services and optical services. Unless context otherwise indicates, Surgery Partners, Inc. and its subsidiaries are referred to herein as the "Company."
As of September 30, 2018, the Company owned or operated a portfolio of 124 surgical facilities, comprised of 106 ASCs and 18 surgical hospitals in 32 states. The Company owns a majority of these facilities in partnership with physicians and, in some cases, healthcare systems in the markets and communities it serves. The Company owned a majority interest in 84 of the surgical facilities and consolidated 105 of these facilities for financial reporting purposes.
Basis of Presentation
The accompanying condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for fair presentation of the Company's financial position and results of operations have been included. The Company’s fiscal year ends on December 31 and interim results are not necessarily indicative of results for a full year or any other interim period. The information contained in these condensed consolidated financial statements should be read in conjunction with the Company’s consolidated financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2017.
The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, as well as interests in partnerships and limited liability companies controlled by the Company through its ownership of a majority voting interest or other rights granted to the Company by contract to manage and control the affiliate's business. All significant intercompany balances and transactions are eliminated in consolidation.
In connection with the change of control effective August 31, 2017, the Company elected to apply “pushdown” accounting by applying the guidance in Accounting Standards Codification Topic ("ASC") 805, Business Combinations. Accordingly, the condensed consolidated financial statements of the Company for periods before and after August 31, 2017 reflect different bases of accounting, and the financial positions and results of operations of those periods are not comparable. Throughout the Company's condensed consolidated financial statements and the accompanying notes herein, periods prior to the change of control are identified as "Predecessor" and periods after the change of control are identified as "Successor." See Note 2. Acquisitions and Developments for further discussion of the change of control.
Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and footnotes. Examples include, but are not limited to, estimates of accounts receivable allowances, professional and general liabilities and the estimate of deferred tax assets or liabilities. Actual results could differ from those estimates.
Variable Interest Entities
The condensed consolidated financial statements include the accounts of variable interest entities ("VIEs") in which the Company is the primary beneficiary under the provisions of ASC 810, Consolidation. The Company has the power to direct the activities that most significantly impact a VIEs economic performance, and the Company would absorb the majority of the expected losses from any of these entities should such expected losses occur. As of September 30, 2018 (Successor), the consolidated VIEs include four surgical facilities, three anesthesia practices and four physician practices. During the nine months ended September 30, 2018 (Successor), the Company divested of one surgical facility and acquired a physician practice, which were classified as VIEs. As of December 31, 2017 (Successor), the consolidated VIEs included five surgical facilities, three anesthesia practices and three physician practices.
The total assets (excluding goodwill and intangible assets, net) of the consolidated VIEs included in the accompanying condensed consolidated balance sheets as of September 30, 2018 (Successor) and December 31, 2017 (Successor), were $6.5 million and $13.1 million, respectively, and the total liabilities of the consolidated VIEs were $3.4 million and $5.8 million, respectively.
Fair Value of Financial Instruments
The fair value of a financial instrument is the amount at which the instrument could be exchanged in an orderly transaction between market participants to sell the asset or transfer the liability. The Company uses fair value measurements based on quoted prices in active


6
SURGERY PARTNERS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)

markets for identical assets or liabilities (Level 1), inputs other than quoted prices in active markets that are either directly or indirectly observable (Level 2), or unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions (Level 3), depending on the nature of the item being valued.
The carrying amounts reported in the condensed consolidated balance sheets for cash and cash equivalents, accounts receivable, restricted invested assets and accounts payable approximate their fair values.
A summary of the carrying amounts and fair values of the Company's long-term debt follows (in thousands):
 
 
Successor
 
 
Carrying Amount
 
Fair Value
 
 
September 30,
2018
 
December 31, 2017
 
September 30,
2018
 
December 31, 2017
2017 Senior Secured Credit Facilities:
 
 
 
 
 
 
 
 
Revolver
 
$
11,000

 
$
—

 
$
11,000

 
$
—

Term Loan
 
$
1,271,397

 
$
1,280,532

 
$
1,272,986

 
$
1,267,189

Senior Unsecured Notes due 2021
 
$
407,372

 
$
409,235

 
$
423,667

 
$
422,535

Senior Unsecured Notes due 2025
 
$
370,000

 
$
370,000

 
$
355,200

 
$
346,413

The fair values of the Term Loan, Senior Unsecured Notes due 2021 and the Senior Unsecured Notes due 2025 were based on a Level 2 inputs using quoted prices for identical liabilities in inactive markets at September 30, 2018 (Successor) and December 31, 2017 (Successor). The carrying amounts related to the Company's other long-term debt obligations, including the Revolver, approximate their fair values.
During the nine months ended September 30, 2018 (Successor), the Company entered into certain derivative financial instruments. A summary of the fair values of the Company's derivative financial instruments follows (in thousands):
 
 
Successor
 
 
Fair Value
 
 
September 30,
2018
 
December 31, 2017
Derivative liabilities
 
 
 
 
Interest rate swap agreement
 
$
1,389

 
$
—

The fair value of the derivative financial instruments was based on a quoted market price, or a Level 2 computation. As of September 30, 2018 (Successor), the fair value of the derivative liabilities was included in other long-term liabilities in the condensed consolidated balance sheets. As of December 31, 2017 (Successor), the Company had no derivative financial instruments.
The Company maintains a supplemental executive retirement savings plan (the "SERP") for certain executives. The SERP is a non-qualified deferred compensation plan for eligible executive officers and other key employees of the Company that allows participants to defer portions of their compensation. The fair value of the SERP asset and liability was based on a quoted market price, or a Level 1 computation. As of both September 30, 2018 (Successor) and December 31, 2017 (Successor), the fair value of both the assets and liabilities in the SERP were $1.6 million and were included in other long-term assets and other long-term liabilities in the condensed consolidated balance sheets.
Revenues
In May 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2014-09, Revenue from Contracts with Customers. The Company adopted the new standard effective January 1, 2018, using the modified retrospective method. The adoption of the new standard did not have an impact on our recognition of net revenues for any periods prior to adoption. The majority of the “Provision for doubtful accounts” will continue to be recognized as an operating expense rather than as a direct reduction to revenues, given the Company’s practice of assessing a patient’s ability to pay prior to or on the date of providing healthcare services. After initial recognition, the Company’s accounts receivables are subject to impairment assessments periodically based on changes in credit risks using historical trends of cash collections, write-offs, accounts receivable agings and other factors.
The Company's revenues generally relate to contracts with patients in which the performance obligations are to provide healthcare services. The Company recognizes revenues in the period in which our obligations to provide health care services are satisfied and reports the amount that reflects the consideration the Company expects to be entitled to. The Company's performance obligations are generally satisfied over a period of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payer (Medicare, Medicaid, managed care health plans, employers and commercial insurance companies, including plans offered through the health insurance exchanges) and the transaction prices for the services provided are dependent upon the terms provided by (Medicare and Medicaid) or negotiated with (managed care health plans, employers and commercial insurance companies) the third-party payers. The payment arrangements with third-party payers for the services provided to the related patients typically specify payments at amounts less than the Company's standard charges.


7
SURGERY PARTNERS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)

Medicare generally pays for services at prospectively determined rates based on clinical, diagnostic and other factors. Services provided to patients having Medicaid coverage are generally paid at prospectively determined rates per discharge, per identified service or per covered member. Agreements with commercial insurance carriers, managed care and preferred provider organizations generally provide for payments based upon predetermined rates per diagnosis, per diem rates or discounted fee-for-service rates. The Company continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.
A summary of revenues by service type as a percentage of total revenues follows:
 
 
Successor
 
 
 
Predecessor
 
Successor
 
 
 
Predecessor
 
 
Three Months Ended September 30,
 
September 1 to September 30,
 
 
 
July 1 to August 31,
 
Nine Months Ended September 30,
 
 
 
January 1 to August 31,
 
 
2018
 
2017
 
 
 
2017
 
2018
 
 
 
2017
Patient service revenues:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   Surgical facilities revenues
 
93.2
%
 
94.0
%
 
 
 
95.5
%
 
93.2
%
 
 
 
91.4
%
   Ancillary services revenues
 
4.7
%
 
4.2
%
 
 
 
2.7
%
 
4.8
%
 
 
 
7.0
%
 
 
97.9
%
 
98.2
%
 
 
 
98.2
%
 
98.0
%
 
 
 
98.4
%
Other service revenues:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   Optical services revenues
 
0.6
%
 
0.7
%
 
 
 
1.1
%
 
0.6
%
 
 
 
1.0
%
   Other revenues
 
1.5
%
 
1.1
%
 
 
 
0.7
%
 
1.4
%
 
 
 
0.6
%
 
 
2.1
%
 
1.8
%
 
 
 
1.8
%
 
2.0
%
 
 
 
1.6
%
Total revenues
 
100.0
%
 
100.0
%
 
 
 
100.0
%
 
100.0
%
 
 
 
100.0
%
Patient service revenues.  This includes revenue related to charging facility fees in exchange for providing patient care. The fee charged for healthcare procedures performed in surgical facilities varies depending on the type of service provided, but usually includes all charges for usage of an operating room, a recovery room, special equipment, medical supplies, nursing staff and medications. The fee does not normally include professional fees charged by the patient’s surgeon, anesthesiologist or other attending physician, which are billed directly by such physicians to the patient or third-party payor. However, in several surgical facilities, the Company charges for anesthesia services. Ancillary service revenues include fees for patient visits to the Company's physician practices, pharmacy services and diagnostic tests ordered by physicians.
Patient service revenues are recognized as performance obligations are satisfied. Performance obligations are based on the nature of services provided. Typically, the Company recognizes revenue at a point in time in which services are rendered and the Company has no obligation to provide further patient services. As the Company primarily performs outpatient procedures, performance obligations are generally satisfied same day and revenue is recognized on the date of service.
The Company determines the transaction price based on gross charges for services provided, net of estimated contractual adjustments, discounts from third-party payors, including Medicare and Medicaid. The Company estimates its contractual adjustments and discounts based on contractual agreements, its discount policies and historical experience. Changes in estimated contractual adjustments and discounts are recorded in the period of change. During the three and nine months ended September 30, 2018 (Successor), the Company recognized an increase in patient service revenues as a result of changes in estimates to third-party settlements related to prior years of approximately $1.4 million for both periods. There were no adjustments as a result of changes in estimates to third-party settlements related to prior years for the one month ended September 30, 2017 (Successor). During the two and eight months ended August 31, 2017 (Predecessor), the Company recognized an increase to patient service revenues as a result of changes in estimates to third-party settlements related to prior years of approximately $0.6 million and $1.1 million, respectively.


8
SURGERY PARTNERS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)

The following table sets forth patient service revenues by type of payor and as a percentage of total patient service revenues for the Company's consolidated surgical facilities (dollars in thousands):
 
 
Successor
 
 
 
Predecessor
 
 
Three Months Ended September 30,
 
September 1 to September 30,
 
 
 
July 1 to August 31,
 
 
2018
 
2017
 
 
 
2017
 
 
Amount
 
%
 
Amount
 
%
 
 
 
Amount
 
%
Patient service revenues:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Private insurance
 
$
230,718

 
53.1
%
 
$
72,930

 
56.2
%
 
 
 
$
80,166

 
46.9
%
Government
 
166,880

 
38.4
%
 
46,162

 
35.5
%
 
 
 
73,734

 
43.1
%
Self-pay
 
12,742

 
2.9
%
 
3,861

 
3.0
%
 
 
 
4,119

 
2.4
%
Other (1)
 
24,345

 
5.6
%
 
6,883

 
5.3
%
 
 
 
12,909

 
7.6
%
Total patient service revenues
 
434,685

 
100.0
%
 
129,836

 
100.0
%
 
 
 
170,928

 
100.0
%
Other service revenues:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Optical services revenues
 
2,699

 
 
 
888

 
 
 
 
 
1,905

 
 
Other revenues
 
6,548

 
 
 
1,534

 
 
 
 
 
1,246

 
 
Total revenues
 
$
443,932

 
 
 
$
132,258

 
 
 
 
 
$
174,079

 
 
 
 
Successor
 
 
 
Predecessor
 
 
Nine Months Ended September 30,
 
September 1 to September 30,
 
 
 
January 1 to August 31,
 
 
2018
 
2017
 
 
 
2017
 
 
Amount
 
%
 
Amount
 
%
 
 
 
Amount
 
%
Patient service revenues:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Private insurance
 
$
682,479

 
53.3
%
 
$
72,930

 
56.2
%
 
 
 
$
360,092

 
48.9
%
Government
 
493,362

 
38.6
%
 
46,162

 
35.5
%
 
 
 
308,993

 
42.0
%
Self-pay
 
39,050

 
3.1
%
 
3,861

 
3.0
%
 
 
 
15,949

 
2.2
%
Other (1)
 
64,075

 
5.0
%
 
6,883

 
5.3
%
 
 
 
51,374

 
6.9
%
Total patient service revenues
 
1,278,966

 
100.0
%
 
129,836

 
100.0
%
 
 
 
736,408

 
100.0
%
Other service revenues:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Optical services revenues
 
8,437

 
 
 
888

 
 
 
 
 
7,629

 
 
Other revenues
 
18,673

 
 
 
1,534

 
 
 
 
 
4,578

 
 
Total revenues
 
$
1,306,076

 
 
 
$
132,258

 
 
 
 
 
$
748,615

 
 
(1)
Other is comprised of anesthesia service agreements, auto liability, letters of protection and other payor types.
Other service revenues. Optical service revenues consist of product sales from the Company's optical laboratories as well as handling charges billed to the members of the Company's optical products purchasing organization. The Company's optical products purchasing organization negotiates volume buying discounts with optical products manufacturers. The buying discounts and any handling charges billed to the members of the buying group represent the revenue recognized for financial reporting purposes. The Company satisfies the performance obligation and recognizes revenue when the orders are shipped to members. The Company bases its estimates for sales returns and discounts on historical experience and has not experienced significant fluctuations between estimated and actual return activity and discounts given. The Company's optical laboratories manufacture and distribute corrective lenses and eyeglasses to ophthalmologists and optometrists. The Company satisfies the performance obligation and recognize revenue when the product is shipped, net of allowance for discounts.
Other revenues include management and administrative service fees derived from the non-consolidated facilities that the Company accounts for under the equity method, management of surgical facilities in which it does not own an interest, and management services provided to physician practices for which the Company is not required to provide capital or additional assets. These agreements typically require the Company to provide recurring management services over a multi-year period which are billed and collected on a monthly basis. The fees derived from these management arrangements are based on a predetermined percentage of the revenues of each facility or practice and are recognized in the period in which management services are rendered and billed.


9
SURGERY PARTNERS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)

Cash, Cash Equivalents and Restricted Cash
The following table reconciles cash, cash equivalents and restricted cash reported within the condensed consolidated balance sheets to the totals shown within the condensed consolidated statement of cash flows (in thousands):
 
 
Successor
 
 
September 30,
2018
 
December 31,
2017
 
 
 
 
 
Cash and cash equivalents
 
$
79,123

 
$
174,914

Restricted invested assets included in other long-term assets
 
315

 
315

Total cash, cash equivalents and restricted cash in the statement of cash flows
 
$
79,438

 
$
175,229

Restricted invested assets included in other long-term assets on the condensed consolidated balance sheet represents restricted cash held in accordance with the provisions of the operating lease agreement at the Company's Chesterfield, Missouri facility. The Company has a deposit with the landlord that shall be held as security for performance under the Company's covenants and obligations within the agreement through January 2024.
Accounts Receivable and Allowances for Contractual Adjustments and Doubtful Accounts
With the Company's adoption of ASC 2014-09 on January 1, 2018, for those accounts in which the Company has an unconditional right to payment, subject only to the passage of time, the right is recorded as a receivable. Accounts receivable are recorded net of contractual adjustments and allowances for doubtful accounts to reflect accounts receivable at net realizable value. Accounts receivable consists of receivables from federal and state agencies (under the Medicare and Medicaid programs), managed care health plans, commercial insurance companies, employers and patients. Management recognizes that revenues and receivables from government agencies are significant to the Company's operations, but it does not believe that there is significant credit risk associated with these government agencies. Concentration of credit risk with respect to other payors is limited because of the large number of such payors. The Company had a net third-party Medicaid settlements liability of $7.7 million and $1.0 million as of September 30, 2018 (Successor) and December 31, 2017 (Successor), respectively, included in other current liabilities in the condensed consolidated balance sheets.
The Company recognizes that final reimbursement of accounts receivable is subject to final approval by each third-party payor. However, because the Company has contracts with its third-party payors and also verifies insurance coverage of the patient before medical services are rendered, the amounts that are pending approval from third-party payors are not considered significant. The Company's policy is to collect co-payments and deductibles prior to providing medical services. It is also the Company's policy to verify a patient’s insurance prior to the patient’s procedure. Patient services of the Company are primarily non-emergency, which allows the surgical facilities to control the procedures for which third-party reimbursement is sought and obtained. The Company does not require collateral from self-pay patients.
The Company analyzes accounts receivable at each of its facilities to ensure the proper aged category and collection assessment. At a consolidated level, the Company's policy is to review accounts receivable aging, by facility, to determine the appropriate allowance for doubtful accounts. Patient account balances are reviewed for delinquency based on contractual terms. This review is supported by an analysis of the actual revenues, contractual adjustments and cash collections received. An account balance is written off only after the Company has pursued collection with legal or collection agency assistance or otherwise has deemed an account to be uncollectible.
The receivables related to the Company's optical products purchasing organization are recognized separately from patient accounts receivable, as discussed above, and are included in other current assets in the condensed consolidated balance sheets. Such receivables were $9.3 million and $7.6 million at September 30, 2018 (Successor) and December 31, 2017 (Successor), respectively.
Goodwill
Goodwill represents the fair value of the consideration provided in an acquisition over the fair value of net assets acquired and is not amortized. Additions to goodwill include amounts resulting from new business combinations and incremental ownership purchases in the Company's subsidiaries. A summary of the Company's acquisitions for the nine months ended September 30, 2018 is included in Note 2. Acquisitions and Developments.
A summary of activity related to goodwill for the nine months ended September 30, 2018 (Successor) follows (in thousands):
Successor
 
 
Balance at December 31, 2017
 
$
3,346,838

Acquisitions, including post acquisition adjustments
 
57,710

Divestitures and deconsolidations
 
(31,942
)
Balance at September 30, 2018
 
$
3,372,606



10
SURGERY PARTNERS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)

Other Current Liabilities
A summary of other current liabilities follows (in thousands):
 
 
Successor
 
 
September 30,
2018
 
December 31,
2017
 
 
 
 
 
Interest payable
 
$
28,322

 
$
20,537

Amounts due to patients and payors
 
22,400

 
18,096

Accrued expenses and other
 
72,216

 
71,311

Total
 
$
122,938

 
$
109,944

Other Long-Term Liabilities
A summary of other long-term liabilities follows (in thousands):
 
 
Successor
 
 
September 30,
2018
 
December 31,
2017
 
 
 
 
 
Facility lease obligations
 
$
138,116

 
$
121,627

Other
 
109,195

 
100,853

Total
 
$
247,311

 
$
222,480

At four of the Company's surgical facilities, the Company has financing obligations payable to the lessors of certain land, buildings and improvements. Payments are allocated to principal adjustments of the financing obligations and interest expense. The current portions of the financing obligations were $6.8 million and $6.3 million at September 30, 2018 (Successor) and December 31, 2017 (Successor), respectively, and were included in other current liabilities in the condensed consolidated balance sheets. The long-term portions of the financing obligations are included as facility lease obligations in the table above.
In 2017, one of the Company's surgical facilities entered into a development agreement to construct a new hospital. Due to certain provisions of the agreement, the surgical facility is deemed the owner during construction, and as such, the Company records the ongoing costs as incurred as a deferred financing obligation. As of September 30, 2018 (Successor), the Company has recorded a total of $36.7 million of costs for this project, of which $23.1 million was recorded during the nine months ended September 30, 2018 (Successor). These project costs are included as non-cash additions to property and equipment, net in the condensed consolidated balance sheet and as a component of facility lease obligations.
Derivative Instruments and Hedging Activities
In accordance with ASC 815, Derivatives and Hedging (“ASC 815”), the Company records all derivatives on the balance sheet at fair value. The accounting for changes in the fair value of derivatives depends on the intended use of the derivative, whether the Company has elected to designate a derivative in a hedging relationship and apply hedge accounting and whether the hedging relationship has satisfied the criteria necessary to apply hedge accounting. Hedge accounting generally provides for the matching of the timing of gain or loss recognition on the hedging instrument with the recognition of the changes in the fair value of the hedged asset or liability that are attributable to the hedged risk in a fair value hedge or the earnings effect of the hedged forecasted transactions in a cash flow hedge. The Company may enter into derivative contracts that are intended to economically hedge certain of its risk, even though hedge accounting does not apply or the Company elects not to apply hedge accounting.
In accordance with the FASB’s fair value measurement guidance in ASU 2011-04, the Company made an accounting policy election to measure the credit risk of its derivative financial instruments that are subject to master netting agreements on a net basis by counterparty portfolio.
Non-Controlling Interests—Redeemable
Each partnership and limited liability company through which the Company owns and operates its surgical facilities is governed by a partnership or operating agreement, respectively. In certain circumstances, the applicable partnership or operating agreements for the Company's surgical facilities provide that the facilities will purchase all of the physician limited partners’ or physician minority members’, as applicable, ownership if certain adverse regulatory events occur, such as it becoming illegal for the physician(s) to own an interest in a surgical facility, refer patients to a surgical facility or receive cash distributions from a surgical facility. The non-controlling interests—redeemable are reported outside of stockholders' equity in the condensed consolidated balance sheets.


11
SURGERY PARTNERS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)

A summary of activity related to the non-controlling interests—redeemable follows (in thousands):
Successor
 
 
Balance at December 31, 2017
 
$
299,316

Net income attributable to non-controlling interests—redeemable
 
20,528

Acquisition and disposal of shares of non-controlling interests, net—redeemable (1)
 
20,279

Distributions to non-controlling interest—redeemable holders
 
(22,582
)
Balance at September 30, 2018
 
$
317,541

(1)
Includes post acquisition date adjustments.
Recent Accounting Pronouncements
In May 2014, the FASB issued ASU 2014-09, "Revenue from Contracts with Customers," along with subsequent amendments, updates and an extension of the effective date (collectively the "New Revenue Standard"), which outlines a single comprehensive model for recognizing revenue and supersedes most existing revenue recognition guidance, including guidance specific to the healthcare industry. This five-step process requires significant management judgment in addition to changing the way many companies recognize revenue in their financial statements. The Company adopted this ASU on January 1, 2018 using the modified retrospective approach. The adoption of this standard did not have a significant impact on the recognition of net revenues for any period. Adoption of the standard resulted in the Company revising its related disclosures.
In February 2016, the FASB issued ASU 2016-02, "Leases," which will require, among other items, lessees to recognize most leases as assets and liabilities on the balance sheet. Qualitative and quantitative disclosures will be enhanced to better understand the amount, timing and uncertainty of cash flows arising from leases. This guidance is effective for financial statements issued for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years, with early adoption permitted. The guidance is required to be applied using a modified retrospective transition approach for leases existing at, or entered into after, the beginning of the earliest comparative periods presented in the financial statements. In preparation of adopting the new standard, the Company has engaged outside consultants to assist in the identification of the Company's population of leases, implementing a new software for lease accounting and assisting in evaluating new accounting policy elections. The Company will adopt this ASU on January 1, 2019 and believes the primary effect of adopting the new standard will be to record right-of-use assets and obligations for current operating leases with material increases in reported property and equipment and liabilities. The Company is still evaluating the effect of adoption on financial disclosures, policies, procedures and control framework.
In November 2016, the FASB issued ASU 2016-18, "Statement of Cash Flows – Restricted Cash," which requires that a statement of cash flows explain the change during the period in the total of cash, cash equivalents, and amounts generally described as restricted cash or restricted cash equivalents. ASU 2016-18 is effective for fiscal years beginning after December 15, 2017, including interim periods within those years. The Company adopted this ASU on January 1, 2018 and retrospectively applied the guidance to all periods presented in the condensed consolidated statement of cash flows. The retrospective application to prior periods had no impact on the Company's cash flows from operating, investing and financing activities as previously disclosed. The adoption of this ASU resulted in the modification of the Company's presentation of the reconciliation of beginning-of-period and end-of-period total amounts shown on the condensed consolidated statement of cash flows to include restricted cash as discussed under the heading "Cash and Cash Equivalents" above.
2. Acquisitions and Developments
The Company accounts for its business combinations in accordance with the fundamental requirements of the acquisition method of accounting and under the premise that an acquirer can be identified for each business combination. The acquirer is the entity that obtains control of one or more businesses in the business combination and the acquisition date is the date the acquirer achieves control. The assets acquired, liabilities assumed and any non-controlling interests in the acquired business at the acquisition date are recognized at their fair values as of that date, and the direct costs incurred in connection with the business combination are recorded and expensed separately from the business combination. Any goodwill recognized is determined as the excess of the fair value of the consideration conveyed plus the fair value of any non-controlling interests in the acquisition over the fair value of the net assets acquired. Acquisitions in which the Company is able to exert significant influence but does not have control are accounted for using the equity method.
Acquired assets and assumed liabilities typically include, but are not limited to, fixed assets, intangible assets and professional liabilities. The valuations are based on appraisal reports, discounted cash flow analyses, actuarial analyses or other appropriate valuation techniques to determine the fair value of the assets acquired or liabilities assumed. Fair value attributable to non-controlling interests is based on a Level 3 computation using significant inputs that are not observable in the market. Key inputs used to determine the fair value include financial multiples used in the purchase of non-controlling interests, primarily from acquisitions of surgical facilities. Such multiples, based on earnings, are used as a benchmark for the discount to be applied for the lack of control or marketability. Fair value attributable to the property and equipment acquired is based on Level 3 computations using key inputs such as cost trend data and comparable asset sales. Fair value attributable to the intangible assets acquired is based on Level 3 computations using key inputs such as the Company's internally-prepared financial projections. Fair values assigned to acquired working capital are based on carrying amounts reported by the acquiree at the date of acquisition, which approximate their fair values. The preliminary estimated fair value assigned to goodwill is primarily attributable to the acquisitions


12
SURGERY PARTNERS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)

favorable reputations in their markets, their market positions and their ability to deliver quality care with high patient satisfaction consistent with the Company's business model.
Acquisitions
During the nine months ended September 30, 2018 (Successor), the Company acquired a controlling interest in two surgical facilities in new markets, a surgical facility in an existing market, which was merged into an existing facility and a physician practice for a combined cash purchase price of $32.9 million, net of cash acquired. The Company also acquired a controlling interest in an integrated physician practice, including multiple practice and surgical facility locations, in an existing market for a purchase price of $21.1 million, net of cash acquired. The purchase price for the 2018 acquisitions was funded through cash from operations. The total consideration related to these acquisitions was allocated to the assets acquired and liabilities assumed based upon their respective acquisition date fair values.
The aggregate amounts preliminarily recognized for each major class of assets acquired and liabilities assumed for acquisitions completed in the nine months ended September 30, 2018 (Successor), including post acquisition date adjustments, are as follows (in thousands):
Cash consideration
 
$
54,308

Fair value of non-controlling interests
 
28,776

Aggregate acquisition date fair value
 
$
83,084

Net assets acquired:
 
 
Current Assets
 
$
4,708

Property and equipment
 
2,301

Goodwill
 
75,947

Other long-term assets
 
3,460

Current liabilities
 
(2,332
)
Long-term liabilities
 
(1,000
)
Aggregate acquisition date fair value
 
$
83,084

The fair values assigned to certain assets and liabilities assumed by the Company have been estimated on a preliminary basis and are subject to change as new facts and circumstances emerge that were present at the date of acquisition. The goodwill acquired in connection with the 2018 acquisitions was allocated to the Company's reportable segments as follows: $68.6 million to surgical facility services and $7.4 million to ancillary services. Approximately $49.9 million of goodwill recorded for the 2018 acquisitions is deductible for tax purposes. The results of operations of the acquisitions are included in the Company’s results of operations beginning on the dates of acquisitions, and were not considered significant for the nine months ended September 30, 2018 (Successor).
During the one month ended September 30, 2017 (Successor), the Company completed acquisitions in existing markets of one physician practice and the assets of an endoscopy practice for a combined purchase price of $1.2 million. During the eight months ended August 31, 2017 (Predecessor), the Company completed acquisitions (excluding the NSH Holdco, Inc. acquisition) in existing markets of three physician practices for a combined cash purchase price of $14.2 million. During the nine months ended September 30, 2018 (Successor), no significant changes were made to the purchase price allocation of assets and liabilities, existing at the date of acquisition, related to individual acquisitions completed in 2017, excluding the acquisition of NSH as discussed below.
2018 Disposals and Deconsolidation
During the nine months ended September 30, 2018 (Successor), the Company sold its interests in three surgery centers and its optical laboratory for net cash proceeds of $17.6 million, and recognized a net pretax loss of $9.5 million included in loss on disposals and deconsolidations, net in the condensed consolidated statement of operations for the three and nine months ended September 30, 2018 (Successor). This non-cash loss was primarily a result of the write-off of the net assets of the facility (net of proceeds received) and was primarily driven by the write-off of the associated goodwill.
During the nine months ended September 30, 2018 (Successor), the Company sold a portion of its interest in one surgery center for net cash proceeds of $0.5 million. As a result of this transaction, the Company lost control of the previously controlled entity but retains a noncontrolling interest, resulting in the deconsolidation of the previously consolidated entity. The remaining noncontrolling interest was accounted for as an equity method investment, and initially measured and recorded at fair value as of the date of the transaction.
The fair value measurement utilizes Level 3 inputs, which include unobservable data, to measure the fair value of the retained noncontrolling interest. The fair value determination was based on a combination of multiple valuation methods, which included discounted cash flow and market value approach, which incorporates estimates of future earnings and market valuation multiples for certain guideline companies. The fair value of the investment of $2.0 million was recorded as a component of investments in and advances to affiliates in the accompanying condensed consolidated balance sheets.


13
SURGERY PARTNERS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)

Further, the transaction resulted in a pretax gain on deconsolidation of $1.1 million, which is included in loss on disposals and deconsolidations, net, in the accompanying condensed consolidated statement of operations for the three and nine months ended September 30, 2018 (Successor). The gain was determined based on the difference between the fair value of the Company's retained interest in the entity and the carrying value of both the tangible and intangible assets of the entity immediately prior to the transaction less cash proceeds received.
Acquisition of NSH
On August 31, 2017 (Predecessor), the Company completed its acquisition of NSH Holdco, Inc. (“NSH”) for total cash consideration of $711.7 million, net of cash acquired, including $19.6 million funded to an escrow account. During the nine months ended September 30, 2018 (Successor), information existing at the acquisition date became known to the Company as part of its continuing evaluation of the assets and liabilities existing at the date of acquisition, resulting in a net increase to goodwill of $1.1 million. The corresponding changes to certain classes of assets and liabilities from the preliminary allocation recorded at August 31, 2017 (Predecessor), are reflected in the table below, which has been finalized as of September 30, 2018 (Successor). The increase to goodwill during the period includes a working capital settlement payment resulting in additional cash consideration of $1.2 million.
The acquisition date fair value for each major class of assets acquired and liabilities assumed, including post acquisition date adjustments, are as follows (in thousands):
Cash consideration
 
$
764,007

Fair value of non-controlling interests
 
325,965

Acquisition date fair value
 
$
1,089,972

Net assets acquired:
 
 
Cash and cash equivalents
 
$
51,159

Accounts receivable
 
71,639

Inventories
 
14,986

Prepaid expenses and other current assets
 
18,367

Property and equipment
 
174,100

Intangible assets
 
27,881

Goodwill
 
871,373

Investments in and advances to affiliates
 
29,737

Long-term deferred tax assets
 
20,212

Other long-term assets
 
26,988

Accounts payable
 
(29,652
)
Accrued payroll and benefits
 
(30,853
)
Other current liabilities
 
(23,937
)
Current maturities of long-term debt
 
(16,416
)
Long-term debt, less current maturities
 
(42,770
)
Other long-term liabilities
 
(72,842
)
Acquisition date fair value
 
$
1,089,972

Change of Control - Pushdown Accounting
On August 31, 2017, BCPE Seminole Holdings LP (“Bain”), a fund advised by an affiliate of Bain Capital Private Equity, completed its purchase of 26,455,651 shares of the Company's common stock at a purchase price of $19.00 per share in cash (the “Private Sale”). As a result of the Private Sale and the Preferred Private Placement (defined in Note 4. Redeemable Preferred Stock), Bain became the controlling stockholder of the Company, holding preferred and common stock that collectively represent approximately 65.7% of the voting power of all classes of capital stock of the Company as of August 31, 2017. In connection with this change of control, the Company elected to apply “pushdown” accounting by applying the guidance in ASC 805, Business Combinations. In accordance with ASC 805, all identifiable assets and liabilities of the Company were measured at and adjusted to fair value as of August 31, 2017, and similarly goodwill was recognized based on the terms of the transaction and the fair value of the new basis of the net assets of the Company.
During the nine months ended September 30, 2018 (Successor), information existing at the transaction date became known to the Company as part of its evaluation of the assets and liabilities existing at August 31, 2017, resulting in a net decrease to goodwill of $18.2 million and corresponding changes to certain classes of assets and liabilities from the preliminary allocation recorded, that are reflected in the table below, which has been finalized as of September 30, 2018 (Successor).


14
SURGERY PARTNERS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)

The transaction date fair value recognized in connection with the application of pushdown accounting for each major class of assets and liabilities as of August 31, 2017, including post transaction date adjustments, are as follows (in thousands):
Equity attributable to Surgery Partners, Inc.
$
721,764

Redeemable preferred stock
310,000

Fair value of non-controlling interests
939,083

Transaction date fair value
$
1,970,847

Net assets:
 
Cash and cash equivalents
214,206

Accounts receivable
252,911

Inventories
44,310

Prepaid expenses and other current assets
61,438

Property and equipment
379,685

Intangible assets
63,978

Goodwill
3,281,728

Investments in and advances to affiliates
75,113

Restricted invested assets
315

Long-term deferred tax asset
206,073

Other long-term assets
50,666

Accounts payable
(64,921
)
Accrued payroll and benefits
(56,535
)
Other current liabilities
(97,617
)
Current maturities of long-term debt
(49,942
)
Long-term debt, less current maturities
(2,142,375
)
Long-term tax receivable agreement liability
(78,498
)
Other long-term liabilities
(169,688
)
Transaction date fair value
$
1,970,847

The post transaction date adjustments for pushdown accounting during the period includes a net increase of $3.9 million to the preliminary amounts assigned to intangible assets. The remaining adjustments to goodwill are attributable to a $17.9 million decrease to the preliminary fair value assigned to non-controlling interests, a $1.1 million increase related to the Acquisition of NSH (discussed above), and a $2.5 million increase to other long-term liabilities.


15
SURGERY PARTNERS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)

3. Long-Term Debt
A summary of long-term debt follows (in thousands):
 
 
Successor
 
 
September 30,
2018
 
December 31,
2017
 
 
 
 
 
2017 Senior Secured Credit Facilities:
 
 
 
 
Revolver
 
$
11,000

 
$
—

Term Loan (1)
 
1,271,397

 
1,280,532

Senior Unsecured Notes due 2021 (2)

407,372

 
409,235

Senior Unsecured Notes due 2025
 
370,000

 
370,000

Notes payable and secured loans
 
88,068

 
101,921

Capital lease obligations
 
24,836

 
27,594

Total debt
 
2,172,673

 
2,189,282

Less: Current maturities
 
54,106

 
58,726

Total long-term debt
 
$
2,118,567

 
$
2,130,556

(1)
In connection with the application of pushdown accounting, the Company remeasured and recorded the Term Loan at fair value using a measurement date of August 31, 2017. The fair value was based on a Level 2 input using quoted prices for identical liabilities in inactive markets. As a result, the Company recorded a fair value discount as of the measurement date, which is reported in the consolidated balance sheets as a direct rededuction from the face amount the Term Loan and amortized to interest expense over the life of the Term Loan. The unamortized fair value discount as of September 30, 2018 (Successor) and December 31, 2017 (Successor) was $5.7 million and $6.2 million, respectively.
(2)
In connection with the application of pushdown accounting, the Company remeasured and recorded the Senior Unsecured Notes due 2021 at fair value using a measurement date of August 31, 2017. The fair value was based on a Level 2 input using quoted prices for identical liabilities in inactive markets. As a result, the Company recorded a fair value premium as of the measurement date, which is reported in the consolidated balance sheets as a direct addition to the face amount the notes and amortized to interest expense over the life of the Senior Unsecured Notes due 2021. The unamortized fair value premium as of September 30, 2018 (Successor) and December 31, 2017 (Successor) was $7.4 million and $9.2 million, respectively.
4. Redeemable Preferred Stock
On August 31, 2017 (Predecessor), the Company issued 310,000 shares of Series A Preferred Stock to Bain at a purchase price of $1,000 per share for an aggregate purchase price of $310.0 million (the "Preferred Private Placement"). The net proceeds from the issuance were used to finance a portion of the NSH acquisition.
A summary of activity related to the redeemable preferred stock follows (in thousands):
Successor
 
 
Balance at December 31, 2017
 
$
330,806

Dividends accrued
 
23,973

Cash dividends declared
 
(3,886
)
Balance at September 30, 2018
 
$
350,893

There were no unpaid cash dividends declared at September 30, 2018 (Successor). The cash dividends declared but unpaid at December 31, 2017 (Successor) was $3.9 million, and were included in other current liabilities in the condensed consolidated balance sheet. The aggregate and per share amounts of unpaid cumulative preferred dividends as of September 30, 2018 (Successor) were $25.3 million and $81.70, respectively.
5. Derivatives and Hedging Activities
Cash Flow Hedges of Interest Rate Risk
The Company’s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish this objective, the Company primarily uses interest rate swaps as part of its interest rate risk management strategy. During 2018, such derivatives were used to hedge the variable cash flows associated with existing variable-rate debt.
For derivatives designated and that qualify as cash flow hedges of interest rate risk, the gain or loss on the derivative is recorded in Accumulated Other Comprehensive Income and subsequently reclassified into interest expense in the same period(s) during which the hedged transaction affects earnings, as documented at hedge inception in accordance with the Company’s accounting policy election. The earnings


16
SURGERY PARTNERS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)

recognition of excluded components is presented in interest expense. Amounts reported in accumulated other comprehensive income related to derivatives will be reclassified to interest expense as interest payments are made on the Company’s variable-rate debt. Over the next 12 months, the Company estimates that an additional $1.1 million will be reclassified as a reduction to interest expense.
As of September 30, 2018 (Successor), the Company had one interest rate swap with a current notional amount of $330.0 million and a termination date of November 30, 2023. The Company had no derivative instruments as of December 31, 2017 (Successor).
The Company classifies its derivative financial instruments of $1.4 million as a long-term liability on the Balance Sheet as of September 30, 2018 (Successor). The Company had no derivative financial instruments as of December 31, 2017 (Successor).
The table below presents the effect of fair value and cash flow hedge accounting on the Company's consolidated balance sheets.
 
 
Successor
 
 
 
Predecessor
 
Successor
 
 
 
Predecessor
 
 
Three Months Ended September 30,
 
September 1 to September 30,
 
 
 
July 1 to August 31,
 
Nine Months Ended September 30,
 
 
 
January 1 to August 31,
 
 
2018
 
2017
 
 
 
2017
 
2018
 
 
 
2017
Derivatives in Cash Flow Hedging Relationships
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Losses related to effective portion of derivatives recognized in accumulated OCI, gross of tax effect
 
$
(1,389
)
 
$
—

 
 
 
$
—

 
$
(1,389
)
 
 
 
$
—

Loss related to effective portion of derivatives reclassified from accumulated OCI to interest expense, gross of tax effect
 
—

 
—

 
 
 
—

 
—

 
 
 
—

6. Earnings Per Share
Basic and diluted earnings per share are calculated in accordance with ASC 260, Earnings Per Share, based on the weighted-average number of shares outstanding in each period and dilutive stock options, unvested shares and warrants, to the extent such securities exist and have a dilutive effect on earnings per share. Beginning in the Successor period, in connection with the issuance of the Series A Preferred Stock, the Company began computing basic and diluted earnings per share using the two-class method. The two-class method of computing earnings per share is an earnings allocation method that determines earnings per share for common shares and participating securities according to their participation rights in dividends and undistributed earnings.


17
SURGERY PARTNERS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)

A reconciliation of the numerator and denominator of basic and diluted earnings per share follows (in thousands except share and per share amounts):
 
 
Successor
 
 
 
Predecessor
 
Successor
 
 
 
Predecessor
 
 
Three Months Ended September 30,
 
September 1 to September 30,
 
 
 
July 1 to August 31,
 
Nine Months Ended September 30,
 
 
 
January 1 to August 31,
 
 
2018
 
2017
 
 
 
2017
 
2018
 
 
 
2017
Numerator:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net loss attributable to Surgery Partners, Inc.
 
$
(20,981
)
 
$
(9,140
)
 
 
 
$
(4,444
)
 
$
(57,964
)
 
 
 
$
(11,669
)
Less: amounts allocated to participating securities (1)
 
8,245

 
2,633

 
 
 
—

 
23,973

 
 
 
—

Less: mark to redemption adjustment
 
—

 
15,566

 
 
 
—

 
—

 
 
 
—

Net loss attributable to common stockholders
 
$
(29,226
)
 
$
(27,339
)
 
 
 
$
(4,444
)
 
$
(81,937
)
 
 
 
$
(11,669
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Denominator:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Weighted average shares outstanding- basic
 
48,037,634

 
48,314,746

 
 
 
48,146,611

 
48,020,369

 
 
 
48,121,404

Effect of dilutive securities (2)
 
—

 
—

 
 
 
—

 
—

 
 
 
—

Weighted average shares outstanding- diluted
 
48,037,634

 
48,314,746

 
 
 
48,146,611

 
48,020,369

 
 
 
48,121,404

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Loss per share:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Basic
 
$
(0.61
)
 
$
(0.57
)
 
 
 
$
(0.09
)
 
$
(1.71
)
 
 
 
$
(0.24
)
Diluted (2)
 
$
(0.61
)
 
$
(0.57
)
 
 
 
$
(0.09
)
 
$
(1.71
)
 
 
 
$
(0.24
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dilutive securities outstanding not included in the computation of (loss) earnings per share as their effect is antidilutive:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Stock options
 
144,795

 
—

 
 
 
—

 
153,884

 
 
 
—

Restricted shares
 
134,054

 
112,529

 
 
 
34,506

 
140,552

 
 
 
105,944

Convertible preferred stock
 
—

 
—

 
 
 
N/A

 
—

 
 
 
N/A

(1) 
Includes dividends accrued during the Successor periods for the Series A Preferred Stock. The Series A Preferred Stock does not participate in undistributed losses. There were no participating securities during the Predecessor periods.
(2) 
The impact of potentially dilutive securities for all periods presented was not considered because the effect would be anti-dilutive in each period.
Share Repurchase Transactions
On December 15, 2017 (Successor), the Company's Board of Directors authorized a share repurchase program of up to $50.0 million of the Company's issued and outstanding common stock from time to time. The timing and size of repurchases will be determined based on market conditions and other factors. The authorization does not obligate the repurchase of any shares and the Company may repurchase shares of common stock at any time without prior notice. The share repurchases will be made in accordance with applicable securities laws in open market or privately negotiated transactions. The authorization does not have a specified expiration date, and the share repurchase program may be suspended, recommenced or discontinued at any time or from time to time without prior notice.
There were no share repurchases under the share repurchase program during the three months ended September 30, 2018 (Successor). During the nine months ended September 30, 2018 (Successor), the Company repurchased 156,818 shares of its common stock stock at an average price of $12.64 per share through market purchases. At September 30, 2018 (Successor), the Company had $46.0 million of repurchase authorization available under the December 2017 authorization.
7. Income Taxes
The Company uses the asset and liability method to account for income taxes. Under this method, deferred income tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. If a net operating loss ("NOL") or Section 163(j) interest (“163(j)”) carryforward exists, the Company makes a determination as to whether the NOL or 163(j) carryforward will be utilized in the future. A valuation allowance is established for certain carryforwards when their recoverability is deemed to be uncertain. The carrying value of the net deferred tax assets assumes that the Company will be able to generate sufficient future taxable income in certain tax jurisdictions, based on estimates and assumptions. If these estimates and related assumptions change in the future, the Company may be required to adjust its deferred tax valuation allowances.


18
SURGERY PARTNERS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)

The Company and certain of its subsidiaries file a consolidated federal income tax return. The partnerships, limited liability companies, and certain non-consolidated physician practice corporations also file separate income tax returns. The Company's allocable portion of each partnership's and limited liability company's income or loss is included in taxable income of the Company. The remaining income or loss of each partnership and limited liability company is allocated to the other owners.
The Company, or one or more of its subsidiaries, files income tax returns in the U.S. federal jurisdiction and various state jurisdictions. With few exceptions, the Company is no longer subject to U.S. federal income tax examinations for years prior to 2015 or state income tax examinations for years prior to 2014.
Section 382 (“Section 382”) of the Internal Revenue Code of 1986, as amended (the “Code”) imposes an annual limit on the ability of a corporation that undergoes an “ownership change” to use its NOLs to reduce its tax liability. An “ownership change” is generally defined as any change in ownership of more than 50.0% of a corporation’s “stock” by its “5-percent shareholders” (as defined in Section 382) over a rolling three-year period based upon each of those shareholder’s lowest percentage of stock owned during such period. As a result of the Symbion acquisition, approximately $179.0 million in NOL carryforwards are subject to an annual Section 382 base limitation of $4.9 million, and, as a result of the NovaMed acquisition, approximately $17.0 million in NOL carryforwards are subject to an annual Section 382 base limitation of $4.9 million. As a result of the NSH acquisition, approximately $20.5 million in NOL carryforwards are subject to an annual Section 382 base limitation of $2.8 million. The Private Sale resulted in an ownership change as defined in Section 382. As a result, approximately $449.7 million in NOL carryforwards are subject to an annual Section 382 base limitation of $14.2 million. At this time, the Company does not believe this limitation, when combined with amounts allowable due to net unrecognized built in gains, will affect its ability to use any NOLs before they expire. However, no such assurances can be provided. If the Company's ability to utilize its NOLs to offset taxable income generated in the future is subject to this limitation, it could have an adverse effect on the Company's business, prospects, results of operations and financial condition.
The Tax Cuts and Jobs Act (the "Tax Act") was enacted on December 22, 2017. The Tax Act reduced the US federal corporate tax rate from 35% to 21%, allows for 100% expensing of qualified capital expenditures, and limits interest expense deductions beginning in 2018.
The Company's accounting for the Tax Act is incomplete. As of the year ended December 31, 2017 (Successor), the Company was able to reasonably estimate certain effects and, therefore, recorded a provisional adjustment associated with the tax rate change (as discussed further in the 2017 form 10-K). The Company has not made any additional measurement-period adjustments to this item during the nine months ended September 30, 2018. The Company completed its the accounting for its 2017 temporary book/tax differences when it filed its 2017 federal tax return during the third quarter. However, the Company requires additional time to complete the analysis of the tax impact of the deferred re-measurement and record the adjustment. The Company expects to complete the accounting within the prescribed measurement period.
For the following tax reform items, the Company was able to reasonably estimate certain effects of the Tax Act in the nine months ended September 30, 2018 and, therefore, recorded provisional adjustments as follows:
Interest Expense Limitation: Under the Tax Act, interest expense is limited to 30% of the Company’s adjusted taxable income beginning in 2018 resulting in a temporary book to tax difference. Any disallowed interest expense is carried forward indefinitely. The Company was able to reasonably estimate the interest limitation and recorded an estimate for the disallowed interest expense. The provisional amount of disallowed interest expense as of September 30, 2018 is $69.8 million. The Company has recorded a valuation allowance of $11.4 million on a tax-effected basis against the deferred tax asset resulting from the disallowed interest expense. However, the Company is continuing to gather additional information to more precisely compute the amount of the interest limitation, and the accounting for this item is not yet complete as the Company is waiting for additional guidance to be released around the application of the law. The Company expects to complete its accounting within the prescribed measurement period.
100% Bonus Depreciation: Qualified capital expenditures placed in service after September 27, 2017 are eligible for 100% expensing under the Tax Act. The Company was able to reasonably estimate the 100% bonus depreciation expense and made a provisional estimate. However, the Company is continuing to gather additional information to more precisely compute the amount of 100% bonus depreciation, and the accounting for this item is not yet complete because the Company needs additional time to complete an accurate and thorough analysis of its fixed assets. The Company expects to complete its accounting within the prescribed measurement period.
The Company's effective tax rate was 48.8% for the nine months ended September 30, 2018 (Successor), compared to 7.4% for the one month ended September 30, 2017 (Successor) and (146.7)% for the eight months ended August 31, 2018 (Predecessor). The increase in the effective tax rate was primarily due to the Tax Act, which implemented an interest expense limitation resulting in a deferred tax asset that required a valuation allowance to be reported at its net realizable value. The Company recorded additional tax expense in 2018 to account for the gain on divestitures and valuation allowances on state tax attributes resulting from legislative changes enacted during the second quarter. The effective tax rate was further impacted by the Tax Act due to the reduced the U.S. federal corporate income tax rate, as discussed above, effective January 1, 2018.
8. Commitments and Contingencies
Professional, General and Workers' Compensation Liability Risks
The Company is subject to claims and legal actions in the ordinary course of business, including claims relating to patient treatment, employment practices and personal injuries. The Company maintains general liability and professional liability insurance in excess of self-


19
SURGERY PARTNERS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)

insured retentions, on a claims-made basis through third party commercial insurance carriers. Although management believes the coverage is sufficient for the Company's operations, some claims may potentially exceed the scope of coverage in effect. The Company also maintains workers' compensation insurance, subject to a deductible. Plaintiffs in these matters may request punitive or other damages that may not be covered by insurance. The Company is not aware of any such proceedings that are reasonably possible to have a material adverse effect on the Company's business, financial position, results of operations or liquidity.
Insurance Reserves
The Company expenses the costs under the self-insured retention exposure for general and professional liability and workers' compensation claims which relate to (i) claims made during the policy period, which are offset by insurance recoveries and (ii) an estimate of claims incurred but not yet reported that are expected to be reported after the policy period expires. Reserves and provisions are based upon periodic actuarially determined estimates. The reserves are estimated using individual case-basis valuations and actuarial analysis. Reserves for professional, general and workers' compensation claim liabilities are determined with no regard for expected insurance recoveries and are presented gross on the condensed consolidated balance sheets. Total professional, general and workers' compensation claim liabilities as of September 30, 2018 (Successor) and December 31, 2017 (Successor) are $19.8 million and $21.0 million, respectively. The balances include expected insurance recoveries of $14.7 million and $12.8 million, respectively.
Laws and Regulations
Laws and regulations governing the Company's business, including those relating to the Medicare and Medicaid programs, are complex and subject to interpretation. These laws and regulations govern every aspect of how the Company's surgical facilities conduct their operations, from licensing requirements to how and whether the Company's facilities may receive payments pursuant to the Medicare and Medicaid programs. Compliance with such laws and regulations can be subject to future government agency review and interpretation as well as legislative changes to such laws. Noncompliance with such laws and regulations may subject the Company to significant regulatory action including fines, penalties, and exclusion from the Medicare, Medicaid and other federal healthcare programs. From time to time, governmental regulatory agencies will conduct inquiries of the Company's practices, including, but not limited to, the Company's compliance with federal and state fraud and abuse laws, billing practices and relationships with physicians. On October 23, 2017, the Company received a civil investigative demand (“CID”) from the federal government under the False Claims Act (“FCA”) for documents and information dating back to January 1, 2010 relating to the medical necessity of certain drug tests conducted by the Company’s physicians and submitted to laboratories owned and operated by the Company. The government’s investigation remains ongoing and the Company intends to continue to respond to the CID and engage in further discussions with the U.S. Attorney’s Office in connection with the FCA investigation. In addition, the Company has been informed by CMS that payments to its diagnostic laboratory, Logan Laboratories, have been suspended pending further investigation by CMS. The Company is unable to predict the duration, scope or outcome of these investigations. While it is possible that a loss related to these matters may be incurred, given the ongoing nature of these investigations, management cannot reasonably estimate the potential magnitude of any such loss or range of loss, or the cost of the ongoing investigation, the entirety of which has been recorded in our operating expenses to date. An adverse outcome in these matters or any related litigation, including a determination that we were not, or are not, in compliance with the existing laws or regulations could result in the imposition of fines, civil and criminal penalties, equitable remedies, including disgorgement, injunctive relief, and/or other sanctions against us, and remediation of any such findings could have an adverse effect on the Company’s financial condition and results of operations. See Item 1A “Risk Factors” in our Annual Report on Form 10-K for the period ended December 31, 2017 under the heading “Risk Factors - Risks Related to Government Regulation - Companies within the healthcare industry continue to be the subject of federal and state audits and investigations, and we may be subject to such audits and investigations, including actions for false and other improper claims.” 
Acquired Facilities
The Company, through its wholly-owned subsidiaries or controlled partnerships and limited liability companies, has acquired and will continue to acquire surgical facilities with prior operating histories. Such facilities may have unknown or contingent liabilities, including liabilities for failure to comply with healthcare laws and regulations, such as billing and reimbursement, fraud and abuse and similar anti-referral laws. Although the Company attempts to assure that no such liabilities exist, obtain indemnification from prospective sellers covering such matters and institute policies designed to conform centers to its standards following completion of acquisitions, there can be no assurance that the Company will not become liable for past activities that may later be asserted to be improper by private plaintiffs or government agencies. There can be no assurance that any such matter will be covered by indemnification or, if covered, that the liability sustained will not exceed contractual limits or the financial capacity of the indemnifying party.
The Company cannot predict whether federal or state statutory or regulatory provisions will be enacted that would prohibit or otherwise regulate relationships which the Company has established or may establish with other healthcare providers or have materially adverse effects on its business or revenues arising from such future actions. Management believes, however, that it will be able to adjust the Company's operations so as to be in compliance with any statutory or regulatory provision as may be applicable.


20
SURGERY PARTNERS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)

Potential Physician Investor Liability
A majority of the physician investors in the partnerships and limited liability companies which operate the Company's surgical facilities carry general and professional liability insurance on a claims-made basis. Each partnership or limited liability company may, however, be liable for damages to persons or property arising from occurrences at the surgical facilities. Although the various physician investors and other surgeons generally are required to obtain general and professional liability insurance with tail coverage that extends beyond the period of any claims-made policies, such individuals may not be able to obtain coverage in amounts sufficient to cover all potential liability. Since most insurance policies contain exclusions, the physician investors will not be insured against all possible occurrences. In the event of an uninsured or underinsured loss, the value of an investment in the partnership interests or limited liability company membership units and the amount of distributions could be adversely affected.
Tax Receivable Agreement
On May 9, 2017, the Company entered into an agreement to amend that certain Income Tax Receivable Agreement, dated September 30, 2015 (as amended, the “TRA”), by and between the Company, and the other parties referred to therein, which amendment became effective on August 31, 2017. Pursuant to the amendment to the TRA, the Company agreed to make payments to H.I.G., the Company's former controlling shareholder, in its capacity as the stockholders representative pursuant to a fixed payment schedule. The amounts payable under the TRA are calculated as the product of (i) an annual base amount and (ii) the maximum corporate federal income tax rate for the applicable year plus three percent. The amounts payable under the TRA are related to the Company’s projected realized tax savings over the next six years and are not dependent on the Company’s actual tax savings over such period. The calculation of amounts payable pursuant to the TRA is thus dependent on the maximum corporate federal income tax rate. To the extent that the Company is unable to make payments under the TRA and such inability is a result of the terms of credit agreements and other debt documents that are materially more restrictive than those existing as of September 30, 2015, such payments will be deferred and will accrue interest at a rate of LIBOR plus 500 basis points until paid. If the terms of such credit agreements and other debt documents cause the Company to be unable to make payments under the TRA and such terms are not materially more restrictive than those existing as of September 30, 2015, such payments will be deferred and will accrue interest at a rate of LIBOR plus 300 basis points until paid.
Assuming the Company’s effective tax rate is 24%, calculated as the maximum corporate federal tax rate plus three percent, throughout the remaining term of the TRA, the Company estimates that the total remaining amounts payable under the TRA was approximately $65.1 million as of both September 30, 2018 (Successor) and December 31, 2017 (Successor). As a result of the amendment to the TRA, the Company was required to value the liability under the TRA by discounting the fixed payment schedule using the Company’s incremental borrowing rate. The carrying value of the liability under the TRA, reflecting the discount, was $47.8 million as of September 30, 2018 (Successor) and $44.3 million as of December 31, 2017 (Successor).
Contingent Consideration
In connection with certain prior period acquisitions, pursuant to the applicable purchase agreements, the Company was required to pay consideration to the prior owners of the applicable facilities should the requirements for continuing employment agreed to in the purchase agreements be met. In accordance with ASC 805, Business Combinations, contingent consideration with a continuing employment provision is recognized ratably over the defined performance period as compensation expense. As disclosed in the footnotes to the condensed consolidated statements of operations, the Company recognized contingent acquisition compensation expense of $0.5 million and $1.5 million for the three and nine months ended September 30, 2018 (Successor), respectively, $0.6 million for the one month ended September 30, 2017 (Successor), and $1.2 million and $5.1 million for the two and eight months ended August 31, 2017 (Predecessor), respectively.
Other
In connection with the Company's integration of the corporate office functions related to the acquisition of NSH, the Company closed it's Chicago, Illinois office on September 30, 2018 (Successor). As a result, the Company recognized a cease-use liability of $1.4 million, representing the estimated costs that will continue to be incurred under the office lease for its remaining term. The estimated costs were included as transaction and integration costs in the condensed consolidated statement of operations for the three and nine months ended September 30, 2018 (Successor) and as a component of other current liabilities and other long-term liabilities in the condensed consolidated balance sheet as of September 30, 2018 (Successor). During the second quarter 2018, the Company recognized a liability of $4.5 million for estimated severance costs in connection with the corporate office integration. The estimated costs were included as transaction and integration costs in the condensed consolidated statement of operations for the nine months ended September 30, 2018 (Successor) and the unpaid severance was included as a component of accrued payroll and benefits in the condensed consolidated balance sheet as of September 30, 2018 (Successor).


21
SURGERY PARTNERS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)

9. Segment Reporting
The Company operates in three major lines of business that are also the Company's reportable operating segments - the operation of surgical facilities, the operation of ancillary services and the operation of optical services. "All other" primarily consists of the Company's corporate general and administrative functions.
The following tables present financial information for each reportable segment (in thousands):
 
 
Successor
 
 
 
Predecessor
 
Successor
 
 
 
Predecessor

 
Three Months Ended September 30,
 
September 1 to September 30,
 
 
 
July 1 to August 31,
 
Nine Months Ended September 30,
 
 
 
January 1 to August 31,

 
2018
 
2017
 
 
 
2017
 
2018
 
 
 
2017
Revenues:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Surgical facility services
 
$
420,514

 
$
125,595

 
 
 
$
167,765

 
$
1,234,984

 
 
 
$
688,725

Ancillary services
 
20,719

 
5,775

 
 
 
4,409

 
62,655

 
 
 
52,261

Optical services
 
2,699

 
888

 
 
 
1,905

 
8,437

 
 
 
7,629

Total
 
$
443,932

 
$
132,258

 
 
 
$
174,079

 
$
1,306,076

 
 
 
$
748,615

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adjusted EBITDA (1):
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Surgical facility services
 
$
74,525

 
$
20,947

 
 
 
$
27,726

 
$
216,540

 
 
 
$
125,912

Ancillary services
 
875

 
(1,265
)
 
 
 
(10,737
)
 
2,925

 
 
 
(6,526
)
Optical services
 
571

 
193

 
 
 
555

 
2,087

 
 
 
2,214

All other
 
(16,983
)
 
(5,033
)
 
 
 
(9,142
)
 
(60,087
)
 
 
 
(36,036
)
Total
 
$
58,988

 
$
14,842

 
 
 
$
8,402

 
$
161,465

 
 
 
$
85,564

(1)
When the Company uses the term “Adjusted EBITDA,” it is referring to income before income taxes adjusted for (a) net income attributable to non-controlling interests, (b) depreciation and amortization, (c) interest expense, net, (d) equity-based compensation, (e) contingent acquisition compensation expense, (f) transaction, integration and acquisition costs, (g) gain on litigation settlement, (h) gain on acquisition escrow release, (i) reserve adjustments, (j) loss on disposals and deconsolidations, net, (k) gain on amendment to tax receivable agreement and (l) loss on debt refinancing. Adjusted EBITDA is the primary profit/loss metric reviewed by the chief operating decision maker in making key business decisions and on allocation of resources. Adjusted EBITDA is not a measurement of financial performance under GAAP, and should not be considered in isolation or as a substitute for net income, operating income or any other measure calculated in accordance with generally accepted accounting principles. The items excluded from Adjusted EBITDA are significant components in understanding and evaluating the Company's financial performance. The Company's calculation of Adjusted EBITDA may not be comparable to similarly titled measures reported by other companies.


22
SURGERY PARTNERS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)

A reconciliation of Adjusted EBITDA to income before income taxes included in the condensed consolidated statement of operations is as follows:
 
 
Successor
 
 
 
Predecessor
 
Successor
 
 
 
Predecessor
 
 
Three Months Ended September 30,
 
September 1 to September 30,
 
 
 
July 1 to August 31,
 
Nine Months Ended September 30,
 
 
 
January 1 to August 31,
 
 
2018
 
2017
 
 
 
2017
 
2018
 
 
 
2017
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adjusted EBITDA
 
$
58,988

 
$
14,842

 
 
 
$
8,402

 
$
161,465

 
 
 
$
85,564

Net income attributable to non-controlling interests
 
23,000

 
6,492

 
 
 
8,813

 
69,418

 
 
 
42,087

Depreciation and amortization
 
(16,945
)
 
(3,330
)
 
 
 
(7,599
)
 
(49,379
)
 
 
 
(30,124
)
Interest expense, net
 
(37,159
)
 
(15,883
)
 
 
 
(18,147
)
 
(107,368
)
 
 
 
(68,929
)
Equity-based compensation
 
(1,526
)
 
(1,683
)
 
 
 
(1,628
)
 
(6,303
)
 
 
 
(3,697
)
Contingent acquisition compensation expense
 
(503
)
 
(605
)
 
 
 
(1,210
)
 
(1,510
)
 
 
 
(5,057
)
Transaction, integration and acquisition costs (1)
 
(7,489
)
 
(3,457
)
 
 
 
(2,949
)
 
(25,419
)
 
 
 
(7,677
)
Gain on litigation settlement
 
—

 
—

 
 
 
—

 
—

 
 
 
3,794

Gain on acquisition escrow release
 
—

 
—

 
 
 
1,000

 
—

 
 
 
1,000

Reserve adjustments (2)
 
2,109

 
—

 
 
 
—

 
(2,670
)
 
 
 
—

Loss on disposals and deconsolidations, net
 
(12,631
)
 
(333
)
 
 
 
(114
)
 
(15,875
)
 
 
 
(1,715
)
Gain on amendment to tax receivable agreement
 
—

 
1,098

 
 
 
15,294

 
—

 
 
 
15,294

Loss on debt refinancing
 
—

 
—

 
 
 
(18,211
)
 
—

 
 
 
(18,211
)
Income before income taxes
 
$
7,844

 
$
(2,859
)
 
 
 
$
(16,349
)
 
$
22,359

 
 
 
$
12,329

(1)
This amount includes transaction and integration costs of $7.1 million and $23.8 million for the three and nine months ended September 30, 2018 (Successor), respectively, $3.0 million for the one month ended September 30, 2017 (Successor), and $2.3 million and $5.6 million for the two and eight months ended August 31, 2017 (Predecessor), respectively. This amount includes acquisition costs of $0.4 million and $1.6 million for the three and nine months ended September 30, 2018 (Successor), respectively, $0.5 million for the one month ended September 30, 2017 (Successor), and $0.6 million and $2.1 million for the two and eight months ended August 31, 2017 (Predecessor), respectively.
(2)
This amount represents adjustments to revenue in connection with applying consistent policies across the combined company as a result of the integration of Surgery Partners and NSH.
 
 
Successor
 
 
September 30,
2018
 
December 31,
2017
Assets:
 
 
 
 
Surgical facility services
 
$
4,015,094

 
$
4,072,521

Ancillary services
 
110,588

 
104,274

Optical services
 
34,811

 
48,309

All other
 
398,171

 
397,669

Total assets
 
$
4,558,664

 
$
4,622,773

 
 
Successor
 
 
 
Predecessor
 
 
Nine Months Ended September 30,
 
September 1 to September 30,
 
 
 
January 1 to August 31,
 
 
2018
 
2017
 
 
 
2017
Cash purchases of property and equipment, net:
 
 
 
 
 
 
 
 
Surgical facility services
 
$
21,590

 
$
1,613

 
 
 
$
14,582

Ancillary services
 
334

 
2

 
 
 
1,875

Optical services
 
42

 
23

 
 
 
73

All other
 
4,652

 
202

 
 
 
2,243

Total cash purchases of property and equipment, net
 
$
26,618

 
$
1,840

 
 
 
$
18,773



23
SURGERY PARTNERS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)

10. Subsequent Events
On October 23, 2018, Surgery Partners, Inc. (the “Company”) announced that SP Holdco I, Inc., a Delaware corporation (“Holdings”), and Surgery Center Holdings, Inc., a Delaware corporation (the “Borrower”), each a wholly-owned subsidiary of the Company, together with certain wholly-owned subsidiaries of the Borrower, entered into an incremental term loan amendment, dated as of October 23, 2018 (“the Amendment”), with Jefferies Finance LLC, as administrative agent and collateral agent, and the other financial institutions party thereto from time to time, which amended and supplemented the credit agreement, dated as of August 31, 2017, by and among the Borrower, Holdings, certain wholly-owned subsidiaries of the Borrower party thereto from time to time, Jefferies Finance LLC, as administrative agent and collateral agent, and the other financial institutions party thereto from time to time (the “Credit Agreement”) to provide for a $180.0 million senior secured incremental term loan (the “Incremental Term Loan”). The Incremental Term Loan was fully drawn on October 23, 2018 and bears interest at a rate per annum equal to (x) LIBOR plus a margin ranging from 3.00% to 3.25% per annum, depending on the Borrower's first lien net leverage ratio or (y) an alternate base rate (which will be the highest of (i) the prime rate, (ii) 0.5% per annum above the federal funds effective rate, (iii) one-month LIBOR plus 1.00% per annum and (iv) 2.00% per annum) plus a margin ranging from 2.00% to 2.25% per annum, depending on the Borrower's first lien net leverage ratio. The Incremental Term Loan is subject to maturity, amortization and other terms consistent with the existing term loans outstanding under the Credit Agreement on the date of the Amendment.
Subsequent to the balance sheet date, the Company entered into two interest rate swaps with notional amounts of $330 million and $240 million and termination dates of November 30, 2023.
On October 31, 2018, the Company purchased three surgery centers for a combined purchase price of $50.0 million. The Company funded the purchase price with the cash flow received from the proceeds received from the $180.0 million Incremental Term Loan borrowings. As of the date of this filing, the Company has not completed its preliminary estimation of the fair values assigned to the assets acquired and liabilities assumed.






24
SURGERY PARTNERS, INC.
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATIONS


Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the condensed consolidated financial statements and related notes included elsewhere in this report and included in our Annual Report on Form 10-K for the year ended December 31, 2017. This discussion contains forward-looking statements that involve risks and uncertainties. Our actual results may differ materially from those estimated or projected in any of these forward-looking statements.
Unless otherwise indicated or the context otherwise requires, references herein to the “Company”, “Surgery Partners”, “we”, “us” and “our” refer: (i) immediately prior to the Reorganization, to Surgery Center Holdings, LLC and its consolidated subsidiaries, including Surgery Center Holdings, Inc., (ii) immediately following the Reorganization but immediately prior to the consummation of the NSH Merger, to Surgery Partners, Inc. and its consolidated subsidiaries, including Surgery Center Holdings, LLC and Surgery Center Holdings, Inc., and, (iii) immediately following the consummation of the NSH Merger, to Surgery Partners, Inc. and its consolidated subsidiaries, including Surgery Center Holdings, LLC, Surgery Center Holdings, Inc. and NSH.
Unless the context implies otherwise, the term “affiliates” means direct and indirect subsidiaries of Surgery Partners, Inc., and partnerships and joint ventures in which such subsidiaries are partners. The terms “facilities” or “hospitals” refer to entities owned and operated by affiliates of Surgery Partners, Inc. and the term “employees” refers to employees of affiliates of Surgery Partners, Inc.
Cautionary Note Regarding Forward-Looking Statements
This report contains forward-looking statements, which are based on our current expectations, estimates and assumptions about future events. All statements other than statements of current or historical fact contained in this report are forward-looking statements. These statements include, but are not limited to, statements regarding our future financial position, business strategy, budgets, effective tax rate, projected costs and plans and objectives of management for future operations, as well as our expectations regarding the benefits of the NSH acquistion, including the projected synergies thereof, the performance of our business and other non-historical statements. The words “anticipate,” “believe,” “continue,” “estimate,” “expect,” “intend,” “may,” “plan,” “will,” and similar expressions are generally intended to identify forward-looking statements. These statements involve risks, uncertainties and other factors that may cause actual results to differ from the expectations expressed in the statements. Many of these factors are beyond our ability to control or predict. These factors include, without limitation, the risks and uncertainties described in this report, and set forth under the heading “Risk Factors” in our Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 16, 2018 and discussed from time to time in our reports filed with the SEC.
In light of these risks, uncertainties and assumptions, the forward-looking events and circumstances discussed in this report may not occur, and actual results could differ materially from those anticipated or implied in the forward-looking statements. When you consider these forward-looking statements, you should keep in mind these risk factors and other cautionary statements in this report.
These forward-looking statements speak only as of the date made. Other than as required by law, we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Executive Overview
The following discussion and analysis of our financial condition and results of operations covers periods both prior to and subsequent to the transactions that were effective August 31, 2017. Accordingly, the discussion and analysis of historical periods do not reflect the significant impact the transactions had. As discussed in the notes to the condensed consolidated financial statements included in this report, in connection with the change of control effective August 31, 2017, we elected to apply “pushdown” accounting. We have presented the information for the three and nine months ended September 30, 2017 on a Predecessor period and Successor period combined basis (each as defined in Note 1 of our condensed consolidated financial statements) to facilitate meaningful comparisons of operating results to the prior year period. You should read the following discussion together with our historical financial statements and related notes included elsewhere herein.
We continue to focus on improving our same-facility performance, selectively acquiring established facilities and developing new facilities. During the nine months ended September 30, 2018, we completed acquisitions of two surgical facilities in a new market, a surgical facility in an existing market, which was merged into an existing facility, a physician practice, and an integrated physician practice, including multiple practice and surgical facility locations, in an existing market for an aggregate investment of $54.3 million.
Revenues
Our revenues consist of patient service revenues and other service revenues. Patient service revenues consist of revenue from our surgical facility services and ancillary services segments. Specifically, patient service revenues include fees for surgical or diagnostic procedures performed at surgical facilities that we consolidate for financial reporting purposes, as well as for patient visits to our physician practices, anesthesia services, pharmacy services and diagnostic screens ordered by our physicians. Other service revenues consist of product sales from our optical laboratories, as well as the discounts and handling charges billed to the members of our optical products purchasing organization. Other service revenues also include management and administrative service fees derived from our non-consolidated facilities that we account for under the equity method, management of surgical facilities and physician practices in which we do not own an interest and management services we provide to physician practices for which we are not required to provide capital or additional assets.
The following table summarizes our revenues by service type as a percentage of total revenues for the periods indicated:
 
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
 
2018
 
2017
 
2018
 
2017
Patient service revenues:
 
 
 
 
 
 
 
 
Surgical facilities revenues
 
93.2
%
 
95.5
%
 
93.2
%
 
91.4
%
Ancillary services revenues
 
4.7
%
 
2.7
%
 
4.8
%
 
7.0
%
 
 
97.9
%
 
98.2
%
 
98.0
%
 
98.4
%
Other service revenues:
 
 
 
 
 
 
 
 
Optical services revenues
 
0.6
%
 
1.1
%
 
0.6
%
 
1.0
%
Other
 
1.5
%
 
0.7
%
 
1.4
%
 
0.6
%
 
 
2.1
%
 
1.8
%
 
2.0
%
 
1.6
%
Total revenues
 
100.0
%
 
100.0
%
 
100.0
%
 
100.0
%
Payor Mix
The following table sets forth by type of payor the percentage of our patient service revenues generated at the surgical facilities which we consolidate for financial reporting purposes in the periods indicated:
 
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
 
2018
 
2017
 
2018
 
2017
 
 
 
 
 
 
 
 
 
Private insurance payors
 
53.1
%
 
50.8
%
 
53.3
%
 
50.0
%
Government payors
 
38.4
%
 
39.9
%
 
38.6
%
 
41.0
%
Self-pay payors
 
2.9
%
 
2.7
%
 
3.1
%
 
2.3
%
Other payors (1)
 
5.6
%
 
6.6
%
 
5.0
%
 
6.7
%
Total
 
100.0
%
 
100.0
%
 
100.0
%
 
100.0
%
(1)
Other is comprised of anesthesia service agreements, auto liability, letters of protection and other payor types.
Surgical Case Mix
We primarily operate multi-specialty surgical facilities where physicians perform a variety of procedures in various specialties, including GI, general surgery, ophthalmology, orthopedics and pain management, among others. We believe this diversification helps to protect us from adverse pricing and utilization trends in any individual procedure type and results in greater consistency in our case volume.
The following table sets forth the percentage of cases in each specialty performed at the surgical facilities which we consolidate for financial reporting purposes for the periods indicated:
 
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
 
2018
 
2017
 
2018
 
2017
 
 
 
 
 
 
 
 
 
Gastrointestinal
 
22.0
%
 
22.8
%
 
21.6
%
 
23.2
%
General surgery
 
2.9
%
 
2.8
%
 
3.0
%
 
2.5
%
Ophthalmology
 
25.4
%
 
28.8
%
 
25.7
%
 
28.5
%
Orthopedic and pain management
 
37.6
%
 
33.9
%
 
37.4
%
 
33.5
%
Other
 
12.1
%
 
11.7
%
 
12.3
%
 
12.3
%
Total
 
100.0
%
 
100.0
%
 
100.0
%
 
100.0
%


25
SURGERY PARTNERS, INC.
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATIONS


Case Growth
Same-facility Information
Same-facility revenues include revenues from our consolidated and non-consolidated surgical facilities (excluding facilities acquired in new markets or divested during the current and prior period) along with the revenues from our ancillary services comprised of a diagnostic laboratory, multi-specialty physician practices, urgent care facilities, anesthesia services and optical services that complement our surgical facilities in our existing markets. The below table reflects the pro forma effect of the NSH acquisition for the three and nine months ended September 30, 2017.

 
Three Months Ended September 30,
 
Nine Months Ended September 30,

 
2018
 
2017
 
2018
 
2017

 
 
 
 
 
 
 
 
Cases
 
136,919

 
135,742

 
412,599

 
418,919

Case growth
 
0.9
%
 
N/A

 
(1.5
)%
 
N/A

Revenue per case
 
$
3,460

 
$
3,132

 
$
3,376

 
$
3,178

Revenue per case growth
 
10.5
%
 
N/A

 
6.2
 %
 
N/A

Number of facilities
 
113

 
N/A

 
113

 
N/A

Allowance for Contractual Adjustments and Doubtful Accounts
Our patient service revenues and other receivables from third-party payors are recorded net of estimated contractual adjustments and allowances from third-party payors, which we estimate based on the historical trend of our surgical facilities’ cash collections and contractual write-offs, accounts receivable agings, established fee schedules, relationships with payors and procedure statistics. While changes in estimated reimbursement from third-party payors remain a possibility, we expect that any such changes would be minimal and, therefore, would not have a material effect on our financial condition or results of operations.
We estimate our allowances for doubtful accounts using similar information and analysis. While we believe that our allowances for contractual adjustments and doubtful accounts are adequate, if the actual write-offs are significantly different from our estimates, it could have a material adverse effect on our financial condition and results of operations. Because in most cases we have the ability to verify a patient’s insurance coverage before services are rendered, and because we have entered into contracts with third-party payors which account for a majority of our total revenues, the out-of-period contractual adjustments have been minimal.
Our collection policies and procedures are based on the type of payor, size of claim and estimated collection percentage for each patient account. The operating systems used to manage our patient accounts provide for an aging schedule in 30-day increments, by payor, physician and patient. We analyze accounts receivable at each of our surgical facilities to ensure the proper collection and aged category. The operating systems generate reports that assist in the collection efforts by prioritizing patient accounts. Collection efforts include direct contact with insurance carriers or patients, written correspondence and the use of legal or collection agency assistance, as required. Our days sales outstanding were 61 days for both the nine months ended September 30, 2018 and year ended December 31, 2017.
Critical Accounting Policies
A summary of significant accounting policies is disclosed in our 2017 Annual Report on Form 10-K under the caption “Critical Accounting Policies” in Management’s Discussion and Analysis of Financial Condition and Results of Operations. There have been no material changes in the nature of our critical accounting policies or the application of those policies other than the addition of the derivatives and hedging policy discussed below since December 31, 2017.
Derivative Instruments and Hedging Activities
In accordance with ASC 815, Derivatives and Hedging (“ASC 815”), the Company records all derivatives on the balance sheet at fair value. The accounting for changes in the fair value of derivatives depends on the intended use of the derivative, whether the Company has elected to designate a derivative in a hedging relationship and apply hedge accounting and whether the hedging relationship has satisfied the criteria necessary to apply hedge accounting. Hedge accounting generally provides for the matching of the timing of gain or loss recognition on the hedging instrument with the recognition of the changes in the fair value of the hedged asset or liability that are attributable to the hedged risk in a fair value hedge or the earnings effect of the hedged forecasted transactions in a cash flow hedge. The Company may enter into derivative contracts that are intended to economically hedge certain of its risk, even though hedge accounting does not apply or the Company elects not to apply hedge accounting.
In accordance with the FASB’s fair value measurement guidance in ASU 2011-04, the Company made an accounting policy election to measure the credit risk of its derivative financial instruments that are subject to master netting agreements on a net basis by counterparty portfolio.


26
SURGERY PARTNERS, INC.
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATIONS


Results of Operations
Three Months Ended September 30, 2018 Compared to Three Months Ended September 30, 2017
The following table summarizes certain results from the statements of operations for the three months ended September 30, 2018 and 2017. The table also shows the percentage relationship to revenues for the periods indicated (dollars in thousands):
 
 
Three Months Ended September 30,
 
 
2018
 
2017
 
 
Amount
 
% of Revenues
 
Amount
 
% of Revenues
 
 
 
 
 
 
 
 
 
Revenues
 
$
443,932

 
100.0
 %
 
$
306,337

 
100.0
 %
Operating expenses:
 
 
 
 
 
 
 
 
Cost of revenues
 
334,289

 
75.3
 %
 
246,696

 
80.5
 %
General and administrative expenses
 
19,478

 
4.4
 %
 
20,378

 
6.7
 %
Depreciation and amortization
 
16,945

 
3.8
 %
 
10,929

 
3.6
 %
Provision for doubtful accounts
 
11,555

 
2.6
 %
 
8,524

 
2.8
 %
Income from equity investments
 
(1,861
)
 
(0.4
)%
 
(1,608
)
 
(0.5
)%
Loss on disposals and deconsolidations, net
 
12,631

 
2.8
 %
 
447

 
0.1
 %
Transaction and integration costs
 
7,099

 
1.6
 %
 
5,326

 
1.7
 %
Loss on debt refinancing
 
—

 
—
 %
 
18,211

 
5.9
 %
Gain on acquisition escrow release
 
—

 
—
 %
 
(1,000
)
 
(0.3
)%
Other income
 
(1,207
)
 
(0.3
)%
 
4

 
—
 %
Total operating expenses
 
398,929

 
89.9
 %
 
307,907

 
100.5
 %
Operating income (loss)
 
45,003

 
10.1
 %
 
(1,570
)
 
(0.5
)%
Gain on amendment to tax receivable agreement
 
—

 
—
 %
 
16,392

 
5.4
 %
Interest expense, net
 
(37,159
)
 
(8.4
)%
 
(34,030
)
 
(11.1
)%
Income (loss) before income taxes
 
7,844

 
1.8
 %
 
(19,208
)
 
(6.3
)%
Income tax expense (benefit)
 
5,825

 
1.3
 %
 
(20,929
)
 
(6.8
)%
Net income
 
2,019

 
0.5
 %
 
1,721

 
0.6
 %
Less: Net income attributable to non-controlling interests
 
(23,000
)
 
(5.2
)%
 
(15,305
)
 
(5.0
)%
Net loss attributable to Surgery Partners, Inc.
 
$
(20,981
)
 
(4.7
)%
 
$
(13,584
)
 
(4.4
)%
Overview. During the three months ended September 30, 2018, our revenues increased 44.9% to $443.9 million compared to $306.3 million for the three months ended September 30, 2017. Revenue growth for the period was primarily attributable to the acquisition of NSH (closed on August 31, 2017). We incurred a net loss attributable to Surgery Partners, Inc. of $21.0 million for the 2018 period, compared to $13.6 million for the 2017 period.
Revenues. Revenues for the three months ended September 30, 2018 compared to the three months ended September 30, 2017 were as follows (dollars in thousands):
 
 
Three Months Ended September 30,
 
 
 
 
 
 
2018
 
2017
 
Dollar
Variance
 
Percent
Variance
 
 
 
 
 
 
 
 
 
Patient service revenues
 
$
434,685

 
$
300,763

 
$
133,922

 
44.5
 %
Optical service revenues
 
2,699

 
2,794

 
(95
)
 
(3.4
)%
Other service revenues
 
6,548

 
2,780

 
3,768

 
135.5
 %
Total revenues
 
$
443,932

 
$
306,337

 
$
137,595

 
44.9
 %
Patient service revenues increased 44.5% to $434.7 million for the three months ended September 30, 2018 compared to $300.8 million for the three months ended September 30, 2017. The increase in patient service revenues was primarily attributable to the acquisition of NSH.
Cost of Revenues. Cost of revenues increased 35.5%, to $334.3 million for the three months ended September 30, 2018 compared to $246.7 million for the three months ended September 30, 2017. The increase is primarily due to the acquisition of NSH and an increase in


27
SURGERY PARTNERS, INC.
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATIONS


supply costs due to a higher acuity case mix. As a percentage of revenues, cost of revenues were 75.3% for the 2018 period and 80.5% for the 2017 period.
General and Administrative Expenses. General and administrative expenses decreased 4.4%, to $19.5 million for the three months ended September 30, 2018 compared to $20.4 million for the three months ended September 30, 2017. The decrease is primarily due a decrease in stock compensation expense of $1.8 million offset slightly by the acquisition of NSH. As a percentage of revenues, general and administrative expenses decreased to 4.4% for the 2018 period compared to 6.7% for the 2017 period.
Depreciation and Amortization. Depreciation and amortization increased 55.0%, to $16.9 million for the three months ended September 30, 2018 compared to $10.9 million for the three months ended September 30, 2017. The increase is primarily attributable to the acquisition of NSH. As a percentage of revenues, depreciation and amortization expenses increased to 3.8% for the 2018 period compared to 3.6% for the 2017 period.
Provision for Doubtful Accounts. The provision for doubtful accounts increased 35.6%, to $11.6 million for the three months ended September 30, 2018 compared to $8.5 million for the three months ended September 30, 2017. The increase primarily attributable to the acquisition of NSH. As a percentage of revenues, the provision for doubtful accounts decreased to 2.6% for the 2018 period compared to 2.8% for the 2017 period.
Income from Equity Investments. The income from equity investments increased 15.7%, to $1.9 million for the three months ended September 30, 2018 compared to $1.6 million for the three months ended September 30, 2017. The increase is primarily attributable to the acquisition of NSH which added four equity method investment entities to our structure.
Loss on Disposals and Deconsolidations, Net. The net loss on disposals and deconsolidations was $12.6 million for the three months ended September 30, 2018, including a net loss of $8.0 million on the sale of surgical and other facilities and $4.6 million on disposals of other long-lived assets. The net loss on disposals and deconsolidations for the 2017 period was attributable to disposals of other long-lived assets.
Transaction and Integration Costs. We incurred $7.1 million of transaction and integration costs for the three months ended September 30, 2018 compared to $5.3 million for the three months ended September 30, 2017. The increase is primarily relates to reorganization costs as we continue to invest in our infrastructure and costs related to the integration of the NSH acquisition.
Operating Income (Loss). Our operating income margin for the three months ended September 30, 2018 was 10.1% compared to (0.5)% during the three months ended September 30, 2017. During the three months ended September 30, 2018, we recorded $7.1 million of transaction and integration costs, contingent acquisition compensation expense of $0.5 million, a net loss on disposals and deconsolidations of $12.6 million and other income of $1.2 million. Excluding the impact of these items, our operating income margin was 14.3% for the three months ended September 30, 2018.
During the three months ended September 30, 2017, we recorded transaction and integration costs related to acquisitions of $5.3 million, contingent acquisition compensation expense of $1.8 million, loss on debt refinancing of $18.2 million, a gain on acquisition escrow release of $1.0 million and a loss on disposals and deconsolidations, net, of $0.4 million. Excluding the impact of these items, our operating income margin was 7.6% for the three months ended September 30, 2017. Operating income margin for the 2017 period included the impact of hurricanes Irma and Harvey and the impact associated with an increase in reserves for certain accounts receivables.
Interest Expense, Net. Interest expense, net, increased 9.2%, to $37.2 million for the three months ended September 30, 2018 compared to $34.0 million for the three months ended September 30, 2017. As a percentage of revenues, interest expense, net decreased to 8.4% for the 2018 period compared to 11.1% for the 2017 period. The increase primarily relates to the issuance of our $370 million Senior Unsecured Notes on June 30, 2017 due 2025 and an increase in our variable rate debt due to the refinancing of our Senior Secured Credit Facility as of August 31, 2017.
Income Tax Expense (Benefit).  The income tax expense was $5.8 million for the three months ended September 30, 2018 compared to an income tax benefit of $20.9 million for the three months ended September 30, 2017. The effective tax rate was 74.3% for the three months ended September 30, 2018 compared to 109.0% for the three months ended September 30, 2017. The decrease in the effective tax rate was primarily due to the tax effect of the gain on amendment of the tax receivable agreement recognized in the three months ended September 30, 2017.  The effective tax rate was further impacted by the Tax Act due to the reduced U.S. federal corporate income tax rate from 35% to 21%, effective January 1, 2018.  Based upon the application of interim accounting guidance, the tax rate as a percentage of net income after income attributable to non-controlling interests will vary based upon the relative net income from period to period.
Net Income Attributable to Non-Controlling Interests. Net income attributable to non-controlling interests was $23.0 million for the three months ended September 30, 2018 compared to $15.3 million for the three months ended September 30, 2017. The increase is primarily attributable to the acquisition of NSH. As a percentage of revenues, net income attributable to non-controlling interests was 5.2% in the 2018 period and 5.0% for the 2017 period.


28
SURGERY PARTNERS, INC.
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATIONS


Nine Months Ended September 30, 2018 Compared to Nine Months Ended September 30, 2017
The following table summarizes certain results from the statements of operations for the nine months ended September 30, 2018 and 2017. The table also shows the percentage relationship to revenues for the periods indicated (dollars in thousands):
 
 
Nine Months Ended September 30,
 
 
2018
 
2017
 
 
Amount
 
% of Revenues
 
Amount
 
% of Revenues
 
 
 
 
 
 
 
 
 
Revenues
 
$
1,306,076

 
100.0
 %
 
$
880,873

 
100.0
 %
Operating expenses:
 
 
 
 
 
 
 
 
Cost of revenues
 
1,001,691

 
76.7
 %
 
675,096

 
76.6
 %
General and administrative expenses
 
69,729

 
5.3
 %
 
54,574

 
6.2
 %
Depreciation and amortization
 
49,379

 
3.8
 %
 
33,454

 
3.8
 %
Provision for doubtful accounts
 
25,788

 
2.0
 %
 
19,987

 
2.3
 %
Income from equity investments
 
(6,283
)
 
(0.5
)%
 
(3,860
)
 
(0.4
)%
Loss on disposals and deconsolidations, net
 
15,875

 
1.2
 %
 
2,048

 
0.2
 %
Transaction and integration costs
 
23,771

 
1.8
 %
 
8,567

 
1.0
 %
Loss on debt refinancing
 
—

 
—
 %
 
18,211

 
2.1
 %
Gain on litigation settlement
 
—

 
—
 %
 
(3,794
)
 
(0.4
)%
Gain on acquisition escrow release
 
—

 
—
 %
 
(1,000
)
 
(0.1
)%
Other income
 
(3,601
)
 
(0.3
)%
 
(300
)
 
—
 %
Total operating expenses
 
1,176,349

 
90.1
 %
 
802,983

 
91.2
 %
Operating income
 
129,727

 
9.9
 %
 
77,890

 
8.8
 %
Gain on amendment to tax receivable agreement
 
—

 
—
 %
 
16,392

 
1.9
 %
Interest expense, net
 
(107,368
)
 
(8.2
)%
 
(84,812
)
 
(9.6
)%
Income before income taxes
 
22,359

 
1.7
 %
 
9,470

 
1.1
 %
Income tax expense (benefit)
 
10,905

 
0.8
 %
 
(18,300
)
 
(2.1
)%
Net income
 
11,454

 
0.9
 %
 
27,770

 
3.2
 %
Less: Net income attributable to non-controlling interests
 
(69,418
)
 
(5.3
)%
 
(48,579
)
 
(5.5
)%
Net loss attributable to Surgery Partners, Inc.
 
$
(57,964
)
 
(4.4
)%
 
$
(20,809
)
 
(2.4
)%
Overview. During the nine months ended September 30, 2018, our revenues increased 48.3% to $1,306.1 million compared to $880.9 million for the nine months ended September 30, 2017. Revenue growth for the period was primarily attributable to the acquisition of NSH (closed on August 31, 2017). We incurred a net loss attributable to Surgery Partners, Inc. of $58.0 million for the 2018 period, compared to $20.8 million for the 2017 period.
Revenues. Revenues for the nine months ended September 30, 2018 compared to the nine months ended September 30, 2017 were as follows (dollars in thousands):
 
 
Nine Months Ended September 30,
 
 
 
 
 
 
2018
 
2017
 
Dollar
Variance
 
Percent
Variance
 
 
 
 
 
 
 
 
 
Patient service revenues
 
$
1,278,966

 
$
866,244

 
$
412,722

 
47.6
 %
Optical service revenues
 
8,437

 
8,518

 
(81
)
 
(1.0
)%
Other service revenues
 
18,673

 
6,111

 
12,562

 
205.6
 %
Total revenues
 
$
1,306,076

 
$
880,873

 
$
425,203

 
48.3
 %
Patient service revenues increased 47.6% to $1.28 billion for the nine months ended September 30, 2018 compared to $866.2 million for the nine months ended September 30, 2017. The increase in patient service revenues was primarily attributable to the acquisition of NSH, offset by a decline in our ancillary service business and adjustments to revenue recorded in the first quarter in connection with applying consistent revenue policies across the combined company.


29
SURGERY PARTNERS, INC.
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATIONS


Cost of Revenues. Cost of revenues increased 48.4%, to $1.00 billion for the nine months ended September 30, 2018 compared to $675.1 million for the nine months ended September 30, 2017. The increase is primarily related to the acquisition of NSH and an increase in supply costs due to a higher acuity case mix. As a percentage of revenues, cost of revenues were 76.7% for the 2018 period and 76.6% for the 2017 period.
General and Administrative Expenses. General and administrative expenses increased 27.8%, to $69.7 million for the nine months ended September 30, 2018 compared to $54.6 million for the nine months ended September 30, 2017. The increase is primarily related to the acquisition of NSH and an increase in stock compensation expense of $0.9 million. The remaining increase is primarily due to continued investment in our corporate infrastructure. As a percentage of revenues, general and administrative expenses decreased to 5.3% for the 2018 period compared to 6.2% for the 2017 period.
Depreciation and Amortization. Depreciation and amortization increased 47.6%, to $49.4 million for the nine months ended September 30, 2018 compared to $33.5 million for the nine months ended September 30, 2017. The increase is primarily attributable to the acquisition of NSH. As a percentage of revenues, depreciation and amortization expenses were 3.8% for both the 2018 and 2017 periods.
Provision for Doubtful Accounts. The provision for doubtful accounts increased 29.0%, to $25.8 million for the nine months ended September 30, 2018 compared to $20.0 million for the nine months ended September 30, 2017. The increase is primarily attributable to the acquisition of NSH. As a percentage of revenues, the provision for doubtful accounts was 2.0% for the 2018 period and 2.3% for the 2017 period.
Income from Equity Investments. The income from equity investments increased 62.8%, to $6.3 million for the nine months ended September 30, 2018 compared to $3.9 million for the nine months ended September 30, 2017. The increase is primarily attributable to the acquisition of NSH which added four equity method investment entities to our structure.
Loss on Disposals and Deconsolidations, Net. The net loss on disposals and deconsolidations was $15.9 million for the nine months ended September 30, 2018, including a net loss of $9.5 million on the sale of surgical and other facilities and $7.5 million on disposals of other long-lived assets, offset by a net gain of $1.1 million on the deconsolidation of a surgical facility. The net loss on disposals and deconsolidations for the 2017 period was attributable to disposals of other long-lived assets.
Transaction and Integration Costs. We incurred $23.8 million of transaction and integration costs for the nine months ended September 30, 2018 compared to $8.6 million for the nine months ended September 30, 2017. The increase is primarily relates to reorganization costs as we continue to invest in our infrastructure and costs related to the integration of the NSH acquisition, which includes approximately $4.5 million in severance costs incurred during the period related to the integration of the corporate office functions.
Operating Income. Our operating income margin for the nine months ended September 30, 2018 was 9.9% compared to 8.8% during the nine months ended September 30, 2017. During the nine months ended September 30, 2018, we recorded $23.8 million of transaction and integration costs, contingent acquisition compensation expense of $1.5 million, a net loss on disposals and deconsolidations of $15.9 million and an other income of $3.6 million. Excluding the impact of these items, our operating income margin was 12.7% for the nine months ended September 30, 2018.
During the nine months ended September 30, 2017, we recorded a gain on litigation settlement of $3.8 million, transaction and integration costs related to acquisitions of $8.6 million, loss on debt refinancing of $18.2 million, gain on acquisition escrow release of $1.0 million, contingent acquisition compensation expense of $5.7 million and a net loss on disposals and deconsolidations of $2.0 million. Excluding the impact of these items, our operating income margin was 12.2% for the nine months ended September 30, 2017.
Interest Expense, Net. Interest expense, net, increased 26.6%, to $107.4 million for the nine months ended September 30, 2018 compared to $84.8 million for the nine months ended September 30, 2017. As a percentage of revenues, interest expense, net was 8.2% for the 2018 period compared to 9.6% for the 2017 period. The increase primarily relates to the issuance of our $370 million Senior Unsecured Notes on June 30, 2017 due 2025 and an increase in our variable rate debt due to the refinancing of our Senior Secured Credit Facility as of August 31, 2017.
Income Tax Expense (Benefit).  The income tax expense was $10.9 million for the nine months ended September 30, 2018 compared to an income tax benefit of $18.3 million for the nine months ended September 30, 2017. The effective tax rate was 48.8% for the nine months ended September 30, 2018 compared to (193.2)% for the nine months ended September 30, 2017. The increase in the effective tax rate was primarily due to the Tax Act, which implemented an interest expense limitation resulting in a deferred tax asset that required a valuation allowance to be reported at its net realizable value. The Company recorded additional tax expense in 2018 to account for the gain on divestitures and valuation allowances on state tax attributes resulting from legislative changes enacted during the second quarter. The effective tax rate was further impacted by the Tax Act due to the reduced the U.S. federal corporate income tax rate from 35% to 21%, effective January 1, 2018. Based upon the application of interim accounting guidance, the tax rate as a percentage of net income after income attributable to non-controlling interests will vary based upon the relative net income from period to period.
Net Income Attributable to Non-Controlling Interests. Net income attributable to non-controlling interests was $69.4 million for the nine months ended September 30, 2018 compared to $48.6 million for the nine months ended September 30, 2017. The increase is primarily attributable to the acquisition of NSH.As a percentage of revenues, net income attributable to non-controlling interests was 5.3% in the 2018 period and 5.5% for the 2017 period.


30
SURGERY PARTNERS, INC.
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATIONS


Liquidity and Capital Resources
Operating Activities
The primary source of our operating cash flow is the collection of accounts receivable from federal and state agencies (under the Medicare and Medicaid programs), managed care health plans, commercial insurance companies and individuals. During the nine months ended September 30, 2018, our cash flow provided by operating activities was $99.1 million compared to $66.5 million in the nine months ended September 30, 2017. The increase period over period is primarily attributable to the acquisition of NSH. At September 30, 2018, we had working capital of $167.7 million compared to $260.2 million at December 31, 2017.
Investing Activities
Net cash used in investing activities during the nine months ended September 30, 2018 was $66.6 million, which included $26.6 million related to purchases of property and equipment. During the period, we paid approximately $55.2 million (net of cash acquired) related to acquisitions, which included: (a) purchase of three surgical facilities and a physician practice for $32.9 million, (b) purchase of an integrated physician practice, including multiple practice and surgical facility locations for $21.1 million, and (c) additional cash consideration related to the working capital settlement for the acquisition of NSH of $1.2 million. Further, we sold our controlling interests in four surgical facilities, retaining a non-controlling interest in one, and our optical laboratory for cash proceeds of $18.0 million.
Net cash used in investing activities during the nine months ended September 30, 2017 was $747.6 million, which included $20.6 million related to purchases of property and equipment. We acquired NSH for a purchase price of $711.4 million, net of cash acquired. Additionally, we purchased four physician practices and the assets of an endoscopy practice for an aggregate purchase price of $15.4 million.
Financing Activities
Net cash used in financing activities during the nine months ended September 30, 2018 was $128.2 million. During this period, we made distributions to non-controlling interest holders of $80.1 million and paid cash related to ownership transactions with consolidated affiliates of $0.5 million. Further, we made repayments on our long-term debt of $94.9 million offset by borrowings of $62.8 million. In addition, we made preferred dividend payments of $7.8 million and repurchased $2.0 million of our common stock pursuant to our $50 million repurchase program announced on December 15, 2017.
Net cash used in financing activities during the nine months ended September 30, 2017 was $811.1 million. During this period, we made distributions to non-controlling interest holders of $56.8 million and paid cash related to ownership transactions with consolidated affiliates of $1.5 million. Further, we made repayments on our long-term debt of $1.2 billion offset by borrowings of $1.8 billion. Our repayments and borrowings include a $132.5 million draw down and subsequent repayment of $217.5 million on our Revolver during the period. In addition, we paid debt issuance costs of $58.6 million and received proceeds on the issuance of preferred stock of $291.7 million, net of issuance costs.
Debt
As of September 30, 2018, the carrying value of our total indebtedness, including capital leases, was $2.173 billion, consisting of outstanding aggregate principal of $2.171 billion and net unamortized fair value premium of $1.7 million.
2017 Senior Secured Credit Facilities
We have term loan borrowings with a carrying value of $1.271 billion, consisting of outstanding aggregate principal of $1.277 billion and unamortized fair value discount of $5.7 million (the "Term Loan"). The Term Loan matures on August 31, 2024 (or, if at least 50.0% of the 2021 Unsecured Notes (as defined below) shall have not either been repaid or refinanced with permitted indebtedness having a maturity date not earlier than six months after the maturity date of the Term Loan by no later than October 15, 2020, then October 15, 2020). The Term Loan amortizes in equal quarterly installments of 0.25% of the aggregate original principal amount of the Term Loan.
We have a revolving credit facility providing for revolving borrowings of up to $75.0 million (the "Revolver" and, together with the Term Loan, the "2017 Senior Secured Credit Facilities"). The Revolver will mature on August 31, 2022 (or, if at least 50.0% of the 2021 Notes have not either been repaid or refinanced with permitted indebtedness having a maturity date not earlier than six months after the maturity date of the Term Loan by no later than October 15, 2020, then October 15, 2020). As of September 30, 2018, our availability on the Revolver was $60.5 million (including outstanding letters of credit of $3.5 million).
The Revolver may be utilized for working capital, capital expenditures and general corporate purposes. Subject to certain conditions and requirements set forth in the credit agreement, we may request one or more additional incremental term loan facilities or one or more increases in the commitments under the Revolver.
The 2017 Senior Secured Credit Facilities bear interest at a rate per annum equal to (x) LIBOR plus a margin ranging from 3.00% to 3.25% per annum, depending on our first lien net leverage ratio or (y) an alternate base rate (which will be the highest of (i) the prime rate, (ii) 0.5% per annum above the federal funds effective rate and (iii) one-month LIBOR plus 1.00% per annum (solely with respect to the Term Loan, the alternate base rate shall not be less than 2.00% per annum)) plus a margin ranging from 2.00% to 2.25% per annum. In addition, we are required to pay a commitment fee of 0.50% per annum in respect of unused commitments under the Revolver.


31
SURGERY PARTNERS, INC.
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATIONS


Senior Unsecured Notes
We have senior unsecured notes due April 15, 2021 with a carrying value of $407.4 million, consisting of outstanding aggregate principal of $400.0 million and unamortized fair value premium of $7.4 million (the "2021 Unsecured Notes"). The 2021 Unsecured Notes bear interest at the rate of 8.875% per year, payable semi-annually on April 15 and October 15 of each year.
We have $370.0 million aggregate principal amount of senior unsecured notes due July 1, 2025 outstanding (the "2025 Unsecured Notes"). The 2025 Unsecured Notes bear interest at the rate of 6.750% per year, payable semi-annually on January 1 and July 1 of each year.
Other Debt
We and certain of our subsidiaries have other debt consisting of outstanding bank indebtedness of $88.1 million, which is collateralized by the real estate and equipment owned by the surgical facilities to which the loans were made, and capital lease obligations of $24.8 million for which we are liable to various vendors for several property and equipment leases classified as capital leases.
Summary
Based on our current level of operations, we believe cash flow from operations and available cash, together with available borrowings under the Revolver, will be adequate to meet our short-term (12 months or less) liquidity needs.
Certain Non-GAAP Metrics
EBITDA and Adjusted EBITDA are not measurements of financial performance under GAAP. They should not be considered in isolation or as a substitute for net income, operating income or any other measure calculated in accordance with generally accepted accounting principles. The items excluded from these non-GAAP metrics are significant components in understanding and evaluating our financial performance. We believe such adjustments are appropriate, as the magnitude and frequency of such items can vary significantly and are not related to the assessment of normal operating performance.
When we use the term “EBITDA,” we are referring to income before income taxes, adjusted for net income attributable to non-controlling interests, interest expense, net and depreciation and amortization. Non-controlling interests represent the interests of third parties, such as physicians, and in some cases, healthcare systems that own an interest in surgical facilities that we consolidate for financial reporting purposes. Our operating strategy is to apply a market-based approach in structuring our partnerships with individual market dynamics driving the structure. We believe that it is helpful to investors to present EBITDA as defined above because it excludes the portion of net income attributable to these third-party interests and clarifies for investors our portion of EBITDA generated by our surgical facilities and other operations.
When we use the term "Adjusted EBITDA", we are referring to EBITDA, as defined above, adjusted for equity-based compensation expense, transaction, integration and acquisition costs, contingent acquisition compensation expense, reserve adjustments, loss on disposals and deconsolidations, net, gain on litigation settlement, gain on acquisition escrow release, gain on amendment to tax receivable agreement and loss on debt refinancing. We use Adjusted EBITDA as a measure of financial performance. Adjusted EBITDA is a key measure used by our management to assess operating performance, make business decisions and allocate resources. Our calculation of Adjusted EBITDA may not be comparable to similarly titled measures reported by other companies.


32
SURGERY PARTNERS, INC.
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATIONS


The following table reconciles EBITDA and Adjusted EBITDA to income before income taxes, the most directly comparable GAAP financial measure (in thousands and unaudited):
 
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
 
2018
 
2017
 
2018
 
2017
Condensed Consolidated Statements of Operations Data:
 
 
 
 
 
 
 
 
Income before income taxes
 
$
7,844

 
$
(19,208
)
 
$
22,359

 
$
9,470

Minus:
 
 
 
 
 
 
 
 
Net income attributable to non-controlling interests
 
23,000

 
15,305

 
69,418

 
48,579

Plus:
 
 
 
 
 
 
 
 
Interest expense, net
 
37,159

 
34,030

 
107,368

 
84,812

Depreciation and amortization
 
16,945

 
10,929

 
49,379

 
33,454

EBITDA
 
38,948

 
10,446

 
109,688

 
79,157

Plus (minus):
 
 
 
 
 
 
 
 
Equity-based compensation
 
1,526

 
3,311

 
6,303

 
5,380

Transaction, integration and acquisition costs (1)
 
7,489

 
6,406

 
25,419

 
11,134

Reserve adjustments (2)
 
(2,109
)
 
—

 
2,670

 
—

Loss on disposals and deconsolidations, net
 
12,631

 
447

 
15,875

 
2,048

Contingent acquisition compensation expense
 
503

 
1,815

 
1,510

 
5,662

Gain on litigation settlement
 
—

 
—

 
—

 
(3,794
)
Gain on acquisition escrow release
 
—

 
(1,000
)
 
—

 
(1,000
)
Gain on amendment to tax receivable agreement
 
—

 
(16,392
)
 
—

 
(16,392
)
Loss on debt refinancing
 
—

 
18,211

 
—

 
18,211

Adjusted EBITDA
 
$
58,988

 
$
23,244

 
$
161,465

 
$
100,406

(1)
This amount includes transaction and integration costs of $7.1 million and $5.3 million for the three months ended September 30, 2018 and 2017, respectively, and acquisition costs of $0.4 million and $1.1 million for the three months ended September 30, 2018 and 2017, respectively. This amount includes transaction and integration costs of $23.8 million and $8.6 million for the nine months ended September 30, 2018 and 2017, respectively, and acquisition costs of $1.6 million and $2.6 million for the nine months ended September 30, 2018 and 2017, respectively.
(2)
This amount represents adjustments to revenue in connection with applying consistent policies across the combined company as a result of the integration of Surgery Partners and NSH.
We use Credit Agreement EBITDA as a measure of liquidity and to determine our compliance under certain covenants pursuant to our credit facilities. Credit Agreement EBITDA is determined on a trailing twelve month basis. We have included it because we believe that it provides investors with additional information about our ability to incur and service debt and make capital expenditures. Credit Agreement EBITDA is not a measurement of liquidity under GAAP, and should not be considered in isolation or as a substitute for any other measure calculated in accordance with generally accepted accounting principles. The items excluded from Credit Agreement EBITDA are significant components in understanding and evaluating our liquidity. Our calculation of Credit Agreement EBITDA may not be comparable to similarly titled measures reported by other companies.
When we use the term “Credit Agreement EBITDA,” we are referring to Adjusted EBITDA, as defined above, further adjusted for other items related to our historical financial performance during the trailing twelve month period, including gain on acquisition escrow release, gain on amendment to tax receivable agreement, tax receivable agreement benefit, loss on debt refinancing, and the estimated impact of the hurricanes and one-time adjustment to revenue that occurred in the third quarter of 2017. Also included are adjustments for acquisitions and non-cash expenses. These adjustments do not relate to our historical financial performance and instead relate to estimates compiled by our management and calculated in conformance with the definition of “Consolidated EBITDA” used in the credit agreements governing our credit facilities.


33
SURGERY PARTNERS, INC.
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATIONS


The following table reconciles Credit Agreement EBITDA to cash flows from operating activities, the most directly comparable GAAP financial measure (in thousands and unaudited):
 
 
Twelve Months Ended September 30, 2018
 
 
 
Cash flows from operating activities
 
$
153,501

Minus:
 
 
Net income attributable to non-controlling interests
 
102,560

Plus (minus):
 
 
Non-cash interest income, net
 
1,691

Deferred income taxes
 
(80,960
)
Provision for doubtful accounts
 
(34,553
)
Income from equity investments, net of distributions received
 
(695
)
Changes in operating assets and liabilities, net of acquisitions and divestitures
 
29,274

Income tax expense
 
82,755

Interest expense, net
 
140,225

Transaction, integration and acquisition costs
 
31,292

Reserve adjustments
 
2,670

Contingent acquisition compensation expense
 
2,887

Gain on acquisition escrow release
 
(167
)
Acquisitions (1)
 
38,660

Credit Agreement EBITDA
 
$
264,020

(1)
Represents impact of acquired anesthesia entities, physician practices and surgical facilities as if each acquisition had occurred on October 1, 2017 including cost savings from reductions in corporate overhead, supply chain rationalization, enhanced physician engagement, improved payor contracting and revenue synergies associated with the NSH acquisition. Further, this includes revenue synergies from other business initiatives as defined in the Credit Agreement.
Inflation
Inflation and changing prices have not significantly affected our operating results or the markets in which we operate.
Recent Accounting Pronouncements
Please refer to Note 2 to our condensed consolidated financial statements included elsewhere in this report for a discussion of the impact of the adoption of recently issued accounting standards and accounting standards not yet adopted.
Sources of Revenue and Recent Regulatory Developments
General
The healthcare industry is highly regulated, and we cannot provide any assurance that the regulatory environment in which we operate will not significantly change in the future or that we will be able to successfully address any such changes.
Every state imposes licensing requirements on individual physicians and healthcare facilities. In addition, federal and state laws regulate health maintenance organizations ("HMOs") and other managed care organizations. Many states require regulatory approval, including licensure and accreditation, and in some cases, certificates of need, before establishing certain types of healthcare facilities, including surgical hospitals and ASCs, offering certain services, including the services we offer, or making expenditures in excess of certain amounts for healthcare equipment, facilities or programs. Our ability to operate profitably will depend in part upon our surgical facilities obtaining and maintaining all necessary licenses, accreditation, certificates of need and other approvals and operating in compliance with applicable healthcare regulations. Failure to do so could have a material adverse effect on our business.
Our surgical facilities are subject to federal, state and local laws dealing with issues such as occupational safety, employment, medical leave, insurance regulations, civil rights, discrimination, building codes and medical waste and other environmental issues. Federal, state and local governments are expanding the regulatory requirements on businesses like ours. The imposition of these regulatory requirements may have the effect of increasing operating costs and reducing the profitability of our operations.
We believe that hospital, outpatient surgery, physician, laboratory and other diagnostic and healthcare services will continue to be subject to intense regulation at the federal and state levels. We are unable to predict what additional government regulations, if any, affecting our business may be enacted in the future or how existing or future laws and regulations might be interpreted. If we, or any of our surgical facilities, fail to comply with applicable laws, it might have a material adverse effect on our business.


34
SURGERY PARTNERS, INC.
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATIONS


Certificates of Need and Licensure
Capital expenditures for the construction of new healthcare facilities, the addition of beds or new healthcare services or the acquisition of existing healthcare facilities may be reviewable by state regulators under statutory schemes that are sometimes referred to as certificate of need laws. States with certificate of need laws place limits on the construction and acquisition of healthcare facilities and the expansion of existing facilities and services. In these states, approvals, generally known as certificates of need ("CON"), are required for capital expenditures exceeding certain preset monetary thresholds for the development, acquisition and/or expansion of certain facilities, equipment, or services, including those involving surgical facilities. Failure to comply with CON requirements could result in fines and/or penalties, including loss of licensure. We have a concentration of surgical facilities in certificate of need states as we believe the regulations present a competitive advantage to existing operators.
Our healthcare facilities also are subject to state licensing requirements for medical providers. Our ASCs have licenses to operate in the states in which they operate and must meet all applicable requirements for ASCs. In addition, even though our surgical facilities that are licensed as hospitals primarily provide surgical services, they must meet all applicable requirements for general hospital licensure. To assure continued compliance with these regulations, governmental and other authorities periodically inspect our surgical facilities. The failure to comply with these regulations could result in the suspension or revocation of a facility’s license. In addition, based on the specific operations of our surgical facilities, some of these facilities maintain a pharmacy license, a controlled substance registration, a clinical laboratory certification waiver, and environmental protection permits for biohazards and/or radioactive materials, as required by applicable law.
Healthcare Reform
The Affordable Care Act has been subject to a number of challenges to its constitutionality. On June 28, 2012, the United States Supreme Court struck down as unconstitutional the provision that would have allowed the federal government to revoke all federal Medicaid funding to any state that did not expand its Medicaid program. As a result, many states have refused to extend Medicaid eligibility to more individuals as envisioned by the law.
On June 25, 2015, the United States Supreme Court upheld the legality of premium subsidies made available by the federal government to individuals residing in the 36 states that have federally-run health insurance exchanges. The subsidies are provided to low-income individuals to assist with the cost of purchasing health insurance through federally-run health insurance exchanges.
Additionally, until Congress explicitly appropriates funding, President Trump ordered the Centers for Medicare and Medicaid Services (“CMS") to stop making payments to insurers that were designed to offset the cost of reductions in out-of-pocket expenses (deductibles and coinsurance) that insurers are required to provide to certain enrollees whose incomes are below certain specified levels. It is uncertain whether and when Congress will enact legislation appropriating such funds, and it is therefore uncertain whether these payments will be reinstated in the future. This uncertainty has reduced the number of health plans participating in the Exchanges and has reduced the total number of individuals covered through the Exchanges. The Trump administration has recently taken additional actions that may modify the impact of the Affordable Care Act. For example, the administration has revised federal regulations to create more opportunities for individuals to purchase insurance outside of the individual and small group insurance markets through short-term, limited duration health insurance policies and association health plans, which are subject to fewer regulations than comprehensive individual market health insurance plans. In addition, the Trump administration has taken steps to approve state requests to modify Medicaid eligibility standards, including the imposition of work and community engagement requirements, which may reduce Medicaid eligibility. These actions have added to market uncertainty, may reduce the number of health plans participating in the Exchanges, may increase insurance market premiums, and may reduce the number of individuals covered in the individual insurance market.
Initiatives to repeal the Affordable Care Act, in whole or in part, to delay elements of implementation or funding, and to offer amendments or supplements to modify its provisions have been persistent and have increased as a result of the 2016 election. The ultimate outcomes of legislative attempts to repeal or amend the Affordable Care Act and legal challenges to the Affordable Care Act are unknown. There have been numerous pieces of legislation introduced in Congress for the repeal and replacement of the Affordable Care Act. Republicans and President Trump repealed the individual mandate, effective in calendar year 2019, as part of their tax reform legislation, but did not pass the broader repeal legislation that was being considered throughout 2017. The repeal of the individual mandate will provide tax relief to individuals who forgo insurance coverage, but it is also predicted to reduce the number of covered individuals and cause premiums to increase in the individual and small group insurance markets as healthier individuals choose to not purchase coverage. Republicans have continued to call for a substantial reduction in federal spending over the next ten years primarily related to the termination of federal funding for the expanded eligibility for Medicaid coverage. Such legislation, if enacted, may have a significant impact on the reimbursement for healthcare services generally, and may cause more individuals to become uninsured, rendering them unable to afford healthcare services offered by the Company. Accordingly, there can be no assurance that the adoption of any future federal or state healthcare reform legislation will not have a negative financial impact on the Company.
Moreover, other legislative changes have also been proposed and adopted since the Affordable Care Act was enacted. On August 2, 2011, the Budget Control Act of 2011, among other things, created measures for spending reductions by Congress. A Joint Select Committee on Deficit Reduction, tasked with recommending a targeted deficit reduction of at least $1.2 trillion for the years 2013 through 2021, was unable to reach required goals, thereby triggering the legislation’s automatic reduction to several government programs. This included aggregate reductions to Medicare payments to providers of 2% per fiscal year, which went into effect on April 1, 2013 and, due to subsequent legislative amendments, will remain in effect through 2025 unless additional Congressional action is taken. On January 2, 2013, President Obama signed into law the American Taxpayer Relief Act of 2012, which, among other things, further reduced Medicare payments to several providers,


35
SURGERY PARTNERS, INC.
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATIONS


including hospitals, and increased the statute of limitations period for the government to recover overpayments to providers from three to five years. These and other similar new laws may result in additional reductions in Medicare and other health care funding, which could have a material adverse effect on our financial operations.
Medicare and Medicaid Private Contractor Audits
CMS has implemented a number of programs that use private contractors that contract with CMS to identify overpayments and underpayments and other potential sources of billing fraud. These contractors, known as Recovery Audit Contractors (“RACs”) and Unified Program Integrity Contractors (“UPICs”) conduct both post-payment and pre-payment review of claims submitted by Medicare providers. In addition, CMS employs Medicaid Integrity Contractors (“MICs”) to perform post-payment audits of Medicaid claims and identify overpayments. Our facilities and providers continue to receive letters from auditors such as RACs and UPICs requesting repayment of alleged overpayments for services and incur expenses associated with responding to and appealing these determinations, as well as the costs of repaying any overpayments. Moreover, in recent years, the increase in Medicare payment appeals has created a backlog such that resolving appeals often takes multiple years.
For instance, we received the results of a MIC audit that resulted in an overpayment obligation. HMS Federal Solutions, a MIC, completed the audit of one of our surgical hospitals for the period July 1, 2009 through May 31, 2012 and determined an overpayment obligation in the amount of approximately $4.6 million based on its extrapolation of a statistical sampling of claims, as well as a civil monetary penalty in the amount of $162,000, for a total amount owed to Idaho’s Department of Health and Welfare, Medicaid Program Integrity Unit of approximately $4.7 million for failure to comply with Medicaid rules by billing for (i) non-covered services, (ii) services provided by non-eligible providers, (iii) services not provided and (iv) unauthorized services. We appealed the audit, which was settled during the quarter ending June 30, 2017 for $1.3 million.
Although all other repayments requested to date as a result of RAC, MIC and UPIC audits have not been material to our Company, we are unable to quantify the aggregate financial impact of these audits on our facilities given the pending appeals and uncertainty about the extent of future audits.
Quality Improvement
The Medicare program presently requires hospitals and ASCs to report performance data on a variety of quality metrics. Facilities that fail to report are penalized with reduced Medicare payments. Additionally, payments to hospitals are adjusted based on the hospital’s performance on these quality measures. A substantial portion of hospital payment is at risk depending on its individual performance relative to benchmarks and other hospitals’ performance. There is a substantial risk that our Medicare payments could be reduced if our hospitals fail to perform adequately on these measures. Additionally, there is a risk that Medicare payments could be reduced if our facilities-hospitals and ASCs-fail to adequately report data as required by CMS. ASC payments are not yet adjusted based on performance against quality measures, but there is a substantial risk that Congress may soon link ASC Medicare payments to actual performance, in addition to the reporting requirements.
If public performance data becomes a primary factor in determining where patients choose to receive care, and if competing hospitals and ASCs have better results than our facilities on those measures, we would expect that our patient volumes could decline.
Medicare and Medicaid Participation
The majority of our revenue is expected to continue to be received from third-party payors, including federal and state programs, such as Medicare and Medicaid, and commercial payors. To participate in the Medicare program and receive Medicare payment, our surgical facilities must comply with regulations promulgated by the Department of Health and Human Services (“HHS”). Among other things, these regulations, known as “conditions for coverage” for ASCs and “conditions of participation” for hospitals, impose numerous requirements on our facilities, their equipment, their personnel and their standards of medical care. In addition, our facilities must maintain compliance with all applicable state and local laws and regulations. As of September 30, 2018, seven of our hospitals, which do not have an emergency room, have in place a protocol for the transfer of patients requiring emergency treatment that could be interpreted as inconsistent with a 2007 CMS survey and certification memorandum which clarified the expectation that even hospitals without emergency rooms are to appraise medical emergencies and provide initial treatment before facilitating a referral or transfer as appropriate. Such protocols could lead to an increased risk of a finding of noncompliance with CMS conditions of participation upon survey.
Our surgical facilities must also satisfy the CMS conditions for coverage to be eligible to participate in the various state Medicaid programs. The requirements for certification under Medicare and Medicaid are subject to change and, in order to remain qualified for these programs, we may have to make changes from time to time in our facilities, equipment, personnel or services. Although we intend to continue to participate in these reimbursement programs, we cannot assure you that our surgical facilities will continue to qualify for participation.
The Affordable Care Act and its implementing regulations require a hospital to provide written disclosure of physician ownership interests to the hospital’s patients and on the hospital’s website and in any advertising, along with annual reports to the government detailing such interests. Additionally, hospitals that do not have 24/7 physician coverage are required to inform patients of this fact and receive signed acknowledgment from the patients of the disclosure. A hospital’s provider agreement may be terminated if it fails to provide the required notices (if the hospital failed to resolve the deficiencies as part of the survey process). In 2010, CMS issued a “self-referral disclosure protocol” for hospitals and other providers that wish to self-disclose potential violations of the Stark Law to CMS and to attempt to resolve those potential violations and any related overpayment liabilities at levels below the maximum penalties and amounts set forth in the statute. The disclosure


36
SURGERY PARTNERS, INC.
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATIONS


requirements set forth in the Affordable Care Act and the self-referral disclosure protocol reflect a move towards increasing government scrutiny of the financial relationships between hospitals and referring physicians and increasing disclosure of potential violations of the Stark Law to the government by hospitals and other healthcare providers. We intend for all of our facilities to meet their disclosure obligations.
Survey and Accreditation
Hospitals and healthcare facilities are subject to periodic inspection by federal, state and local authorities to determine their compliance with applicable regulations and requirements necessary for licensing, certification and accreditation. All of our hospitals and surgical facilities currently are licensed under appropriate state laws and are qualified to participate in the Medicare and Medicaid programs. Renewal and continuation of certain of these licenses, certifications and accreditations are based on inspections or other reviews generally conducted in the normal course of business of healthcare facilities. Loss of, or limitations imposed on, licenses or accreditations could reduce a facility’s utilization or revenue, or its ability to operate all or a portion of its facilities.
Utilization Review
Federal law contains numerous provisions designed to ensure that services rendered by hospitals to Medicare and Medicaid patients meet professionally recognized standards and are medically necessary and that claims for reimbursement are properly filed. These provisions include a requirement that a sampling of admissions of Medicare and Medicaid patients must be reviewed by quality improvement organizations, which review the appropriateness of Medicare and Medicaid patient admissions and discharges, the quality of care provided, the validity of MS-DRG classifications and the appropriateness of cases of extraordinary length of stay or cost. Quality improvement organizations may deny payment for services provided or assess fines and also have the authority to recommend to HHS that a provider which is in substantial noncompliance with the standards of the quality improvement organization be excluded from participation in the Medicare program. Utilization review is also a requirement of most non-governmental managed care organizations.
Federal Anti-Kickback Statute and Medicare Fraud and Abuse Laws
The Social Security Act includes provisions addressing false statements, illegal remuneration and other instances of fraud and abuse in federal health care programs. These provisions include the statute commonly known as the federal Anti-Kickback statute (the “Anti-Kickback Statute”). The Anti-Kickback Statute prohibits providers and others from, among other things, soliciting, receiving, offering or paying, directly or indirectly, any remuneration in return for either making a referral for, or ordering or arranging for, or recommending the order of, any item or service covered by a federal healthcare program, including, but not limited to, the Medicare and Medicaid programs. Violations of the Anti-Kickback Statute are criminal offenses punishable by imprisonment and fines of up to $100,000 for each violation. Civil violations are punishable by fines of up to $100,000 (which are subject to annual increases for inflation) for each violation, as well as damages of up to three times the total amount of remuneration received from the government for healthcare claims.
Because physician-investors in our surgical facilities are in a position to generate referrals to the facilities, our financial arrangements with physician-investors could come under scrutiny under the Anti-Kickback Statute. Some courts have held that the Anti-Kickback Statute is violated if one purpose (as opposed to a primary or the sole purpose) of a payment to a provider is to induce referrals. Further, Section 6402(f)(2) of the Affordable Care Act amends the Anti-Kickback Statute by adding a provision to clarify that a person need not have actual knowledge of such section or specific intent to commit a violation of the Anti-Kickback Statute. Because none of these cases involved a joint venture such as those owning and operating our surgical facilities, it is not clear how a court would apply these holdings to our activities. It is clear, however, that a physician’s investment income from a surgical facility may not vary directly with the number of his or her referrals to the surgical facility, and we believe that we comply with this prohibition.
Under regulations issued by the Office of the Inspector General of the U.S. Department of Health and Human Services (the “OIG"), certain categories of activities are deemed not to violate the Anti-Kickback Statute (commonly referred to as the safe harbors). The failure of a particular business arrangement to comply with a safe harbor does not determine whether the arrangement violates the Anti-Kickback Statute. The safe harbor regulations do not make conduct illegal, but instead outline standards that, if complied with, protect conduct that might otherwise be deemed in violation of the Anti-Kickback Statute. Failure to meet a safe harbor does not indicate that the arrangement violates the Anti-Kickback Statute, although it may be subject to additional scrutiny.
We believe the ownership and operations of our surgery centers and hospitals do not fit wholly within any of the safe harbors, but we attempt to structure our ASCs to fit as closely as possible within the safe harbor designed to protect distributions to physician-investors in ASCs who directly refer patients to the ASC and personally perform the procedures at the center as an extension of their practice (the “ASC Safe Harbor”). The ASC Safe Harbor protects four categories of investors, including ASCs owned by (1) general surgeons, (2) single-specialty physicians, (3) multi-specialty physicians and (4) hospital/physician joint ventures, provided that certain requirements are satisfied. These requirements include the following:
•
The ASC must be an ASC certified to participate in the Medicare program, and its operating and recovery room space must be dedicated exclusively to the ASC and not a part of a hospital (although such space may be leased from a hospital if such lease meets the requirements of the safe harbor for space rental).
•
Each investor must be either (a) a physician who derived at least one-third of his or her medical practice income for the previous fiscal year or 12-month period from performing procedures on the list of Medicare-covered procedures for ASCs, (b) a hospital, or (c) a person or entity not in a position to make or influence referrals to the center, nor to provide items or services to the ASC, nor employed by the ASC or any investor.


37
SURGERY PARTNERS, INC.
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATIONS


•
Unless all physician-investors are members of a single specialty, each physician-investor must perform at least one-third of his or her procedures at the ASC each year. This requirement is in addition to the requirement that the physician-investor has derived at least one-third of his or her medical practice income for the past year from performing procedures.
•
Physician-investors must have fully informed their referred patients of the physician’s investment.
•
The terms on which an investment interest is offered to an investor are not related to the previous or expected volume of referrals, services furnished or the amount of business otherwise generated from that investor to the entity.
•
Neither the ASC nor any other investor nor any person acting on their behalf may loan funds to or guarantee a loan for an investor if the investor uses any part of such loan to obtain the investment interest.
•
The amount of payment to an investor in return for the investment interest is directly proportional to the amount of the capital investment (including the fair market value of any pre-operational services rendered) of that investor.
•
All physician-investors, any hospital-investor and the center agree to treat patients receiving benefits or assistance under a federal healthcare program in a non-discriminatory manner.
•
All ancillary services performed at the ASC for beneficiaries of federal healthcare programs must be directly and integrally related to primary procedures performed at the ASC and may not be billed separately.
•
No hospital-investor may include on its cost report or any claim for payment from a federal healthcare program any costs associated with the ASC.
•
The ASC may not use equipment owned by or services provided by a hospital-investor unless such equipment is leased in accordance with a lease that complies with the Anti-Kickback Statute equipment rental safe harbor and such services are provided in accordance with a contract that complies with the Anti-Kickback Statute personal services and management contract safe harbor.
•
No hospital-investor may be in a position to make or influence referrals directly or indirectly to any other investor or the ASC.
We believe that the ownership and operations of our surgical centers will not satisfy this ASC Safe Harbor for investment interests in ASCs because, among other things, we or one of our subsidiaries will generally be an investor in and provide management services to each ASC. We do not believe the ownership and operations of our surgery centers violates the Anti-Kickback Statute because, among other things, we have adopted most of the safeguards required by the ASC Safe Harbor, but we cannot assure you that the OIG would not take the position that our activities violate the Anti-Kickback Statute because we do not meet all of the requirements of the ASC Safe Harbor.
In addition, although we expect each physician-investor to utilize the ASC as an extension of his or her practice and ask each physician-investor to certify this practice, we cannot assure you that all physician-investors will derive at least one-third of their medical practice income from performing Medicare-covered ASC procedures, perform one-third of their procedures at the ASC (if multi-specialty) or inform their referred patients of their investment interests. Interests in our ASC joint ventures are purchased at what we believe to be fair market value. Investors who purchase at a later time generally pay more for a given percentage interest than founding investors. The result is that while all investors are paid distributions in accordance with their ownership interests, for ASCs where there are later purchases, we cannot meet the safe harbor requirement that return on investment is directly proportional to the amount of capital investment. The OIG has on several occasions reviewed investments relating to ASCs, and in Advisory Opinion No. 07-05, raised concerns that (a) purchases of interests from physicians might yield gains on investment rather than capital infusion to the ASCs, (b) such purchases could be meant to reward or influence the selling physicians’ referrals to the ASC or the hospital, and (c) such returns might not be directly proportional to the amount of capital invested. Nonetheless, we believe our fair market value purchase requirements and distribution policies comply with the Anti-Kickback Statute.
In OIG Advisory Opinion No. 09-09 (July 29, 2009), the OIG concluded that an arrangement involving an ASC joint venture between a hospital and physicians involving the combination of their two ASCs into a single, larger ASC presented minimal risk of fraud or abuse, despite the fact that it did not fit within any applicable Anti-Kickback safe harbors. Additionally, the OIG stated that fair market value should be determined based only on the tangible assets of each ASC since the physician investors are referral sources for the ASC. The OIG stated that a cash flow-based valuation of the business contributed by the physician investors potentially would include the value of the physician investors’ referrals over the time that their ASC was in existence prior to the merger with the hospital’s ASC. The OIG went on to note that a valuation involving intangible assets would not necessarily result in a violation of the Anti-Kickback Statute, but would require a review of all the facts and circumstances. It is not clear whether the OIG is concerned about using a cash flow-based valuation in most healthcare transactions involving referral sources, or just transactions, similar to this one, where the parties’ contributions would be valued differently for contributing the same assets if only one party’s contribution is valued as a going concern based on cash flow. Also, the OIG appears to be focused on historical cash flow rather than a projected, discounted cash flow, which is a commonly used valuation methodology. What is clear is that for the first time, the OIG addressed valuation methodologies, which could lead to increased scrutiny of all transactions involving physicians.
Our hospital investments do not fit wholly within the safe harbor for investments in small entities because more than 40.0% of the investment interests are held by investors who are either in a position to refer to the hospital or who provide services to the hospital and more than 40.0% of the hospital’s gross revenue last year were derived from referrals generated by investors. However, we believe we comply with the remaining elements of the safe harbor.


38
SURGERY PARTNERS, INC.
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATIONS


In addition to the physician ownership in our surgical facilities, other financial relationships of ours with potential referral sources could potentially be scrutinized under the Anti-Kickback Statute. We have entered into management agreements to manage the majority of our surgical facilities. Most of these agreements call for our subsidiary to be paid a percentage-based management fee. Although there is a safe harbor for personal services and management contracts (the “Personal Services and Management Safe Harbor”), the Personal Services and Management Safe Harbor requires, among other things, that the amount of the aggregate compensation paid to the manager over the term of the agreement be set in advance. Because our management fees are generally based on a percentage of revenue, our management agreements do not typically meet this requirement. We do, however, believe that our management arrangements satisfy the other requirements of the Personal Services and Management Safe Harbor for personal services and management contracts. The OIG has taken the position in several advisory opinions that percentage-based management agreements are not protected by a safe harbor, and consequently, may violate the Anti-Kickback Statute. We have implemented formal compliance programs designed to safeguard against overbilling and believe that our management agreements comply with the requirements of the Anti-Kickback Statute. However, we cannot assure you that the OIG would find our compliance programs to be adequate or that our management agreements would be found to comply with the Anti-Kickback Statute.
Certain of our ASCs have entered into arrangements for professional services, including arrangements for anesthesia services. In a Special Advisory Bulletin issued in April 2003, the OIG focused on “questionable” contractual arrangements where a health care provider in one line of business (the “Owner”) expands into a related health care business by contracting with an existing provider of a related item or service (the “Manager/Supplier”) to provide the new item or service to the Owner’s existing patient population, including federal health care program patients (so called “suspect Contractual Joint Ventures”). The Manager/Supplier not only manages the new line of business, but may also supply it with inventory, employees, space, billing, and other services. In other words, the Owner contracts out substantially the entire operation of the related line of business to the Manager/Supplier-otherwise a potential competitor-receiving in return the profits of the business as remuneration for its referrals. Through an Advisory Opinion, the OIG extended this suspect contractual joint venture analysis to arrangements between anesthesiologists and physician owners of ASCs. In Advisory Opinion 12-06, the OIG concluded that certain proposed arrangements between anesthesia groups and physician-owned ASCs could result in prohibited remuneration under the federal Anti-Kickback Statute. We believe our arrangements for anesthesia services are distinguishable from those described in Advisory Opinion 12-06 (May 25, 2012) and are in compliance with the requirements of the federal Anti-Kickback Statute. However, we cannot assure you that regulatory authorities would agree with that position.
We also may guarantee a surgical facility’s third-party debt financing and certain lease obligations as part of our obligations under a management agreement. Physician investors are generally not required to enter into similar guarantees. The OIG might take the position that the failure of the physician investors to enter into similar guarantees represents a special benefit to the physician investors given to induce patient referrals and that such failure constitutes a violation of the Anti-Kickback Statute. We believe that the management fees (and in some cases guarantee fees) are adequate compensation to us for the credit risk associated with the guarantees and that, therefore, the failure of the physician investors to enter into similar guarantees does not create a material risk of violating the Anti-Kickback Statute. However, the OIG has not issued any guidance in this regard.
The OIG is authorized to issue advisory opinions regarding the interpretation and applicability of the Anti-Kickback Statute, including whether an activity constitutes grounds for the imposition of civil or criminal sanctions. We have not, however, sought such an opinion regarding any of our arrangements. If it were determined that our activities, or those of our surgical facilities or hospitals, violate the Anti-Kickback Statute, we, our subsidiaries, our officers, our directors and each surgical facility and hospital investor could be subject, individually, to substantial monetary liability, prison sentences and/or exclusion from participation in any healthcare program funded in whole or in part by the U.S. government, including Medicare, Medicaid, TRICARE or state healthcare programs.
Evolving interpretations of current, or the adoption of new, federal or state laws or regulations could affect many of our arrangements. Law enforcement authorities, including the OIG, the courts and Congress, are increasing their scrutiny of arrangements between healthcare providers and potential referral sources to ensure that the arrangements are not designed as a mechanism to exchange remuneration for patient care referrals or opportunities. Investigators have also demonstrated a willingness to look behind the formalities of a business transaction to determine the underlying purposes of payments between healthcare providers and potential referral sources.
Federal Physician Self-Referral Law
Congress has enacted the federal physician self-referral law, or Stark Law, that prohibits certain self-referrals for healthcare services. As currently enacted, the Stark Law prohibits a practitioner, including a physician, dentist or podiatrist, from referring patients to an entity with which the practitioner or a member of his or her immediate family has a “financial relationship” for the provision of certain “designated health services” that are payable, in whole or in part, by Medicare unless an exception applies. The term “financial relationship” is broadly defined and includes most types of ownership and compensation relationships. The Stark Law also prohibits the entity from seeking payment from Medicare for services that are rendered through a prohibited referral and prohibits payment of federal financial participation payments to a state for designated health services payable by the state's Medicaid plan when the designated health service is furnished pursuant to a referral that would be prohibited by the Stark Law. If an entity is paid for services provided through a prohibited referral, it may be required to refund the payments. Violations of the Stark Law may also result in the imposition of damages equal to three times the amount improperly claimed and civil monetary penalties of up to $15,000 per prohibited claim and $100,000 per prohibited circumvention scheme and exclusion from participation in state or federal healthcare programs. For the purposes of the Stark Law, the term “designated health services” is defined to include:
•
clinical laboratory services;


39
SURGERY PARTNERS, INC.
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATIONS


•
physical therapy services;
•
occupational therapy services;
•
radiology services, including magnetic resonance imaging, computerized axial tomography scan and ultrasound services;
•
radiation therapy services and supplies;
•
durable medical equipment and supplies;
•
parenteral and enteral nutrients, equipment and supplies;
•
prosthetics, orthotics and prosthetic devices and supplies;
•
home health services;
•
outpatient prescription drugs; and
•
inpatient and outpatient hospital services.
The list of designated health services does not, however, include surgical services that are provided in an ASC. Furthermore, in final Stark Law regulations published by HHS on January 4, 2001, the term “designated health services” was specifically defined to not include services that are reimbursed by Medicare as part of a composite rate, such as services that are provided in an ASC. However, if designated health services are provided by an ASC and separately billed, referrals to the ASC by a physician-investor would be prohibited by the Stark Law. Because our facilities that are licensed as ASCs do not have independent laboratories and do not provide designated health services apart from surgical services, we do not believe referrals to these facilities by physician-investors are prohibited. If legislation or regulations are implemented that prohibit physicians from referring patients to surgical facilities in which the physician has a beneficial interest, our business and financial results would be materially adversely affected.
Eighteen of our facilities are licensed as hospitals as of September 30, 2018. The Stark Law currently includes the Whole Hospital Exception, which applies to physician ownership of a hospital, provided such ownership is in the whole hospital and the physician is authorized to perform services at the hospital. We believe that physician investments in our facilities licensed as hospitals meet this requirement. However, changes to the Whole Hospital Exception have been the subject of recent regulatory action and legislation. Changes in the Affordable Care Act include:
•
a prohibition on hospitals from having any physician ownership unless the hospital already had physician ownership and a Medicare provider agreement in effect as of December 31, 2010;
•
a limitation on the percentage of total physician ownership or investment interests in the hospital or entity whose assets include the hospital to the percentage of physician ownership or investment as of March 23, 2010;
•
a prohibition from expanding the number of beds, operating rooms, and procedure rooms for which it is licensed after March 23, 2010, unless the hospital obtains an exception from the Secretary;
•
a requirement that return on investment be proportionate to the investment by each investor;
•
restrictions on preferential treatment of physician versus non-physician investors;
•
a requirement for written disclosures of physician ownership interests to the hospital’s patients and on the hospital’s website and in any advertising, along with annual reports to the government detailing such interests;
•
a prohibition on the hospital or other investors from providing financing to physician investors;
•
a requirement that any hospital that does not have 24/7 physician coverage inform patients of this fact and receive signed acknowledgments from the patients of the disclosure; and
•
a prohibition on “grandfathered” status for any physician owned hospital that converted from an ASC to a hospital on or after March 23, 2010.
The Affordable Care Act also requires that each hospital with physician ownership submit an annual report of ownership and/or investment interest. Our hospitals have submitted their first reports. CMS has delayed the collection of the second report and publication of the first annual report. We cannot predict whether other proposed amendments to the Whole Hospital Exception will be included in any future legislation, including a repeal of the Affordable Care Act, or if Congress will adopt any similar provisions that would prohibit or otherwise restrict physicians from holding ownership interests in hospitals. Any such changes could have an adverse effect on our financial condition and results of operations.
In addition to the physician ownership in our surgical facilities, we have other financial relationships with potential referral sources that potentially could be scrutinized under the Stark Law. We have entered into personal service agreements, such as medical director agreements, with physicians at our hospitals. We believe that our agreements with referral sources satisfy the requirements of the personal service arrangements exception to the Stark Law and have implemented formal compliance programs designed to ensure continued compliance. However, we cannot assure you that the OIG or CMS would find our compliance programs to be adequate or that our agreements with referral sources would be found to comply with the Stark Law.


40
SURGERY PARTNERS, INC.
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATIONS


False and Other Improper Claims
The U.S. government is authorized to impose criminal, civil and administrative penalties on any person or entity that files a false claim for payment from the Medicare or Medicaid programs or other federal and state healthcare programs. Claims filed with private insurers can also lead to criminal and civil penalties, including, but not limited to, penalties relating to violations of federal mail and wire fraud statutes, as well as penalties under the anti-fraud provisions of HIPAA. While the criminal statutes are generally reserved for instances of fraudulent intent, the U.S. government is applying its criminal, civil and administrative penalty statutes in an ever-expanding range of circumstances. For example, the U.S. government has taken the position that a pattern of claiming reimbursement for unnecessary services violates these statutes if the claimant merely should have known the services were unnecessary, even if the government cannot demonstrate actual knowledge. The U.S. government has also taken the position that claiming payment for low-quality services is a violation of these statutes if the claimant should have known that the care being provided was substandard.
Over the past several years, the U.S. government has investigated an increasing number of healthcare providers for potential violations of the federal False Claims Act. The federal False Claims Act prohibits a person from knowingly presenting, or causing to be presented, a false or fraudulent claim to the U.S. government. The statute defines “knowingly” to include not only actual knowledge of a claim’s falsity, but also reckless disregard for or deliberate ignorance of the truth or falsity of a claim. The Fraud Enforcement and Recovery Act of 2009 further expanded the scope of the False Claims Act by, among other things, creating liability for knowingly and improperly avoiding or decreasing an obligation to pay money to the federal government. The Affordable Care Act also created federal False Claims Act liability for the knowing failure to report and return an overpayment within 60 days of the identification of the overpayment or the date by which a corresponding cost report is due, whichever is later. This requirement has led to an increasing use of the self-disclosure protocols that have been implemented by CMS, the OIG and other governmental agencies by the healthcare industry. The Affordable Care Act also provided that claims submitted in connection with patient referrals that result from violations of the Anti-Kickback Statute constitute false claims for the purposes of the federal False Claims Act, and some courts have held that a violation of the Stark Law can result in False Claims Act liability as well. Because our surgical facilities perform hundreds of similar procedures a year for which they are paid by Medicare and other government health care programs, and there is a relatively long statute of limitations, a billing error or cost reporting error could result in significant civil or criminal penalties.
Under the qui tam, or whistleblower, provisions of the False Claims Act, private parties may bring actions on behalf of the U.S. government. These private parties, often referred to as relators, are entitled to share in any amounts recovered by the government through trial or settlement. Both whistleblower lawsuits and direct enforcement activity by the government have increased significantly in recent years and have increased the risk that a healthcare company, like us, will have to defend a false claims action, pay fines or be excluded from the Medicare and Medicaid programs and other federal and state healthcare programs as a result of an investigation resulting from a whistleblower case. Although we believe that our operations materially comply with both federal and state laws, they may nevertheless be the subject of a whistleblower lawsuit or may otherwise be challenged or scrutinized by governmental authorities. Providers found liable for False Claims Act violations are subject to damages of up to three times the actual damage sustained by the government plus mandatory civil monetary penalties. The per claim penalties for False Claims Act violations occurring on or after November 2, 2015 and assessed after January 29, 2018 are between $11,181 and $22,363 per claim, and these penalty amounts are periodically readjusted for inflation. A determination that we have violated these laws could have a material adverse effect on us.
Other Fraud and Abuse Laws
The Social Security Act (“SSA”), as amended by the Medicare Patient and Program Protection Act of 1987, as amended by the Health Insurance Portability and Accountability Act of 1996, (“HIPAA”), and the Balanced Budget Act of 1997, impose civil monetary penalties and exclusion from state and federal healthcare programs on individuals or entities who commit violations of fraud and abuse laws. SSA authorizes the Secretary of the Department of Health & Human Services (“Secretary”), and in some cases requires the Secretary, to exclude individuals and entities that have been convicted of certain criminal offenses or that the Secretary determines have “committed an act” in violation of applicable fraud and abuse laws or improperly filed claims in violation of such laws from participating in any federal healthcare program. Federal health care programs include Medicare, Medicaid, and other programs that provide health benefits, whether directly or indirectly, in whole or in part, by the U.S. government (except the Federal Employee Health Benefits Program). Additionally, individuals who hold a direct or indirect ownership or controlling interest in an entity that has been convicted of certain criminal offenses or has been excluded may also be excluded from federal and state healthcare programs if the individual knew or acted with deliberate ignorance or reckless disregard of the basis for the conviction or exclusion of the entity, or where the individual is an officer or managing employee of such entity. This standard does not require that specific intent to defraud be proven by OIG. Under HIPAA it is also a crime to defraud any commercial healthcare benefit program.
Federal and State Privacy and Security Requirements
The Health Insurance Portability and Accountability Act, Public Law 104-191, the Health Information Technology for Economic and Clinical Health Act, Public Law 111-5 § 13001 et seq., and their implementing regulations (collectively, “HIPAA”) govern the privacy, security, and breach of “protected health information” (“PHI”) by “covered entities” and “business associates”. A “covered entity” is a health plan, a health care clearinghouse, or a health care provider that engages in certain electronic transactions as described by HIPAA involving PHI. A “business associate” is a person that provides services to, or performs a function on behalf of, a covered entity involving the creation, receipt, maintenance, or transmission of PHI by that person. Our affiliates and subsidiaries that own and operate surgical facilities or hospitals are generally covered entities. Our affiliates and subsidiaries that provide management or administrative services to surgical facilities or hospitals are generally business associates.


41
SURGERY PARTNERS, INC.
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATIONS


HIPAA requires that covered entities and business associates, such as our affiliates and subsidiaries, among other things: (i) appoint a privacy officer and a security officer; (ii) maintain written privacy, security, and breach notification compliance policies and procedures implementing the HIPAA privacy, security, and breach notification standards; (iii) conduct a comprehensive information security risk analysis and implement and review regularly the administrative, physical, and technical safeguards that the covered entity or business associate applies with respect to electronic PHI; (iv) report “breaches” of “unsecured PHI” to certain third parties; (v) enter into “business associate contracts” with upstream covered entities and downstream business associates or “subcontractors;” and (vi) train applicable “workforce” members regarding compliance with the HIPAA privacy, security, and breach notification standards, as well as the covered entity’s or business associate’s own written privacy, security, and breach notification compliance policies and procedures.
The HIPAA privacy standards apply to individually identifiable information held or disclosed by a covered entity or business associate in any form, whether communicated electronically, on paper or orally. These standards impose extensive administrative requirements on us. These standards require our compliance with rules governing the use and disclosure of this health information. They create rights for patients in their health information, such as the right to amend their health information, and they require us to impose these rules, by contract, on any business associate to whom we disclose such information in order to perform functions on our behalf.
The HIPAA security standards require us to establish and maintain reasonable and appropriate administrative, technical and physical safeguards to ensure the integrity, confidentiality and the availability of electronic protected health and related financial information. Although the security standards do not reference or advocate a specific technology, and covered healthcare providers, plans and clearinghouses have the flexibility to choose their own technical solutions, the security standards have required us to implement significant new systems, business procedures and training programs.
HIPAA breach notification standards require us to report breaches of unsecured PHI to certain third parties, including affected individuals, HHS, and the media.
Violations of the HIPAA privacy, security, and breach notification standards may result in civil money or criminal penalties. HHS has authority to impose civil money penalties against covered entities and business associates for failure to comply with HIPAA’s requirements. These penalties may range from $100 to $1.5 million per each violated requirement per year, depending on the culpability and knowledge of the covered entity or business associate. However, a single breach incident, investigation, or audit can result in violations of multiple requirements, resulting in possible penalties well in excess of $1.5 million. HHS is required to conduct periodic compliance audits of covered entities and their business associates. HHS has allocated increased funding towards HIPAA enforcement activity, and such enforcement activity has seen an increase in recent years. We cannot predict whether our surgical facilities or hospitals will be selected for an audit, or the results of such an audit.
HIPAA authorizes state attorneys general to bring civil actions seeking either an injunction or damages in response to violations of the HIPAA privacy, security, and breach notification standards that affect their states’ residents.
Our facilities are also subject to any state laws that relate to privacy or the reporting of data breaches that are more restrictive than HIPAA. For example, various state laws and regulations may require us to notify affected individuals in the event of a data breach involving certain personal information, such as social security numbers, dates of birth and credit card information.
Adoption of Electronic Health Records
The HITECH Act, which was enacted as part of the American Recovery and Reinvestment Act of 2009, included provisions designed to increase the use of EHR by both physicians and hospitals. Beginning in 2011 and extending through 2016, Medicare eligible hospitals and professionals could receive incentive payments based upon successfully demonstrating meaningful use of its certified EHR technology. Beginning in 2015, those Medicare eligible hospitals and professionals that did not successfully demonstrate meaningful use of certified EHR technology began to be subject to reduced payments from Medicare. Starting in 2019, Medicare eligible professionals will no longer be subject to a downward payment adjustment for failing to demonstrate meaningful use. Instead, Medicare eligible professionals will receive a payment increase or reduction based on their participation in the Merit-based Incentive Payment System (“MIPS”) or an advanced alternative payment model (e.g., an accountable care organization meeting certain requirements). All Medicare eligible professionals that do not participate in an advanced alternative payment model will be subject to MIPS. MIPS evaluates Medicare eligible professionals on various quality and cost measures, as well as their use of certified EHR technology. These measures make up an overall MIPS performance score that is used by CMS to determine whether a Medicare eligible professional will receive an increase or reduction to its Medicare reimbursement. The payment increase or reduction in 2019 will be based on the Medicare eligible professional’s MIPS performance score in 2017. Our facilities licensed as hospitals began the implementation of certified EHR technology to qualify for incentives in 2012. We strive to comply with the EHR meaningful use requirements of the HITECH Act so as to avoid payment reductions. Continued implementation of certified EHR technology and compliance with the HITECH Act may result in significant costs.
HIPAA Administrative Simplification Requirements
The HIPAA transaction regulations were issued to encourage electronic commerce in the healthcare industry. These regulations include standards that healthcare providers must follow when electronically transmitting certain healthcare transactions, such as healthcare claims.
Emergency Medical Treatment and Active Labor Act
Our hospitals are subject to the Emergency Medical Treatment and Labor Act (“EMTALA”). EMTALA is a federal civil statute that requires Medicare-participating hospitals to provide any individual that presents to a dedicated emergency department requesting examination


42
SURGERY PARTNERS, INC.
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATIONS


or treatment with a medical screening examination to determine the presence or absence of an emergency medical condition and to provide treatment sufficient to stabilize such emergency medical condition before discharging or transferring the patient. The obligation to screen and stabilize emergency medical conditions or transfer exists regardless of a patient’s ability to pay for treatment. Off-campus facilities such as surgery centers that lack dedicated emergency departments or otherwise do not treat emergency medical conditions generally are not subject to EMTALA. However, such facilities must have policies in place to address how the facility is to proceed if an individual presents in need of emergency care, such as providing immediate first aid and transferring the patient to the closest hospital with an emergency department.
A hospital found to have violated EMTALA may be subject to civil monetary penalties (“CMPs”) and termination of its Medicare provider agreement, which renders the hospital unable to participate in federal health care programs. CMPs for EMTALA violations found to have occurred in 2017 may be imposed against hospitals up to $104,826 per violation. This CMP amount is scheduled to increase annually in accordance with changes to the Consumer Price Index, as established by government mandate and published in the Federal Register. EMTALA also provides for a limited private right of action against hospitals, and as a result a hospital could be subject to claims for personal injury where an individual suffers harm as a result of an EMTALA violation, or where another medical facility suffers a financial loss as a direct result of a hospital’s violation of the law.
CMS has actively enforced EMTALA and has indicated that it will continue to do so in the future. Although we believe that our hospitals comply with EMTALA, given the complexities of the law and the heightened enforcement environment we cannot predict whether a particular patient care incident might trigger an investigation or whether CMS will implement even more stringent requirements in the future and, if so, whether our hospitals will be in a position to demonstrate continued compliance. See also Medicare and Medicaid Participation.
State Regulation
Many of the states in which our surgical facilities operate have adopted statutes and/or regulations that prohibit the payment of kickbacks or any type of remuneration in exchange for patient referrals and that prohibit healthcare providers from, in certain circumstances, referring a patient to a healthcare facility in which the provider has an ownership or investment interest. While these statutes generally mirror the federal Anti-Kickback Statute and Stark Law, they vary widely in their scope and application. Some are specifically limited to healthcare services that are paid for in whole or in part by the Medicaid program; others apply to all healthcare services regardless of payor; and others apply only to state-defined designated services, which may differ from the designated health services under the Stark Law. In addition, many states have adopted statutes that mirror the False Claims Act and that prohibit the filing of a false or fraudulent claim with a state governmental agency. We intend to comply with all applicable state healthcare laws, rules and regulations. However, these laws, rules and regulations have typically been the subject of limited judicial and regulatory interpretation. As a result, we cannot assure you that our surgical facilities will not be investigated or scrutinized by the governmental authorities empowered to do so or, if challenged, that their activities would be found to be lawful. A determination of non-compliance with the applicable state healthcare laws, rules, and regulations could subject our surgical facilities to civil and criminal penalties and could have a material adverse effect on our operations.
We are also subject to various state insurance statutes and regulations that prohibit us from submitting inaccurate, incorrect or misleading claims. Many state insurance laws and regulations are broadly worded and could be implicated, for example, if our surgical facilities were to adjust an out-of-network co-payment or other patient responsibility amounts without fully disclosing the adjustment on the claim submitted to the payor. While some of our surgical facilities adjust the out-of-network costs of patient co-payment and deductible amounts to reflect in-network co-payment costs when providing services to patients whose health insurance is covered by a payor with which the surgical facilities are not contracted, our policy is to fully disclose adjustments in the claims submitted to the payors. Additionally, many states have adopted or are considering standards that may limit the amount of our costs we may recover from patients for whom we are an out-of-network provider. In such case, we may be limited in recovering our costs above and beyond what is paid by the non-contracted payor. The adoption of such standards may reduce our collections and negotiating power with payors. We believe that our surgical facilities are in compliance with all applicable state insurance laws and regulations regarding the submission of claims. We cannot assure you, however, that none of our surgical facilities’ insurance claims will ever be challenged. If we were found to be in violation of a state’s insurance laws or regulations, we could be forced to discontinue the violative practice, which could have an adverse effect on our financial position and results of operations, and we could be subject to fines and criminal penalties.
Fee Splitting; Corporate Practice of Medicine
Many states have enacted fee splitting laws that prohibit physicians from splitting professional fees with non-physicians. Many states have also implemented corporate practice of medicine restrictions, which generally prohibit non-professional entities (such as us) from practicing medicine, exercising control over clinical decision-making, or employing physicians. The existence, interpretation and enforcement of these laws vary significantly from state to state. In light of these restrictions, in certain states we enter into long-term management services agreements through our subsidiaries with affiliated medical practices, which employ or contract with physicians and other healthcare professionals. Under these arrangements, our subsidiary management companies perform only non-medical administrative services, do not represent that they offer medical services, and do not exercise influence or control over the practice of medicine. Although we believe that the management fees we receive from our affiliated medical practices have been structured in a manner that is compliant with applicable fee-splitting laws, it is possible that a government regulator could interpret such fee arrangements to be in violation of certain fee-splitting laws. Future interpretations of, or changes in, these laws might require structural and organizational modifications of our existing management relationships, and we cannot assure you that we would be able to appropriately modify such relationships. In addition, statutes in some states could restrict our expansion into those states.


43
SURGERY PARTNERS, INC.
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATIONS


Clinical Laboratory Regulation
Our clinical laboratories are subject to federal oversight under the Clinical Laboratory Improvement Amendments of 1988 (“CLIA”), which extends federal oversight to non-exempt clinical laboratories by requiring that they be certified by the federal government, by a federally-approved accreditation organization, or by a state with a licensure program that has an exemption from CLIA program requirements. CLIA requires clinical laboratories to meet certain quality assurance, quality control, proficiency testing, inspection, and personnel standards, as may be applicable. The requirements that apply under CLIA are based on the complexity of the tests performed by the laboratory, with tests classified as “high complexity,” “moderate complexity,” or “waived.” Laboratories performing high complexity testing are required to meet more stringent requirements than laboratories that perform only moderate complexity or waived tests. Laboratories performing only waived tests (which are tests that have been cleared by the Food and Drug Administration for home use, employ methodologies that are so simple and accurate as to render the likelihood of erroneous results negligible, or pose no reasonable risk of harm to the patient if the test is performed incorrectly) may apply for a certificate of waiver exempting them from most of the requirements of CLIA.
Our operations are also subject to state and local laboratory regulation. State or local laboratory regulatory schemes may impose requirements that are different from or more stringent than the requirements imposed under federal law. A number of states have implemented their own laboratory licensure requirements. State laws may also require that laboratories meet other regulatory requirements, such as that laboratory personnel meet certain qualifications, that certain quality control procedures be implemented, or that certain records be maintained for a period of time (among other requirements). We believe that we are in material compliance with all applicable laboratory requirements, but no assurances can be given that our laboratories will pass all future licensure or certification inspections.
Regulatory Compliance Program
It is our policy to conduct our business with integrity and in compliance with the law. We have in place and continue to enhance a company-wide compliance program that focuses on all areas of regulatory compliance including billing, reimbursement, cost reporting practices and contractual arrangements with referral sources.
This regulatory compliance program is intended to help ensure that high standards of conduct are maintained in the operation of our business and that policies and procedures are implemented so that employees act in full compliance with all applicable laws, regulations and company policies. Under the regulatory compliance program, every employee and certain contractors involved in patient care, and coding and billing, receive initial and periodic legal compliance and ethics training. In addition, we regularly monitor our ongoing compliance efforts and develop and implement policies and procedures designed to foster compliance with the law. The program also includes a mechanism for employees to report, without fear of retaliation, any suspected legal or ethical violations to their supervisors, designated compliance officers in our facilities, our compliance hotline or directly to our corporate compliance office. We believe our compliance program is consistent with standard industry practices. However, we cannot provide any assurances that our compliance program will detect all violations of law or protect against qui tam suits or government enforcement actions.


44

Item 3. Quantitative and Qualitative Disclosures about Market Risk
We are subject to market risk primarily from exposure to changes in interest rates based on our financing, investing and cash management activities. We utilize a balanced mix of maturities along with both fixed rate and variable rate debt to manage our exposures to changes in interest rates, and do not hold or issue any derivative financial instruments for this purpose. 
Our variable rate debt instruments are primarily indexed to the prime rate or LIBOR. Interest rate changes would result in gains or losses in the market value of our fixed rate debt portfolio due to differences in market interest rates and the rates at the inception of the debt agreements. At September 30, 2018, we had outstanding principal amount of debt of $962.8 million in variable rate instruments. Assuming a hypothetical 100 basis points increase in LIBOR on our debt as of September 30, 2018, our quarterly interest expense would increase by approximately $2.4 million. Although there can be no assurances that interest rates will not change significantly, we do not expect changes in interest rates to have a material effect on our net earnings or cash flows in 2018 based on our indebtedness at September 30, 2018.
Item 4. Controls and Procedures
An evaluation was performed under the supervision and with the participation of our management, including the Chief Executive Officer and the Chief Financial Officer, of the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities and Exchange Act of 1934, as amended (the “Exchange Act”)) as of the end of the period covered by this report to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act, is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including the Chief Executive Officer and the Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure. Based on, and as of the time of such evaluation, our management, including the Chief Executive Officer and Chief Financial Officer, concluded that our disclosure controls and procedures were not effective as a result of the material weaknesses identified by management as disclosed under “Item 9A-Controls and Procedures” in our Annual Report on Form 10-K for the year ended December 31, 2017.
Such material weaknesses pertain to lack of documentation evidencing certain controls involving revenue, accounts receivable and related allowances and business combinations. Notwithstanding the identified material weaknesses, as of the date of this filing, management, including the Chief Executive Officer and Chief Financial Officer, believes that the unaudited consolidated financial statements contained in this Quarterly Report on Form 10-Q fairly present, in all material respects, our financial condition, results of operations and cash flows for the fiscal years presented in conformity with GAAP. Management is actively engaged in the implementation of a remediation plan to address the lack of documentation issue. The plan includes the implementation of enhanced documentation policies and procedures, along with the allocation of resources dedicated to training and monitoring these policies and procedures.
As a result of these efforts, as of the date of this filing management believes we have made progress toward remediating the underlying causes of the material weaknesses. Although we believe our remediation efforts will be effective in remediating the material weaknesses, there can be no assurance as to when the remediation plan will be fully implemented, or that the plan, as currently designed, will adequately remediate the material weaknesses. The material weaknesses will not be considered fully addressed until the enhanced policies and procedures over documentation evidencing certain controls involving revenue, accounts receivable and related allowances and business combinations have been in operation for a sufficient period of time for our management to conclude that the material weaknesses have been fully remediated. We will continue to work on implementing and testing the enhanced documentation policies and procedures in order to make this final determination.
Other than our progress in our remediation efforts outlined above, there have been no changes during the quarter ended September 30, 2018 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.


45

PART II - OTHER INFORMATION
Item 1. Legal Proceedings
Stockholder Litigation. On December 4, 2017, the Company, certain current and former members of the Company’s board of directors, H.I.G. Capital LLC and certain of its affiliates and Bain Capital Private Equity, L.P. and certain of its affiliates and advised funds (collectively, the “Defendants”) were named as defendants in a suit filed in the Delaware Court of Chancery (the “Delaware Action”) by a purported Company stockholder relating to the Transactions. The plaintiff in the Delaware Action claims that the Defendants breached their fiduciary duties in connection with the Transactions, and that, in the alternative, Bain Capital aided and abetted those purported breaches. The plaintiff in the Delaware Action purports to assert those claims on the Company’s behalf, as well as on behalf of a putative class of Company stockholders and requests that the Court award monetary damages to the purported class and/or the Company. On January 2, 2018 the defendants in the Delaware Action moved to dismiss all of the claims asserted in that suit. The defendants' motions to dismiss have been fully briefed and argued, and the parties await a decision from the court.
Other Litigation. In addition, we are, from time to time, subject to claims and suits, or threats of claims or suits, relating to our business, including claims for damages for personal injuries, breach of management contracts and employment related claims. In certain of these actions, plaintiffs request payment for damages, including punitive damages, which may not be covered by insurance or may otherwise have a material adverse effect on our business or results of operations. See Note 7. Commitments and Contingencies for additional information regarding pending legal proceedings, which information is incorporated herein by reference.
In the opinion of management, we are not currently a party to any proceedings that would have a material adverse effect on our business, financial condition, results of operations or cash flows.
Item 1A. Risk Factors
There have been no material changes with respect to the risk factors discussed in the Annual Report on Form 10-K for the period ended December 31, 2017.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
The following table presents information related to our repurchases of common stock for the periods indicated:
 
 
Total Number of Shares Purchased (1)
 
Average Price Paid per Share
 
Total Number of Shares Purchased as Part of Publicly Announced Programs (2)
 
Approximate Dollar Value of Shares that May Yet Be Purchased Under the Program
(in thousands, except share and per share amounts)
 
 
 
 
 
 
 
 
July 1, 2018 to July 30, 2018
 
—

 
$
—

 
—

 
$
—

August 1, 2018 to August 31, 2018
 
18,441

 
$
12.84

 
—

 
$
—

September 1, 2018 to September 30, 2018
 
—

 
$
—

 
—

 
$
—

Total
 
18,441

 
$
12.84

 
—

 
$
46,009

(1) 
Includes shares delivered to or withheld by us in connection with employee payroll tax withholding upon exercise or vesting of stock awards.
(2) 
Made pursuant to the $50 million share repurchase program authorized by our Board of Directors on December 15, 2017. The authorization does not have a specified expiration date, and the share repurchase program may be suspended, recommenced or discontinued at any time or from time to time without prior notice.
Item 3. Defaults Upon Senior Securities
None.
Item 4. Mine Safety Disclosures
Not applicable.
Item 5. Other Information
None.




46

Item 6. Exhibits
No.
 
Description
 
 
 
31.1
 
31.2
 
32.1
 
32.2
 
101.INS
 
XBRL Instance Document
101.SCH
 
XBRL Taxonomy Extension Schema Document
101.CAL
 
XBRL Taxonomy Extension Calculation Linkbase Document 
101.DEF
 
XBRL Taxonomy Extension Definition Linkbase Document
101.LAB
 
XBRL Taxonomy Extension Label Linkbase Document
101.PRE
 
XBRL Taxonomy Extension Presentation Linkbase Document

* Schedules and/or Exhibits have been omitted pursuant to Item 601(b)(2) of Regulation S-K. The Company agrees to furnish a supplemental copy of any omitted schedule or exhibit to the SEC upon request.


47

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
SURGERY PARTNERS, INC.
 
 
By:
/s/ Thomas F. Cowhey
Thomas F. Cowhey
Executive Vice President and Chief Financial Officer
(Principal Financial and Accounting Officer)
Date: November 9, 2018


48
 EX-31.1 2 a2018q3exhibit311.htm EXHIBIT 31.1 Exhibit


Exhibit 31.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO RULE 13a-14(a) AND RULE 15d- 14(a) OF THE SECURITIES AND EXCHANGE ACT, AS AMENDED AS ADOPTED PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Wayne S. DeVeydt, certify that:

1.
I have reviewed this quarterly report on Form 10-Q of Surgery Partners, Inc.;

2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.
The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)
evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report, based on such evaluation; and
d)
disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.
The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a)
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b)
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.


By:
/s/ Wayne S. DeVeydt
Wayne S. DeVeydt
Chief Executive Officer
(Principal Executive Officer)
Date: November 9, 2018




EX-31.2 3 a2018q3exhibit312.htm EXHIBIT 31.2 Exhibit


Exhibit 31.2

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO RULE 13a-14(a) AND RULE 15d- 14(a) OF THE SECURITIES AND EXCHANGE ACT, AS AMENDED AS ADOPTED PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Thomas F. Cowhey, certify that:

1.
I have reviewed this quarterly report on Form 10-Q of Surgery Partners, Inc.;

2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.
The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)
evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report, based on such evaluation; and
d)
disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.
The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a)
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b)
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.


By:
/s/ Thomas F. Cowhey
Thomas F. Cowhey
Executive Vice President and Chief Financial Officer
(Principal Financial and Accounting Officer)
Date: November 9, 2018




EX-32.1 4 a2018q3exhibit321.htm EXHIBIT 32.1 Exhibit


Exhibit 32.1
CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report on Form 10-Q of Surgery Partners, Inc. (the “Company”) for the period ended September 30, 2018, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Wayne S. DeVeydt, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002, that:

1.
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2.
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for the periods presented therein.

By:
/s/ Wayne S. DeVeydt
Wayne S. DeVeydt
Chief Executive Officer
(Principal Executive Officer)
Date: November 9, 2018





EX-32.2 5 a2018q3exhibit322.htm EXHIBIT 32.2 Exhibit


Exhibit 32.2
CERTIFICATION OF THE CHIEF FINANCIAL OFFICER PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report on Form 10-Q of Surgery Partners, Inc. (the “Company”) for the period ended September 30, 2018, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Thomas F. Cowhey, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002, that:

1.
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2.
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for the periods presented therein.

By:
/s/ Thomas F. Cowhey
Thomas F. Cowhey
Executive Vice President and Chief Financial Officer
(Principal Financial and Accounting Officer)
Date: November 9, 2018



EX-101.INS 6 sgry-20180930.xml XBRL INSTANCE DOCUMENT 0001638833 2018-01-01 2018-09-30 0001638833 2018-11-08 0001638833 2017-12-31 0001638833 2018-09-30 0001638833 us-gaap:RedeemablePreferredStockMember 2017-12-31 0001638833 us-gaap:RedeemablePreferredStockMember 2018-09-30 0001638833 2017-09-01 2017-09-30 0001638833 2018-07-01 2018-09-30 0001638833 us-gaap:PredecessorMember 2017-01-01 2017-08-31 0001638833 us-gaap:PredecessorMember 2017-07-01 2017-08-31 0001638833 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-09-30 0001638833 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0001638833 us-gaap:CommonStockMember 2018-01-01 2018-09-30 0001638833 us-gaap:RetainedEarningsMember 2018-09-30 0001638833 us-gaap:RetainedEarningsMember 2018-01-01 2018-09-30 0001638833 us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-09-30 0001638833 us-gaap:RetainedEarningsMember 2017-12-31 0001638833 us-gaap:NoncontrollingInterestMember 2018-01-01 2018-09-30 0001638833 us-gaap:NoncontrollingInterestMember 2018-09-30 0001638833 us-gaap:NoncontrollingInterestMember 2017-12-31 0001638833 us-gaap:CommonStockMember 2018-09-30 0001638833 us-gaap:AdditionalPaidInCapitalMember 2018-09-30 0001638833 us-gaap:CommonStockMember 2017-12-31 0001638833 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-01-01 2018-09-30 0001638833 us-gaap:PredecessorMember 2017-08-31 0001638833 2017-09-30 0001638833 us-gaap:PredecessorMember 2016-12-31 0001638833 2017-08-31 0001638833 sgry:OtherServicesMember 2018-07-01 2018-09-30 0001638833 sgry:OpticalServicesMember 2018-07-01 2018-09-30 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember us-gaap:SelfPayMember 2017-09-01 2017-09-30 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember sgry:PrivateInsuranceMember 2017-09-01 2017-09-30 0001638833 sgry:HealthcareOrganizationPatientServiceMember 2018-07-01 2018-09-30 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:SelfPayMember 2017-09-01 2017-09-30 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember sgry:OtherPatientServiceRevenueSourcesMember 2017-09-01 2017-09-30 0001638833 sgry:OpticalServicesMember us-gaap:PredecessorMember 2017-07-01 2017-08-31 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:SelfPayMember 2018-07-01 2018-09-30 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:PredecessorMember 2017-07-01 2017-08-31 0001638833 sgry:HealthcareOrganizationPatientServiceMember 2017-09-01 2017-09-30 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:SelfPayMember us-gaap:PredecessorMember 2017-07-01 2017-08-31 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:GovernmentMember 2018-07-01 2018-09-30 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember us-gaap:SelfPayMember us-gaap:PredecessorMember 2017-07-01 2017-08-31 0001638833 sgry:HealthcareOrganizationPatientServiceMember sgry:PrivateInsuranceMember 2017-09-01 2017-09-30 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember us-gaap:GovernmentMember us-gaap:PredecessorMember 2017-07-01 2017-08-31 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember sgry:OtherPatientServiceRevenueSourcesMember us-gaap:PredecessorMember 2017-07-01 2017-08-31 0001638833 sgry:OpticalServicesMember 2017-09-01 2017-09-30 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember sgry:PrivateInsuranceMember 2018-07-01 2018-09-30 0001638833 sgry:HealthcareOrganizationPatientServiceMember sgry:PrivateInsuranceMember us-gaap:PredecessorMember 2017-07-01 2017-08-31 0001638833 sgry:OtherServicesMember us-gaap:PredecessorMember 2017-07-01 2017-08-31 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:GovernmentMember us-gaap:PredecessorMember 2017-07-01 2017-08-31 0001638833 sgry:HealthcareOrganizationPatientServiceMember sgry:OtherPatientServiceRevenueSourcesMember us-gaap:PredecessorMember 2017-07-01 2017-08-31 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember us-gaap:PredecessorMember 2017-07-01 2017-08-31 0001638833 sgry:HealthcareOrganizationPatientServiceMember sgry:PrivateInsuranceMember 2018-07-01 2018-09-30 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember us-gaap:GovernmentMember 2018-07-01 2018-09-30 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2017-09-01 2017-09-30 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember sgry:PrivateInsuranceMember us-gaap:PredecessorMember 2017-07-01 2017-08-31 0001638833 sgry:HealthcareOrganizationPatientServiceMember sgry:OtherPatientServiceRevenueSourcesMember 2018-07-01 2018-09-30 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember us-gaap:GovernmentMember 2017-09-01 2017-09-30 0001638833 sgry:OtherServicesMember 2017-09-01 2017-09-30 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:GovernmentMember 2017-09-01 2017-09-30 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2018-07-01 2018-09-30 0001638833 sgry:HealthcareOrganizationPatientServiceMember sgry:OtherPatientServiceRevenueSourcesMember 2017-09-01 2017-09-30 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember sgry:OtherPatientServiceRevenueSourcesMember 2018-07-01 2018-09-30 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember us-gaap:SelfPayMember 2018-07-01 2018-09-30 0001638833 us-gaap:VariableInterestEntityPrimaryBeneficiaryAggregatedDisclosureMember 2017-12-31 0001638833 sgry:FacilitiesSurgicalHospitalsMember 2018-09-30 0001638833 us-gaap:FairValueInputsLevel1Member 2018-09-30 0001638833 sgry:FacilitiesAmbulatorySurgeryCentersMember 2018-09-30 0001638833 us-gaap:VariableInterestEntityPrimaryBeneficiaryAggregatedDisclosureMember 2018-09-30 0001638833 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember us-gaap:PredecessorMember 2017-01-01 2017-08-31 0001638833 sgry:OpticalServicesMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember us-gaap:PredecessorMember 2017-01-01 2017-08-31 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2017-09-01 2017-09-30 0001638833 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2017-09-01 2017-09-30 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2018-07-01 2018-09-30 0001638833 sgry:HealthcareOrganizationOtherServiceMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2018-07-01 2018-09-30 0001638833 sgry:HealthcareOrganizationOtherServiceMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2017-09-01 2017-09-30 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2018-01-01 2018-09-30 0001638833 sgry:OpticalServicesMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2017-09-01 2017-09-30 0001638833 sgry:OtherServicesMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2018-07-01 2018-09-30 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember us-gaap:PredecessorMember 2017-01-01 2017-08-31 0001638833 sgry:SurgicalFacilityServicesMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2018-01-01 2018-09-30 0001638833 sgry:OpticalServicesMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2018-07-01 2018-09-30 0001638833 sgry:AncillaryServicesMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2018-07-01 2018-09-30 0001638833 sgry:AncillaryServicesMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2018-01-01 2018-09-30 0001638833 sgry:SurgicalFacilityServicesMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2018-07-01 2018-09-30 0001638833 sgry:OtherServicesMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2018-01-01 2018-09-30 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember us-gaap:PredecessorMember 2017-07-01 2017-08-31 0001638833 sgry:OpticalServicesMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2018-01-01 2018-09-30 0001638833 sgry:AncillaryServicesMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember us-gaap:PredecessorMember 2017-01-01 2017-08-31 0001638833 sgry:HealthcareOrganizationOtherServiceMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember us-gaap:PredecessorMember 2017-07-01 2017-08-31 0001638833 sgry:HealthcareOrganizationOtherServiceMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember us-gaap:PredecessorMember 2017-01-01 2017-08-31 0001638833 sgry:OtherServicesMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember us-gaap:PredecessorMember 2017-07-01 2017-08-31 0001638833 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2018-01-01 2018-09-30 0001638833 sgry:OtherServicesMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2017-09-01 2017-09-30 0001638833 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember us-gaap:PredecessorMember 2017-07-01 2017-08-31 0001638833 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2018-07-01 2018-09-30 0001638833 sgry:SurgicalFacilityServicesMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember us-gaap:PredecessorMember 2017-07-01 2017-08-31 0001638833 sgry:SurgicalFacilityServicesMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2017-09-01 2017-09-30 0001638833 sgry:HealthcareOrganizationOtherServiceMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2018-01-01 2018-09-30 0001638833 sgry:OtherServicesMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember us-gaap:PredecessorMember 2017-01-01 2017-08-31 0001638833 sgry:AncillaryServicesMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2017-09-01 2017-09-30 0001638833 sgry:AncillaryServicesMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember us-gaap:PredecessorMember 2017-07-01 2017-08-31 0001638833 sgry:OpticalServicesMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember us-gaap:PredecessorMember 2017-07-01 2017-08-31 0001638833 sgry:SurgicalFacilityServicesMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember us-gaap:PredecessorMember 2017-01-01 2017-08-31 0001638833 us-gaap:RevolvingCreditFacilityMember sgry:A2017RevolverLoanMaturing2022Member us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SeniorNotesMember 2017-12-31 0001638833 us-gaap:RevolvingCreditFacilityMember sgry:A2017TermLoanMaturing2024Member us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SeniorNotesMember 2018-09-30 0001638833 sgry:SeniorUnsecuredNotesDue2025Member us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SeniorNotesMember 2017-12-31 0001638833 sgry:SeniorUnsecuredNotesDue2021Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SeniorNotesMember 2018-09-30 0001638833 sgry:SeniorUnsecuredNotesDue2021Member us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SeniorNotesMember 2017-12-31 0001638833 us-gaap:RevolvingCreditFacilityMember sgry:A2017RevolverLoanMaturing2022Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SeniorNotesMember 2018-09-30 0001638833 sgry:SeniorUnsecuredNotesDue2025Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SeniorNotesMember 2018-09-30 0001638833 us-gaap:RevolvingCreditFacilityMember sgry:A2017RevolverLoanMaturing2022Member us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SeniorNotesMember 2018-09-30 0001638833 sgry:SeniorUnsecuredNotesDue2025Member us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SeniorNotesMember 2018-09-30 0001638833 us-gaap:RevolvingCreditFacilityMember sgry:A2017TermLoanMaturing2024Member us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SeniorNotesMember 2017-12-31 0001638833 us-gaap:RevolvingCreditFacilityMember sgry:A2017RevolverLoanMaturing2022Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SeniorNotesMember 2017-12-31 0001638833 sgry:SeniorUnsecuredNotesDue2021Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SeniorNotesMember 2017-12-31 0001638833 sgry:SeniorUnsecuredNotesDue2025Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SeniorNotesMember 2017-12-31 0001638833 us-gaap:RevolvingCreditFacilityMember sgry:A2017TermLoanMaturing2024Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SeniorNotesMember 2018-09-30 0001638833 us-gaap:RevolvingCreditFacilityMember sgry:A2017TermLoanMaturing2024Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SeniorNotesMember 2017-12-31 0001638833 sgry:SeniorUnsecuredNotesDue2021Member us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SeniorNotesMember 2018-09-30 0001638833 sgry:HealthcareOrganizationPatientServiceMember sgry:OtherPatientServiceRevenueSourcesMember 2018-01-01 2018-09-30 0001638833 sgry:OpticalServicesMember us-gaap:PredecessorMember 2017-01-01 2017-08-31 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember sgry:OtherPatientServiceRevenueSourcesMember 2018-01-01 2018-09-30 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:PredecessorMember 2017-01-01 2017-08-31 0001638833 sgry:HealthcareOrganizationPatientServiceMember sgry:PrivateInsuranceMember 2018-01-01 2018-09-30 0001638833 sgry:OtherServicesMember us-gaap:PredecessorMember 2017-01-01 2017-08-31 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember us-gaap:PredecessorMember 2017-01-01 2017-08-31 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember sgry:PrivateInsuranceMember 2018-01-01 2018-09-30 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:SelfPayMember 2018-01-01 2018-09-30 0001638833 sgry:OpticalServicesMember 2018-01-01 2018-09-30 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember us-gaap:GovernmentMember us-gaap:PredecessorMember 2017-01-01 2017-08-31 0001638833 sgry:HealthcareOrganizationPatientServiceMember sgry:PrivateInsuranceMember us-gaap:PredecessorMember 2017-01-01 2017-08-31 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:SelfPayMember us-gaap:PredecessorMember 2017-01-01 2017-08-31 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:GovernmentMember us-gaap:PredecessorMember 2017-01-01 2017-08-31 0001638833 sgry:HealthcareOrganizationPatientServiceMember sgry:OtherPatientServiceRevenueSourcesMember us-gaap:PredecessorMember 2017-01-01 2017-08-31 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember us-gaap:GovernmentMember 2018-01-01 2018-09-30 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:GovernmentMember 2018-01-01 2018-09-30 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember sgry:OtherPatientServiceRevenueSourcesMember us-gaap:PredecessorMember 2017-01-01 2017-08-31 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2018-01-01 2018-09-30 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember us-gaap:SelfPayMember us-gaap:PredecessorMember 2017-01-01 2017-08-31 0001638833 sgry:OtherServicesMember 2018-01-01 2018-09-30 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember us-gaap:SelfPayMember 2018-01-01 2018-09-30 0001638833 sgry:HealthcareOrganizationPatientServiceMember 2018-01-01 2018-09-30 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember sgry:PrivateInsuranceMember us-gaap:PredecessorMember 2017-01-01 2017-08-31 0001638833 us-gaap:FairValueInputsLevel1Member 2017-12-31 0001638833 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2018-01-01 2018-09-30 0001638833 sgry:NSHHoldcoInc.Member us-gaap:PredecessorMember 2017-08-31 0001638833 sgry:NSHHoldcoInc.Member us-gaap:PredecessorMember 2017-08-31 2017-08-31 0001638833 sgry:TotalAcquisitionsIn2018Member 2018-09-30 0001638833 sgry:TotalAcquisitionsIn2018Member 2017-09-01 2017-09-30 0001638833 sgry:BCPESeminoleHoldingsLPMember us-gaap:PredecessorMember 2017-08-31 0001638833 sgry:SurgeryCenterMember 2018-01-01 2018-09-30 0001638833 sgry:BCPESeminoleHoldingsLPMember 2018-01-01 2018-09-30 0001638833 sgry:TwoSurgeryCentersMember 2018-01-01 2018-09-30 0001638833 sgry:TotalAcquisitionsIn2018Member us-gaap:PredecessorMember 2017-01-01 2017-08-31 0001638833 sgry:BCPESeminoleHoldingsLPMember us-gaap:PredecessorMember 2017-08-31 2017-08-31 0001638833 sgry:SurgicalFacilityNewMarketMember 2018-01-01 2018-09-30 0001638833 sgry:TotalAcquisitionsIn2018Member sgry:AncillaryServicesMember 2018-09-30 0001638833 sgry:SurgicalFacilityAndPhysicianPracticeAcquisitionsMember 2018-01-01 2018-09-30 0001638833 sgry:TotalAcquisitionsIn2018Member sgry:SurgicalFacilityServicesMember 2018-09-30 0001638833 sgry:NSHHoldcoInc.Member 2018-01-01 2018-09-30 0001638833 sgry:IntegratedPhysicianPracticeAcquisitionsMember 2018-01-01 2018-09-30 0001638833 sgry:TotalAcquisitionsIn2018Member 2018-01-01 2018-09-30 0001638833 sgry:PhysicianPracticeMember 2018-01-01 2018-09-30 0001638833 sgry:SurgicalFacilityExistingMarketMember 2018-01-01 2018-09-30 0001638833 sgry:SurgicalFacilityNoncontrollingInterestNewMarketMember 2018-01-01 2018-09-30 0001638833 sgry:EndoscopyPracticeMember 2017-01-01 2017-08-31 0001638833 sgry:NotesPayableAndSecuredLoansMember 2018-09-30 0001638833 sgry:SeniorUnsecuredNotesDue2021Member us-gaap:SeniorNotesMember 2017-12-31 0001638833 us-gaap:RevolvingCreditFacilityMember sgry:A2017RevolverLoanMaturing2022Member us-gaap:SecuredDebtMember 2017-12-31 0001638833 sgry:A2017TermLoanMaturing2024Member us-gaap:SecuredDebtMember 2017-12-31 0001638833 sgry:SeniorUnsecuredNotesDue2021Member us-gaap:SeniorNotesMember 2018-09-30 0001638833 sgry:A2017TermLoanMaturing2024Member us-gaap:SecuredDebtMember 2018-09-30 0001638833 sgry:SeniorUnsecuredNotesDue2025Member us-gaap:SeniorNotesMember 2018-09-30 0001638833 us-gaap:RevolvingCreditFacilityMember sgry:A2017RevolverLoanMaturing2022Member us-gaap:SecuredDebtMember 2018-09-30 0001638833 sgry:NotesPayableAndSecuredLoansMember 2017-12-31 0001638833 sgry:SeniorUnsecuredNotesDue2025Member us-gaap:SeniorNotesMember 2017-12-31 0001638833 us-gaap:MajorityShareholderMember us-gaap:SeriesAPreferredStockMember 2017-08-31 0001638833 us-gaap:SeriesAPreferredStockMember 2018-09-30 0001638833 us-gaap:SeriesAPreferredStockMember 2017-12-31 0001638833 us-gaap:MajorityShareholderMember us-gaap:SeriesAPreferredStockMember 2017-08-31 2017-08-31 0001638833 us-gaap:SeriesAPreferredStockMember 2018-01-01 2018-09-30 0001638833 us-gaap:InterestRateSwapMember 2018-09-30 0001638833 us-gaap:EmployeeStockOptionMember 2018-07-01 2018-09-30 0001638833 us-gaap:ConvertiblePreferredStockMember 2018-01-01 2018-09-30 0001638833 us-gaap:EmployeeStockOptionMember 2018-01-01 2018-09-30 0001638833 us-gaap:ConvertiblePreferredStockMember 2018-07-01 2018-09-30 0001638833 us-gaap:ConvertiblePreferredStockMember 2017-09-01 2017-09-30 0001638833 us-gaap:RestrictedStockMember us-gaap:PredecessorMember 2017-07-01 2017-08-31 0001638833 us-gaap:EmployeeStockOptionMember us-gaap:PredecessorMember 2017-07-01 2017-08-31 0001638833 us-gaap:RestrictedStockMember us-gaap:PredecessorMember 2017-01-01 2017-08-31 0001638833 us-gaap:EmployeeStockOptionMember 2017-09-01 2017-09-30 0001638833 us-gaap:RestrictedStockMember 2018-01-01 2018-09-30 0001638833 us-gaap:RestrictedStockMember 2018-07-01 2018-09-30 0001638833 us-gaap:RestrictedStockMember 2017-09-01 2017-09-30 0001638833 us-gaap:EmployeeStockOptionMember us-gaap:PredecessorMember 2017-01-01 2017-08-31 0001638833 2017-12-15 0001638833 sgry:NSHHoldcoInc.Member 2018-09-30 0001638833 sgry:BCPESeminoleHoldingsLPMember 2018-09-30 0001638833 sgry:NovaMedMember 2018-09-30 0001638833 sgry:SymbionMember 2018-09-30 0001638833 2018-04-01 2018-06-30 0001638833 sgry:NotMateriallyMoreRestrictiveMember us-gaap:LondonInterbankOfferedRateLIBORMember 2018-01-01 2018-09-30 0001638833 sgry:MateriallyMoreRestrictiveMember us-gaap:LondonInterbankOfferedRateLIBORMember 2018-01-01 2018-09-30 0001638833 us-gaap:OperatingSegmentsMember sgry:AncillaryServicesMember 2018-09-30 0001638833 us-gaap:CorporateNonSegmentMember 2017-12-31 0001638833 us-gaap:OperatingSegmentsMember sgry:SurgicalFacilityServicesMember 2018-09-30 0001638833 us-gaap:OperatingSegmentsMember sgry:OpticalServicesMember 2018-09-30 0001638833 us-gaap:OperatingSegmentsMember sgry:SurgicalFacilityServicesMember 2017-12-31 0001638833 us-gaap:OperatingSegmentsMember sgry:OpticalServicesMember 2017-12-31 0001638833 us-gaap:CorporateNonSegmentMember 2018-09-30 0001638833 us-gaap:OperatingSegmentsMember sgry:AncillaryServicesMember 2017-12-31 0001638833 us-gaap:CorporateNonSegmentMember us-gaap:PredecessorMember 2017-07-01 2017-08-31 0001638833 us-gaap:OperatingSegmentsMember sgry:SurgicalFacilityServicesMember us-gaap:PredecessorMember 2017-01-01 2017-08-31 0001638833 us-gaap:OperatingSegmentsMember sgry:SurgicalFacilityServicesMember 2018-01-01 2018-09-30 0001638833 us-gaap:OperatingSegmentsMember sgry:SurgicalFacilityServicesMember us-gaap:PredecessorMember 2017-07-01 2017-08-31 0001638833 us-gaap:OperatingSegmentsMember sgry:OpticalServicesMember 2018-01-01 2018-09-30 0001638833 us-gaap:OperatingSegmentsMember sgry:SurgicalFacilityServicesMember 2018-07-01 2018-09-30 0001638833 us-gaap:OperatingSegmentsMember sgry:AncillaryServicesMember 2018-01-01 2018-09-30 0001638833 us-gaap:OperatingSegmentsMember sgry:AncillaryServicesMember us-gaap:PredecessorMember 2017-07-01 2017-08-31 0001638833 us-gaap:OperatingSegmentsMember sgry:AncillaryServicesMember us-gaap:PredecessorMember 2017-01-01 2017-08-31 0001638833 us-gaap:OperatingSegmentsMember sgry:AncillaryServicesMember 2018-07-01 2018-09-30 0001638833 us-gaap:OperatingSegmentsMember sgry:OpticalServicesMember us-gaap:PredecessorMember 2017-01-01 2017-08-31 0001638833 us-gaap:OperatingSegmentsMember sgry:AncillaryServicesMember 2017-09-01 2017-09-30 0001638833 us-gaap:OperatingSegmentsMember sgry:OpticalServicesMember us-gaap:PredecessorMember 2017-07-01 2017-08-31 0001638833 us-gaap:OperatingSegmentsMember sgry:OpticalServicesMember 2017-09-01 2017-09-30 0001638833 us-gaap:OperatingSegmentsMember sgry:OpticalServicesMember 2018-07-01 2018-09-30 0001638833 us-gaap:OperatingSegmentsMember sgry:SurgicalFacilityServicesMember 2017-09-01 2017-09-30 0001638833 us-gaap:CorporateNonSegmentMember 2017-09-01 2017-09-30 0001638833 us-gaap:CorporateNonSegmentMember us-gaap:PredecessorMember 2017-01-01 2017-08-31 0001638833 us-gaap:CorporateNonSegmentMember 2018-01-01 2018-09-30 0001638833 us-gaap:CorporateNonSegmentMember 2018-07-01 2018-09-30 0001638833 sgry:IncrementalTermLoanMember us-gaap:SeniorNotesMember us-gaap:SubsequentEventMember us-gaap:BaseRateMember 2018-10-23 2018-10-23 0001638833 us-gaap:SubsequentEventMember 2018-11-09 0001638833 sgry:ThreeSurgeryCentersMember us-gaap:SubsequentEventMember 2018-10-31 2018-10-31 0001638833 sgry:IncrementalTermLoanMember us-gaap:SeniorNotesMember us-gaap:SubsequentEventMember 2018-10-23 0001638833 sgry:IncrementalTermLoanMember us-gaap:SeniorNotesMember us-gaap:SubsequentEventMember us-gaap:FederalFundsEffectiveSwapRateMember 2018-10-23 2018-10-23 0001638833 srt:MaximumMember sgry:IncrementalTermLoanMember us-gaap:SeniorNotesMember us-gaap:SubsequentEventMember us-gaap:LondonInterbankOfferedRateLIBORMember 2018-10-23 2018-10-23 0001638833 sgry:IncrementalTermLoanMember us-gaap:SeniorNotesMember us-gaap:SubsequentEventMember sgry:OneMonthLondonInterbankOfferedRateLIBORMember 2018-10-23 2018-10-23 0001638833 srt:MinimumMember sgry:IncrementalTermLoanMember us-gaap:SeniorNotesMember us-gaap:SubsequentEventMember us-gaap:LondonInterbankOfferedRateLIBORMember 2018-10-23 2018-10-23 0001638833 us-gaap:InterestRateSwapMember us-gaap:SubsequentEventMember 2018-11-09 0001638833 srt:MaximumMember sgry:IncrementalTermLoanMember us-gaap:SeniorNotesMember us-gaap:SubsequentEventMember sgry:MarginRateMember 2018-10-23 2018-10-23 0001638833 sgry:InterestRateSwapTwoMember us-gaap:SubsequentEventMember 2018-11-09 0001638833 srt:MinimumMember sgry:IncrementalTermLoanMember us-gaap:SeniorNotesMember us-gaap:SubsequentEventMember sgry:MarginRateMember 2018-10-23 2018-10-23 sgry:Anesthesia_Practice sgry:swap sgry:surgical_facility xbrli:pure sgry:physician_practice iso4217:USD xbrli:shares xbrli:shares sgry:endoscopy_practice sgry:state iso4217:USD sgry:surgery_center sgry:segment false --12-31 Q3 2018 2018-09-30 10-Q 0001638833 48891520 false Accelerated Filer Surgery Partners, Inc. false 330000000 240000000 330000000 721764000 310000000 1210000 5100000 5057000 605000 503000 1510000 1500000 1000000 1000000 0 0 0 2949000 7677000 3457000 7489000 25419000 600000 2100000 500000 400000 1600000 56535000 30853000 78498000 315000 36700000 44300000 47800000 1 3 -9142000 -10737000 555000 27726000 8402000 -36036000 -6526000 2214000 125912000 85564000 14842000 -5033000 -1265000 193000 20947000 58988000 -16983000 875000 571000 74525000 161465000 -60087000 2925000 2087000 216540000 15294000 15294000 1098000 0 0 -114000 -1715000 -333000 -12631000 -15875000 31942000 600000 1100000 0 1400000 1400000 121627000 138116000 -19093000 -3527000 -15566000 -4874000 130000 1041000 124 106 18 105 84 7600000 9300000 23100000 -17900000 3900000 2500000 22582000 20279000 14200000 2800000 4900000 4900000 69800000 1000000 7700000 0 0 2633000 8245000 23973000 1 5 3 3 3 4 4 84710000 76979000 288023000 286260000 19680000 49534000 0 -1389000 695560000 671252000 23973000 23973000 6303000 6303000 2026000 3416000 0 34506 0 105944 0 0 112529 0 144795 134054 0 153884 140552 4622773000 397669000 104274000 48309000 4072521000 4558664000 398171000 110588000 34811000 4015094000 563225000 463318000 0.657 49900000 28776000 939083000 325965000 1970847000 14200000 1200000 50000000 21100000 32900000 2343000 2300000 5600000 5584000 2983000 3000000 7099000 7100000 23800000 23771000 214206000 51159000 4708000 61438000 18367000 252911000 71639000 2332000 64921000 29652000 49942000 16416000 97617000 23937000 206073000 20212000 75113000 29737000 63978000 27881000 44310000 14986000 1000000 2142375000 42770000 169688000 72842000 3460000 50666000 26988000 2301000 379685000 174100000 83084000 1089972000 83084000 1970847000 1089972000 27594000 24836000 174914000 79123000 70014000 200016000 175229000 79438000 214521000 214521000 144507000 -14505000 -95791000 1100000 0.01 0.01 300000000 300000000 48687136 48891520 48687136 48687136 48891520 48891520 487000 489000 -4444000 -11669000 -9140000 -22370000 -59353000 8813000 42087000 6492000 23000000 69418000 4369000 30418000 -2648000 630000 10065000 0.027 0.018 0.076 0.469 0.431 0.024 1 0.982 0.011 0.007 0.955 1 0.070 0.016 0.069 0.489 0.420 0.022 1 0.984 0.010 0.006 0.914 1 0.042 0.018 1 0.053 0.562 0.355 0.030 0.982 0.007 0.011 0.940 1 0.047 0.021 1 0.056 0.531 0.384 0.029 0.979 0.006 0.015 0.932 1 0.048 0.020 1 0.050 0.533 0.386 0.031 0.980 0.006 0.014 0.932 1 143772000 572172000 102924000 334289000 1001691000 25300000 0.0225 0.0325 0.02 0.03 0.01 0.02 0.005 0.05 0.03 180000000.0 6200000 5700000 9200000 7400000 1100000 1100000 1600000 1600000 -18703000 -465000 9464000 65100000 65100000 132319000 126660000 11400000 7599000 30124000 3330000 16945000 49379000 0 0 0 0 0 0 1389000 -9500000 3900000 0 -0.09 -0.24 -0.57 -0.61 -1.71 -0.09 -0.24 -0.57 -0.61 -1.71 -1.467 0.074 0.488 0.24 49625000 41563000 2000000 19600000 12800000 14700000 6300000 6800000 0 3794000 0 0 0 -18211000 -18211000 0 0 0 12601000 46797000 7777000 19478000 69729000 3346838000 3372606000 75947000 7400000 68600000 3281728000 871373000 57710000 1100000 -18200000 1200000 -16349000 12329000 -2859000 7844000 22359000 896000 3148000 712000 1861000 6283000 -489000 203000 186000 -20718000 -18089000 -211000 5825000 10905000 -8837000 2795000 23665000 12947000 2919000 -5683000 58908000 55607000 -18147000 -68929000 -15883000 -37159000 -107368000 20537000 28322000 44951000 44360000 74282000 80785000 61240000 241149000 41784000 131441000 395196000 4622773000 4558664000 303005000 295586000 0 0 0 1267189000 1280532000 1280532000 422535000 409235000 409235000 346413000 370000000 370000000 101921000 11000000 11000000 11000000 1272986000 1271397000 1271397000 423667000 407372000 407372000 355200000 370000000 370000000 88068000 2130556000 2118567000 58726000 54106000 2189282000 2172673000 681879000 657694000 57509000 57509000 821345000 -10280000 -128234000 -744556000 -3003000 -66611000 67718000 -1222000 99054000 -4444000 -11669000 -9140000 -20981000 -57964000 8813000 42087000 6492000 23000000 69418000 20528000 -4444000 -11669000 -27339000 -29226000 -81937000 -9074000 48890000 -57964000 1000 3 1 3 1000 1000 1000 2 1000 1 1 2 3 32 187575000 682651000 120332000 398929000 1176349000 -13496000 65964000 11926000 45003000 129727000 1400000 9203000 36503000 6858000 21629000 64910000 449700000 20500000 17000000 179000000 71311000 72216000 48665000 39675000 0 0 0 -1389000 -1389000 -1389000 11022000 43267000 8000000 26194000 78590000 109944000 122938000 222480000 247311000 -3000 -307000 7000 -1207000 -3601000 100853000 109195000 18096000 22400000 0 0 2811000 0 0 1982000 58591000 4000 0 50343000 6444000 80091000 0 0 7810000 18347000 0 0 764007000 54308000 711700000 725853000 1163000 55213000 2243000 1875000 73000 14582000 18773000 1840000 202000 2000 23000 1613000 26618000 4652000 334000 42000 21590000 0.01 0.01 81.70 20000000 20000000 0 0 0 0 0 0 55337000 53575000 70000 0 18031000 1805966000 0 62759000 310000000 0 0 -789000 0 -1125000 -1518000 30000 -483000 500000 17600000 14229000 57931000 11254000 34902000 107294000 4369000 30418000 -2648000 2019000 11454000 398536000 420013000 4834000 16297000 3690000 11555000 25788000 299316000 317541000 330806000 350893000 796000 253000 4622000 1164237000 3609000 94880000 315000 315000 4500000 -41316000 -99280000 4409000 1905000 167765000 12909000 80166000 73734000 4119000 170928000 1905000 1246000 174079000 52261000 7629000 688725000 51374000 360092000 308993000 15949000 736408000 7629000 4578000 748615000 132258000 5775000 888000 125595000 129836000 6883000 72930000 46162000 3861000 888000 1534000 443932000 20719000 2699000 420514000 434685000 24345000 230718000 166880000 12742000 2699000 6548000 1306076000 62655000 8437000 1234984000 1278966000 64075000 682479000 493362000 39050000 8437000 18673000 21000000 19800000 1628000 3697000 1683000 1526000 6303000 19.00 1000 26455651 310000 151746 512948 310000000 1127000 1126000 1000 -5000 5000 50000000.0 46000000 156818 1982000 1980000 2000 654731000 571072000 1336610000 695560000 487000 681879000 -41316000 1228766000 -1389000 671252000 489000 657694000 -99280000 48078000 193322000 35028000 120123000 355701000 23973000 0 0 15566000 0 0 330806000 330806000 350893000 350893000 3886000 310000 310000 310000 310000 310000 310000 12.64 0 156818 0 0 18199000 8245000 23973000 0 0 0 -1389000 -1389000 0 0 0 2109000 -2670000 13100000 6500000 5800000 3400000 0 0 0 0 0 48146611 48121404 48314746 48037634 48020369 48146611 48121404 48314746 48037634 48020369 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Non-Controlling Interests&#8212;Redeemable</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Each partnership and limited liability company through which the Company owns and operates its surgical facilities is governed by a partnership or operating agreement, respectively.&#160;In certain circumstances, the applicable partnership or operating agreements for the Company's surgical facilities provide that the facilities will purchase all of the physician limited partners&#8217; or physician minority members&#8217;, as applicable, ownership if certain adverse regulatory events occur, such as it becoming illegal for the physician(s) to own an interest in a surgical facility, refer patients to a surgical facility or receive cash distributions from a surgical facility.&#160;The non-controlling interests</font><font style="font-family:inherit;font-size:9pt;font-style:italic;">&#8212;</font><font style="font-family:inherit;font-size:9pt;">redeemable are reported outside of stockholders' equity in the condensed consolidated balance sheets.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:16px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Redeemable Preferred Stock</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">On August 31, 2017 (Predecessor), the Company issued </font><font style="font-family:inherit;font-size:9pt;">310,000</font><font style="font-family:inherit;font-size:9pt;"> shares of Series A Preferred Stock to Bain at a purchase price of </font><font style="font-family:inherit;font-size:9pt;">$1,000</font><font style="font-family:inherit;font-size:9pt;"> per share for an aggregate purchase price of </font><font style="font-family:inherit;font-size:9pt;">$310.0 million</font><font style="font-family:inherit;font-size:9pt;"> (the "Preferred Private Placement"). The net proceeds from the issuance were used to finance a portion of the NSH acquisition. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">A summary of activity related to the redeemable preferred stock follows (in thousands):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:86%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">Successor</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Balance at December 31, 2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">330,806</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Dividends accrued</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">23,973</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Cash dividends declared</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(3,886</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Balance at September&#160;30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">350,893</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">There were </font><font style="font-family:inherit;font-size:9pt;">no</font><font style="font-family:inherit;font-size:9pt;"> unpaid cash dividends declared at </font><font style="font-family:inherit;font-size:9pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:9pt;"> (Successor). The cash dividends declared but unpaid at December 31, 2017 (Successor) was </font><font style="font-family:inherit;font-size:9pt;">$3.9 million</font><font style="font-family:inherit;font-size:9pt;">, and were included in other current liabilities in the condensed consolidated balance sheet. The aggregate and per share amounts of unpaid cumulative preferred dividends as of </font><font style="font-family:inherit;font-size:9pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:9pt;"> (Successor) were </font><font style="font-family:inherit;font-size:9pt;">$25.3 million</font><font style="font-family:inherit;font-size:9pt;"> and </font><font style="font-family:inherit;font-size:9pt;">$81.70</font><font style="font-family:inherit;font-size:9pt;">, respectively.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Basis of Presentation</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The accompanying condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (&#8220;GAAP&#8221;) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for fair presentation of the Company's financial position and results of operations have been included. The Company&#8217;s fiscal year ends on December&#160;31 and interim results are not necessarily indicative of results for a full year or any other interim period. The information contained in these condensed consolidated financial statements should be read in conjunction with the Company&#8217;s consolidated financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the fiscal year ended </font><font style="font-family:inherit;font-size:9pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:9pt;">.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:16px;text-align:justify;padding-left:24px;text-indent:-24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;"> Organization, Basis of Presentation and Significant Accounting Policies</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:12px;text-align:justify;padding-left:24px;text-indent:-24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Organization</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:9pt;">Surgery Partners, Inc.</font><font style="font-family:inherit;font-size:9pt;">,</font><font style="font-family:inherit;font-size:10pt;"> a </font><font style="font-family:inherit;font-size:9pt;">Delaware corporation, acting through its subsidiaries, owns and operates a national network of surgical facilities and ancillary services.&#160;The surgical facilities, which include ambulatory surgery centers ("ASCs") and surgical hospitals, primarily provide non-emergency surgical procedures across many specialties, including, among others, gastroenterology&#160;("GI"), general surgery, ophthalmology, orthopedics and pain management.&#160;The surgical hospitals also provide services such as diagnostic imaging, laboratory, obstetrics, oncology, pharmacy, physical therapy and wound care. Ancillary services are comprised of a diagnostic laboratory, multi-specialty physician practices, urgent care facilities, anesthesia services and optical services. Unless context otherwise indicates, Surgery Partners, Inc. and its subsidiaries are referred to herein as the "Company."</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">As of </font><font style="font-family:inherit;font-size:9pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:9pt;">, the Company owned or operated a portfolio of </font><font style="font-family:inherit;font-size:9pt;">124</font><font style="font-family:inherit;font-size:9pt;"> surgical facilities, comprised of </font><font style="font-family:inherit;font-size:9pt;">106</font><font style="font-family:inherit;font-size:9pt;"> ASCs and </font><font style="font-family:inherit;font-size:9pt;">18</font><font style="font-family:inherit;font-size:9pt;"> surgical hospitals in </font><font style="font-family:inherit;font-size:9pt;">32</font><font style="font-family:inherit;font-size:9pt;"> states. The Company owns a majority of these facilities in partnership with physicians and, in some cases, healthcare systems in the markets and communities it serves.&#160;The Company owned a majority interest in </font><font style="font-family:inherit;font-size:9pt;">84</font><font style="font-family:inherit;font-size:9pt;"> of the surgical facilities and consolidated </font><font style="font-family:inherit;font-size:9pt;">105</font><font style="font-family:inherit;font-size:9pt;"> of these facilities for financial reporting purposes.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Basis of Presentation</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The accompanying condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (&#8220;GAAP&#8221;) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for fair presentation of the Company's financial position and results of operations have been included. The Company&#8217;s fiscal year ends on December&#160;31 and interim results are not necessarily indicative of results for a full year or any other interim period. The information contained in these condensed consolidated financial statements should be read in conjunction with the Company&#8217;s consolidated financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the fiscal year ended </font><font style="font-family:inherit;font-size:9pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:9pt;">.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, as well as interests in partnerships and limited liability companies controlled by the Company through its ownership of a majority voting interest or other rights granted to the Company by contract to manage and control the affiliate's business. All significant intercompany balances and transactions are eliminated in consolidation.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">In connection with the change of control effective August 31, 2017, the Company elected to apply &#8220;pushdown&#8221; accounting by applying the guidance in Accounting Standards Codification Topic ("ASC") 805, </font><font style="font-family:inherit;font-size:9pt;font-style:italic;">Business Combinations</font><font style="font-family:inherit;font-size:9pt;">. Accordingly, the condensed consolidated financial statements of the Company for periods before and after August 31, 2017 reflect different bases of accounting, and the financial positions and results of operations of those periods are not comparable. Throughout the Company's condensed consolidated financial statements and the accompanying notes herein, periods prior to the change of control are identified as "Predecessor" and periods after the change of control are identified as "Successor." See Note 2. Acquisitions and Developments for further discussion of the change of control.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and footnotes. Examples include, but are not limited to, estimates of accounts receivable allowances, professional and general liabilities and the estimate of deferred tax assets or liabilities. Actual results could differ from those estimates.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Variable Interest Entities</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The condensed consolidated financial statements include the accounts of variable interest entities ("VIEs") in which the Company is the primary beneficiary under the provisions of ASC 810, </font><font style="font-family:inherit;font-size:9pt;font-style:italic;">Consolidation</font><font style="font-family:inherit;font-size:9pt;">. The Company has the power to direct the activities that most significantly impact a VIEs economic performance, and the Company would absorb the majority of the expected losses from any of these entities should such expected losses occur. As of </font><font style="font-family:inherit;font-size:9pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:9pt;"> (Successor), the consolidated VIEs include </font><font style="font-family:inherit;font-size:9pt;">four</font><font style="font-family:inherit;font-size:9pt;"> surgical facilities, </font><font style="font-family:inherit;font-size:9pt;">three</font><font style="font-family:inherit;font-size:9pt;"> anesthesia practices and </font><font style="font-family:inherit;font-size:9pt;">four</font><font style="font-family:inherit;font-size:9pt;"> physician practices. During the nine months ended </font><font style="font-family:inherit;font-size:9pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:9pt;"> (Successor), the Company divested of </font><font style="font-family:inherit;font-size:9pt;">one</font><font style="font-family:inherit;font-size:9pt;"> surgical facility and acquired a physician practice, which were classified as VIEs. As of December 31, 2017 (Successor), the consolidated VIEs included </font><font style="font-family:inherit;font-size:9pt;">five</font><font style="font-family:inherit;font-size:9pt;"> surgical facilities, </font><font style="font-family:inherit;font-size:9pt;">three</font><font style="font-family:inherit;font-size:9pt;"> anesthesia practices and </font><font style="font-family:inherit;font-size:9pt;">three</font><font style="font-family:inherit;font-size:9pt;"> physician practices. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The total assets (excluding goodwill and intangible assets, net) of the consolidated VIEs included in the accompanying condensed consolidated balance sheets as of </font><font style="font-family:inherit;font-size:9pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:9pt;"> (Successor) and </font><font style="font-family:inherit;font-size:9pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:9pt;"> (Successor), were </font><font style="font-family:inherit;font-size:9pt;">$6.5 million</font><font style="font-family:inherit;font-size:9pt;"> and </font><font style="font-family:inherit;font-size:9pt;">$13.1 million</font><font style="font-family:inherit;font-size:9pt;">, respectively, and the total liabilities of the consolidated VIEs were </font><font style="font-family:inherit;font-size:9pt;">$3.4 million</font><font style="font-family:inherit;font-size:9pt;"> and </font><font style="font-family:inherit;font-size:9pt;">$5.8 million</font><font style="font-family:inherit;font-size:9pt;">, respectively.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Fair Value of Financial Instruments</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The fair value of a financial instrument is the amount at which the instrument could be exchanged in an orderly transaction between market participants to sell the asset or transfer the liability. The Company uses fair value measurements based on quoted prices in active markets for identical assets or liabilities (Level&#160;1), inputs other than quoted prices in active markets that are either directly or indirectly observable (Level 2), or unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions (Level 3), depending on the nature of the item being valued.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The carrying amounts reported in the condensed consolidated balance sheets for cash and cash equivalents, accounts receivable, restricted invested assets and accounts payable approximate their fair values.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">A summary of the carrying amounts and fair values of the Company's long-term debt follows (in thousands):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:48%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">Successor</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Carrying Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2017 Senior Secured Credit Facilities:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Revolver</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">11,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">11,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Term Loan</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,271,397</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,280,532</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,272,986</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,267,189</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Senior Unsecured Notes due 2021</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">407,372</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">409,235</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">423,667</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">422,535</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Senior Unsecured Notes due 2025</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">370,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">370,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">355,200</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">346,413</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The fair values of the Term Loan, Senior Unsecured Notes due 2021 and the Senior Unsecured Notes due 2025 were based on a Level 2 inputs using quoted prices for identical liabilities in inactive markets at </font><font style="font-family:inherit;font-size:9pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:9pt;"> (Successor) and </font><font style="font-family:inherit;font-size:9pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:9pt;"> (Successor). The carrying amounts related to the Company's other long-term debt obligations, including the Revolver, approximate their fair values.</font></div><div style="line-height:120%;text-align:justify;text-indent:18px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">During the nine months ended </font><font style="font-family:inherit;font-size:9pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:9pt;"> (Successor), the Company entered into certain derivative financial instruments. A summary of the fair values of the Company's derivative financial instruments follows (in thousands):</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;text-indent:24px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:71.42857142857143%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:66%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Successor</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Derivative liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Interest rate swap agreement</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,389</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The fair value of the derivative financial instruments was based on a quoted market price, or a Level 2 computation. As of </font><font style="font-family:inherit;font-size:9pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:9pt;"> (Successor), the fair value of the derivative liabilities was included in other long-term liabilities in the condensed consolidated balance sheets. As of </font><font style="font-family:inherit;font-size:9pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:9pt;"> (Successor), the Company had no derivative financial instruments.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company maintains a supplemental executive retirement savings plan (the "SERP") for certain executives. The SERP is a non-qualified deferred compensation plan for eligible executive officers and other key employees of the Company that allows participants to defer portions of their compensation. The fair value of the SERP asset and liability was based on a quoted market price, or a Level 1 computation. As of both </font><font style="font-family:inherit;font-size:9pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:9pt;"> (Successor) and </font><font style="font-family:inherit;font-size:9pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:9pt;"> (Successor), the fair value of both the assets and liabilities in the SERP were </font><font style="font-family:inherit;font-size:9pt;">$1.6 million</font><font style="font-family:inherit;font-size:9pt;"> and were included in other long-term assets and other long-term liabilities in the condensed consolidated balance sheets.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Revenues</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">In May 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2014-09, </font><font style="font-family:inherit;font-size:9pt;font-style:italic;">Revenue from Contracts with Customers</font><font style="font-family:inherit;font-size:9pt;">. The Company adopted the new standard effective January 1, 2018, using the modified retrospective method. The adoption of the new standard did not have an impact on our recognition of net revenues for any periods prior to adoption. The majority of the &#8220;Provision for doubtful accounts&#8221; will continue to be recognized as an operating expense rather than as a direct reduction to revenues, given the Company&#8217;s practice of assessing a patient&#8217;s ability to pay prior to or on the date of providing healthcare services. After initial recognition, the Company&#8217;s accounts receivables are subject to impairment assessments periodically based on changes in credit risks using historical trends of cash collections, write-offs, accounts receivable agings and other factors.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company's revenues generally relate to contracts with patients in which the performance obligations are to provide healthcare services. The Company recognizes revenues in the period in which our obligations to provide health care services are satisfied and reports the amount that reflects the consideration the Company expects to be entitled to. The Company's performance obligations are generally satisfied over a period of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payer (Medicare, Medicaid, managed care health plans, employers and commercial insurance companies, including plans offered through the health insurance exchanges) and the transaction prices for the services provided are dependent upon the terms provided by (Medicare and Medicaid) or negotiated with (managed care health plans, employers and commercial insurance companies) the third-party payers. The payment arrangements with third-party payers for the services provided to the related patients typically specify payments at amounts less than the Company's standard charges. Medicare generally pays for services at prospectively determined rates based on clinical, diagnostic and other factors. Services provided to patients having Medicaid coverage are generally paid at prospectively determined rates per discharge, per identified service or per covered member. Agreements with commercial insurance carriers, managed care and preferred provider organizations generally provide for payments based upon predetermined rates per diagnosis, per diem rates or discounted fee-for-service rates. The Company continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">A summary of revenues by service type as a percentage of total revenues follows:</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="20" rowspan="1"></td></tr><tr><td style="width:41%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-style:italic;">Successor</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-style:italic;">Predecessor</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-style:italic;">Successor</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-style:italic;">Predecessor</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Three Months Ended September 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">September 1 to September 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">July 1 to August 31,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Nine Months Ended September 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">January 1 to August 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Patient service revenues:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;Surgical facilities revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">93.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">94.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">95.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">93.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">91.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;Ancillary services revenues</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">97.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">98.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">98.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">98.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">98.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Other service revenues:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;Optical services revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;Other revenues</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total revenues</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">100.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">100.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">100.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">100.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">100.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">Patient service revenues.</font><font style="font-family:inherit;font-size:9pt;">&#160; This includes revenue related to charging facility fees in exchange for providing patient care. The fee charged for healthcare procedures performed in surgical facilities varies depending on the type of service provided, but usually includes all charges for usage of an operating room, a recovery room, special equipment, medical supplies, nursing staff and medications.&#160;The fee does not normally include professional fees charged by the patient&#8217;s surgeon, anesthesiologist or other attending physician, which are billed directly by such physicians to the patient or third-party payor. However, in several surgical facilities, the Company charges for anesthesia services. Ancillary service revenues include fees for patient visits to the Company's physician practices, pharmacy services and diagnostic tests ordered by physicians.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Patient service revenues are recognized as performance obligations are satisfied. Performance obligations are based on the nature of services provided. Typically, the Company recognizes revenue at a point in time in which services are rendered and the Company has no obligation to provide further patient services. As the Company primarily performs outpatient procedures, performance obligations are generally satisfied same day and revenue is recognized on the date of service.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company determines the transaction price based on gross charges for services provided, net of estimated contractual adjustments, discounts from third-party payors, including Medicare and Medicaid. The Company estimates its contractual adjustments and discounts based on contractual agreements, its discount policies and historical experience. Changes in estimated contractual adjustments and discounts are recorded in the period of change. During the three and </font><font style="font-family:inherit;font-size:9pt;">nine</font><font style="font-family:inherit;font-size:9pt;"> months ended </font><font style="font-family:inherit;font-size:9pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:9pt;"> (Successor), the Company recognized an increase in patient service revenues as a result of changes in estimates to third-party settlements related to prior years of approximately </font><font style="font-family:inherit;font-size:9pt;">$1.4 million</font><font style="font-family:inherit;font-size:9pt;"> for both periods. There were </font><font style="font-family:inherit;font-size:9pt;">no</font><font style="font-family:inherit;font-size:9pt;"> adjustments as a result of changes in estimates to third-party settlements related to prior years for the one month ended </font><font style="font-family:inherit;font-size:9pt;">September&#160;30, 2017</font><font style="font-family:inherit;font-size:9pt;"> (Successor). During the two and eight months ended August&#160;31, 2017 (Predecessor), the Company recognized an increase to patient service revenues as a result of changes in estimates to third-party settlements related to prior years of approximately </font><font style="font-family:inherit;font-size:9pt;">$0.6 million</font><font style="font-family:inherit;font-size:9pt;"> and </font><font style="font-family:inherit;font-size:9pt;">$1.1 million</font><font style="font-family:inherit;font-size:9pt;">, respectively.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The following table sets forth patient service revenues by type of payor and as a percentage of total patient service revenues for the Company's consolidated surgical facilities (dollars in thousands):</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24" rowspan="1"></td></tr><tr><td style="width:35%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="13" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-style:italic;">Successor</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-style:italic;">Predecessor</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Three Months Ended September 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">September 1 to September 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">July 1 to August 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Patient service revenues:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Private insurance</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">230,718</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">53.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">72,930</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">56.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">80,166</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">46.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Government</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">166,880</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">38.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">46,162</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">35.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">73,734</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">43.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Self-pay</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">12,742</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,861</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,119</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other </font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">24,345</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6,883</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">12,909</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:18px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total patient service revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">434,685</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">100.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">129,836</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">100.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">170,928</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">100.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Other service revenues:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Optical services revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,699</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">888</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,905</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other revenues</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6,548</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,534</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,246</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:18px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">443,932</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">132,258</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">174,079</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24" rowspan="1"></td></tr><tr><td style="width:35%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="13" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-style:italic;">Successor</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-style:italic;">Predecessor</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Nine Months Ended September 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">September 1 to September 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">January 1 to August 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Patient service revenues:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Private insurance</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">682,479</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">53.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">72,930</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">56.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">360,092</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">48.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Government</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">493,362</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">38.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">46,162</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">35.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">308,993</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">42.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Self-pay</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">39,050</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,861</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">15,949</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other </font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">64,075</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6,883</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">51,374</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:18px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total patient service revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,278,966</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">100.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">129,836</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">100.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">736,408</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">100.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Other service revenues:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Optical services revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8,437</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">888</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7,629</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other revenues</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">18,673</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,534</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,578</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:18px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,306,076</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">132,258</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">748,615</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-top:6px;padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:18px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:7pt;padding-left:0px;"><font style="font-family:inherit;font-size:7pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Other is comprised of anesthesia service agreements, auto liability, letters of protection and other payor types. </font></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">Other service revenues.</font><font style="font-family:inherit;font-size:9pt;font-style:italic;font-weight:bold;"> </font><font style="font-family:inherit;font-size:9pt;"> Optical service revenues consist of product sales from the Company's optical laboratories as well as handling charges billed to the members of the Company's optical products purchasing organization. The Company's optical products purchasing organization negotiates volume buying discounts with optical products manufacturers. The buying discounts and any handling charges billed to the members of the buying group represent the revenue recognized for financial reporting purposes. The Company satisfies the performance obligation and recognizes revenue when the orders are shipped to members. The Company bases its estimates for sales returns and discounts on historical experience and has not experienced significant fluctuations between estimated and actual return activity and discounts given. The Company's optical laboratories manufacture and distribute corrective lenses and eyeglasses to ophthalmologists and optometrists. The Company satisfies the performance obligation and recognize revenue when the product is shipped, net of allowance for discounts. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other revenues include management and administrative service fees derived from the non-consolidated facilities that the Company accounts for under the equity method, management of surgical facilities in which it does not own an interest, and management services provided to physician practices for which the Company is not required to provide capital or additional assets. These agreements typically require the Company to provide recurring management services over a multi-year period which are billed and collected on a monthly basis. The fees derived from these management arrangements are based on a predetermined percentage of the revenues of each facility or practice and are recognized in the period in which management services are rendered and billed.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Cash, Cash Equivalents and Restricted Cash</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The following table reconciles cash, cash equivalents and restricted cash reported within the condensed consolidated balance sheets to the totals shown within the condensed consolidated statement of cash flows (in thousands):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:74%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-style:italic;">Successor</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Cash and cash equivalents</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">79,123</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">174,914</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Restricted invested assets included in other long-term assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">315</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">315</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total cash, cash equivalents and restricted cash in the statement of cash flows</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">79,438</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">175,229</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Restricted invested assets included in other long-term assets on the condensed consolidated balance sheet represents restricted cash held in accordance with the provisions of the operating lease agreement at the Company's Chesterfield, Missouri facility. The Company has a deposit with the landlord that shall be held as security for performance under the Company's covenants and obligations within the agreement through January 2024.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Accounts Receivable and Allowances for Contractual Adjustments and Doubtful Accounts</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">With the Company's adoption of ASC 2014-09 on January 1, 2018, for those accounts in which the Company has an unconditional right to payment, subject only to the passage of time, the right is recorded as a receivable. Accounts receivable are recorded net of contractual adjustments and allowances for doubtful accounts to reflect accounts receivable at net realizable value. Accounts receivable consists of receivables from federal and state agencies (under the Medicare and Medicaid programs), managed care health plans, commercial insurance companies, employers and patients. Management recognizes that revenues and receivables from government agencies are significant to the Company's operations, but it does not believe that there is significant credit risk associated with these government agencies. Concentration of credit risk with respect to other payors is limited because of the large number of such payors. The Company had a net third-party Medicaid settlements liability of </font><font style="font-family:inherit;font-size:9pt;">$7.7 million</font><font style="font-family:inherit;font-size:9pt;"> and </font><font style="font-family:inherit;font-size:9pt;">$1.0 million</font><font style="font-family:inherit;font-size:9pt;"> as of </font><font style="font-family:inherit;font-size:9pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:9pt;"> (Successor) and </font><font style="font-family:inherit;font-size:9pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:9pt;"> (Successor), respectively, included in other current liabilities in the condensed consolidated balance sheets.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company recognizes that final reimbursement of accounts receivable is subject to final approval by each third-party payor.&#160;However, because the Company has contracts with its third-party payors and also verifies insurance coverage of the patient before medical services are rendered, the amounts that are pending approval from third-party payors are not considered significant.&#160;The Company's policy is to collect co-payments and deductibles prior to providing medical services. It is also the Company's policy to verify a patient&#8217;s insurance prior to the patient&#8217;s procedure.&#160;Patient services of the Company are primarily non-emergency, which allows the surgical facilities to control the procedures for which third-party reimbursement is sought and obtained. The Company does not require collateral from self-pay patients.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company analyzes accounts receivable at each of its facilities to ensure the proper aged category and collection assessment. At a consolidated level, the Company's policy is to review accounts receivable aging, by facility, to determine the appropriate allowance for doubtful accounts. Patient account balances are reviewed for delinquency based on contractual terms. This review is supported by an analysis of the actual revenues, contractual adjustments and cash collections received. An account balance is written off only after the Company has pursued collection with legal or collection agency assistance or otherwise has deemed an account to be uncollectible.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The receivables related to the Company's optical products purchasing organization are recognized separately from patient accounts receivable, as discussed above, and are included in other current assets in the condensed consolidated balance sheets. Such receivables were </font><font style="font-family:inherit;font-size:9pt;">$9.3 million</font><font style="font-family:inherit;font-size:9pt;"> and </font><font style="font-family:inherit;font-size:9pt;">$7.6 million</font><font style="font-family:inherit;font-size:9pt;"> at </font><font style="font-family:inherit;font-size:9pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:9pt;"> (Successor) and </font><font style="font-family:inherit;font-size:9pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:9pt;"> (Successor), respectively. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Goodwill</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Goodwill represents the fair value of the consideration provided in an acquisition over the fair value of net assets acquired and is not amortized. Additions to goodwill include amounts resulting from new business combinations and incremental ownership purchases in the Company's subsidiaries. A summary of the Company's acquisitions for the </font><font style="font-family:inherit;font-size:9pt;">nine</font><font style="font-family:inherit;font-size:9pt;"> months ended </font><font style="font-family:inherit;font-size:9pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:9pt;"> is included in Note 2. Acquisitions and Developments.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">A summary of activity related to goodwill for the </font><font style="font-family:inherit;font-size:9pt;">nine</font><font style="font-family:inherit;font-size:9pt;"> months ended </font><font style="font-family:inherit;font-size:9pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:9pt;"> (Successor) follows (in thousands):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.40476190476191%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:85%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">Successor</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Balance at December&#160;31, 2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,346,838</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Acquisitions, including post acquisition adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">57,710</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Divestitures and deconsolidations</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(31,942</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Balance at September&#160;30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,372,606</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Other Current Liabilities</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">A summary of other current liabilities follows (in thousands):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:74%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-style:italic;">Successor</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Interest payable</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">28,322</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">20,537</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Amounts due to patients and payors</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">22,400</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">18,096</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Accrued expenses and other</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">72,216</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">71,311</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">122,938</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">109,944</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Other Long-Term Liabilities</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">A summary of other long-term liabilities follows (in thousands):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:74%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-style:italic;">Successor</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Facility lease obligations</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">138,116</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">121,627</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">109,195</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">100,853</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">247,311</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">222,480</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">At four of the Company's surgical facilities, the Company has financing obligations payable to the lessors of certain land, buildings and improvements. Payments are allocated to principal adjustments of the financing obligations and interest expense. The current portions of the financing obligations were </font><font style="font-family:inherit;font-size:9pt;">$6.8 million</font><font style="font-family:inherit;font-size:9pt;"> and </font><font style="font-family:inherit;font-size:9pt;">$6.3 million</font><font style="font-family:inherit;font-size:9pt;"> at </font><font style="font-family:inherit;font-size:9pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:9pt;"> (Successor) and </font><font style="font-family:inherit;font-size:9pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:9pt;"> (Successor), respectively, and were included in other current liabilities in the condensed consolidated balance sheets. The long-term portions of the financing obligations are included as facility lease obligations in the table above.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">In 2017, one of the Company's surgical facilities entered into a development agreement to construct a new hospital. Due to certain provisions of the agreement, the surgical facility is deemed the owner during construction, and as such, the Company records the ongoing costs as incurred as a deferred financing obligation. As of </font><font style="font-family:inherit;font-size:9pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:9pt;"> (Successor), the Company has recorded a total of </font><font style="font-family:inherit;font-size:9pt;">$36.7 million</font><font style="font-family:inherit;font-size:9pt;"> of costs for this project, of which </font><font style="font-family:inherit;font-size:9pt;">$23.1 million</font><font style="font-family:inherit;font-size:9pt;"> was recorded during the nine months ended </font><font style="font-family:inherit;font-size:9pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:9pt;"> (Successor). These project costs are included as non-cash additions to property and equipment, net in the condensed consolidated balance sheet and as a component of facility lease obligations.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Derivative Instruments and Hedging Activities</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:18px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">In accordance with ASC 815, Derivatives and Hedging (&#8220;ASC 815&#8221;), the Company records all derivatives on the balance sheet at fair value.&#160;The accounting for changes in the fair value of derivatives depends on the intended use of the derivative, whether the Company has elected to designate a derivative in a hedging relationship and apply hedge accounting and whether the hedging relationship has satisfied the criteria necessary to apply hedge accounting. Hedge accounting generally provides for the matching of the timing of gain or loss recognition on the hedging instrument with the recognition of the changes in the fair value of the hedged asset or liability that are attributable to the hedged risk in a fair value hedge or the earnings effect of the hedged forecasted transactions in a cash flow hedge. The Company may enter into derivative contracts that are intended to economically hedge certain of its risk, even though hedge accounting does not apply or the Company elects not to apply hedge accounting.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:18px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">In accordance with the FASB&#8217;s fair value measurement guidance in ASU 2011-04, the Company made an accounting policy election to measure the credit risk of its derivative financial instruments that are subject to master netting agreements on a net basis by counterparty portfolio.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Non-Controlling Interests&#8212;Redeemable</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Each partnership and limited liability company through which the Company owns and operates its surgical facilities is governed by a partnership or operating agreement, respectively.&#160;In certain circumstances, the applicable partnership or operating agreements for the Company's surgical facilities provide that the facilities will purchase all of the physician limited partners&#8217; or physician minority members&#8217;, as applicable, ownership if certain adverse regulatory events occur, such as it becoming illegal for the physician(s) to own an interest in a surgical facility, refer patients to a surgical facility or receive cash distributions from a surgical facility.&#160;The non-controlling interests</font><font style="font-family:inherit;font-size:9pt;font-style:italic;">&#8212;</font><font style="font-family:inherit;font-size:9pt;">redeemable are reported outside of stockholders' equity in the condensed consolidated balance sheets.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">A summary of activity related to the non-controlling interests&#8212;redeemable follows (in thousands):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:84%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-style:italic;">Successor</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Balance at December&#160;31, 2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">299,316</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net income attributable to non-controlling interests&#8212;redeemable</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">20,528</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Acquisition and disposal of shares of non-controlling interests, net&#8212;redeemable </font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">20,279</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Distributions to non-controlling interest&#8212;redeemable holders</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(22,582</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Balance at September&#160;30, 2018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">317,541</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:18px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:7pt;padding-left:0px;"><font style="font-family:inherit;font-size:7pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Includes post acquisition date adjustments.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Recent Accounting Pronouncements</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">In May 2014, the FASB issued ASU 2014-09, "</font><font style="font-family:inherit;font-size:9pt;font-style:italic;">Revenue from Contracts with Customers</font><font style="font-family:inherit;font-size:9pt;">," along with subsequent amendments, updates and an extension of the effective date (collectively the "New Revenue Standard"), which outlines a single comprehensive model for recognizing revenue and supersedes most existing revenue recognition guidance, including guidance specific to the healthcare industry. This five-step process requires significant management judgment in addition to changing the way many companies recognize revenue in their financial statements.&#160;The Company adopted this ASU on January 1, 2018 using the modified retrospective approach.&#160;The adoption of this standard did not have a significant impact on the recognition of net revenues for any period. Adoption of the standard resulted in the Company revising its related disclosures.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">In February 2016, the FASB issued ASU 2016-02, "</font><font style="font-family:inherit;font-size:9pt;font-style:italic;">Leases,</font><font style="font-family:inherit;font-size:9pt;">" which will require, among other items, lessees to recognize most leases as assets and liabilities on the balance sheet. Qualitative and quantitative disclosures will be enhanced to better understand the amount, timing and uncertainty of cash flows arising from leases. This guidance is effective for financial statements issued for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years, with early adoption permitted. The guidance is required to be applied using a modified retrospective transition approach for leases existing at, or entered into after, the beginning of the earliest comparative periods presented in the financial statements. In preparation of adopting the new standard, the Company has engaged outside consultants to assist in the identification of the Company's population of leases, implementing a new software for lease accounting and assisting in evaluating new accounting policy elections. The Company will adopt this ASU on January 1, 2019 and believes the primary effect of adopting the new standard will be to record right-of-use assets and obligations for current operating leases with material increases in reported property and equipment and liabilities. The Company is still evaluating the effect of adoption on financial disclosures, policies, procedures and control framework.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">In November 2016, the FASB issued ASU 2016-18, "</font><font style="font-family:inherit;font-size:9pt;font-style:italic;">Statement of Cash Flows &#8211; Restricted Cash</font><font style="font-family:inherit;font-size:9pt;">," which requires that a statement of cash flows explain the change during the period in the total of cash, cash equivalents, and amounts generally described as restricted cash or restricted cash equivalents. ASU 2016-18 is effective for fiscal years beginning after December 15, 2017, including interim periods within those years. The Company adopted this ASU on January 1, 2018 and retrospectively applied the guidance to all periods presented in the condensed consolidated statement of cash flows. The retrospective application to prior periods had no impact on the Company's cash flows from operating, investing and financing activities as previously disclosed. The adoption of this ASU resulted in the modification of the Company's presentation of the reconciliation of beginning-of-period and end-of-period total amounts shown on the condensed consolidated statement of cash flows to include restricted cash as discussed under the heading "Cash and Cash Equivalents" above.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Acquisitions and Developments</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company accounts for its business combinations in accordance with the fundamental requirements of the acquisition method of accounting and under the premise that an acquirer can be identified for each business combination. The acquirer is the entity that obtains control of one or more businesses in the business combination and the acquisition date is the date the acquirer achieves control. The assets acquired, liabilities assumed and any non-controlling interests in the acquired business at the acquisition date are recognized at their fair values as of that date, and the direct costs incurred in connection with the business combination are recorded and expensed separately from the business combination. Any goodwill recognized is determined as the excess of the fair value of the consideration conveyed plus the fair value of any non-controlling interests in the acquisition over the fair value of the net assets acquired. Acquisitions in which the Company is able to exert significant influence but does not have control are accounted for using the equity method.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Acquired assets and assumed liabilities typically include, but are not limited to, fixed assets, intangible assets and professional liabilities. The valuations are based on appraisal reports, discounted cash flow analyses, actuarial analyses or other appropriate valuation techniques to determine the fair value of the assets acquired or liabilities assumed. Fair value attributable to non-controlling interests is based on a Level 3 computation using significant inputs that are not observable in the market. Key inputs used to determine the fair value include financial multiples used in the purchase of non-controlling interests, primarily from acquisitions of surgical facilities. Such multiples, based on earnings, are used as a benchmark for the discount to be applied for the lack of control or marketability. Fair value attributable to the property and equipment acquired is based on Level 3 computations using key inputs such as cost trend data and comparable asset sales. Fair value attributable to the intangible assets acquired is based on Level 3 computations using key inputs such as the Company's internally-prepared financial projections. Fair values assigned to acquired working capital are based on carrying amounts reported by the acquiree at the date of acquisition, which approximate their fair values. The preliminary estimated fair value assigned to goodwill is primarily attributable to the acquisitions favorable reputations in their markets, their market positions and their ability to deliver quality care with high patient satisfaction consistent with the Company's business model.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">Acquisitions</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">During the nine months ended </font><font style="font-family:inherit;font-size:9pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:9pt;"> (Successor), the Company acquired a controlling interest in </font><font style="font-family:inherit;font-size:9pt;">two</font><font style="font-family:inherit;font-size:9pt;"> surgical facilities in new markets, a surgical facility in an existing market, which was merged into an existing facility and a physician practice for a combined cash purchase price of </font><font style="font-family:inherit;font-size:9pt;">$32.9 million</font><font style="font-family:inherit;font-size:9pt;">, net of cash acquired. The Company also acquired a controlling interest in an integrated physician practice, including multiple practice and surgical facility locations, in an existing market for a purchase price of </font><font style="font-family:inherit;font-size:9pt;">$21.1 million</font><font style="font-family:inherit;font-size:9pt;">, net of cash acquired. The purchase price for the 2018 acquisitions was funded through cash from operations. The total consideration related to these acquisitions was allocated to the assets acquired and liabilities assumed based upon their respective acquisition date fair values.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The aggregate amounts preliminarily recognized for each major class of assets acquired and liabilities assumed for acquisitions completed in the </font><font style="font-family:inherit;font-size:9pt;">nine</font><font style="font-family:inherit;font-size:9pt;"> months ended </font><font style="font-family:inherit;font-size:9pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:9pt;"> (Successor), including post acquisition date adjustments, are as follows (in thousands):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:85%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Cash consideration</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">54,308</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Fair value of non-controlling interests</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">28,776</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Aggregate acquisition date fair value</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">83,084</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net assets acquired:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Current Assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,708</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Property and equipment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,301</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Goodwill</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">75,947</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other long-term assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,460</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Current liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2,332</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Long-term liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1,000</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Aggregate acquisition date fair value</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">83,084</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The fair values assigned to certain assets and liabilities assumed by the Company have been estimated on a preliminary basis and are subject to change as new facts and circumstances emerge that were present at the date of acquisition. The goodwill acquired in connection with the 2018 acquisitions was allocated to the Company's reportable segments as follows: </font><font style="font-family:inherit;font-size:9pt;">$68.6 million</font><font style="font-family:inherit;font-size:9pt;"> to surgical facility services and </font><font style="font-family:inherit;font-size:9pt;">$7.4 million</font><font style="font-family:inherit;font-size:9pt;"> to ancillary services. Approximately </font><font style="font-family:inherit;font-size:9pt;">$49.9 million</font><font style="font-family:inherit;font-size:9pt;"> of goodwill recorded for the 2018 acquisitions is deductible for tax purposes. The results of operations of the acquisitions are included in the Company&#8217;s results of operations beginning on the dates of acquisitions, and were not considered significant for the </font><font style="font-family:inherit;font-size:9pt;">nine</font><font style="font-family:inherit;font-size:9pt;"> months ended </font><font style="font-family:inherit;font-size:9pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:9pt;"> (Successor).</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">During the one month ended September 30, 2017 (Successor), the Company completed acquisitions in existing markets of </font><font style="font-family:inherit;font-size:9pt;">one</font><font style="font-family:inherit;font-size:9pt;"> physician practice and the assets of an endoscopy practice for a combined purchase price of </font><font style="font-family:inherit;font-size:9pt;">$1.2 million</font><font style="font-family:inherit;font-size:9pt;">. During the eight months ended August 31, 2017 (Predecessor), the Company completed acquisitions (excluding the NSH Holdco, Inc. acquisition) in existing markets of </font><font style="font-family:inherit;font-size:9pt;">three</font><font style="font-family:inherit;font-size:9pt;"> physician practices for a combined cash purchase price of </font><font style="font-family:inherit;font-size:9pt;">$14.2 million</font><font style="font-family:inherit;font-size:9pt;">. During the </font><font style="font-family:inherit;font-size:9pt;">nine</font><font style="font-family:inherit;font-size:9pt;"> months ended </font><font style="font-family:inherit;font-size:9pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:9pt;"> (Successor), no significant changes were made to the purchase price allocation of assets and liabilities, existing at the date of acquisition, related to individual acquisitions completed in 2017, excluding the acquisition of NSH as discussed below.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">2018 Disposals and Deconsolidation</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">During the </font><font style="font-family:inherit;font-size:9pt;">nine</font><font style="font-family:inherit;font-size:9pt;"> months ended </font><font style="font-family:inherit;font-size:9pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:9pt;"> (Successor), the Company sold its interests in </font><font style="font-family:inherit;font-size:9pt;">three</font><font style="font-family:inherit;font-size:9pt;"> surgery centers and its optical laboratory for net cash proceeds of </font><font style="font-family:inherit;font-size:9pt;">$17.6 million</font><font style="font-family:inherit;font-size:9pt;">, and recognized a net pretax loss of </font><font style="font-family:inherit;font-size:9pt;">$9.5 million</font><font style="font-family:inherit;font-size:9pt;"> included in loss on disposals and deconsolidations, net in the condensed consolidated statement of operations for the three and </font><font style="font-family:inherit;font-size:9pt;">nine</font><font style="font-family:inherit;font-size:9pt;"> months ended </font><font style="font-family:inherit;font-size:9pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:9pt;"> (Successor). This non-cash loss was primarily a result of the write-off of the net assets of the facility (net of proceeds received) and was primarily driven by the write-off of the associated goodwill. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">During the </font><font style="font-family:inherit;font-size:9pt;">nine</font><font style="font-family:inherit;font-size:9pt;"> months ended </font><font style="font-family:inherit;font-size:9pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:9pt;"> (Successor), the Company sold a portion of its interest in </font><font style="font-family:inherit;font-size:9pt;">one</font><font style="font-family:inherit;font-size:9pt;"> surgery center for net cash proceeds of </font><font style="font-family:inherit;font-size:9pt;">$0.5 million</font><font style="font-family:inherit;font-size:9pt;">. As a result of this transaction, the Company lost control of the previously controlled entity but retains a noncontrolling interest, resulting in the deconsolidation of the previously consolidated entity. The remaining noncontrolling interest was accounted for as an equity method investment, and initially measured and recorded at fair value as of the date of the transaction. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The fair value measurement utilizes Level 3 inputs, which include unobservable data, to measure the fair value of the retained noncontrolling interest. The fair value determination was based on a combination of multiple valuation methods, which included discounted cash flow and market value approach, which incorporates estimates of future earnings and market valuation multiples for certain guideline companies. The fair value of the investment of </font><font style="font-family:inherit;font-size:9pt;">$2.0 million</font><font style="font-family:inherit;font-size:9pt;"> was recorded as a component of investments in and advances to affiliates in the accompanying condensed consolidated balance sheets.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Further, the transaction resulted in a pretax gain on deconsolidation of </font><font style="font-family:inherit;font-size:9pt;">$1.1 million</font><font style="font-family:inherit;font-size:9pt;">, which is included in loss on disposals and deconsolidations, net, in the accompanying condensed consolidated statement of operations for the three and nine months ended </font><font style="font-family:inherit;font-size:9pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:9pt;"> (Successor). The gain was determined based on the difference between the fair value of the Company's retained interest in the entity and the carrying value of both the tangible and intangible assets of the entity immediately prior to the transaction less cash proceeds received.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">Acquisition of NSH</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">On August 31, 2017 (Predecessor), the Company completed its acquisition of NSH Holdco, Inc. (&#8220;NSH&#8221;) for total cash consideration of </font><font style="font-family:inherit;font-size:9pt;">$711.7 million</font><font style="font-family:inherit;font-size:9pt;">, net of cash acquired, including </font><font style="font-family:inherit;font-size:9pt;">$19.6 million</font><font style="font-family:inherit;font-size:9pt;"> funded to an escrow account. During the nine months ended </font><font style="font-family:inherit;font-size:9pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:9pt;"> (Successor), information existing at the acquisition date became known to the Company as part of its continuing evaluation of the assets and liabilities existing at the date of acquisition, resulting in a net increase to goodwill of </font><font style="font-family:inherit;font-size:9pt;">$1.1 million</font><font style="font-family:inherit;font-size:9pt;">. The corresponding changes to certain classes of assets and liabilities from the preliminary allocation recorded at August 31, 2017 (Predecessor), are reflected in the table below, which has been finalized as of </font><font style="font-family:inherit;font-size:9pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:9pt;"> (Successor). The increase to goodwill during the period includes a working capital settlement payment resulting in additional cash consideration of </font><font style="font-family:inherit;font-size:9pt;">$1.2 million</font><font style="font-family:inherit;font-size:9pt;">.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The acquisition date fair value for each major class of assets acquired and liabilities assumed, including post acquisition date adjustments, are as follows (in thousands):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:85%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Cash consideration</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">764,007</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Fair value of non-controlling interests</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">325,965</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Acquisition date fair value</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,089,972</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net assets acquired:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Cash and cash equivalents</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">51,159</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Accounts receivable</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">71,639</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Inventories</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">14,986</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Prepaid expenses and other current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">18,367</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Property and equipment</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">174,100</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Intangible assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">27,881</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Goodwill</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">871,373</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Investments in and advances to affiliates</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">29,737</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Long-term deferred tax assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">20,212</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other long-term assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">26,988</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Accounts payable</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(29,652</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Accrued payroll and benefits</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(30,853</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other current liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(23,937</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Current maturities of long-term debt</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(16,416</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Long-term debt, less current maturities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(42,770</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other long-term liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(72,842</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Acquisition date fair value</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,089,972</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">Change of Control - Pushdown Accounting</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">On August 31, 2017, BCPE Seminole Holdings LP (&#8220;Bain&#8221;), a fund advised by an affiliate of Bain Capital Private Equity, completed its purchase of </font><font style="font-family:inherit;font-size:9pt;">26,455,651</font><font style="font-family:inherit;font-size:9pt;"> shares of the Company's common stock at a purchase price of </font><font style="font-family:inherit;font-size:9pt;">$19.00</font><font style="font-family:inherit;font-size:9pt;"> per share in cash (the &#8220;Private Sale&#8221;). As a result of the Private Sale and the Preferred Private Placement (defined in Note 4. Redeemable Preferred Stock), Bain became the controlling stockholder of the Company, holding preferred and common stock that collectively represent approximately </font><font style="font-family:inherit;font-size:9pt;">65.7%</font><font style="font-family:inherit;font-size:9pt;"> of the voting power of all classes of capital stock of the Company as of August 31, 2017. In connection with this change of control, the Company elected to apply &#8220;pushdown&#8221; accounting by applying the guidance in ASC 805, </font><font style="font-family:inherit;font-size:9pt;font-style:italic;">Business Combinations</font><font style="font-family:inherit;font-size:9pt;">. In accordance with ASC 805, all identifiable assets and liabilities of the Company were measured at and adjusted to fair value as of August 31, 2017, and similarly goodwill was recognized based on the terms of the transaction and the fair value of the new basis of the net assets of the Company. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">During the </font><font style="font-family:inherit;font-size:9pt;">nine</font><font style="font-family:inherit;font-size:9pt;"> months ended </font><font style="font-family:inherit;font-size:9pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:9pt;"> (Successor), information existing at the transaction date became known to the Company as part of its evaluation of the assets and liabilities existing at August 31, 2017, resulting in a net decrease to goodwill of </font><font style="font-family:inherit;font-size:9pt;">$18.2 million</font><font style="font-family:inherit;font-size:9pt;"> and corresponding changes to certain classes of assets and liabilities from the preliminary allocation recorded, that are reflected in the table below, which has been finalized as of </font><font style="font-family:inherit;font-size:9pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:9pt;"> (Successor). </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:18px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The transaction date fair value recognized in connection with the application of pushdown accounting for each major class of assets and liabilities as of August 31, 2017, including post transaction date adjustments, are as follows (in thousands): </font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.0079365079365%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:86%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Equity attributable to Surgery Partners, Inc.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">721,764</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Redeemable preferred stock</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">310,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Fair value of non-controlling interests</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">939,083</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Transaction date fair value</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,970,847</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net assets:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Cash and cash equivalents</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">214,206</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Accounts receivable</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">252,911</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Inventories</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">44,310</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Prepaid expenses and other current assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">61,438</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Property and equipment</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">379,685</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Intangible assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">63,978</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Goodwill</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,281,728</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Investments in and advances to affiliates</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">75,113</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Restricted invested assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">315</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Long-term deferred tax asset</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">206,073</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other long-term assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">50,666</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Accounts payable</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(64,921</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Accrued payroll and benefits</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(56,535</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other current liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(97,617</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Current maturities of long-term debt</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(49,942</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Long-term debt, less current maturities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2,142,375</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Long-term tax receivable agreement liability</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(78,498</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other long-term liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(169,688</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Transaction date fair value</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,970,847</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:18px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The post transaction date adjustments for pushdown accounting during the period includes a net increase of </font><font style="font-family:inherit;font-size:9pt;">$3.9 million</font><font style="font-family:inherit;font-size:9pt;"> to the preliminary amounts assigned to intangible assets. The remaining adjustments to goodwill are attributable to a </font><font style="font-family:inherit;font-size:9pt;">$17.9 million</font><font style="font-family:inherit;font-size:9pt;"> decrease to the preliminary fair value assigned to non-controlling interests, a </font><font style="font-family:inherit;font-size:9pt;">$1.1 million</font><font style="font-family:inherit;font-size:9pt;"> increase related to the Acquisition of NSH (discussed above), and a </font><font style="font-family:inherit;font-size:9pt;">$2.5 million</font><font style="font-family:inherit;font-size:9pt;"> increase to other long-term liabilities.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company accounts for its business combinations in accordance with the fundamental requirements of the acquisition method of accounting and under the premise that an acquirer can be identified for each business combination. The acquirer is the entity that obtains control of one or more businesses in the business combination and the acquisition date is the date the acquirer achieves control. The assets acquired, liabilities assumed and any non-controlling interests in the acquired business at the acquisition date are recognized at their fair values as of that date, and the direct costs incurred in connection with the business combination are recorded and expensed separately from the business combination. Any goodwill recognized is determined as the excess of the fair value of the consideration conveyed plus the fair value of any non-controlling interests in the acquisition over the fair value of the net assets acquired. Acquisitions in which the Company is able to exert significant influence but does not have control are accounted for using the equity method.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Acquired assets and assumed liabilities typically include, but are not limited to, fixed assets, intangible assets and professional liabilities. The valuations are based on appraisal reports, discounted cash flow analyses, actuarial analyses or other appropriate valuation techniques to determine the fair value of the assets acquired or liabilities assumed. Fair value attributable to non-controlling interests is based on a Level 3 computation using significant inputs that are not observable in the market. Key inputs used to determine the fair value include financial multiples used in the purchase of non-controlling interests, primarily from acquisitions of surgical facilities. Such multiples, based on earnings, are used as a benchmark for the discount to be applied for the lack of control or marketability. Fair value attributable to the property and equipment acquired is based on Level 3 computations using key inputs such as cost trend data and comparable asset sales. Fair value attributable to the intangible assets acquired is based on Level 3 computations using key inputs such as the Company's internally-prepared financial projections. Fair values assigned to acquired working capital are based on carrying amounts reported by the acquiree at the date of acquisition, which approximate their fair values. The preliminary estimated fair value assigned to goodwill is primarily attributable to the acquisitions favorable reputations in their markets, their market positions and their ability to deliver quality care with high patient satisfaction consistent with the Company's business model.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Restricted invested assets included in other long-term assets on the condensed consolidated balance sheet represents restricted cash held in accordance with the provisions of the operating lease agreement at the Company's Chesterfield, Missouri facility. The Company has a deposit with the landlord that shall be held as security for performance under the Company's covenants and obligations within the agreement through January 2024.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:6px;padding-top:16px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Commitments and Contingencies</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;font-weight:bold;">Professional, General and Workers' Compensation Liability Risks</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company is subject to claims and legal actions in the ordinary course of business, including claims relating to patient treatment, employment practices and personal injuries. The Company maintains general liability and professional liability insurance in excess of self-insured retentions, on a claims-made basis through third party commercial insurance carriers. Although management believes the coverage is sufficient for the Company's operations, some claims may potentially exceed the scope of coverage in effect. The Company also maintains workers' compensation insurance, subject to a deductible. Plaintiffs in these matters may request punitive or other damages that may not be covered by insurance. The Company is not aware of any such proceedings that are reasonably possible to have a material adverse effect on the Company's business, financial position, results of operations or liquidity.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">Insurance Reserves</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company expenses the costs under the self-insured retention exposure for general and professional liability and workers' compensation claims which relate to (i)&#160;claims made during the policy period, which are offset by insurance recoveries and (ii)&#160;an estimate of claims incurred but not yet reported that are expected to be reported after the policy period expires. Reserves and provisions are based upon periodic actuarially determined estimates. The reserves are estimated using individual case-basis valuations and actuarial analysis. Reserves for professional, general and workers' compensation claim liabilities are determined with no regard for expected insurance recoveries and are presented gross on the condensed consolidated balance sheets. Total professional, general and workers' compensation claim liabilities as of </font><font style="font-family:inherit;font-size:9pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:9pt;"> (Successor) and </font><font style="font-family:inherit;font-size:9pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:9pt;"> (Successor) are </font><font style="font-family:inherit;font-size:9pt;">$19.8 million</font><font style="font-family:inherit;font-size:9pt;"> and </font><font style="font-family:inherit;font-size:9pt;">$21.0 million</font><font style="font-family:inherit;font-size:9pt;">, respectively. The balances include expected insurance recoveries of </font><font style="font-family:inherit;font-size:9pt;">$14.7 million</font><font style="font-family:inherit;font-size:9pt;"> and </font><font style="font-family:inherit;font-size:9pt;">$12.8 million</font><font style="font-family:inherit;font-size:9pt;">, respectively. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;font-weight:bold;">Laws and Regulations</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Laws and regulations governing the Company's business, including those relating to the Medicare and Medicaid programs, are complex and subject to interpretation. These laws and regulations govern every aspect of how the Company's surgical facilities conduct their operations, from licensing requirements to how and whether the Company's facilities may receive payments pursuant to the Medicare and Medicaid programs. Compliance with such laws and regulations can be subject to future government agency review and interpretation as well as legislative changes to such laws. Noncompliance with such laws and regulations may subject the Company to significant regulatory action including fines, penalties, and exclusion from the Medicare, Medicaid and other federal healthcare programs. From time to time, governmental regulatory agencies will conduct inquiries of the Company's practices, including, but not limited to, the Company's compliance with federal and state fraud and abuse laws, billing practices and relationships with physicians. On October 23, 2017, the Company received a civil investigative demand (&#8220;CID&#8221;) from the federal government under the False Claims Act (&#8220;FCA&#8221;) for documents and information dating back to January 1, 2010 relating to the medical necessity of certain drug tests conducted by the Company&#8217;s physicians and submitted to laboratories owned and operated by the Company. The government&#8217;s investigation remains ongoing and the Company intends to continue to respond to the CID and engage in further discussions with the U.S. Attorney&#8217;s Office in connection with the FCA investigation.&#160;In addition, the Company has been informed by CMS that payments to its diagnostic laboratory, Logan Laboratories, have been suspended pending further investigation by CMS. The Company is unable to predict the duration, scope or outcome of these investigations. While it is possible that a loss related to these matters may be incurred, given the ongoing nature of these investigations, management cannot reasonably estimate the potential magnitude of any such loss or range of loss, or the cost of the ongoing investigation, the entirety of which has been recorded in our operating expenses to date. An adverse outcome in these matters or any related litigation, including a determination that we were not, or are not, in compliance with the existing laws or regulations could result in the imposition of fines, civil and criminal penalties, equitable remedies, including disgorgement, injunctive relief, and/or other sanctions against us, and remediation of any such findings could have an adverse effect on the Company&#8217;s financial condition and results of operations. See Item 1A &#8220;Risk Factors&#8221; in our Annual Report on Form 10-K for the period ended December 31, 2017 under the heading &#8220;Risk Factors - Risks Related to Government Regulation - </font><font style="font-family:inherit;font-size:9pt;font-style:italic;">Companies within the healthcare industry continue to be the subject of federal and state audits and investigations, and we may be subject to such audits and investigations, including actions for false and other improper claims</font><font style="font-family:inherit;font-size:9pt;">.&#8221;&#160;</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;font-weight:bold;">Acquired Facilities</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company, through its wholly-owned subsidiaries or controlled partnerships and limited liability companies, has acquired and will continue to acquire surgical facilities with prior operating histories. Such facilities may have unknown or contingent liabilities, including liabilities for failure to comply with healthcare laws and regulations, such as billing and reimbursement, fraud and abuse and similar anti-referral laws. Although the Company attempts to assure that no such liabilities exist, obtain indemnification from prospective sellers covering such matters and institute policies designed to conform centers to its standards following completion of acquisitions, there can be no assurance that the Company will not become liable for past activities that may later be asserted to be improper by private plaintiffs or government agencies. There can be no assurance that any such matter will be covered by indemnification or, if covered, that the liability sustained will not exceed contractual limits or the financial capacity of the indemnifying party.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company cannot predict whether federal or state statutory or regulatory provisions will be enacted that would prohibit or otherwise regulate relationships which the Company has established or may establish with other healthcare providers or have materially adverse effects on its business or revenues arising from such future actions. Management believes, however, that it will be able to adjust the Company's operations so as to be in compliance with any statutory or regulatory provision as may be applicable.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;font-weight:bold;">Potential Physician Investor Liability</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">A majority of the physician investors in the partnerships and limited liability companies which operate the Company's surgical facilities carry general and professional liability insurance on a claims-made basis. Each partnership or limited liability company may, however, be liable for damages to persons or property arising from occurrences at the surgical facilities. Although the various physician investors and other surgeons generally are required to obtain general and professional liability insurance with tail coverage that extends beyond the period of any claims-made policies, such individuals may not be able to obtain coverage in amounts sufficient to cover all potential liability. Since most insurance policies contain exclusions, the physician investors will not be insured against all possible occurrences. In the event of an uninsured or underinsured loss, the value of an investment in the partnership interests or limited liability company membership units and the amount of distributions could be adversely affected.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;font-weight:bold;">Tax Receivable Agreement</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">On May 9, 2017, the Company entered into an agreement to amend that certain Income Tax Receivable Agreement, dated September&#160;30, 2015 (as amended, the &#8220;TRA&#8221;), by and between the Company, and the other parties referred to therein, which amendment became effective on August 31, 2017. Pursuant to the amendment to the TRA, the Company agreed to make payments to H.I.G., the Company's former controlling shareholder, in its capacity as the stockholders representative pursuant to a fixed payment schedule. The amounts payable under the TRA are calculated as the product of (i) an annual base amount and (ii) the maximum corporate federal income tax rate for the applicable year plus three percent. The amounts payable under the TRA are related to the Company&#8217;s projected realized tax savings over the next six years and are not dependent on the Company&#8217;s actual tax savings over such period. The calculation of amounts payable pursuant to the TRA is thus dependent on the maximum corporate federal income tax rate. To the extent that the Company is unable to make payments under the TRA and such inability is a result of the terms of credit agreements and other debt documents that are materially more restrictive than those existing as of September 30, 2015, such payments will be deferred and will accrue interest at a rate of LIBOR plus </font><font style="font-family:inherit;font-size:9pt;">500</font><font style="font-family:inherit;font-size:9pt;"> basis points until paid. If the terms of such credit agreements and other debt documents cause the Company to be unable to make payments under the TRA and such terms are not materially more restrictive than those existing as of September 30, 2015, such payments will be deferred and will accrue interest at a rate of LIBOR plus </font><font style="font-family:inherit;font-size:9pt;">300</font><font style="font-family:inherit;font-size:9pt;"> basis points until paid.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Assuming the Company&#8217;s effective tax rate is </font><font style="font-family:inherit;font-size:9pt;">24%</font><font style="font-family:inherit;font-size:9pt;">, calculated as the maximum corporate federal tax rate plus three percent, throughout the remaining term of the TRA, the Company estimates that the total remaining amounts payable under the TRA was approximately </font><font style="font-family:inherit;font-size:9pt;">$65.1 million</font><font style="font-family:inherit;font-size:9pt;"> as of both September 30, 2018 (Successor) and December 31, 2017 (Successor). As a result of the amendment to the TRA, the Company was required to value the liability under the TRA by discounting the fixed payment schedule using the Company&#8217;s incremental borrowing rate. The carrying value of the liability under the TRA, reflecting the discount, was </font><font style="font-family:inherit;font-size:9pt;">$47.8 million</font><font style="font-family:inherit;font-size:9pt;"> as of </font><font style="font-family:inherit;font-size:9pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:9pt;"> (Successor) and </font><font style="font-family:inherit;font-size:9pt;">$44.3 million</font><font style="font-family:inherit;font-size:9pt;"> as of December 31, 2017 (Successor).</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;font-weight:bold;">Contingent Consideration</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">In connection with certain prior period acquisitions, pursuant to the applicable purchase agreements, the Company was required to pay consideration to the prior owners of the applicable facilities should the requirements for continuing employment agreed to in the purchase agreements be met. In accordance with ASC 805, Business Combinations, contingent consideration with a continuing employment provision is recognized ratably over the defined performance period as compensation expense. As disclosed in the footnotes to the condensed consolidated statements of operations, the Company recognized contingent acquisition compensation expense of </font><font style="font-family:inherit;font-size:9pt;">$0.5 million</font><font style="font-family:inherit;font-size:9pt;"> and </font><font style="font-family:inherit;font-size:9pt;">$1.5 million</font><font style="font-family:inherit;font-size:9pt;"> for the three and nine months ended September 30, 2018 (Successor), respectively, </font><font style="font-family:inherit;font-size:9pt;">$0.6 million</font><font style="font-family:inherit;font-size:9pt;"> for the one month ended September 30, 2017 (Successor), and </font><font style="font-family:inherit;font-size:9pt;">$1.2 million</font><font style="font-family:inherit;font-size:9pt;"> and </font><font style="font-family:inherit;font-size:9pt;">$5.1 million</font><font style="font-family:inherit;font-size:9pt;"> for the two and eight months ended August 31, 2017 (Predecessor), respectively.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;font-weight:bold;">Other</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">In connection with the Company's integration of the corporate office functions related to the acquisition of NSH, the Company closed it's Chicago, Illinois office on September 30, 2018 (Successor). As a result, the Company recognized a cease-use liability of </font><font style="font-family:inherit;font-size:9pt;">$1.4 million</font><font style="font-family:inherit;font-size:9pt;">, representing the estimated costs that will continue to be incurred under the office lease for its remaining term. The estimated costs were included as transaction and integration costs in the condensed consolidated statement of operations for the three and nine months ended September 30, 2018 (Successor) and as a component of other current liabilities and other long-term liabilities in the condensed consolidated balance sheet as of September 30, 2018 (Successor). During the second quarter 2018, the Company recognized a liability of </font><font style="font-family:inherit;font-size:9pt;">$4.5 million</font><font style="font-family:inherit;font-size:9pt;"> for estimated severance costs in connection with the corporate office integration. The estimated costs were included as transaction and integration costs in the condensed consolidated statement of operations for the nine months ended September 30, 2018 (Successor) and the unpaid severance was included as a component of accrued payroll and benefits in the condensed consolidated balance sheet as of September 30, 2018 (Successor).</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, as well as interests in partnerships and limited liability companies controlled by the Company through its ownership of a majority voting interest or other rights granted to the Company by contract to manage and control the affiliate's business. All significant intercompany balances and transactions are eliminated in consolidation.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Variable Interest Entities</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The condensed consolidated financial statements include the accounts of variable interest entities ("VIEs") in which the Company is the primary beneficiary under the provisions of ASC 810, </font><font style="font-family:inherit;font-size:9pt;font-style:italic;">Consolidation</font><font style="font-family:inherit;font-size:9pt;">. The Company has the power to direct the activities that most significantly impact a VIEs economic performance, and the Company would absorb the majority of the expected losses from any of these entities should such expected losses occur. As of </font><font style="font-family:inherit;font-size:9pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:9pt;"> (Successor), the consolidated VIEs include </font><font style="font-family:inherit;font-size:9pt;">four</font><font style="font-family:inherit;font-size:9pt;"> surgical facilities, </font><font style="font-family:inherit;font-size:9pt;">three</font><font style="font-family:inherit;font-size:9pt;"> anesthesia practices and </font><font style="font-family:inherit;font-size:9pt;">four</font><font style="font-family:inherit;font-size:9pt;"> physician practices. During the nine months ended </font><font style="font-family:inherit;font-size:9pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:9pt;"> (Successor), the Company divested of </font><font style="font-family:inherit;font-size:9pt;">one</font><font style="font-family:inherit;font-size:9pt;"> surgical facility and acquired a physician practice, which were classified as VIEs. As of December 31, 2017 (Successor), the consolidated VIEs included </font><font style="font-family:inherit;font-size:9pt;">five</font><font style="font-family:inherit;font-size:9pt;"> surgical facilities, </font><font style="font-family:inherit;font-size:9pt;">three</font><font style="font-family:inherit;font-size:9pt;"> anesthesia practices and </font><font style="font-family:inherit;font-size:9pt;">three</font><font style="font-family:inherit;font-size:9pt;"> physician practices. </font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:16px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Derivatives and Hedging Activities</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;font-weight:bold;">Cash Flow Hedges of Interest Rate Risk</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company&#8217;s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish this objective, the Company primarily uses interest rate swaps as part of its interest rate risk management strategy. During </font><font style="font-family:inherit;font-size:9pt;">2018</font><font style="font-family:inherit;font-size:9pt;">, such derivatives were used to hedge the variable cash flows associated with existing variable-rate debt. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">For derivatives designated and that qualify as cash flow hedges of interest rate risk, the gain or loss on the derivative is recorded in Accumulated Other Comprehensive Income and subsequently reclassified into interest expense in the same period(s) during which the hedged transaction affects earnings, as documented at hedge inception in accordance with the Company&#8217;s accounting policy election. The earnings recognition of excluded components is presented in interest expense. Amounts reported in accumulated other comprehensive income related to derivatives will be reclassified to interest expense as interest payments are made on the Company&#8217;s variable-rate debt. Over the next 12 months, the Company estimates that an additional </font><font style="font-family:inherit;font-size:9pt;">$1.1 million</font><font style="font-family:inherit;font-size:9pt;"> will be reclassified as a reduction to interest expense. </font></div><div style="line-height:120%;text-align:justify;text-indent:18px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">As of </font><font style="font-family:inherit;font-size:9pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:9pt;"> (Successor), the Company had </font><font style="font-family:inherit;font-size:9pt;">one</font><font style="font-family:inherit;font-size:9pt;"> interest rate swap with a current notional amount of </font><font style="font-family:inherit;font-size:9pt;">$330.0 million</font><font style="font-family:inherit;font-size:9pt;"> and a termination date of </font><font style="font-family:inherit;font-size:9pt;">November&#160;30, 2023</font><font style="font-family:inherit;font-size:9pt;">. The Company had no derivative instruments as of </font><font style="font-family:inherit;font-size:9pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:9pt;"> (Successor).</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company classifies its derivative financial instruments of </font><font style="font-family:inherit;font-size:9pt;">$1.4 million</font><font style="font-family:inherit;font-size:9pt;"> as a long-term liability on the Balance Sheet as of </font><font style="font-family:inherit;font-size:9pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:9pt;"> (Successor). The Company had no derivative financial instruments as of </font><font style="font-family:inherit;font-size:9pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:9pt;"> (Successor). </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The table below presents the effect of fair value and cash flow hedge accounting on the Company's consolidated balance sheets.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;text-indent:24px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:96.03174603174604%;border-collapse:collapse;text-align:left;"><tr><td colspan="25" rowspan="1"></td></tr><tr><td style="width:41%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">Successor</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">Predecessor</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">Successor</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">Predecessor</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Three Months Ended September 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">September 1 to September 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">July 1 to August 31,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Nine Months Ended September 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">January 1 to August 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Derivatives in Cash Flow Hedging Relationships</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Losses related to effective portion of derivatives recognized in accumulated OCI, gross of tax effect</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1,389</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1,389</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Loss related to effective portion of derivatives reclassified from accumulated OCI to interest expense, gross of tax effect</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Derivative Instruments and Hedging Activities</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:18px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">In accordance with ASC 815, Derivatives and Hedging (&#8220;ASC 815&#8221;), the Company records all derivatives on the balance sheet at fair value.&#160;The accounting for changes in the fair value of derivatives depends on the intended use of the derivative, whether the Company has elected to designate a derivative in a hedging relationship and apply hedge accounting and whether the hedging relationship has satisfied the criteria necessary to apply hedge accounting. Hedge accounting generally provides for the matching of the timing of gain or loss recognition on the hedging instrument with the recognition of the changes in the fair value of the hedged asset or liability that are attributable to the hedged risk in a fair value hedge or the earnings effect of the hedged forecasted transactions in a cash flow hedge. The Company may enter into derivative contracts that are intended to economically hedge certain of its risk, even though hedge accounting does not apply or the Company elects not to apply hedge accounting.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:18px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">In accordance with the FASB&#8217;s fair value measurement guidance in ASU 2011-04, the Company made an accounting policy election to measure the credit risk of its derivative financial instruments that are subject to master netting agreements on a net basis by counterparty portfolio.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:16px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Earnings Per Share</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Basic and diluted earnings per share are calculated in accordance with ASC 260, </font><font style="font-family:inherit;font-size:9pt;font-style:italic;">Earnings Per Share</font><font style="font-family:inherit;font-size:9pt;">, based on the weighted-average number of shares outstanding in each period and dilutive stock options, unvested shares and warrants, to the extent such securities exist and have a dilutive effect on earnings per share. Beginning in the Successor period, in connection with the issuance of the Series A Preferred Stock, the Company began computing basic and diluted earnings per share using the two-class method. The two-class method of computing earnings per share is an earnings allocation method that determines earnings per share for common shares and participating securities according to their participation rights in dividends and undistributed earnings.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:16px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Earnings Per Share</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Basic and diluted earnings per share are calculated in accordance with ASC 260, </font><font style="font-family:inherit;font-size:9pt;font-style:italic;">Earnings Per Share</font><font style="font-family:inherit;font-size:9pt;">, based on the weighted-average number of shares outstanding in each period and dilutive stock options, unvested shares and warrants, to the extent such securities exist and have a dilutive effect on earnings per share. Beginning in the Successor period, in connection with the issuance of the Series A Preferred Stock, the Company began computing basic and diluted earnings per share using the two-class method. The two-class method of computing earnings per share is an earnings allocation method that determines earnings per share for common shares and participating securities according to their participation rights in dividends and undistributed earnings.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">A reconciliation of the numerator and denominator of basic and diluted earnings per share follows (in thousands except share and per share amounts): </font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="25" rowspan="1"></td></tr><tr><td style="width:41%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-style:italic;">Successor</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-style:italic;">Predecessor</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-style:italic;">Successor</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-style:italic;">Predecessor</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Three Months Ended September 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">September 1 to September 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">July 1 to August 31,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Nine Months Ended September 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">January 1 to August 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Numerator:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net loss attributable to Surgery Partners, Inc.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(20,981</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(9,140</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(4,444</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(57,964</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(11,669</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Less: amounts allocated to participating securities </font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">8,245</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2,633</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">23,973</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Less: mark to redemption adjustment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">15,566</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net loss attributable to common stockholders</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(29,226</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(27,339</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(4,444</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(81,937</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(11,669</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Denominator:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Weighted average shares outstanding- basic</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">48,037,634</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">48,314,746</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">48,146,611</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">48,020,369</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">48,121,404</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Effect of dilutive securities </font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(2)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Weighted average shares outstanding- diluted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">48,037,634</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">48,314,746</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">48,146,611</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">48,020,369</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">48,121,404</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Loss per share:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Basic</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.61</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.57</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.09</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1.71</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.24</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Diluted </font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(2)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.61</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.57</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.09</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1.71</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.24</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Dilutive securities outstanding not included in the computation of (loss) earnings per share as their effect is antidilutive:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Stock options</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">144,795</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">153,884</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Restricted shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">134,054</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">112,529</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">34,506</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">140,552</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">105,944</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Convertible preferred stock</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">N/A</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">N/A</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:18px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:7pt;padding-left:0px;"><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Includes dividends accrued during the Successor periods for the Series A Preferred Stock. The Series A Preferred Stock does not participate in undistributed losses. There were no participating securities during the Predecessor periods.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:18px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:7pt;padding-left:0px;"><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(2)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">The impact of potentially dilutive securities for all periods presented was not considered because the effect would be anti-dilutive in each period.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">Share Repurchase Transactions</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">On December 15, 2017 (Successor), the Company's Board of Directors authorized a share repurchase program of up to </font><font style="font-family:inherit;font-size:9pt;">$50.0 million</font><font style="font-family:inherit;font-size:9pt;"> of the Company's issued and outstanding common stock from time to time. The timing and size of repurchases will be determined based on market conditions and other factors. The authorization does not obligate the repurchase of any shares and the Company may repurchase shares of common stock at any time without prior notice. The share repurchases will be made in accordance with applicable securities laws in open market or privately negotiated transactions. The authorization does not have a specified expiration date, and the share repurchase program may be suspended, recommenced or discontinued at any time or from time to time without prior notice.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">There were </font><font style="font-family:inherit;font-size:9pt;">no</font><font style="font-family:inherit;font-size:9pt;"> share repurchases under the share repurchase program during the three months ended September 30, 2018 (Successor). During the nine months ended September 30, 2018 (Successor), the Company repurchased </font><font style="font-family:inherit;font-size:9pt;">156,818</font><font style="font-family:inherit;font-size:9pt;"> shares of its common stock stock at an average price of </font><font style="font-family:inherit;font-size:9pt;">$12.64</font><font style="font-family:inherit;font-size:9pt;"> per share through market purchases. At September 30, 2018 (Successor), the Company had </font><font style="font-family:inherit;font-size:9pt;">$46.0 million</font><font style="font-family:inherit;font-size:9pt;"> of repurchase authorization available under the December 2017 authorization.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Fair Value of Financial Instruments</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The fair value of a financial instrument is the amount at which the instrument could be exchanged in an orderly transaction between market participants to sell the asset or transfer the liability. The Company uses fair value measurements based on quoted prices in active markets for identical assets or liabilities (Level&#160;1), inputs other than quoted prices in active markets that are either directly or indirectly observable (Level 2), or unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions (Level 3), depending on the nature of the item being valued.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The carrying amounts reported in the condensed consolidated balance sheets for cash and cash equivalents, accounts receivable, restricted invested assets and accounts payable approximate their fair values.</font></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The fair value of the derivative financial instruments was based on a quoted market price, or a Level 2 computation. As of </font><font style="font-family:inherit;font-size:9pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:9pt;"> (Successor), the fair value of the derivative liabilities was included in other long-term liabilities in the condensed consolidated balance sheets. As of </font><font style="font-family:inherit;font-size:9pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:9pt;"> (Successor), the Company had no derivative financial instruments.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company maintains a supplemental executive retirement savings plan (the "SERP") for certain executives. The SERP is a non-qualified deferred compensation plan for eligible executive officers and other key employees of the Company that allows participants to defer portions of their compensation. The fair value of the SERP asset and liability was based on a quoted market price, or a Level 1 computation.</font></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The fair values of the Term Loan, Senior Unsecured Notes due 2021 and the Senior Unsecured Notes due 2025 were based on a Level 2 inputs using quoted prices for identical liabilities in inactive markets at </font><font style="font-family:inherit;font-size:9pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:9pt;"> (Successor) and </font><font style="font-family:inherit;font-size:9pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:9pt;"> (Successor). The carrying amounts related to the Company's other long-term debt obligations, including the Revolver, approximate their fair values.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Goodwill</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Goodwill represents the fair value of the consideration provided in an acquisition over the fair value of net assets acquired and is not amortized. Additions to goodwill include amounts resulting from new business combinations and incremental ownership purchases in the Company's subsidiaries.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:16px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Income Taxes</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company uses the asset and liability method to account for income taxes.&#160;Under this method, deferred income tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases.&#160;Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled.&#160;The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. If a net operating loss ("NOL") or Section 163(j) interest (&#8220;163(j)&#8221;) carryforward exists, the Company makes a determination as to whether the NOL or 163(j) carryforward will be utilized in the future. A valuation allowance is established for certain carryforwards when their recoverability is deemed to be uncertain.&#160;The carrying value of the net deferred tax assets assumes that the Company will be able to generate sufficient future taxable income in certain tax jurisdictions, based on estimates and assumptions.&#160;If these estimates and related assumptions change in the future, the Company may be required to adjust its deferred tax valuation allowances.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company and certain of its subsidiaries file a consolidated federal income tax return. The partnerships, limited liability companies, and certain non-consolidated physician practice corporations also file separate income tax returns. The Company's allocable portion of each partnership's and limited liability company's income or loss is included in taxable income of the Company. The remaining income or loss of each partnership and limited liability company is allocated to the other owners. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company, or one or more of its subsidiaries, files income tax returns in the U.S. federal jurisdiction and various state jurisdictions. With few exceptions, the Company is no longer subject to U.S. federal income tax examinations for years prior to 2015 or state income tax examinations for years prior to 2014.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Section&#160;382 (&#8220;Section 382&#8221;) of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;) imposes an annual limit on the ability of a corporation that undergoes an &#8220;ownership change&#8221; to use its NOLs to reduce its tax liability. An &#8220;ownership change&#8221; is generally defined as any change in ownership of more than 50.0% of a corporation&#8217;s &#8220;stock&#8221; by its &#8220;5-percent shareholders&#8221; (as defined in Section&#160;382) over a rolling three-year period based upon each of those shareholder&#8217;s lowest percentage of stock owned during such period. As a result of the Symbion acquisition, approximately </font><font style="font-family:inherit;font-size:9pt;">$179.0 million</font><font style="font-family:inherit;font-size:9pt;"> in NOL carryforwards are subject to an annual Section&#160;382 base limitation of </font><font style="font-family:inherit;font-size:9pt;">$4.9 million</font><font style="font-family:inherit;font-size:9pt;">, and, as a result of the NovaMed acquisition, approximately </font><font style="font-family:inherit;font-size:9pt;">$17.0 million</font><font style="font-family:inherit;font-size:9pt;"> in NOL carryforwards are subject to an annual Section&#160;382 base limitation of </font><font style="font-family:inherit;font-size:9pt;">$4.9 million</font><font style="font-family:inherit;font-size:9pt;">. As a result of the NSH acquisition, approximately </font><font style="font-family:inherit;font-size:9pt;">$20.5 million</font><font style="font-family:inherit;font-size:9pt;"> in NOL carryforwards are subject to an annual Section 382 base limitation of </font><font style="font-family:inherit;font-size:9pt;">$2.8 million</font><font style="font-family:inherit;font-size:9pt;">.&#160;The Private Sale resulted in an ownership change as defined in Section 382.&#160;As a result, approximately </font><font style="font-family:inherit;font-size:9pt;">$449.7 million</font><font style="font-family:inherit;font-size:9pt;"> in NOL carryforwards are subject to an annual Section 382 base limitation of </font><font style="font-family:inherit;font-size:9pt;">$14.2 million</font><font style="font-family:inherit;font-size:9pt;">.&#160;At this time, the Company does not believe this limitation, when combined with amounts allowable due to net unrecognized built in gains, will affect its ability to use any NOLs before they expire. However, no such assurances can be provided. If the Company's ability to utilize its NOLs to offset taxable income generated in the future is subject to this limitation, it could have an adverse effect on the Company's business, prospects, results of operations and financial condition.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Tax Cuts and Jobs Act (the "Tax Act") was enacted on December 22, 2017. The Tax Act reduced the US federal corporate tax rate from 35% to 21%, allows for 100% expensing of qualified capital expenditures, and limits interest expense deductions beginning in 2018.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company's accounting for the Tax Act is incomplete. As of the year ended December 31, 2017 (Successor), the Company was able to reasonably estimate certain effects and, therefore, recorded a provisional adjustment associated with the tax rate change (as discussed further in the 2017 form 10-K). The Company has not made any additional measurement-period adjustments to this item during the nine months ended </font><font style="font-family:inherit;font-size:9pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:9pt;">. The Company completed its the accounting for its 2017 temporary book/tax differences when it filed its 2017 federal tax return during the third quarter. However, the Company requires additional time to complete the analysis of the tax impact of the deferred re-measurement and record the adjustment. The Company expects to complete the accounting within the prescribed measurement period. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">For the following tax reform items, the Company was able to reasonably estimate certain effects of the Tax Act in the nine months ended </font><font style="font-family:inherit;font-size:9pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:9pt;"> and, therefore, recorded provisional adjustments as follows:</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Interest Expense Limitation: Under the Tax Act, interest expense is limited to 30% of the Company&#8217;s adjusted taxable income beginning in 2018 resulting in a temporary book to tax difference. Any disallowed interest expense is carried forward indefinitely. The Company was able to reasonably estimate the interest limitation and recorded an estimate for the disallowed interest expense. The provisional amount of disallowed interest expense as of </font><font style="font-family:inherit;font-size:9pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:9pt;"> is </font><font style="font-family:inherit;font-size:9pt;">$69.8 million</font><font style="font-family:inherit;font-size:9pt;">. The Company has recorded a valuation allowance of </font><font style="font-family:inherit;font-size:9pt;">$11.4 million</font><font style="font-family:inherit;font-size:9pt;"> on a tax-effected basis against the deferred tax asset resulting from the disallowed interest expense. However, the Company is continuing to gather additional information to more precisely compute the amount of the interest limitation, and the accounting for this item is not yet complete as the Company is waiting for additional guidance to be released around the application of the law. The Company expects to complete its accounting within the prescribed measurement period.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">100% Bonus Depreciation: Qualified capital expenditures placed in service after September 27, 2017 are eligible for 100% expensing under the Tax Act. The Company was able to reasonably estimate the 100% bonus depreciation expense and made a provisional estimate. However, the Company is continuing to gather additional information to more precisely compute the amount of 100% bonus depreciation, and the accounting for this item is not yet complete because the Company needs additional time to complete an accurate and thorough analysis of its fixed assets. The Company expects to complete its accounting within the prescribed measurement period.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company's effective tax rate was </font><font style="font-family:inherit;font-size:9pt;">48.8%</font><font style="font-family:inherit;font-size:9pt;"> for the </font><font style="font-family:inherit;font-size:9pt;">nine</font><font style="font-family:inherit;font-size:9pt;"> months ended </font><font style="font-family:inherit;font-size:9pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:9pt;"> (Successor), compared to </font><font style="font-family:inherit;font-size:9pt;">7.4%</font><font style="font-family:inherit;font-size:9pt;"> for the one month ended </font><font style="font-family:inherit;font-size:9pt;">September&#160;30, 2017</font><font style="font-family:inherit;font-size:9pt;"> (Successor) and </font><font style="font-family:inherit;font-size:9pt;">(146.7)%</font><font style="font-family:inherit;font-size:9pt;"> for the eight months ended August 31, 2018 (Predecessor). The increase in the effective tax rate was primarily due to the Tax Act, which implemented an interest expense limitation resulting in a deferred tax asset that required a valuation allowance to be reported at its net realizable value. The Company recorded additional tax expense in 2018 to account for the gain on divestitures and valuation allowances on state tax attributes resulting from legislative changes enacted during the second quarter. The effective tax rate was further impacted by the Tax Act due to the reduced the U.S. federal corporate income tax rate, as discussed above, effective January 1, 2018.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:16px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Income Taxes</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company uses the asset and liability method to account for income taxes.&#160;Under this method, deferred income tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases.&#160;Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled.&#160;The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. If a net operating loss ("NOL") or Section 163(j) interest (&#8220;163(j)&#8221;) carryforward exists, the Company makes a determination as to whether the NOL or 163(j) carryforward will be utilized in the future. A valuation allowance is established for certain carryforwards when their recoverability is deemed to be uncertain.&#160;The carrying value of the net deferred tax assets assumes that the Company will be able to generate sufficient future taxable income in certain tax jurisdictions, based on estimates and assumptions.&#160;If these estimates and related assumptions change in the future, the Company may be required to adjust its deferred tax valuation allowances.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company and certain of its subsidiaries file a consolidated federal income tax return. The partnerships, limited liability companies, and certain non-consolidated physician practice corporations also file separate income tax returns. The Company's allocable portion of each partnership's and limited liability company's income or loss is included in taxable income of the Company. The remaining income or loss of each partnership and limited liability company is allocated to the other owners. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company, or one or more of its subsidiaries, files income tax returns in the U.S. federal jurisdiction and various state jurisdictions. With few exceptions, the Company is no longer subject to U.S. federal income tax examinations for years prior to 2015 or state income tax examinations for years prior to 2014.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Section&#160;382 (&#8220;Section 382&#8221;) of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;) imposes an annual limit on the ability of a corporation that undergoes an &#8220;ownership change&#8221; to use its NOLs to reduce its tax liability. An &#8220;ownership change&#8221; is generally defined as any change in ownership of more than 50.0% of a corporation&#8217;s &#8220;stock&#8221; by its &#8220;5-percent shareholders&#8221; (as defined in Section&#160;382) over a rolling three-year period based upon each of those shareholder&#8217;s lowest percentage of stock owned during such period.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Long-Term Debt</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">A summary of long-term debt follows (in thousands):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:74%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-style:italic;">Successor</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2017 Senior Secured Credit Facilities:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Revolver</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">11,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Term Loan </font><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,271,397</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,280,532</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Senior Unsecured Notes due 2021 </font><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(2)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">407,372</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">409,235</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Senior Unsecured Notes due 2025</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">370,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">370,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Notes payable and secured loans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">88,068</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">101,921</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Capital lease obligations</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">24,836</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">27,594</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total debt</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,172,673</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,189,282</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Less: Current maturities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">54,106</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">58,726</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total long-term debt</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,118,567</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,130,556</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="padding-top:12px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:18px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:7pt;padding-left:0px;"><font style="font-family:inherit;font-size:7pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">In connection with the application of pushdown accounting, the Company remeasured and recorded the Term Loan at fair value using a measurement date of August 31, 2017. The fair value was based on a Level 2 input using quoted prices for identical liabilities in inactive markets. As a result, the Company recorded a fair value discount as of the measurement date, which is reported in the consolidated balance sheets as a direct rededuction from the face amount the Term Loan and amortized to interest expense over the life of the Term Loan. The unamortized fair value discount as of </font><font style="font-family:inherit;font-size:7pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:7pt;"> (Successor) and December 31, 2017 (Successor) was </font><font style="font-family:inherit;font-size:7pt;">$5.7 million</font><font style="font-family:inherit;font-size:7pt;"> and </font><font style="font-family:inherit;font-size:7pt;">$6.2 million</font><font style="font-family:inherit;font-size:7pt;">, respectively.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:18px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:7pt;padding-left:0px;"><font style="font-family:inherit;font-size:7pt;">(2)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">In connection with the application of pushdown accounting, the Company remeasured and recorded the Senior Unsecured Notes due 2021 at fair value using a measurement date of August 31, 2017. The fair value was based on a Level 2 input using quoted prices for identical liabilities in inactive markets. As a result, the Company recorded a fair value premium as of the measurement date, which is reported in the consolidated balance sheets as a direct addition to the face amount the notes and amortized to interest expense over the life of the Senior Unsecured Notes due 2021. The unamortized fair value premium as of </font><font style="font-family:inherit;font-size:7pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:7pt;"> (Successor) and December 31, 2017 (Successor) was </font><font style="font-family:inherit;font-size:7pt;">$7.4 million</font><font style="font-family:inherit;font-size:7pt;"> and </font><font style="font-family:inherit;font-size:7pt;">$9.2 million</font><font style="font-family:inherit;font-size:7pt;">, respectively.</font></div></td></tr></table></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Recent Accounting Pronouncements</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">In May 2014, the FASB issued ASU 2014-09, "</font><font style="font-family:inherit;font-size:9pt;font-style:italic;">Revenue from Contracts with Customers</font><font style="font-family:inherit;font-size:9pt;">," along with subsequent amendments, updates and an extension of the effective date (collectively the "New Revenue Standard"), which outlines a single comprehensive model for recognizing revenue and supersedes most existing revenue recognition guidance, including guidance specific to the healthcare industry. This five-step process requires significant management judgment in addition to changing the way many companies recognize revenue in their financial statements.&#160;The Company adopted this ASU on January 1, 2018 using the modified retrospective approach.&#160;The adoption of this standard did not have a significant impact on the recognition of net revenues for any period. Adoption of the standard resulted in the Company revising its related disclosures.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">In February 2016, the FASB issued ASU 2016-02, "</font><font style="font-family:inherit;font-size:9pt;font-style:italic;">Leases,</font><font style="font-family:inherit;font-size:9pt;">" which will require, among other items, lessees to recognize most leases as assets and liabilities on the balance sheet. Qualitative and quantitative disclosures will be enhanced to better understand the amount, timing and uncertainty of cash flows arising from leases. This guidance is effective for financial statements issued for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years, with early adoption permitted. The guidance is required to be applied using a modified retrospective transition approach for leases existing at, or entered into after, the beginning of the earliest comparative periods presented in the financial statements. In preparation of adopting the new standard, the Company has engaged outside consultants to assist in the identification of the Company's population of leases, implementing a new software for lease accounting and assisting in evaluating new accounting policy elections. The Company will adopt this ASU on January 1, 2019 and believes the primary effect of adopting the new standard will be to record right-of-use assets and obligations for current operating leases with material increases in reported property and equipment and liabilities. The Company is still evaluating the effect of adoption on financial disclosures, policies, procedures and control framework.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">In November 2016, the FASB issued ASU 2016-18, "</font><font style="font-family:inherit;font-size:9pt;font-style:italic;">Statement of Cash Flows &#8211; Restricted Cash</font><font style="font-family:inherit;font-size:9pt;">," which requires that a statement of cash flows explain the change during the period in the total of cash, cash equivalents, and amounts generally described as restricted cash or restricted cash equivalents. ASU 2016-18 is effective for fiscal years beginning after December 15, 2017, including interim periods within those years. The Company adopted this ASU on January 1, 2018 and retrospectively applied the guidance to all periods presented in the condensed consolidated statement of cash flows. The retrospective application to prior periods had no impact on the Company's cash flows from operating, investing and financing activities as previously disclosed. The adoption of this ASU resulted in the modification of the Company's presentation of the reconciliation of beginning-of-period and end-of-period total amounts shown on the condensed consolidated statement of cash flows to include restricted cash as discussed under the heading "Cash and Cash Equivalents" above.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">A summary of other long-term liabilities follows (in thousands):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:74%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-style:italic;">Successor</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Facility lease obligations</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">138,116</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">121,627</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">109,195</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">100,853</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">247,311</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">222,480</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">In connection with the change of control effective August 31, 2017, the Company elected to apply &#8220;pushdown&#8221; accounting by applying the guidance in Accounting Standards Codification Topic ("ASC") 805, </font><font style="font-family:inherit;font-size:9pt;font-style:italic;">Business Combinations</font><font style="font-family:inherit;font-size:9pt;">. Accordingly, the condensed consolidated financial statements of the Company for periods before and after August 31, 2017 reflect different bases of accounting, and the financial positions and results of operations of those periods are not comparable. Throughout the Company's condensed consolidated financial statements and the accompanying notes herein, periods prior to the change of control are identified as "Predecessor" and periods after the change of control are identified as "Successor." See Note 2. Acquisitions and Developments for further discussion of the change of control.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Accounts Receivable and Allowances for Contractual Adjustments and Doubtful Accounts</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">With the Company's adoption of ASC 2014-09 on January 1, 2018, for those accounts in which the Company has an unconditional right to payment, subject only to the passage of time, the right is recorded as a receivable. Accounts receivable are recorded net of contractual adjustments and allowances for doubtful accounts to reflect accounts receivable at net realizable value. Accounts receivable consists of receivables from federal and state agencies (under the Medicare and Medicaid programs), managed care health plans, commercial insurance companies, employers and patients. Management recognizes that revenues and receivables from government agencies are significant to the Company's operations, but it does not believe that there is significant credit risk associated with these government agencies. Concentration of credit risk with respect to other payors is limited because of the large number of such payors. The Company had a net third-party Medicaid settlements liability of </font><font style="font-family:inherit;font-size:9pt;">$7.7 million</font><font style="font-family:inherit;font-size:9pt;"> and </font><font style="font-family:inherit;font-size:9pt;">$1.0 million</font><font style="font-family:inherit;font-size:9pt;"> as of </font><font style="font-family:inherit;font-size:9pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:9pt;"> (Successor) and </font><font style="font-family:inherit;font-size:9pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:9pt;"> (Successor), respectively, included in other current liabilities in the condensed consolidated balance sheets.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company recognizes that final reimbursement of accounts receivable is subject to final approval by each third-party payor.&#160;However, because the Company has contracts with its third-party payors and also verifies insurance coverage of the patient before medical services are rendered, the amounts that are pending approval from third-party payors are not considered significant.&#160;The Company's policy is to collect co-payments and deductibles prior to providing medical services. It is also the Company's policy to verify a patient&#8217;s insurance prior to the patient&#8217;s procedure.&#160;Patient services of the Company are primarily non-emergency, which allows the surgical facilities to control the procedures for which third-party reimbursement is sought and obtained. The Company does not require collateral from self-pay patients.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company analyzes accounts receivable at each of its facilities to ensure the proper aged category and collection assessment. At a consolidated level, the Company's policy is to review accounts receivable aging, by facility, to determine the appropriate allowance for doubtful accounts. Patient account balances are reviewed for delinquency based on contractual terms. This review is supported by an analysis of the actual revenues, contractual adjustments and cash collections received. An account balance is written off only after the Company has pursued collection with legal or collection agency assistance or otherwise has deemed an account to be uncollectible.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The receivables related to the Company's optical products purchasing organization are recognized separately from patient accounts receivable, as discussed above, and are included in other current assets in the condensed consolidated balance sheets.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:74%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">Successor</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Assets:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Surgical facility services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,015,094</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,072,521</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Ancillary services</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">110,588</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">104,274</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Optical services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">34,811</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">48,309</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">All other</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">398,171</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">397,669</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,558,664</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,622,773</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">A reconciliation of Adjusted EBITDA to income before income taxes included in the condensed consolidated statement of operations is as follows:</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="25" rowspan="1"></td></tr><tr><td style="width:41%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">Successor</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">Predecessor</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">Successor</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">Predecessor</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Three Months Ended September 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">September 1 to September 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">July 1 to August 31,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Nine Months Ended September 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">January 1 to August 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Adjusted EBITDA</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">58,988</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">14,842</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8,402</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">161,465</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">85,564</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net income attributable to non-controlling interests</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">23,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6,492</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8,813</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">69,418</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">42,087</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Depreciation and amortization</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(16,945</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(3,330</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(7,599</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(49,379</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(30,124</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Interest expense, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(37,159</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(15,883</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(18,147</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(107,368</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(68,929</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Equity-based compensation</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1,526</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1,683</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1,628</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(6,303</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(3,697</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Contingent acquisition compensation expense</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(503</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(605</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1,210</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1,510</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(5,057</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Transaction, integration and acquisition costs </font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(7,489</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(3,457</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2,949</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(25,419</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(7,677</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Gain on litigation settlement</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,794</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Gain on acquisition escrow release</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Reserve adjustments </font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,109</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2,670</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Loss on disposals and deconsolidations, net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(12,631</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(333</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(114</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(15,875</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1,715</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Gain on amendment to tax receivable agreement</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,098</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">15,294</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">15,294</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Loss on debt refinancing</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(18,211</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(18,211</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Income before income taxes</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7,844</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2,859</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(16,349</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">22,359</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">12,329</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:18px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:7pt;padding-left:0px;"><font style="font-family:inherit;font-size:7pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">This amount includes transaction and integration costs of </font><font style="font-family:inherit;font-size:7pt;">$7.1 million</font><font style="font-family:inherit;font-size:7pt;"> and </font><font style="font-family:inherit;font-size:7pt;">$23.8 million</font><font style="font-family:inherit;font-size:7pt;"> for the three and nine months ended September&#160;30, 2018 (Successor), respectively, </font><font style="font-family:inherit;font-size:7pt;">$3.0 million</font><font style="font-family:inherit;font-size:7pt;"> for the one month ended September 30, 2017 (Successor), and </font><font style="font-family:inherit;font-size:7pt;">$2.3 million</font><font style="font-family:inherit;font-size:7pt;"> and </font><font style="font-family:inherit;font-size:7pt;">$5.6 million</font><font style="font-family:inherit;font-size:7pt;"> for the two and eight months ended August 31, 2017 (Predecessor), respectively. This amount includes acquisition costs of </font><font style="font-family:inherit;font-size:7pt;">$0.4 million</font><font style="font-family:inherit;font-size:7pt;"> and </font><font style="font-family:inherit;font-size:7pt;">$1.6 million</font><font style="font-family:inherit;font-size:7pt;"> for the three and nine months ended September&#160;30, 2018 (Successor), respectively, </font><font style="font-family:inherit;font-size:7pt;">$0.5 million</font><font style="font-family:inherit;font-size:7pt;"> for the one month ended September 30, 2017 (Successor), and </font><font style="font-family:inherit;font-size:7pt;">$0.6 million</font><font style="font-family:inherit;font-size:7pt;"> and </font><font style="font-family:inherit;font-size:7pt;">$2.1 million</font><font style="font-family:inherit;font-size:7pt;"> for the two and eight months ended August 31, 2017 (Predecessor), respectively.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:18px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:7pt;padding-left:0px;"><font style="font-family:inherit;font-size:7pt;">(2)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">This amount represents adjustments to revenue in connection with applying consistent policies across the combined company as a result of the integration of Surgery Partners and NSH.</font></div></td></tr></table></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The following tables present financial information for each reportable segment (in thousands):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="25" rowspan="1"></td></tr><tr><td style="width:41%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-style:italic;">Successor</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-style:italic;">Predecessor</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-style:italic;">Successor</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-style:italic;">Predecessor</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Three Months Ended September 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">September 1 to September 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">July 1 to August 31,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Nine Months Ended September 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">January 1 to August 31,</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Revenues:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Surgical facility services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">420,514</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">125,595</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">167,765</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,234,984</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">688,725</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Ancillary services</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">20,719</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,775</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,409</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">62,655</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">52,261</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Optical services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,699</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">888</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,905</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8,437</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7,629</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">443,932</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">132,258</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">174,079</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,306,076</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">748,615</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Adjusted EBITDA </font><font style="font-family:inherit;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font><font style="font-family:inherit;font-size:9pt;font-weight:bold;">:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Surgical facility services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">74,525</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">20,947</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">27,726</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">216,540</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">125,912</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Ancillary services</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">875</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1,265</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(10,737</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,925</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(6,526</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Optical services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">571</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">193</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">555</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,087</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,214</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">All other</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(16,983</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(5,033</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(9,142</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(60,087</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(36,036</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">58,988</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">14,842</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8,402</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">161,465</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">85,564</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="padding-top:6px;padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:18px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:7pt;padding-left:0px;"><font style="font-family:inherit;font-size:7pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">When the Company uses the term &#8220;Adjusted EBITDA,&#8221; it is referring to income before income taxes adjusted for (a)&#160;net income attributable to non-controlling interests, (b)&#160;depreciation and amortization, (c) interest expense, net, (d) equity-based compensation, (e) contingent acquisition compensation expense, (f) transaction, integration and acquisition costs, (g) gain on litigation settlement, (h) gain on acquisition escrow release, (i) reserve adjustments, (j) loss on disposals and deconsolidations, net, (k) gain on amendment to tax receivable agreement and (l) loss on debt refinancing. Adjusted EBITDA is the primary profit/loss metric reviewed by the chief operating decision maker in making key business decisions and on allocation of resources. Adjusted EBITDA is not a measurement of financial performance under GAAP, and should not be considered in isolation or as a substitute for net income, operating income or any other measure calculated in accordance with generally accepted accounting principles. The items excluded from Adjusted EBITDA are significant components in understanding and evaluating the Company's financial performance. The Company's calculation of Adjusted EBITDA may not be comparable to similarly titled measures reported by other companies.</font></div></td></tr></table></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">A summary of activity related to the non-controlling interests&#8212;redeemable follows (in thousands):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:84%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-style:italic;">Successor</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Balance at December&#160;31, 2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">299,316</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net income attributable to non-controlling interests&#8212;redeemable</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">20,528</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Acquisition and disposal of shares of non-controlling interests, net&#8212;redeemable </font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">20,279</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Distributions to non-controlling interest&#8212;redeemable holders</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(22,582</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Balance at September&#160;30, 2018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">317,541</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:18px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:7pt;padding-left:0px;"><font style="font-family:inherit;font-size:7pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Includes post acquisition date adjustments.</font></div></td></tr></table></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Revenues</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">In May 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2014-09, </font><font style="font-family:inherit;font-size:9pt;font-style:italic;">Revenue from Contracts with Customers</font><font style="font-family:inherit;font-size:9pt;">. The Company adopted the new standard effective January 1, 2018, using the modified retrospective method. The adoption of the new standard did not have an impact on our recognition of net revenues for any periods prior to adoption. The majority of the &#8220;Provision for doubtful accounts&#8221; will continue to be recognized as an operating expense rather than as a direct reduction to revenues, given the Company&#8217;s practice of assessing a patient&#8217;s ability to pay prior to or on the date of providing healthcare services. After initial recognition, the Company&#8217;s accounts receivables are subject to impairment assessments periodically based on changes in credit risks using historical trends of cash collections, write-offs, accounts receivable agings and other factors.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company's revenues generally relate to contracts with patients in which the performance obligations are to provide healthcare services. The Company recognizes revenues in the period in which our obligations to provide health care services are satisfied and reports the amount that reflects the consideration the Company expects to be entitled to. The Company's performance obligations are generally satisfied over a period of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payer (Medicare, Medicaid, managed care health plans, employers and commercial insurance companies, including plans offered through the health insurance exchanges) and the transaction prices for the services provided are dependent upon the terms provided by (Medicare and Medicaid) or negotiated with (managed care health plans, employers and commercial insurance companies) the third-party payers. The payment arrangements with third-party payers for the services provided to the related patients typically specify payments at amounts less than the Company's standard charges. Medicare generally pays for services at prospectively determined rates based on clinical, diagnostic and other factors. Services provided to patients having Medicaid coverage are generally paid at prospectively determined rates per discharge, per identified service or per covered member. Agreements with commercial insurance carriers, managed care and preferred provider organizations generally provide for payments based upon predetermined rates per diagnosis, per diem rates or discounted fee-for-service rates. The Company continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.</font></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">Patient service revenues.</font><font style="font-family:inherit;font-size:9pt;">&#160; This includes revenue related to charging facility fees in exchange for providing patient care. The fee charged for healthcare procedures performed in surgical facilities varies depending on the type of service provided, but usually includes all charges for usage of an operating room, a recovery room, special equipment, medical supplies, nursing staff and medications.&#160;The fee does not normally include professional fees charged by the patient&#8217;s surgeon, anesthesiologist or other attending physician, which are billed directly by such physicians to the patient or third-party payor. However, in several surgical facilities, the Company charges for anesthesia services. Ancillary service revenues include fees for patient visits to the Company's physician practices, pharmacy services and diagnostic tests ordered by physicians.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Patient service revenues are recognized as performance obligations are satisfied. Performance obligations are based on the nature of services provided. Typically, the Company recognizes revenue at a point in time in which services are rendered and the Company has no obligation to provide further patient services. As the Company primarily performs outpatient procedures, performance obligations are generally satisfied same day and revenue is recognized on the date of service.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company determines the transaction price based on gross charges for services provided, net of estimated contractual adjustments, discounts from third-party payors, including Medicare and Medicaid. The Company estimates its contractual adjustments and discounts based on contractual agreements, its discount policies and historical experience. Changes in estimated contractual adjustments and discounts are recorded in the period of change.</font></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">Other service revenues.</font><font style="font-family:inherit;font-size:9pt;font-style:italic;font-weight:bold;"> </font><font style="font-family:inherit;font-size:9pt;"> Optical service revenues consist of product sales from the Company's optical laboratories as well as handling charges billed to the members of the Company's optical products purchasing organization. The Company's optical products purchasing organization negotiates volume buying discounts with optical products manufacturers. The buying discounts and any handling charges billed to the members of the buying group represent the revenue recognized for financial reporting purposes. The Company satisfies the performance obligation and recognizes revenue when the orders are shipped to members. The Company bases its estimates for sales returns and discounts on historical experience and has not experienced significant fluctuations between estimated and actual return activity and discounts given. The Company's optical laboratories manufacture and distribute corrective lenses and eyeglasses to ophthalmologists and optometrists. The Company satisfies the performance obligation and recognize revenue when the product is shipped, net of allowance for discounts. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other revenues include management and administrative service fees derived from the non-consolidated facilities that the Company accounts for under the equity method, management of surgical facilities in which it does not own an interest, and management services provided to physician practices for which the Company is not required to provide capital or additional assets. These agreements typically require the Company to provide recurring management services over a multi-year period which are billed and collected on a monthly basis. The fees derived from these management arrangements are based on a predetermined percentage of the revenues of each facility or practice and are recognized in the period in which management services are rendered and billed.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">A summary of other current liabilities follows (in thousands):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:74%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-style:italic;">Successor</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Interest payable</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">28,322</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">20,537</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Amounts due to patients and payors</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">22,400</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">18,096</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Accrued expenses and other</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">72,216</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">71,311</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">122,938</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">109,944</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">A summary of the carrying amounts and fair values of the Company's long-term debt follows (in thousands):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:48%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">Successor</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Carrying Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2017 Senior Secured Credit Facilities:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Revolver</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">11,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">11,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Term Loan</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,271,397</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,280,532</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,272,986</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,267,189</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Senior Unsecured Notes due 2021</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">407,372</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">409,235</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">423,667</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">422,535</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Senior Unsecured Notes due 2025</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">370,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">370,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">355,200</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">346,413</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The following table reconciles cash, cash equivalents and restricted cash reported within the condensed consolidated balance sheets to the totals shown within the condensed consolidated statement of cash flows (in thousands):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:74%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-style:italic;">Successor</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Cash and cash equivalents</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">79,123</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">174,914</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Restricted invested assets included in other long-term assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">315</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">315</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total cash, cash equivalents and restricted cash in the statement of cash flows</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">79,438</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">175,229</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">A summary of long-term debt follows (in thousands):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:74%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-style:italic;">Successor</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2017 Senior Secured Credit Facilities:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Revolver</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">11,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Term Loan </font><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,271,397</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,280,532</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Senior Unsecured Notes due 2021 </font><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(2)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">407,372</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">409,235</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Senior Unsecured Notes due 2025</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">370,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">370,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Notes payable and secured loans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">88,068</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">101,921</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Capital lease obligations</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">24,836</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">27,594</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total debt</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,172,673</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,189,282</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Less: Current maturities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">54,106</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">58,726</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total long-term debt</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,118,567</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,130,556</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="padding-top:12px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:18px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:7pt;padding-left:0px;"><font style="font-family:inherit;font-size:7pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">In connection with the application of pushdown accounting, the Company remeasured and recorded the Term Loan at fair value using a measurement date of August 31, 2017. The fair value was based on a Level 2 input using quoted prices for identical liabilities in inactive markets. As a result, the Company recorded a fair value discount as of the measurement date, which is reported in the consolidated balance sheets as a direct rededuction from the face amount the Term Loan and amortized to interest expense over the life of the Term Loan. The unamortized fair value discount as of </font><font style="font-family:inherit;font-size:7pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:7pt;"> (Successor) and December 31, 2017 (Successor) was </font><font style="font-family:inherit;font-size:7pt;">$5.7 million</font><font style="font-family:inherit;font-size:7pt;"> and </font><font style="font-family:inherit;font-size:7pt;">$6.2 million</font><font style="font-family:inherit;font-size:7pt;">, respectively.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:18px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:7pt;padding-left:0px;"><font style="font-family:inherit;font-size:7pt;">(2)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">In connection with the application of pushdown accounting, the Company remeasured and recorded the Senior Unsecured Notes due 2021 at fair value using a measurement date of August 31, 2017. The fair value was based on a Level 2 input using quoted prices for identical liabilities in inactive markets. As a result, the Company recorded a fair value premium as of the measurement date, which is reported in the consolidated balance sheets as a direct addition to the face amount the notes and amortized to interest expense over the life of the Senior Unsecured Notes due 2021. The unamortized fair value premium as of </font><font style="font-family:inherit;font-size:7pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:7pt;"> (Successor) and December 31, 2017 (Successor) was </font><font style="font-family:inherit;font-size:7pt;">$7.4 million</font><font style="font-family:inherit;font-size:7pt;"> and </font><font style="font-family:inherit;font-size:7pt;">$9.2 million</font><font style="font-family:inherit;font-size:7pt;">, respectively.</font></div></td></tr></table></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The table below presents the effect of fair value and cash flow hedge accounting on the Company's consolidated balance sheets.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;text-indent:24px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:96.03174603174604%;border-collapse:collapse;text-align:left;"><tr><td colspan="25" rowspan="1"></td></tr><tr><td style="width:41%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">Successor</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">Predecessor</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">Successor</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">Predecessor</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Three Months Ended September 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">September 1 to September 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">July 1 to August 31,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Nine Months Ended September 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">January 1 to August 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Derivatives in Cash Flow Hedging Relationships</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Losses related to effective portion of derivatives recognized in accumulated OCI, gross of tax effect</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1,389</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1,389</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Loss related to effective portion of derivatives reclassified from accumulated OCI to interest expense, gross of tax effect</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:18px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">During the nine months ended </font><font style="font-family:inherit;font-size:9pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:9pt;"> (Successor), the Company entered into certain derivative financial instruments. A summary of the fair values of the Company's derivative financial instruments follows (in thousands):</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;text-indent:24px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:71.42857142857143%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:66%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Successor</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Derivative liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Interest rate swap agreement</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,389</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">A reconciliation of the numerator and denominator of basic and diluted earnings per share follows (in thousands except share and per share amounts): </font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="25" rowspan="1"></td></tr><tr><td style="width:41%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-style:italic;">Successor</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-style:italic;">Predecessor</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-style:italic;">Successor</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-style:italic;">Predecessor</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Three Months Ended September 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">September 1 to September 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">July 1 to August 31,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Nine Months Ended September 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">January 1 to August 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Numerator:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net loss attributable to Surgery Partners, Inc.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(20,981</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(9,140</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(4,444</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(57,964</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(11,669</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Less: amounts allocated to participating securities </font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">8,245</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2,633</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">23,973</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Less: mark to redemption adjustment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">15,566</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net loss attributable to common stockholders</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(29,226</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(27,339</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(4,444</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(81,937</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(11,669</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Denominator:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Weighted average shares outstanding- basic</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">48,037,634</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">48,314,746</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">48,146,611</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">48,020,369</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">48,121,404</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Effect of dilutive securities </font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(2)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Weighted average shares outstanding- diluted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">48,037,634</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">48,314,746</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">48,146,611</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">48,020,369</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">48,121,404</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Loss per share:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Basic</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.61</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.57</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.09</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1.71</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.24</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Diluted </font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(2)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.61</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.57</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.09</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1.71</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.24</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Dilutive securities outstanding not included in the computation of (loss) earnings per share as their effect is antidilutive:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Stock options</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">144,795</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">153,884</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Restricted shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">134,054</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">112,529</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">34,506</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">140,552</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">105,944</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Convertible preferred stock</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">N/A</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">N/A</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:18px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:7pt;padding-left:0px;"><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Includes dividends accrued during the Successor periods for the Series A Preferred Stock. The Series A Preferred Stock does not participate in undistributed losses. There were no participating securities during the Predecessor periods.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:18px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:7pt;padding-left:0px;"><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(2)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">The impact of potentially dilutive securities for all periods presented was not considered because the effect would be anti-dilutive in each period.</font></div></td></tr></table></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">A summary of activity related to goodwill for the </font><font style="font-family:inherit;font-size:9pt;">nine</font><font style="font-family:inherit;font-size:9pt;"> months ended </font><font style="font-family:inherit;font-size:9pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:9pt;"> (Successor) follows (in thousands):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.40476190476191%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:85%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">Successor</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Balance at December&#160;31, 2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,346,838</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Acquisitions, including post acquisition adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">57,710</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Divestitures and deconsolidations</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(31,942</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Balance at September&#160;30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,372,606</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The aggregate amounts preliminarily recognized for each major class of assets acquired and liabilities assumed for acquisitions completed in the </font><font style="font-family:inherit;font-size:9pt;">nine</font><font style="font-family:inherit;font-size:9pt;"> months ended </font><font style="font-family:inherit;font-size:9pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:9pt;"> (Successor), including post acquisition date adjustments, are as follows (in thousands):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:85%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Cash consideration</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">54,308</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Fair value of non-controlling interests</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">28,776</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Aggregate acquisition date fair value</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">83,084</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net assets acquired:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Current Assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,708</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Property and equipment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,301</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Goodwill</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">75,947</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other long-term assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,460</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Current liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2,332</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Long-term liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1,000</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Aggregate acquisition date fair value</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">83,084</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The acquisition date fair value for each major class of assets acquired and liabilities assumed, including post acquisition date adjustments, are as follows (in thousands):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:85%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Cash consideration</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">764,007</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Fair value of non-controlling interests</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">325,965</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Acquisition date fair value</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,089,972</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net assets acquired:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Cash and cash equivalents</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">51,159</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Accounts receivable</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">71,639</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Inventories</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">14,986</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Prepaid expenses and other current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">18,367</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Property and equipment</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">174,100</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Intangible assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">27,881</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Goodwill</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">871,373</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Investments in and advances to affiliates</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">29,737</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Long-term deferred tax assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">20,212</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other long-term assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">26,988</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Accounts payable</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(29,652</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Accrued payroll and benefits</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(30,853</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other current liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(23,937</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Current maturities of long-term debt</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(16,416</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Long-term debt, less current maturities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(42,770</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other long-term liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(72,842</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Acquisition date fair value</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,089,972</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:18px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The transaction date fair value recognized in connection with the application of pushdown accounting for each major class of assets and liabilities as of August 31, 2017, including post transaction date adjustments, are as follows (in thousands): </font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.0079365079365%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:86%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Equity attributable to Surgery Partners, Inc.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">721,764</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Redeemable preferred stock</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">310,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Fair value of non-controlling interests</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">939,083</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Transaction date fair value</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,970,847</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net assets:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Cash and cash equivalents</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">214,206</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Accounts receivable</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">252,911</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Inventories</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">44,310</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Prepaid expenses and other current assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">61,438</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Property and equipment</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">379,685</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Intangible assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">63,978</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Goodwill</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,281,728</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Investments in and advances to affiliates</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">75,113</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Restricted invested assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">315</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Long-term deferred tax asset</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">206,073</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other long-term assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">50,666</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Accounts payable</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(64,921</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Accrued payroll and benefits</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(56,535</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other current liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(97,617</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Current maturities of long-term debt</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(49,942</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Long-term debt, less current maturities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2,142,375</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Long-term tax receivable agreement liability</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(78,498</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other long-term liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(169,688</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Transaction date fair value</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,970,847</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The following table sets forth patient service revenues by type of payor and as a percentage of total patient service revenues for the Company's consolidated surgical facilities (dollars in thousands):</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24" rowspan="1"></td></tr><tr><td style="width:35%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="13" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-style:italic;">Successor</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-style:italic;">Predecessor</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Three Months Ended September 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">September 1 to September 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">July 1 to August 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Patient service revenues:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Private insurance</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">230,718</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">53.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">72,930</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">56.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">80,166</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">46.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Government</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">166,880</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">38.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">46,162</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">35.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">73,734</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">43.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Self-pay</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">12,742</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,861</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,119</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other </font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">24,345</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6,883</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">12,909</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:18px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total patient service revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">434,685</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">100.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">129,836</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">100.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">170,928</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">100.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Other service revenues:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Optical services revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,699</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">888</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,905</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other revenues</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6,548</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,534</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,246</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:18px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">443,932</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">132,258</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">174,079</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24" rowspan="1"></td></tr><tr><td style="width:35%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="13" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-style:italic;">Successor</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-style:italic;">Predecessor</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Nine Months Ended September 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">September 1 to September 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">January 1 to August 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Patient service revenues:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Private insurance</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">682,479</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">53.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">72,930</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">56.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">360,092</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">48.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Government</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">493,362</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">38.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">46,162</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">35.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">308,993</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">42.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Self-pay</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">39,050</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,861</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">15,949</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other </font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">64,075</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6,883</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">51,374</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:18px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total patient service revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,278,966</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">100.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">129,836</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">100.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">736,408</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">100.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Other service revenues:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Optical services revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8,437</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">888</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7,629</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other revenues</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">18,673</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,534</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,578</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:18px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,306,076</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">132,258</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">748,615</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-top:6px;padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:18px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:7pt;padding-left:0px;"><font style="font-family:inherit;font-size:7pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Other is comprised of anesthesia service agreements, auto liability, letters of protection and other payor types. </font></div></td></tr></table></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.60317460317461%;border-collapse:collapse;text-align:left;"><tr><td colspan="15" rowspan="1"></td></tr><tr><td style="width:58%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-style:italic;">Successor</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-style:italic;">Predecessor</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Nine Months Ended September 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">September 1 to September 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">January 1 to August 31,</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Cash purchases of property and equipment, net:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Surgical facility services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">21,590</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,613</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">14,582</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Ancillary services</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">334</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,875</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Optical services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">42</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">23</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">73</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">All other</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,652</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">202</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,243</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total cash purchases of property and equipment, net </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">26,618</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,840</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">18,773</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">A summary of revenues by service type as a percentage of total revenues follows:</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="20" rowspan="1"></td></tr><tr><td style="width:41%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-style:italic;">Successor</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-style:italic;">Predecessor</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-style:italic;">Successor</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-style:italic;">Predecessor</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Three Months Ended September 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">September 1 to September 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">July 1 to August 31,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Nine Months Ended September 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">January 1 to August 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Patient service revenues:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;Surgical facilities revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">93.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">94.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">95.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">93.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">91.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;Ancillary services revenues</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">97.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">98.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">98.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">98.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">98.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Other service revenues:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;Optical services revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;Other revenues</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total revenues</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">100.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">100.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">100.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">100.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">100.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:16px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Segment Reporting</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company operates in&#160;</font><font style="font-family:inherit;font-size:9pt;">three</font><font style="font-family:inherit;font-size:9pt;">&#160;major lines of business that are also the Company's reportable operating segments - the operation of surgical facilities, the operation of ancillary services and the operation of optical services. "All other" primarily consists of the Company's corporate general and administrative functions.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The following tables present financial information for each reportable segment (in thousands):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="25" rowspan="1"></td></tr><tr><td style="width:41%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-style:italic;">Successor</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-style:italic;">Predecessor</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-style:italic;">Successor</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-style:italic;">Predecessor</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Three Months Ended September 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">September 1 to September 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">July 1 to August 31,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Nine Months Ended September 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">January 1 to August 31,</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Revenues:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Surgical facility services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">420,514</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">125,595</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">167,765</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,234,984</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">688,725</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Ancillary services</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">20,719</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,775</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,409</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">62,655</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">52,261</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Optical services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,699</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">888</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,905</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8,437</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7,629</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">443,932</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">132,258</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">174,079</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,306,076</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">748,615</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Adjusted EBITDA </font><font style="font-family:inherit;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font><font style="font-family:inherit;font-size:9pt;font-weight:bold;">:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Surgical facility services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">74,525</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">20,947</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">27,726</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">216,540</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">125,912</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Ancillary services</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">875</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1,265</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(10,737</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,925</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(6,526</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Optical services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">571</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">193</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">555</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,087</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,214</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">All other</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(16,983</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(5,033</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(9,142</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(60,087</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(36,036</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">58,988</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">14,842</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8,402</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">161,465</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">85,564</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="padding-top:6px;padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:18px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:7pt;padding-left:0px;"><font style="font-family:inherit;font-size:7pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">When the Company uses the term &#8220;Adjusted EBITDA,&#8221; it is referring to income before income taxes adjusted for (a)&#160;net income attributable to non-controlling interests, (b)&#160;depreciation and amortization, (c) interest expense, net, (d) equity-based compensation, (e) contingent acquisition compensation expense, (f) transaction, integration and acquisition costs, (g) gain on litigation settlement, (h) gain on acquisition escrow release, (i) reserve adjustments, (j) loss on disposals and deconsolidations, net, (k) gain on amendment to tax receivable agreement and (l) loss on debt refinancing. Adjusted EBITDA is the primary profit/loss metric reviewed by the chief operating decision maker in making key business decisions and on allocation of resources. Adjusted EBITDA is not a measurement of financial performance under GAAP, and should not be considered in isolation or as a substitute for net income, operating income or any other measure calculated in accordance with generally accepted accounting principles. The items excluded from Adjusted EBITDA are significant components in understanding and evaluating the Company's financial performance. The Company's calculation of Adjusted EBITDA may not be comparable to similarly titled measures reported by other companies.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">A reconciliation of Adjusted EBITDA to income before income taxes included in the condensed consolidated statement of operations is as follows:</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="25" rowspan="1"></td></tr><tr><td style="width:41%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">Successor</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">Predecessor</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">Successor</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">Predecessor</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Three Months Ended September 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">September 1 to September 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">July 1 to August 31,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Nine Months Ended September 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">January 1 to August 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Adjusted EBITDA</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">58,988</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">14,842</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8,402</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">161,465</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">85,564</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net income attributable to non-controlling interests</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">23,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6,492</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8,813</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">69,418</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">42,087</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Depreciation and amortization</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(16,945</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(3,330</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(7,599</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(49,379</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(30,124</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Interest expense, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(37,159</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(15,883</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(18,147</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(107,368</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(68,929</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Equity-based compensation</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1,526</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1,683</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1,628</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(6,303</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(3,697</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Contingent acquisition compensation expense</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(503</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(605</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1,210</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1,510</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(5,057</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Transaction, integration and acquisition costs </font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(7,489</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(3,457</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2,949</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(25,419</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(7,677</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Gain on litigation settlement</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,794</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Gain on acquisition escrow release</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Reserve adjustments </font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,109</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2,670</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Loss on disposals and deconsolidations, net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(12,631</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(333</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(114</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(15,875</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1,715</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Gain on amendment to tax receivable agreement</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,098</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">15,294</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">15,294</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Loss on debt refinancing</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(18,211</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(18,211</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Income before income taxes</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7,844</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2,859</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(16,349</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">22,359</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">12,329</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:18px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:7pt;padding-left:0px;"><font style="font-family:inherit;font-size:7pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">This amount includes transaction and integration costs of </font><font style="font-family:inherit;font-size:7pt;">$7.1 million</font><font style="font-family:inherit;font-size:7pt;"> and </font><font style="font-family:inherit;font-size:7pt;">$23.8 million</font><font style="font-family:inherit;font-size:7pt;"> for the three and nine months ended September&#160;30, 2018 (Successor), respectively, </font><font style="font-family:inherit;font-size:7pt;">$3.0 million</font><font style="font-family:inherit;font-size:7pt;"> for the one month ended September 30, 2017 (Successor), and </font><font style="font-family:inherit;font-size:7pt;">$2.3 million</font><font style="font-family:inherit;font-size:7pt;"> and </font><font style="font-family:inherit;font-size:7pt;">$5.6 million</font><font style="font-family:inherit;font-size:7pt;"> for the two and eight months ended August 31, 2017 (Predecessor), respectively. This amount includes acquisition costs of </font><font style="font-family:inherit;font-size:7pt;">$0.4 million</font><font style="font-family:inherit;font-size:7pt;"> and </font><font style="font-family:inherit;font-size:7pt;">$1.6 million</font><font style="font-family:inherit;font-size:7pt;"> for the three and nine months ended September&#160;30, 2018 (Successor), respectively, </font><font style="font-family:inherit;font-size:7pt;">$0.5 million</font><font style="font-family:inherit;font-size:7pt;"> for the one month ended September 30, 2017 (Successor), and </font><font style="font-family:inherit;font-size:7pt;">$0.6 million</font><font style="font-family:inherit;font-size:7pt;"> and </font><font style="font-family:inherit;font-size:7pt;">$2.1 million</font><font style="font-family:inherit;font-size:7pt;"> for the two and eight months ended August 31, 2017 (Predecessor), respectively.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:18px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:7pt;padding-left:0px;"><font style="font-family:inherit;font-size:7pt;">(2)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">This amount represents adjustments to revenue in connection with applying consistent policies across the combined company as a result of the integration of Surgery Partners and NSH.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:74%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">Successor</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Assets:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Surgical facility services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,015,094</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,072,521</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Ancillary services</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">110,588</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">104,274</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Optical services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">34,811</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">48,309</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">All other</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">398,171</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">397,669</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,558,664</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,622,773</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.60317460317461%;border-collapse:collapse;text-align:left;"><tr><td colspan="15" rowspan="1"></td></tr><tr><td style="width:58%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-style:italic;">Successor</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-style:italic;">Predecessor</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Nine Months Ended September 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">September 1 to September 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">January 1 to August 31,</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Cash purchases of property and equipment, net:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Surgical facility services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">21,590</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,613</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">14,582</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Ancillary services</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">334</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,875</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Optical services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">42</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">23</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">73</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">All other</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,652</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">202</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,243</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total cash purchases of property and equipment, net </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">26,618</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,840</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">18,773</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:16px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Subsequent Events</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">On October 23, 2018, Surgery Partners, Inc. (the &#8220;Company&#8221;) announced that SP Holdco I, Inc., a Delaware corporation (&#8220;Holdings&#8221;), and Surgery Center Holdings, Inc., a Delaware corporation (the &#8220;Borrower&#8221;), each a wholly-owned subsidiary of the Company, together with certain wholly-owned subsidiaries of the Borrower, entered into an incremental term loan amendment, dated as of October 23, 2018 (&#8220;the Amendment&#8221;), with Jefferies Finance LLC, as administrative agent and collateral agent, and the other financial institutions party thereto from time to time, which amended and supplemented the credit agreement, dated as of August 31, 2017, by and among the Borrower, Holdings, certain wholly-owned subsidiaries of the Borrower party thereto from time to time, Jefferies Finance LLC, as administrative agent and collateral agent, and the other financial institutions party thereto from time to time (the &#8220;Credit Agreement&#8221;) to provide for a </font><font style="font-family:inherit;font-size:9pt;">$180.0 million</font><font style="font-family:inherit;font-size:9pt;"> senior secured incremental term loan (the &#8220;Incremental Term Loan&#8221;). The Incremental Term Loan was fully drawn on October 23, 2018 and bears interest at a rate per annum equal to (x) LIBOR plus a margin ranging from </font><font style="font-family:inherit;font-size:9pt;">3.00%</font><font style="font-family:inherit;font-size:9pt;"> to </font><font style="font-family:inherit;font-size:9pt;">3.25%</font><font style="font-family:inherit;font-size:9pt;"> per annum, depending on the Borrower's first lien net leverage ratio or (y) an alternate base rate (which will be the highest of (i) the prime rate, (ii) </font><font style="font-family:inherit;font-size:9pt;">0.5%</font><font style="font-family:inherit;font-size:9pt;"> per annum above the federal funds effective rate, (iii) one-month LIBOR plus </font><font style="font-family:inherit;font-size:9pt;">1.00%</font><font style="font-family:inherit;font-size:9pt;"> per annum and (iv) </font><font style="font-family:inherit;font-size:9pt;">2.00%</font><font style="font-family:inherit;font-size:9pt;"> per annum) plus a margin ranging from </font><font style="font-family:inherit;font-size:9pt;">2.00%</font><font style="font-family:inherit;font-size:9pt;"> to </font><font style="font-family:inherit;font-size:9pt;">2.25%</font><font style="font-family:inherit;font-size:9pt;"> per annum, depending on the Borrower's first lien net leverage ratio. The Incremental Term Loan is subject to maturity, amortization and other terms consistent with the existing term loans outstanding under the Credit Agreement on the date of the Amendment.</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Subsequent to the balance sheet date, the Company entered into </font><font style="font-family:inherit;font-size:9pt;">two</font><font style="font-family:inherit;font-size:9pt;"> interest rate swaps with notional amounts of </font><font style="font-family:inherit;font-size:9pt;">$330 million</font><font style="font-family:inherit;font-size:9pt;"> and </font><font style="font-family:inherit;font-size:9pt;">$240 million</font><font style="font-family:inherit;font-size:9pt;"> and termination dates of November 30, 2023. </font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">On October 31, 2018, the Company purchased </font><font style="font-family:inherit;font-size:9pt;">three</font><font style="font-family:inherit;font-size:9pt;"> surgery centers for a combined purchase price of </font><font style="font-family:inherit;font-size:9pt;">$50.0 million</font><font style="font-family:inherit;font-size:9pt;">. The Company funded the purchase price with the cash flow received from the proceeds received from the </font><font style="font-family:inherit;font-size:9pt;">$180.0 million</font><font style="font-family:inherit;font-size:9pt;"> Incremental Term Loan borrowings. As of the date of this filing, the Company has not completed its preliminary estimation of the fair values assigned to the assets acquired and liabilities assumed.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">A summary of activity related to the redeemable preferred stock follows (in thousands):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:86%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">Successor</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Balance at December 31, 2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">330,806</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Dividends accrued</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">23,973</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Cash dividends declared</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(3,886</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Balance at September&#160;30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">350,893</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and footnotes. Examples include, but are not limited to, estimates of accounts receivable allowances, professional and general liabilities and the estimate of deferred tax assets or liabilities. Actual results could differ from those estimates.</font></div></div> Includes post acquisition date adjustments. The impact of potentially dilutive securities for all periods presented was not considered because the effect would be anti-dilutive in those periods. EX-101.SCH 7 sgry-20180930.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 2102100 - Disclosure - Acquisitions and Developments link:presentationLink link:calculationLink link:definitionLink 2402402 - Disclosure - Acquisitions and Developments - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 2402403 - Disclosure - Acquisitions and Developments - Assets Acquired and Liabilities Assumed (Details) link:presentationLink link:calculationLink link:definitionLink 2302301 - Disclosure - Acquisitions and Developments (Tables) link:presentationLink link:calculationLink link:definitionLink 2108100 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 2408401 - Disclosure - Commitments and Contingencies (Details) link:presentationLink link:calculationLink link:definitionLink 1001000 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 1001001 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1006000 - Statement - Condensed Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 1004000 - Statement - Condensed Consolidated Statements of Comprehensive Income (Loss) link:presentationLink link:calculationLink link:definitionLink 1002000 - Statement - Condensed Consolidated Statements of Operations link:presentationLink link:calculationLink link:definitionLink 1005000 - Statement - Condensed Consolidated Statements of Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 2104100 - Disclosure - Derivatives and Hedging Activities link:presentationLink link:calculationLink link:definitionLink 2404402 - Disclosure - Derivatives and Hedging Activities (Details) link:presentationLink link:calculationLink link:definitionLink 2304301 - Disclosure - Derivatives and Hedging Activities (Tables) link:presentationLink link:calculationLink link:definitionLink 0001000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 2106100 - Disclosure - Earnings Per Share link:presentationLink link:calculationLink link:definitionLink 2406402 - Disclosure - Earnings Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 2306301 - Disclosure - Earnings Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 2107100 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 2407401 - Disclosure - Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 2103100 - Disclosure - Long-Term Debt link:presentationLink link:calculationLink link:definitionLink 2403402 - Disclosure - Long-Term Debt (Details) link:presentationLink link:calculationLink link:definitionLink 2403402 - Disclosure - Long-Term Debt (Details) link:presentationLink link:calculationLink link:definitionLink 2303301 - Disclosure - Long-Term Debt (Tables) link:presentationLink link:calculationLink link:definitionLink 2101100 - Disclosure - Organization, Basis of Presentation and Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 2401411 - Disclosure - Organization, Basis of Presentation and Significant Accounting Policies - Accounts Receivable and Allowances for Contractual Adjustments and Doubtful Accounts (Details) link:presentationLink link:calculationLink link:definitionLink 2401410 - Disclosure - Organization, Basis of Presentation and Significant Accounting Policies - Cash and Restricted Cash Balances (Details) link:presentationLink link:calculationLink link:definitionLink 2401407 - Disclosure - Organization, Basis of Presentation and Significant Accounting Policies - Fair Value of Financial Instruments, Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2401403 - Disclosure - Organization, Basis of Presentation and Significant Accounting Policies - Organization (Details) link:presentationLink link:calculationLink link:definitionLink 2201201 - Disclosure - Organization, Basis of Presentation and Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 2401412 - Disclosure - Organization, Basis of Presentation and Significant Accounting Policies - Rollforward of Goodwill and Information on Impairments (Details) link:presentationLink link:calculationLink link:definitionLink 2401405 - Disclosure - Organization, Basis of Presentation and Significant Accounting Policies - Schedule of Carrying Amount and Fair Value of Long-Term Debt (Details) link:presentationLink link:calculationLink link:definitionLink 2401415 - Disclosure - Organization, Basis of Presentation and Significant Accounting Policies - Schedule of Non-Controlling Interests - Redeemable (Details) link:presentationLink link:calculationLink link:definitionLink 2401413 - Disclosure - Organization, Basis of Presentation and Significant Accounting Policies - Schedule of Other Current Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 2401414 - Disclosure - Organization, Basis of Presentation and Significant Accounting Policies - Schedule of Other Long-Term Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 2401408 - Disclosure - Organization, Basis of Presentation and Significant Accounting Policies - Schedule of Revenues by Service Type (Details) link:presentationLink link:calculationLink link:definitionLink 2401409 - Disclosure - Organization, Basis of Presentation and Significant Accounting Policies - Schedule of Revenues by Sources (Details) link:presentationLink link:calculationLink link:definitionLink 2401406 - Disclosure - Organization, Basis of Presentation and Significant Accounting Policies - Summary of the Fair Value of Derivative Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 2301302 - Disclosure - Organization, Basis of Presentation and Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 2401404 - Disclosure - Organization, Basis of Presentation and Significant Accounting Policies - Variable Interest Entities (Details) link:presentationLink link:calculationLink link:definitionLink 2105100 - Disclosure - Redeemable Preferred Stock link:presentationLink link:calculationLink link:definitionLink 2405402 - Disclosure - Redeemable Preferred Stock - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 2405403 - Disclosure - Redeemable Preferred Stock - Redeemable Preferred Stock Activity (Details) link:presentationLink link:calculationLink link:definitionLink 2305301 - Disclosure - Redeemable Preferred Stock (Tables) link:presentationLink link:calculationLink link:definitionLink 2109100 - Disclosure - Segment Reporting link:presentationLink link:calculationLink link:definitionLink 2409404 - Disclosure - Segment Reporting - Assets by Operating Segment (Details) link:presentationLink link:calculationLink link:definitionLink 2409405 - Disclosure - Segment Reporting - Cash Purchases of Property and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 2409402 - Disclosure - Segment Reporting - Revenues by Reportable Segment (Details) link:presentationLink link:calculationLink link:definitionLink 2409403 - Disclosure - Segment Reporting - Segment Operating Income (Details) link:presentationLink link:calculationLink link:definitionLink 2309301 - Disclosure - Segment Reporting (Tables) link:presentationLink link:calculationLink link:definitionLink 2410401 - Disclosure - Subsequent Events (Details) link:presentationLink link:calculationLink link:definitionLink 2110100 - Disclosure - Subsequent Events (Notes) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 sgry-20180930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 9 sgry-20180930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 10 sgry-20180930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Statement of Financial Position [Abstract] Statement [Table] Statement [Table] Class of Stock [Axis] Class of Stock [Axis] Class of Stock [Domain] Class of Stock [Domain] Redeemable Preferred Stock Redeemable Preferred Stock [Member] Statement [Line Items] Statement [Line Items] ASSETS Assets [Abstract] Current assets: Assets, Current [Abstract] Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Accounts receivable, less allowance for doubtful accounts of $3,416 and $2,026, respectively Accounts Receivable, Net, Current Inventories Inventory, Net Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Total current assets Assets, Current Property and equipment, net of accumulated depreciation of $49,534 and $19,680, respectively Property, Plant and Equipment, Net, Excluding Capital Leased Assets Intangible assets, net Intangible Assets, Net (Excluding Goodwill) Goodwill Goodwill Investments in and advances to affiliates Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures Long-term deferred tax assets Deferred Tax Assets, Net, Noncurrent Other long-term assets Other Assets, Noncurrent Total assets Assets LIABILITIES AND STOCKHOLDERS' EQUITY Liabilities and Equity [Abstract] Current liabilities: Liabilities, Current [Abstract] Accounts payable Accounts Payable, Current Accrued payroll and benefits Employee-related Liabilities, Current Other current liabilities Other Liabilities, Current Current maturities of long-term debt Long-term Debt and Capital Lease Obligations, Current Total current liabilities Liabilities, Current Long-term debt, less current maturities Long-term Debt and Capital Lease Obligations Other long-term liabilities Other Liabilities, Noncurrent Non-controlling interests—redeemable Redeemable Noncontrolling Interest, Equity, Carrying Amount Redeemable preferred stock - Series A, 310,000 shares authorized, issued and outstanding at both September 30, 2018 and December 31, 2017; redemption value of $350,893 and $330,806, respectively Temporary Equity, Carrying Amount, Attributable to Parent Stockholders' equity: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract] Preferred stock, $0.01 par value, 20,000,000 shares authorized, no shares issued or outstanding Preferred Stock, Value, Issued Common stock, $0.01 par value, 300,000,000 shares authorized, 48,891,520 shares issued and outstanding at September 30, 2018; 48,687,136 shares issued and outstanding at December 31, 2017 Common Stock, Value, Outstanding Additional paid-in capital Additional Paid in Capital Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Retained deficit Retained Earnings (Accumulated Deficit) Total Surgery Partners, Inc. stockholders' equity Stockholders' Equity Attributable to Parent Non-controlling interests—non-redeemable Stockholders' Equity Attributable to Noncontrolling Interest Total stockholders' equity Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Total liabilities and stockholders' equity Liabilities and Equity Segment Reporting [Abstract] Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Scenario [Axis] Scenario [Axis] Scenario, Unspecified [Domain] Scenario, Unspecified [Domain] Predecessor Predecessor [Member] Consolidation Items [Axis] Consolidation Items [Axis] Consolidation Items [Domain] Consolidation Items [Domain] Operating Segments Operating Segments [Member] All Other Corporate, Non-Segment [Member] Segments [Axis] Segments [Axis] Segments [Domain] Segments [Domain] Surgical Facility Services Surgical Facility Services [Member] Surgical Facility Services [Member] Ancillary Services Ancillary Services [Member] Ancillary Services [Member] Optical Services Optical Services [Member] Optical Services [Member] Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Purchases of property and equipment, net Payments to Acquire Property, Plant, and Equipment Temporary Equity Disclosure [Abstract] Temporary Equity, by Class of Stock [Table] Temporary Equity, by Class of Stock [Table] Related Party [Axis] Related Party [Axis] Related Party [Domain] Related Party [Domain] Majority Shareholder Majority Shareholder [Member] Series A Preferred Stock Series A Preferred Stock [Member] Temporary Equity [Line Items] Temporary Equity [Line Items] Stock issued during period (shares) Stock Issued During Period, Shares, New Issues Purchase price per share (in USD per share) Shares Issued, Price Per Share Proceeds from issuance of preferred shares Stock Issued During Period, Value, New Issues Dividends payable Dividends Payable Cumulative preferred dividends Cumulative Dividends Preferred dividends payable (in USD per share) Preferred Stock, Per Share Amounts of Preferred Dividends in Arrears Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Organization, Consolidation and Presentation of Financial Statements [Abstract] Cash and cash equivalents Restricted invested assets included in other long-term assets Restricted Cash and Investments, Noncurrent Total cash, cash equivalents and restricted cash in the statement of cash flows Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Subsequent Events [Abstract] Subsequent Event [Table] Subsequent Event [Table] Range [Axis] Range [Axis] Range [Domain] Range [Domain] Minimum Minimum [Member] Maximum Maximum [Member] Business Acquisition [Axis] Business Acquisition [Axis] Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Three Surgery Centers Three Surgery Centers [Member] Three Surgery Centers [Member] Derivative Instrument [Axis] Derivative Instrument [Axis] Derivative Contract [Domain] Derivative Contract [Domain] Interest Rate Swap One Interest Rate Swap [Member] Interest Rate Swap Two Interest Rate Swap Two [Member] Interest Rate Swap Two [Member] Variable Rate [Axis] Variable Rate [Axis] Variable Rate [Domain] Variable Rate [Domain] LIBOR London Interbank Offered Rate (LIBOR) [Member] Federal Funds Rate Federal Funds Effective Swap Rate [Member] One Month LIBOR One Month London Interbank Offered Rate (LIBOR) [Member] One Month London Interbank Offered Rate (LIBOR) [Member] Base Rate Base Rate [Member] Margin Rate Margin Rate [Member] Margin Rate [Member] Long-term Debt, Type [Axis] Long-term Debt, Type [Axis] Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] Senior Notes Senior Notes [Member] Debt Instrument [Axis] Debt Instrument [Axis] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Incremental Term Loan Incremental Term Loan [Member] Incremental Term Loan [Member] Subsequent Event Type [Axis] Subsequent Event Type [Axis] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Subsequent Event Subsequent Event [Member] Subsequent Event [Line Items] Subsequent Event [Line Items] Debt instrument face amount Debt Instrument, Face Amount Debt instrument, basis spread on variable rate Debt Instrument, Basis Spread on Variable Rate Number of interest rate swaps Number of Interest Rate Derivatives Held Derivative notional amount Derivative, Notional Amount Number of businesses acquired Number of Businesses Acquired Business acquisition total purchase price Business Combination, Consideration Transferred Business Combinations [Abstract] Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] 2018 Acquisitions Total Acquisitions In 2018 [Member] Total Acquisitions In 2018 [Member] NSH NSH Holdco, Inc. [Member] NSH Holdco, Inc. [Member] Legal Entity [Axis] Legal Entity [Axis] Entity [Domain] Entity [Domain] Bain Capital BCPE Seminole Holdings LP [Member] BCPE Seminole Holdings LP [Member] Business Acquisition [Line Items] Business Acquisition [Line Items] Cash consideration Payments to Acquire Businesses, Gross Equity attributable to Surgery Partners, Inc. Business Combination, Consideration Transferred, Equity Attributable To Acquiree Business Combination, Consideration Transferred, Equity Attributable To Acquiree Redeemable preferred stock Business Combination, Consideration Transferred, Redeemable Preferred Stock Business Combination, Consideration Transferred, Redeemable Preferred Stock Fair value of non-controlling interests Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value Acquisition date fair value Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest Transaction date fair value Net assets acquired: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net [Abstract] Cash and cash equivalents Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents Accounts receivable Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables Inventories Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory Prepaid expenses and other current assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets Current Assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets Property and equipment Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment Intangible assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill Investments in and advances to affiliates Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Financial Assets Restricted invested assets Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Restricted Invested Assets Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Restricted Invested Assets Long-term deferred tax assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets Noncurrent Other long-term assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets Accounts payable Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable Accrued payroll and benefits Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Liabilities, Accrued Payroll And Benefits Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Liabilities, Accrued Payroll And Benefits Other current liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other Current maturities of long-term debt Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Long-term Debt Current liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities Long-term liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities Long-term debt, less current maturities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt Long-term tax receivable agreement liability Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Noncurrent Liabilities, Tax Receivable Agreement Liability Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Noncurrent Liabilities, Tax Receivable Agreement Liability Other long-term liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other Acquisition date fair value Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net Derivative Instruments and Hedging Activities Disclosure [Abstract] Reclassification out of Accumulated Other Comprehensive Income [Table] Reclassification out of Accumulated Other Comprehensive Income [Table] Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items] Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items] Estimated reduction to interest expense Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months Derivative financial instruments, long-term liability Derivative Liability, Noncurrent Losses related to effective portion of derivatives recognized in accumulated OCI, gross of tax effect Unrealized Gain (Loss) on Interest Rate Cash Flow Hedges, Pretax, Accumulated Other Comprehensive Income (Loss) Loss related to effective portion of derivatives reclassified from accumulated OCI to interest expense, gross of tax effect Derivative Instruments, Loss Reclassified from Accumulated OCI into Income, Effective Portion Surgical Facility Acquisitions, New Market Surgical Facility, New Market [Member] Surgical Facility, New Market [Member] Surgical Facility, Existing Market Surgical Facility, Existing Market [Member] Surgical Facility, Existing Market [Member] Physician Practice Physician Practice [Member] Physician Practice [Member] Surgical Facility, Noncontrolling Interest, New Market Surgical Facility, Noncontrolling Interest, New Market [Member] Surgical Facility, Noncontrolling Interest, New Market [Member] Surgical Facility and Physician Practice Acquisitions Surgical Facility And Physician Practice Acquisitions [Member] Surgical Facility And Physician Practice Acquisitions [Member] Integrated Physician Practice Acquisitions Integrated Physician Practice Acquisitions [Member] Integrated Physician Practice Acquisitions [Member] Total Acquisitions Endoscopy Practice Endoscopy Practice [Member] Endoscopy Practice [Member] Disposal Group Name [Axis] Disposal Group Name [Axis] Disposal Group Name [Domain] Disposal Group Name [Domain] Two Surgery Centers Two Surgery Centers [Member] Two Surgery Centers [Member] Surgery Center Surgery Center [Member] Surgery Center [Member] Tax deductible goodwill Business Acquisition, Goodwill, Expected Tax Deductible Amount Number of interests disposed (in surgery centers) Disposal Group, Not Discontinued Operation, Number Of Interests Disposed Disposal Group, Not Discontinued Operation, Number Of Interests Disposed Net proceeds from sale of interests Proceeds from Sale of Productive Assets Loss sale of interests Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal Fair value of investment Equity Method Investments, Fair Value Disclosure Gain on deconsolidation Deconsolidation, Gain (Loss), Amount Payments for acquisitions, net of cash acquired Payments to Acquire Businesses, Net of Cash Acquired Acquisition escrow deposit Escrow Deposit Net increase (decrease) to goodwill Goodwill, Period Increase (Decrease) Additional cash consideration paid increasing goodwill Goodwill, Purchase Accounting Adjustments Shares sold in acquisition (shares) Stock Issued During Period, Shares, Acquisitions Share price (in USD per share) Share Price Percentage of voting interests sold Business Acquisition, Percentage of Voting Interests Acquired Pushdown accounting adjustments, increase (decrease) to intangibles Pushdown Accounting, Adjustments To Preliminary Amounts, Intangible Assets Pushdown Accounting, Adjustments To Preliminary Amounts, Intangible Assets Pushdown accounting adjustments, decrease to preliminary fair value assigned to non-controlling interests Pushdown Accounting, Adjustments To Preliminary Amounts, Fair Value Of Noncontrolling Interests Pushdown Accounting, Adjustments To Preliminary Amounts, Fair Value Of Noncontrolling Interests Pushdown accounting adjustment increase to other long-term liabilities Pushdown Accounting, Adjustments To Preliminary Amounts, Other Long-Term Liabilities Pushdown Accounting, Adjustments To Preliminary Amounts, Other Long-Term Liabilities Allowance for doubtful accounts Allowance for Doubtful Accounts Receivable, Current Accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Redeemable preferred stock, shares authorized (shares) Temporary Equity, Shares Authorized Redeemable preferred stock, shares issued (shares) Temporary Equity, Shares Issued Redeemable preferred stock, shares outstanding (shares) Temporary Equity, Shares Outstanding Redeemable preferred stock, redemption value Redeemable Noncontrolling Interest, Equity, Preferred, Redemption Value Preferred stock, par value (in USD per share) Preferred Stock, Par or Stated Value Per Share Preferred stock, shares authorized (shares) Preferred Stock, Shares Authorized Preferred stock, shares issued (shares) Preferred Stock, Shares Issued Preferred stock, shares outstanding (shares) Preferred Stock, Shares Outstanding Common stock, par value (in USD per share) Common Stock, Par or Stated Value Per Share Common stock, shares authorized (shares) Common Stock, Shares Authorized Common stock, shares issued (shares) Common Stock, Shares, Issued Common stock, shares outstanding (shares) Common Stock, Shares, Outstanding Segment Reporting Segment Reporting Disclosure [Text Block] Earnings Per Share [Abstract] Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table] Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Stock options Employee Stock Option [Member] Restricted shares Restricted Stock [Member] Convertible preferred stock Convertible Preferred Stock [Member] Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items] Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items] Numerator: Net Income (Loss) Attributable to Parent [Abstract] Net loss attributable to Surgery Partners, Inc. Net Income (Loss) Attributable to Parent Less: amounts allocated to participating securities Undistributed Earnings (Loss) Allocated To Participating Securities, Basic, Net Of Temporary Equity Adjustments Undistributed Earnings (Loss) Allocated To Participating Securities, Basic, Net Of Temporary Equity Adjustments Less: mark to redemption adjustment Temporary Equity, Accretion to Redemption Value, Adjustment Net loss attributable to common stockholders Net Income (Loss) Available to Common Stockholders, Basic Denominator: Weighted Average Number of Shares Outstanding, Diluted [Abstract] Weighted average shares outstanding- basic (shares) Weighted Average Number of Shares Outstanding, Basic Effect of dilutive securities (shares) Weighted Average Number Diluted Shares Outstanding Adjustment Weighted average shares outstanding- diluted (shares) Weighted Average Number of Shares Outstanding, Diluted Loss per share: Earnings Per Share, Basic and Diluted [Abstract] Basic (in USD per share) Earnings Per Share, Basic Diluted (in USD per share) Earnings Per Share, Diluted Antidilutive securities excluded from computation of (loss) earnings per share (shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Authorized share repurchase amount Stock Repurchase Program, Authorized Amount Stock repurchased (shares) Treasury Stock, Shares, Acquired Average repurchase cost (in USD per share) Treasury Stock Acquired, Average Cost Per Share Remaining repurchase authorization available Stock Repurchase Program, Remaining Authorized Repurchase Amount Document and Entity Information [Abstract] Document and Entity Information [Abstract] Entity Registrant Name Entity Registrant Name Entity Central Index Key Entity Central Index Key Current Fiscal Year End Date Current Fiscal Year End Date Entity Filer Category Entity Filer Category Document Type Document Type Document Period End Date Document Period End Date Document Fiscal Year Focus Document Fiscal Year Focus Document Fiscal Period Focus Document Fiscal Period Focus Amendment Flag Amendment Flag Entity Emerging Growth Company Entity Emerging Growth Company Entity Small Business Entity Small Business Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Schedule of Revenue Sources, Health Care Organization [Table] Schedule of Revenue Sources, Health Care Organization [Table] Product and Service [Axis] Product and Service [Axis] Product and Service [Domain] Product and Service [Domain] Healthcare Organization, Patient Service Healthcare Organization, Patient Service [Member] Healthcare Organization, Patient Service [Member] Other Other Services [Member] Other Services [Member] Health Care Organization, Revenue Sources [Axis] Health Care Organization, Revenue Sources [Axis] Health Care Organization, Revenue Sources [Domain] Health Care Organization, Revenue Sources [Domain] Private insurance Private Insurance [Member] Private Insurance [Member] Government Government [Member] Self-pay Self-Pay [Member] Other Other Patient Service Revenue Sources [Member] Other Patient Service Revenue Sources [Member] Concentration Risk Type [Axis] Concentration Risk Type [Axis] Concentration Risk Type [Domain] Concentration Risk Type [Domain] Customer Customer Concentration Risk [Member] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Revenue Sales Revenue, Net [Member] Health Care Organization, Receivable and Revenue Disclosures [Line Items] Health Care Organization, Receivable and Revenue Disclosures [Line Items] Total revenues Revenue from Contract with Customer, Including Assessed Tax Service revenues as a percentage of total revenues Concentration Risk, Percentage Earnings Per Share Earnings Per Share [Text Block] Increase (Decrease) in Temporary Equity [Roll Forward] Increase (Decrease) in Temporary Equity [Roll Forward] 12/31/2017 Dividends accrued Temporary Equity, Accretion of Dividends Cash dividends declared Temporary Equity, Dividends, Adjustment September 30, 2018 Schedule of Guarantor Obligations [Table] Schedule of Guarantor Obligations [Table] Unusual Risk or Uncertainty, Nature [Axis] Unusual Risk or Uncertainty, Nature [Axis] Unusual Risk or Uncertainty, Nature [Domain] Unusual Risk or Uncertainty, Nature [Domain] Materially More Restrictive Materially More Restrictive [Member] Materially More Restrictive [Member] Not Materially More Restrictive Not Materially More Restrictive [Member] Not Materially More Restrictive [Member] Guarantor Obligations [Line Items] Guarantor Obligations [Line Items] Professional, general and workers' compensation insurance reserve Self Insurance Reserve Expected insurance recoveries Estimated Insurance Recoveries Federal effective tax rate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Long-term tax receivable agreement liability Deferred Income Tax Liabilities, Net Net long-term tax receivable agreement liability Deferred Income Tax Liabilities, Net Of Discount Deferred Income Tax Liabilities, Net Of Discount Contingent acquisition expense Business Combination, Contingent Acquisition Expense Business Combination, Contingent Acquisition Expense Cease-use liability Operating Lease, Liability Estimated severance costs incurred Restructuring and Related Cost, Incurred Cost Statement of Cash Flows [Abstract] Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Net income Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Adjustments to reconcile net income to net cash provided by operating activities: Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Depreciation and amortization Depreciation, Depletion and Amortization Non-cash interest (income) expense, net Noncash Interest Income (Expense), Net Noncash Interest Income (Expense), Net Equity-based compensation Share-based Compensation Loss on disposals and deconsolidations, net Gain (Loss) On Disposition Of Assets And Deconsolidation Gain (Loss) On Disposition of Assets And Deconsolidation Loss on debt refinancing Gain (Loss) on Extinguishment of Debt Gain on amendment to tax receivable agreement Gain (Loss) On Amendment To Tax Receivable Agreement Gain (Loss) On Amendment To Tax Receivable Agreement Deferred income taxes Deferred Income Tax Expense (Benefit) Provision for doubtful accounts Provision for Doubtful Accounts Income from equity investments, net of distributions received Income (Loss) from Equity Method Investments, Net of Dividends or Distributions Changes in operating assets and liabilities, net of acquisitions and divestitures: Increase (Decrease) in Operating Capital [Abstract] Accounts receivable Increase (Decrease) in Accounts Receivable Other operating assets and liabilities Increase (Decrease) in Other Operating Assets and Liabilities, Net Net cash provided by operating activities Net Cash Provided by (Used in) Operating Activities Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Purchases of property and equipment Payments for acquisitions, net of cash acquired Proceeds from divestitures Proceeds from Divestiture of Businesses Other investing activities Payments for (Proceeds from) Other Investing Activities Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Principal payments on long-term debt Repayments of Long-term Debt Borrowings of long-term debt Proceeds from Issuance of Long-term Debt Payments of debt issuance costs Payments of Debt Issuance Costs Proceeds from preferred stock issuance Proceeds from Issuance of Preferred Stock and Preference Stock Payments of stock issuance costs Payments of Loan Costs Payments of preferred dividends Payments of Ordinary Dividends, Preferred Stock and Preference Stock Distributions to non-controlling interest holders Payments of Ordinary Dividends, Noncontrolling Interest Payments related to ownership transactions with non-controlling interest holders Proceeds from (Payments to) Noncontrolling Interests Repurchase of shares Payments for Repurchase of Equity Principal payments on financing lease obligations Repayments of Long-term Capital Lease Obligations Other financing activities Proceeds from (Payments for) Other Financing Activities Net cash used in financing activities Net Cash Provided by (Used in) Financing Activities Net decrease in cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, cash equivalents and restricted cash at beginning of period Cash, cash equivalents and restricted cash at end of period Statement of Comprehensive Income [Abstract] Net income (loss) Other comprehensive income, net of tax: Other Comprehensive Income (Loss), Net of Tax [Abstract] Derivative activity Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax Comprehensive (loss) income Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Less: Comprehensive loss attributable to non-controlling interests Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Comprehensive loss attributable to Surgery Partners, Inc. Comprehensive Income (Loss), Net of Tax, Attributable to Parent Redeemable Preferred Stock Redeemable Preferred Stock [Text Block] Redeemable Preferred Stock [Text Block] Facility lease obligations Lease Obligation, Noncurrent Lease Obligation, Noncurrent Other Other Sundry Liabilities, Noncurrent Total Current portions of the lease obligations Finance Lease, Liability, Current Noncurrent deferred financing obligation, Noncurrent Deferred Financing Obligation, Noncurrent Deferred Financing Obligation, Noncurrent Payments of noncurrent deferred financing obligations Payments Of Noncurrent Deferred Financing Obligations Payments of Noncurrent Deferred Financing Obligations Reconciliation of Revenue from Segments to Consolidated Reconciliation of Revenue from Segments to Consolidated [Table Text Block] Schedule of Segment Operating Income Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block] Reconciliation of Assets from Segment to Consolidated Reconciliation of Assets from Segment to Consolidated [Table Text Block] Schedule of Other Segment Reporting Information Schedule of Segment Reporting Information, by Segment [Table Text Block] Acquisitions and Developments Business Combination Disclosure [Text Block] Debt Disclosure [Abstract] Summary of long-term debt Schedule of Debt [Table Text Block] Fair Value, by Balance Sheet Grouping [Table] Fair Value, by Balance Sheet Grouping [Table] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Fair Value, Inputs, Level 1 Fair Value, Inputs, Level 1 [Member] Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Assets of SERP Deferred Compensation Plan Assets Revenue from External Customers by Products and Services [Table] Revenue from External Customers by Products and Services [Table] Revenue Source Product Concentration Risk [Member] Healthcare Organization, Other Service Healthcare Organization, Other Service [Member] Healthcare Organization, Other Service [Member] Optical Services Revenue from External Customer [Line Items] Revenue from External Customer [Line Items] Increase of revenue as result of changes in estimates to third-party settlements related to prior years Increase of Revenue as Result of Changes in Estimates to Third-party Settlements Related to Prior Years Increase of Revenue as Result of Changes in Estimates to Third-party Settlements Related to Prior Years Schedule of Carrying Amounts and Fair Values of Long-Term Debt Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block] Summary of Fair Value of Derivative Liabilities Schedule of Derivative Liabilities at Fair Value [Table Text Block] Schedule of Revenues by Service Type Schedules of Concentration of Risk, by Risk Factor [Table Text Block] Schedule of Revenue Sources for Patient Service Revenues Schedule of Revenue Sources, Health Care Organization [Table Text Block] Schedule of Cash, Cash Equivalents and Restricted Cash Cash, Cash Equivalents and Investments [Table Text Block] Schedule of Rollforward of Goodwill Schedule of Goodwill [Table Text Block] Schedule of Other Current Liabilities Schedule of Accrued Liabilities [Table Text Block] Schedule of Other Long-Term Liabilities Other Noncurrent Liabilities [Table Text Block] Schedule of Rollforward of Noncontrolling Interest - Redeemable Redeemable Noncontrolling Interest [Table Text Block] Non-Controlling Interests - Redeemable [Roll Forward] Redeemable Noncontrolling Interest [Roll Forward] Redeemable Noncontrolling Interest [Roll Forward] Beginning balance Net income attributable to non-controlling interests—redeemable Net Income (Loss) Attributable to Redeemable Noncontrolling Interest Acquisition and disposal of shares of non-controlling interests, net—redeemable Redeemable Noncontrolling Interest, Increase (Decrease) from Redemptions or Purchase of Interests Redeemable Noncontrolling Interest, Increase (Decrease) from Redemptions or Purchase of Interests Distributions to non-controlling interest—redeemable holders Redeemable Noncontrolling Interest, Decrease From Distributions To Noncontrolling Interest Holders Redeemable Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders Ending balance Schedule of Long-term Debt Instruments [Table] Schedule of Long-term Debt Instruments [Table] Secured Debt Secured Debt [Member] Notes payable and secured loans Notes Payable and Secured Loans [Member] Notes Payable and Secured Loans [Member] Credit Facility [Axis] Credit Facility [Axis] Credit Facility [Domain] Credit Facility [Domain] Revolving Credit Facility Revolving Credit Facility [Member] 2017 Senior Secured Credit Facility - Revolver 2017 Revolver Loan, Maturing 2022 [Member] 2017 Revolver Loan, Maturing 2022 [Member] 2017 Senior Secured Credit Facility - Term Loan 2017 Term Loan, Maturing 2024 [Member] 2017 Term Loan, Maturing 2024 [Member] Senior Unsecured Notes Due 2021 Senior Unsecured Notes Due 2021 [Member] Senior Unsecured Notes Due 2021 [Member] Senior Unsecured Notes Due 2025 Senior Unsecured Notes Due 2025 [Member] Senior Unsecured Notes Due 2025 [Member] Debt Instrument [Line Items] Debt Instrument [Line Items] Long-term debt Long-term Debt Capital lease obligations Capital Lease Obligations Debt and capital lease obligations Long-term Debt and Capital Lease Obligations, Including Current Maturities Less: Current maturities Total long-term debt Unamortized fair value discount Debt Instrument, Unamortized Discount Unamortized fair value premium Debt Instrument, Unamortized Premium Organization, Basis of Presentation and Significant Accounting Policies Basis of Presentation and Significant Accounting Policies [Text Block] Assets Number of operating segments Number of Operating Segments Revenues Total segment adjusted EBITDA Earnings Before Interest Taxes Depreciation And Amortization Earnings Before Interest Taxes Depreciation And Amortization Measurement Basis [Axis] Measurement Basis [Axis] Fair Value Measurement [Domain] Fair Value Measurement [Domain] Portion at Fair Value Measurement [Member] Portion at Fair Value Measurement [Member] Carrying Amount Reported Value Measurement [Member] Fair Value Estimate of Fair Value Measurement [Member] Fair Value, Inputs, Level 2 Fair Value, Inputs, Level 2 [Member] Third-Party Medicaid settlement liability Third-Party Settlements Payable, Current Third-Party Settlements Payable, Current Optical products receivable Optical Products Receivable Optical Products Receivable Income Statement [Abstract] Operating expenses: Operating Expenses [Abstract] Salaries and benefits Labor and Related Expense Supplies Supplies Expense Professional and medical fees Professional Fees Lease expense Operating Leases, Rent Expense, Net Other operating expenses Other Cost and Expense, Operating Cost of revenues Cost of Revenue General and administrative expenses General and Administrative Expense Income from equity investments Income (Loss) from Equity Method Investments Transaction and integration costs Business Combination, Integration Related Costs Gain on litigation settlement Gain (Loss) Related to Litigation Settlement Gain on acquisition escrow release Business Combination, Gain (Loss) On Acquisition Escrow Business Combination, Gain (Loss) On Acquisition Escrow Other (income) expense Other Nonrecurring (Income) Expense Total operating expenses Operating Expenses Operating income (loss) Operating Income (Loss) Gain on amendment to tax receivable agreement Interest expense, net Interest Income (Expense), Nonoperating, Net Income (loss) before income taxes Income (Loss) from Continuing Operations before Income Taxes, Domestic Income tax expense (benefit) Income Tax Expense (Benefit) Net income (loss) Less: Net income attributable to non-controlling interests Net Income (Loss) Attributable to Noncontrolling Interest Net loss attributable to Surgery Partners, Inc. Less: Amounts attributable to participating securities Undistributed Earnings (Loss) Allocated to Participating Securities, Basic Net loss per share attributable to common stockholders Weighted average common shares outstanding Weighted Average Number of Shares Outstanding Reconciliation [Abstract] Basic (shares) Diluted (shares) Statement of Stockholders' Equity [Abstract] Equity Components [Axis] Equity Components [Axis] Equity Component [Domain] Equity Component [Domain] Common Stock Common Stock [Member] Additional Paid-in Capital Additional Paid-in Capital [Member] Accumulated Other Comprehensive Loss AOCI Attributable to Parent [Member] Retained Deficit Retained Earnings [Member] Non-Controlling Interests— Non-Redeemable Noncontrolling Interest [Member] Increase (Decrease) in Stockholders' Equity [Roll Forward] Beginning Balance, stockholders' equity (shares) Beginning Balance, stockholders' equity Net (loss) income Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest Equity-based compensation Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition Preferred dividends Adjustments to Additional Paid in Capital, Dividends in Excess of Retained Earnings Other comprehensive loss Issuance of restricted and unrestricted shares (shares) Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures Issuance of restricted and unrestricted shares Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures Cancellation of restricted shares (in shares) Stock Issued During Period, Shares, Restricted Stock Award, Forfeited Cancellation of restricted shares Stock Issued During Period, Value, Restricted Stock Award, Forfeitures Repurchase of shares (shares) Stock Repurchased and Retired During Period, Shares Repurchase of shares Stock Repurchased and Retired During Period, Value Acquisition and disposal of shares of non-controlling interests, net (1) Non-Controlling Interest, Acquisitions And Disposals Of Interests Held By Non-Controlling Interest Holders, Net Non-Controlling Interest, Acquisitions And Disposals Of Interests Held By Non-Controlling Interest Holders, Net Distributions to non-controlling interests—non-redeemable holders Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders Ending Balance, stockholders' equity (shares) Ending Balance, stockholders' equity Long-Term Debt Long-term Debt [Text Block] Schedule of Earnings Per Share, Basic and Diluted Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Net income attributable to non-controlling interests Depreciation and amortization Equity-based compensation Contingent acquisition compensation expense Transaction, integration and practice acquisition costs Business Combination, Integration Related Costs, And Merger Costs Business Combination, Integration Related Costs, And Merger Costs Gain on litigation settlement Gain on acquisition escrow release Reserve adjustments SEC Schedule, 12-09, Valuation Allowances and Reserves, Business Acquired Loss on disposals and deconsolidations, net Loss on debt refinancing Practice acquisition costs Business Combination, Practice Acquisition Costs Business Combination, Practice Acquisition Costs Schedule of Variable Interest Entities [Table] Schedule of Variable Interest Entities [Table] Variable Interest Entities [Axis] Variable Interest Entities [Axis] Variable Interest Entity, Classification [Domain] Variable Interest Entity, Classification [Domain] Variable Interest Entity, Primary Beneficiary, Aggregated Disclosure Variable Interest Entity, Primary Beneficiary, Aggregated Disclosure [Member] Variable Interest Entity, Primary Beneficiary Variable Interest Entity, Primary Beneficiary [Member] Variable Interest Entity [Line Items] Variable Interest Entity [Line Items] Number of facilities included in VIE Variable Interest Entity, Number of Facilities Variable Interest Entity, Number of Facilities Number of facilities divested Variable Interest Entity, Number Of Facilities Divested Variable Interest Entity, Number Of Facilities Divested Number of practices acquired, classified as VIE Total assets related to VIE Variable Interest Entity, Consolidated, Carrying Amount, Assets Total liabilities related to VIE Variable Interest Entity, Consolidated, Carrying Amount, Liabilities Derivatives and Hedging Activities Derivative Instruments and Hedging Activities Disclosure [Text Block] Goodwill [Roll Forward] Goodwill [Roll Forward] Goodwill, beginning of period Acquisitions, including post acquisition adjustments Goodwill, Acquired During Period Divestitures and deconsolidations Goodwill, Written Off Related To Sale Of Business Unit And Deconsolidations Goodwill, Written Off Related To Sale Of Business Unit And Deconsolidations Goodwill, end of period Products and Services [Table] Products and Services [Table] Facilities, Ambulatory Surgery Centers Facilities, Ambulatory Surgery Centers [Member] Facilities, Ambulatory Surgery Centers [Member] Facilities, Surgical Hospitals Facilities, Surgical Hospitals [Member] Facilities, Surgical Hospitals [Member] Products And Services [Line Items] Products And Services [Line Items] Products And Services [Line Items] Number of surgical facilities owned Number of Surgical Facilities Owned Number of Surgical Facilities Owned Number of states in which entity operates Number of States in which Entity Operates Number of surgical facilities owned, majority interest Number of Surgical Facilities Owned, Majority Interest Number of Surgical Facilities Owned, Majority Interest Number of surgical facilities owned, consolidated Number of Surgical Facilities Owned, Consolidated Number of Surgical Facilities Owned, Consolidated Subsequent Events Subsequent Events [Text Block] Income Tax Disclosure [Abstract] Income Taxes Income Tax Disclosure [Text Block] Schedule of Assets Acquired and Liabilities Assumed Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] Schedule of the Effect of Fair Value and Cash Flow Hedge Accounting Derivative Instruments, Gain (Loss) [Table Text Block] Operating Loss Carryforwards [Table] Operating Loss Carryforwards [Table] Symbion Symbion [Member] Symbion [Member] NovaMed NovaMed [Member] NovaMed [Member] Operating Loss Carryforwards [Line Items] Operating Loss Carryforwards [Line Items] NOL carryforwards Operating Loss Carryforwards Annual base limitation Tax Credit Carryforward, Subject To Limitation Tax Credit Carryforward, Subject To Limitation Estimated disallowed interest expense Tax Cuts And Jobs Act Of 2017, Provisional Income Tax Expense (Benefit) Tax Cuts And Jobs Act Of 2017, Provisional Income Tax Expense (Benefit) Valuation allowance on deferred tax asset Deferred Tax Assets, Valuation Allowance Effective tax rate Effective Income Tax Rate Reconciliation, Percent Activity Related to Redeemable Preferred Stock Temporary Equity [Table Text Block] Interest payable Interest Payable, Current Amounts due to patients and payors Payables to Customers Accrued expenses and other Other Accrued Liabilities, Current Total Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Principles of Consolidation Consolidation, Policy [Policy Text Block] Pushdown Accounting Pushdown Accounting [Policy Text Block] Use of Estimates Use of Estimates, Policy [Policy Text Block] Variable Interest Entities Consolidation, Variable Interest Entity, Policy [Policy Text Block] Fair Value of Financial Instruments Fair Value of Financial Instruments, Policy [Policy Text Block] Revenues Revenue from Contract with Customer [Policy Text Block] Cash, Cash Equivalents and Restricted Cash Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block] Accounts Receivable and Allowances for Contractual Adjustments and Doubtful Accounts Receivables, Policy [Policy Text Block] Goodwill Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block] Derivative Instruments and Hedging Activities Derivatives, Policy [Policy Text Block] Non-Controlling Interests—Redeemable Redeemable Noncontrolling Interest [Policy Text Block] Redeemable Noncontrolling Interest [Policy Text Block] Recent Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Business Combinations Business Combinations Policy [Policy Text Block] Earnings Per Share Earnings Per Share, Policy [Policy Text Block] Income Taxes Income Tax, Policy [Policy Text Block] Interest rate swap agreement EX-101.PRE 11 sgry-20180930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 12 R1.htm IDEA: XBRL DOCUMENT v3.10.0.1
Document and Entity Information - shares
 9 Months Ended
Sep. 30, 2018
Nov. 08, 2018
Document and Entity Information [Abstract]    
Entity Registrant Name Surgery Partners, Inc.  
Entity Central Index Key 0001638833  
Current Fiscal Year End Date --12-31  
Entity Filer Category Accelerated Filer  
Document Type 10-Q  
Document Period End Date Sep. 30, 2018  
Document Fiscal Year Focus 2018  
Document Fiscal Period Focus Q3  
Amendment Flag false  
Entity Emerging Growth Company false  
Entity Small Business false  
Entity Common Stock, Shares Outstanding   48,891,520
XML 13 R2.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2018
Dec. 31, 2017
Current assets:    
Cash and cash equivalents $ 79,123 $ 174,914
Accounts receivable, less allowance for doubtful accounts of $3,416 and $2,026, respectively 286,260 288,023
Inventories 44,360 44,951
Prepaid expenses and other current assets 53,575 55,337
Total current assets 463,318 563,225
Property and equipment, net of accumulated depreciation of $49,534 and $19,680, respectively 420,013 398,536
Intangible assets, net 55,607 58,908
Goodwill 3,372,606 3,346,838
Investments in and advances to affiliates 80,785 74,282
Long-term deferred tax assets 126,660 132,319
Other long-term assets 39,675 48,665
Total assets 4,558,664 4,622,773
Current liabilities:    
Accounts payable 76,979 84,710
Accrued payroll and benefits 41,563 49,625
Other current liabilities 122,938 109,944
Current maturities of long-term debt 54,106 58,726
Total current liabilities 295,586 303,005
Long-term debt, less current maturities 2,118,567 2,130,556
Other long-term liabilities 247,311 222,480
Non-controlling interests—redeemable 317,541 299,316
Stockholders' equity:    
Preferred stock, $0.01 par value, 20,000,000 shares authorized, no shares issued or outstanding 0 0
Common stock, $0.01 par value, 300,000,000 shares authorized, 48,891,520 shares issued and outstanding at September 30, 2018; 48,687,136 shares issued and outstanding at December 31, 2017 489 487
Additional paid-in capital 671,252 695,560
Accumulated other comprehensive loss (1,389) 0
Retained deficit (99,280) (41,316)
Total Surgery Partners, Inc. stockholders' equity 571,072 654,731
Non-controlling interests—non-redeemable 657,694 681,879
Total stockholders' equity 1,228,766 1,336,610
Total liabilities and stockholders' equity 4,558,664 4,622,773
Redeemable Preferred Stock    
Current liabilities:    
Redeemable preferred stock - Series A, 310,000 shares authorized, issued and outstanding at both September 30, 2018 and December 31, 2017; redemption value of $350,893 and $330,806, respectively $ 350,893 $ 330,806
XML 14 R3.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Sep. 30, 2018
Dec. 31, 2017
Allowance for doubtful accounts $ 3,416 $ 2,026
Accumulated depreciation 49,534 19,680
Redeemable preferred stock, redemption value $ 350,893 $ 330,806
Preferred stock, par value (in USD per share) $ 0.01 $ 0.01
Preferred stock, shares authorized (shares) 20,000,000 20,000,000
Preferred stock, shares issued (shares) 0 0
Preferred stock, shares outstanding (shares) 0 0
Common stock, par value (in USD per share) $ 0.01 $ 0.01
Common stock, shares authorized (shares) 300,000,000 300,000,000
Common stock, shares issued (shares) 48,891,520 48,687,136
Common stock, shares outstanding (shares) 48,891,520 48,687,136
Redeemable Preferred Stock    
Redeemable preferred stock, shares authorized (shares) 310,000 310,000
Redeemable preferred stock, shares issued (shares) 310,000 310,000
Redeemable preferred stock, shares outstanding (shares) 310,000 310,000
XML 15 R4.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
 1 Months Ended 2 Months Ended 3 Months Ended 8 Months Ended 9 Months Ended
Sep. 30, 2017
Aug. 31, 2017
Sep. 30, 2018
Aug. 31, 2017
Sep. 30, 2018
Revenues $ 132,258   $ 443,932   $ 1,306,076
Operating expenses:          
Salaries and benefits 41,784   131,441   395,196
Supplies 35,028   120,123   355,701
Professional and medical fees 11,254   34,902   107,294
Lease expense 6,858   21,629   64,910
Other operating expenses 8,000   26,194   78,590
Cost of revenues 102,924   334,289   1,001,691
General and administrative expenses 7,777   19,478   69,729
Depreciation and amortization 3,330   16,945   49,379
Provision for doubtful accounts 3,690   11,555   25,788
Income from equity investments (712)   (1,861)   (6,283)
Loss on disposals and deconsolidations, net 333   12,631   15,875
Transaction and integration costs 2,983   7,099   23,771
Loss on debt refinancing 0   0   0
Gain on litigation settlement 0   0   0
Gain on acquisition escrow release 0   0   0
Other (income) expense 7   (1,207)   (3,601)
Total operating expenses 120,332   398,929   1,176,349
Operating income (loss) 11,926   45,003   129,727
Gain on amendment to tax receivable agreement 1,098   0   0
Interest expense, net (15,883)   (37,159)   (107,368)
Income (loss) before income taxes (2,859)   7,844   22,359
Income tax expense (benefit) (211)   5,825   10,905
Net income (loss) (2,648)   2,019   11,454
Less: Net income attributable to non-controlling interests (6,492)   (23,000)   (69,418)
Net loss attributable to Surgery Partners, Inc. (9,140)   (20,981)   (57,964)
Less: Amounts attributable to participating securities (18,199)   (8,245)   (23,973)
Net loss attributable to common stockholders $ (27,339)   $ (29,226)   $ (81,937)
Net loss per share attributable to common stockholders          
Basic (in USD per share) $ (0.57)   $ (0.61)   $ (1.71)
Diluted (in USD per share) [1] $ (0.57)   $ (0.61)   $ (1.71)
Weighted average common shares outstanding          
Basic (shares) 48,314,746   48,037,634   48,020,369
Diluted (shares) [1] 48,314,746   48,037,634   48,020,369
Predecessor          
Revenues   $ 174,079   $ 748,615  
Operating expenses:          
Salaries and benefits   61,240   241,149  
Supplies   48,078   193,322  
Professional and medical fees   14,229   57,931  
Lease expense   9,203   36,503  
Other operating expenses   11,022   43,267  
Cost of revenues   143,772   572,172  
General and administrative expenses   12,601   46,797  
Depreciation and amortization   7,599   30,124  
Provision for doubtful accounts   4,834   16,297  
Income from equity investments   (896)   (3,148)  
Loss on disposals and deconsolidations, net   114   1,715  
Transaction and integration costs   2,343   5,584  
Loss on debt refinancing   18,211   18,211  
Gain on litigation settlement   0   (3,794)  
Gain on acquisition escrow release   (1,000)   (1,000)  
Other (income) expense   (3)   (307)  
Total operating expenses   187,575   682,651  
Operating income (loss)   (13,496)   65,964  
Gain on amendment to tax receivable agreement   15,294   15,294  
Interest expense, net   (18,147)   (68,929)  
Income (loss) before income taxes   (16,349)   12,329  
Income tax expense (benefit)   (20,718)   (18,089)  
Net income (loss)   4,369   30,418  
Less: Net income attributable to non-controlling interests   (8,813)   (42,087)  
Net loss attributable to Surgery Partners, Inc.   (4,444)   (11,669)  
Less: Amounts attributable to participating securities   0   0  
Net loss attributable to common stockholders   $ (4,444)   $ (11,669)  
Net loss per share attributable to common stockholders          
Basic (in USD per share)   $ (0.09)   $ (0.24)  
Diluted (in USD per share) [1]   $ (0.09)   $ (0.24)  
Weighted average common shares outstanding          
Basic (shares)   48,146,611   48,121,404  
Diluted (shares) [1]   48,146,611   48,121,404  
[1] The impact of potentially dilutive securities for all periods presented was not considered because the effect would be anti-dilutive in those periods.
XML 16 R5.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Statements of Comprehensive Income (Loss) - USD ($)
$ in Thousands
 1 Months Ended 2 Months Ended 3 Months Ended 8 Months Ended 9 Months Ended
Sep. 30, 2017
Aug. 31, 2017
Sep. 30, 2018
Aug. 31, 2017
Sep. 30, 2018
Net income (loss) $ (2,648)   $ 2,019   $ 11,454
Other comprehensive income, net of tax:          
Derivative activity 0   (1,389)   (1,389)
Comprehensive (loss) income (2,648)   630   10,065
Less: Comprehensive loss attributable to non-controlling interests (6,492)   (23,000)   (69,418)
Comprehensive loss attributable to Surgery Partners, Inc. $ (9,140)   $ (22,370)   $ (59,353)
Predecessor          
Net income (loss)   $ 4,369   $ 30,418  
Other comprehensive income, net of tax:          
Derivative activity   0   0  
Comprehensive (loss) income   4,369   30,418  
Less: Comprehensive loss attributable to non-controlling interests   (8,813)   (42,087)  
Comprehensive loss attributable to Surgery Partners, Inc.   $ (4,444)   $ (11,669)  
XML 17 R6.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Statements of Stockholders' Equity - 9 months ended Sep. 30, 2018 - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Retained Deficit
Non-Controlling Interests— Non-Redeemable
Beginning Balance, stockholders' equity (shares) at Dec. 31, 2017 48,687,136 48,687,136        
Beginning Balance, stockholders' equity at Dec. 31, 2017 $ 1,336,610 $ 487 $ 695,560   $ (41,316) $ 681,879
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net (loss) income (9,074)       (57,964) 48,890
Equity-based compensation 6,303   6,303      
Preferred dividends (23,973)   (23,973)      
Other comprehensive loss (1,389)     $ (1,389)    
Issuance of restricted and unrestricted shares (shares)   512,948        
Issuance of restricted and unrestricted shares   $ 5 (5)      
Cancellation of restricted shares (in shares)   (151,746)        
Cancellation of restricted shares (1,127) $ (1) (1,126)      
Repurchase of shares (shares)   (156,818)        
Repurchase of shares (1,982) $ (2) (1,980)      
Acquisition and disposal of shares of non-controlling interests, net (1) [1] (19,093)   (3,527)     (15,566)
Distributions to non-controlling interests—non-redeemable holders $ (57,509)         (57,509)
Ending Balance, stockholders' equity (shares) at Sep. 30, 2018 48,891,520 48,891,520        
Ending Balance, stockholders' equity at Sep. 30, 2018 $ 1,228,766 $ 489 $ 671,252 $ (1,389) $ (99,280) $ 657,694
[1] Includes post acquisition date adjustments.
XML 18 R7.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 1 Months Ended 2 Months Ended 8 Months Ended 9 Months Ended
Sep. 30, 2017
Aug. 31, 2017
Aug. 31, 2017
Sep. 30, 2018
Cash flows from operating activities:        
Net income $ (2,648)     $ 11,454
Adjustments to reconcile net income to net cash provided by operating activities:        
Depreciation and amortization 3,330     49,379
Non-cash interest (income) expense, net (130)     (1,041)
Equity-based compensation 1,683     6,303
Loss on disposals and deconsolidations, net 333     15,875
Loss on debt refinancing 0     0
Gain on amendment to tax receivable agreement (1,098)     0
Deferred income taxes (465)     9,464
Provision for doubtful accounts 3,690     25,788
Income from equity investments, net of distributions received (203)     (186)
Changes in operating assets and liabilities, net of acquisitions and divestitures:        
Accounts receivable (2,795)     (23,665)
Other operating assets and liabilities (2,919)     5,683
Net cash provided by operating activities (1,222)     99,054
Cash flows from investing activities:        
Purchases of property and equipment (1,840)     (26,618)
Payments for acquisitions, net of cash acquired (1,163)     (55,213)
Proceeds from divestitures 0     18,031
Other investing activities 0     (2,811)
Net cash used in investing activities (3,003)     (66,611)
Cash flows from financing activities:        
Principal payments on long-term debt (3,609)     (94,880)
Borrowings of long-term debt 0     62,759
Payments of debt issuance costs (4)     0
Proceeds from preferred stock issuance 0     0
Payments of stock issuance costs 0     0
Payments of preferred dividends 0     (7,810)
Distributions to non-controlling interest holders (6,444)     (80,091)
Payments related to ownership transactions with non-controlling interest holders 30     (483)
Repurchase of shares 0     (1,982)
Principal payments on financing lease obligations (253)     (4,622)
Other financing activities 0     (1,125)
Net cash used in financing activities (10,280)     (128,234)
Net decrease in cash, cash equivalents and restricted cash (14,505)     (95,791)
Cash, cash equivalents and restricted cash at beginning of period 214,521     175,229
Cash, cash equivalents and restricted cash at end of period 200,016 $ 214,521 $ 214,521 $ 79,438
Predecessor        
Cash flows from operating activities:        
Net income   4,369 30,418  
Adjustments to reconcile net income to net cash provided by operating activities:        
Depreciation and amortization   7,599 30,124  
Non-cash interest (income) expense, net     4,874  
Equity-based compensation   1,628 3,697  
Loss on disposals and deconsolidations, net   114 1,715  
Loss on debt refinancing   18,211 18,211  
Gain on amendment to tax receivable agreement   (15,294) (15,294)  
Deferred income taxes     (18,703)  
Provision for doubtful accounts   4,834 16,297  
Income from equity investments, net of distributions received     489  
Changes in operating assets and liabilities, net of acquisitions and divestitures:        
Accounts receivable     8,837  
Other operating assets and liabilities     (12,947)  
Net cash provided by operating activities     67,718  
Cash flows from investing activities:        
Purchases of property and equipment     (18,773)  
Payments for acquisitions, net of cash acquired     (725,853)  
Proceeds from divestitures     70  
Other investing activities     0  
Net cash used in investing activities     (744,556)  
Cash flows from financing activities:        
Principal payments on long-term debt     (1,164,237)  
Borrowings of long-term debt     1,805,966  
Payments of debt issuance costs     (58,591)  
Proceeds from preferred stock issuance     310,000  
Payments of stock issuance costs     (18,347)  
Payments of preferred dividends     0  
Distributions to non-controlling interest holders     (50,343)  
Payments related to ownership transactions with non-controlling interest holders     (1,518)  
Repurchase of shares     0  
Principal payments on financing lease obligations     (796)  
Other financing activities     (789)  
Net cash used in financing activities     821,345  
Net decrease in cash, cash equivalents and restricted cash     144,507  
Cash, cash equivalents and restricted cash at beginning of period $ 214,521   70,014  
Cash, cash equivalents and restricted cash at end of period   $ 214,521 $ 214,521  
XML 19 R8.htm IDEA: XBRL DOCUMENT v3.10.0.1
Organization, Basis of Presentation and Significant Accounting Policies
 9 Months Ended
Sep. 30, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Organization, Basis of Presentation and Significant Accounting Policies
Organization, Basis of Presentation and Significant Accounting Policies
Organization
Surgery Partners, Inc., a Delaware corporation, acting through its subsidiaries, owns and operates a national network of surgical facilities and ancillary services. The surgical facilities, which include ambulatory surgery centers ("ASCs") and surgical hospitals, primarily provide non-emergency surgical procedures across many specialties, including, among others, gastroenterology ("GI"), general surgery, ophthalmology, orthopedics and pain management. The surgical hospitals also provide services such as diagnostic imaging, laboratory, obstetrics, oncology, pharmacy, physical therapy and wound care. Ancillary services are comprised of a diagnostic laboratory, multi-specialty physician practices, urgent care facilities, anesthesia services and optical services. Unless context otherwise indicates, Surgery Partners, Inc. and its subsidiaries are referred to herein as the "Company."
As of September 30, 2018, the Company owned or operated a portfolio of 124 surgical facilities, comprised of 106 ASCs and 18 surgical hospitals in 32 states. The Company owns a majority of these facilities in partnership with physicians and, in some cases, healthcare systems in the markets and communities it serves. The Company owned a majority interest in 84 of the surgical facilities and consolidated 105 of these facilities for financial reporting purposes.
Basis of Presentation
The accompanying condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for fair presentation of the Company's financial position and results of operations have been included. The Company’s fiscal year ends on December 31 and interim results are not necessarily indicative of results for a full year or any other interim period. The information contained in these condensed consolidated financial statements should be read in conjunction with the Company’s consolidated financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2017.
The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, as well as interests in partnerships and limited liability companies controlled by the Company through its ownership of a majority voting interest or other rights granted to the Company by contract to manage and control the affiliate's business. All significant intercompany balances and transactions are eliminated in consolidation.
In connection with the change of control effective August 31, 2017, the Company elected to apply “pushdown” accounting by applying the guidance in Accounting Standards Codification Topic ("ASC") 805, Business Combinations. Accordingly, the condensed consolidated financial statements of the Company for periods before and after August 31, 2017 reflect different bases of accounting, and the financial positions and results of operations of those periods are not comparable. Throughout the Company's condensed consolidated financial statements and the accompanying notes herein, periods prior to the change of control are identified as "Predecessor" and periods after the change of control are identified as "Successor." See Note 2. Acquisitions and Developments for further discussion of the change of control.
Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and footnotes. Examples include, but are not limited to, estimates of accounts receivable allowances, professional and general liabilities and the estimate of deferred tax assets or liabilities. Actual results could differ from those estimates.
Variable Interest Entities
The condensed consolidated financial statements include the accounts of variable interest entities ("VIEs") in which the Company is the primary beneficiary under the provisions of ASC 810, Consolidation. The Company has the power to direct the activities that most significantly impact a VIEs economic performance, and the Company would absorb the majority of the expected losses from any of these entities should such expected losses occur. As of September 30, 2018 (Successor), the consolidated VIEs include four surgical facilities, three anesthesia practices and four physician practices. During the nine months ended September 30, 2018 (Successor), the Company divested of one surgical facility and acquired a physician practice, which were classified as VIEs. As of December 31, 2017 (Successor), the consolidated VIEs included five surgical facilities, three anesthesia practices and three physician practices.
The total assets (excluding goodwill and intangible assets, net) of the consolidated VIEs included in the accompanying condensed consolidated balance sheets as of September 30, 2018 (Successor) and December 31, 2017 (Successor), were $6.5 million and $13.1 million, respectively, and the total liabilities of the consolidated VIEs were $3.4 million and $5.8 million, respectively.
Fair Value of Financial Instruments
The fair value of a financial instrument is the amount at which the instrument could be exchanged in an orderly transaction between market participants to sell the asset or transfer the liability. The Company uses fair value measurements based on quoted prices in active markets for identical assets or liabilities (Level 1), inputs other than quoted prices in active markets that are either directly or indirectly observable (Level 2), or unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions (Level 3), depending on the nature of the item being valued.
The carrying amounts reported in the condensed consolidated balance sheets for cash and cash equivalents, accounts receivable, restricted invested assets and accounts payable approximate their fair values.
A summary of the carrying amounts and fair values of the Company's long-term debt follows (in thousands):
 
 
Successor
 
 
Carrying Amount
 
Fair Value
 
 
September 30,
2018
 
December 31, 2017
 
September 30,
2018
 
December 31, 2017
2017 Senior Secured Credit Facilities:
 
 
 
 
 
 
 
 
Revolver
 
$
11,000

 
$
—

 
$
11,000

 
$
—

Term Loan
 
$
1,271,397

 
$
1,280,532

 
$
1,272,986

 
$
1,267,189

Senior Unsecured Notes due 2021
 
$
407,372

 
$
409,235

 
$
423,667

 
$
422,535

Senior Unsecured Notes due 2025
 
$
370,000

 
$
370,000

 
$
355,200

 
$
346,413


The fair values of the Term Loan, Senior Unsecured Notes due 2021 and the Senior Unsecured Notes due 2025 were based on a Level 2 inputs using quoted prices for identical liabilities in inactive markets at September 30, 2018 (Successor) and December 31, 2017 (Successor). The carrying amounts related to the Company's other long-term debt obligations, including the Revolver, approximate their fair values.
During the nine months ended September 30, 2018 (Successor), the Company entered into certain derivative financial instruments. A summary of the fair values of the Company's derivative financial instruments follows (in thousands):
 
 
Successor
 
 
Fair Value
 
 
September 30,
2018
 
December 31, 2017
Derivative liabilities
 
 
 
 
Interest rate swap agreement
 
$
1,389

 
$
—


The fair value of the derivative financial instruments was based on a quoted market price, or a Level 2 computation. As of September 30, 2018 (Successor), the fair value of the derivative liabilities was included in other long-term liabilities in the condensed consolidated balance sheets. As of December 31, 2017 (Successor), the Company had no derivative financial instruments.
The Company maintains a supplemental executive retirement savings plan (the "SERP") for certain executives. The SERP is a non-qualified deferred compensation plan for eligible executive officers and other key employees of the Company that allows participants to defer portions of their compensation. The fair value of the SERP asset and liability was based on a quoted market price, or a Level 1 computation. As of both September 30, 2018 (Successor) and December 31, 2017 (Successor), the fair value of both the assets and liabilities in the SERP were $1.6 million and were included in other long-term assets and other long-term liabilities in the condensed consolidated balance sheets.
Revenues
In May 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2014-09, Revenue from Contracts with Customers. The Company adopted the new standard effective January 1, 2018, using the modified retrospective method. The adoption of the new standard did not have an impact on our recognition of net revenues for any periods prior to adoption. The majority of the “Provision for doubtful accounts” will continue to be recognized as an operating expense rather than as a direct reduction to revenues, given the Company’s practice of assessing a patient’s ability to pay prior to or on the date of providing healthcare services. After initial recognition, the Company’s accounts receivables are subject to impairment assessments periodically based on changes in credit risks using historical trends of cash collections, write-offs, accounts receivable agings and other factors.
The Company's revenues generally relate to contracts with patients in which the performance obligations are to provide healthcare services. The Company recognizes revenues in the period in which our obligations to provide health care services are satisfied and reports the amount that reflects the consideration the Company expects to be entitled to. The Company's performance obligations are generally satisfied over a period of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payer (Medicare, Medicaid, managed care health plans, employers and commercial insurance companies, including plans offered through the health insurance exchanges) and the transaction prices for the services provided are dependent upon the terms provided by (Medicare and Medicaid) or negotiated with (managed care health plans, employers and commercial insurance companies) the third-party payers. The payment arrangements with third-party payers for the services provided to the related patients typically specify payments at amounts less than the Company's standard charges. Medicare generally pays for services at prospectively determined rates based on clinical, diagnostic and other factors. Services provided to patients having Medicaid coverage are generally paid at prospectively determined rates per discharge, per identified service or per covered member. Agreements with commercial insurance carriers, managed care and preferred provider organizations generally provide for payments based upon predetermined rates per diagnosis, per diem rates or discounted fee-for-service rates. The Company continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.
A summary of revenues by service type as a percentage of total revenues follows:
 
 
Successor
 
 
 
Predecessor
 
Successor
 
 
 
Predecessor
 
 
Three Months Ended September 30,
 
September 1 to September 30,
 
 
 
July 1 to August 31,
 
Nine Months Ended September 30,
 
 
 
January 1 to August 31,
 
 
2018
 
2017
 
 
 
2017
 
2018
 
 
 
2017
Patient service revenues:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   Surgical facilities revenues
 
93.2
%
 
94.0
%
 
 
 
95.5
%
 
93.2
%
 
 
 
91.4
%
   Ancillary services revenues
 
4.7
%
 
4.2
%
 
 
 
2.7
%
 
4.8
%
 
 
 
7.0
%
 
 
97.9
%
 
98.2
%
 
 
 
98.2
%
 
98.0
%
 
 
 
98.4
%
Other service revenues:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   Optical services revenues
 
0.6
%
 
0.7
%
 
 
 
1.1
%
 
0.6
%
 
 
 
1.0
%
   Other revenues
 
1.5
%
 
1.1
%
 
 
 
0.7
%
 
1.4
%
 
 
 
0.6
%
 
 
2.1
%
 
1.8
%
 
 
 
1.8
%
 
2.0
%
 
 
 
1.6
%
Total revenues
 
100.0
%
 
100.0
%
 
 
 
100.0
%
 
100.0
%
 
 
 
100.0
%

Patient service revenues.  This includes revenue related to charging facility fees in exchange for providing patient care. The fee charged for healthcare procedures performed in surgical facilities varies depending on the type of service provided, but usually includes all charges for usage of an operating room, a recovery room, special equipment, medical supplies, nursing staff and medications. The fee does not normally include professional fees charged by the patient’s surgeon, anesthesiologist or other attending physician, which are billed directly by such physicians to the patient or third-party payor. However, in several surgical facilities, the Company charges for anesthesia services. Ancillary service revenues include fees for patient visits to the Company's physician practices, pharmacy services and diagnostic tests ordered by physicians.
Patient service revenues are recognized as performance obligations are satisfied. Performance obligations are based on the nature of services provided. Typically, the Company recognizes revenue at a point in time in which services are rendered and the Company has no obligation to provide further patient services. As the Company primarily performs outpatient procedures, performance obligations are generally satisfied same day and revenue is recognized on the date of service.
The Company determines the transaction price based on gross charges for services provided, net of estimated contractual adjustments, discounts from third-party payors, including Medicare and Medicaid. The Company estimates its contractual adjustments and discounts based on contractual agreements, its discount policies and historical experience. Changes in estimated contractual adjustments and discounts are recorded in the period of change. During the three and nine months ended September 30, 2018 (Successor), the Company recognized an increase in patient service revenues as a result of changes in estimates to third-party settlements related to prior years of approximately $1.4 million for both periods. There were no adjustments as a result of changes in estimates to third-party settlements related to prior years for the one month ended September 30, 2017 (Successor). During the two and eight months ended August 31, 2017 (Predecessor), the Company recognized an increase to patient service revenues as a result of changes in estimates to third-party settlements related to prior years of approximately $0.6 million and $1.1 million, respectively.
The following table sets forth patient service revenues by type of payor and as a percentage of total patient service revenues for the Company's consolidated surgical facilities (dollars in thousands):
 
 
Successor
 
 
 
Predecessor
 
 
Three Months Ended September 30,
 
September 1 to September 30,
 
 
 
July 1 to August 31,
 
 
2018
 
2017
 
 
 
2017
 
 
Amount
 
%
 
Amount
 
%
 
 
 
Amount
 
%
Patient service revenues:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Private insurance
 
$
230,718

 
53.1
%
 
$
72,930

 
56.2
%
 
 
 
$
80,166

 
46.9
%
Government
 
166,880

 
38.4
%
 
46,162

 
35.5
%
 
 
 
73,734

 
43.1
%
Self-pay
 
12,742

 
2.9
%
 
3,861

 
3.0
%
 
 
 
4,119

 
2.4
%
Other (1)
 
24,345

 
5.6
%
 
6,883

 
5.3
%
 
 
 
12,909

 
7.6
%
Total patient service revenues
 
434,685

 
100.0
%
 
129,836

 
100.0
%
 
 
 
170,928

 
100.0
%
Other service revenues:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Optical services revenues
 
2,699

 
 
 
888

 
 
 
 
 
1,905

 
 
Other revenues
 
6,548

 
 
 
1,534

 
 
 
 
 
1,246

 
 
Total revenues
 
$
443,932

 
 
 
$
132,258

 
 
 
 
 
$
174,079

 
 
 
 
Successor
 
 
 
Predecessor
 
 
Nine Months Ended September 30,
 
September 1 to September 30,
 
 
 
January 1 to August 31,
 
 
2018
 
2017
 
 
 
2017
 
 
Amount
 
%
 
Amount
 
%
 
 
 
Amount
 
%
Patient service revenues:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Private insurance
 
$
682,479

 
53.3
%
 
$
72,930

 
56.2
%
 
 
 
$
360,092

 
48.9
%
Government
 
493,362

 
38.6
%
 
46,162

 
35.5
%
 
 
 
308,993

 
42.0
%
Self-pay
 
39,050

 
3.1
%
 
3,861

 
3.0
%
 
 
 
15,949

 
2.2
%
Other (1)
 
64,075

 
5.0
%
 
6,883

 
5.3
%
 
 
 
51,374

 
6.9
%
Total patient service revenues
 
1,278,966

 
100.0
%
 
129,836

 
100.0
%
 
 
 
736,408

 
100.0
%
Other service revenues:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Optical services revenues
 
8,437

 
 
 
888

 
 
 
 
 
7,629

 
 
Other revenues
 
18,673

 
 
 
1,534

 
 
 
 
 
4,578

 
 
Total revenues
 
$
1,306,076

 
 
 
$
132,258

 
 
 
 
 
$
748,615

 
 
(1)
Other is comprised of anesthesia service agreements, auto liability, letters of protection and other payor types.
Other service revenues. Optical service revenues consist of product sales from the Company's optical laboratories as well as handling charges billed to the members of the Company's optical products purchasing organization. The Company's optical products purchasing organization negotiates volume buying discounts with optical products manufacturers. The buying discounts and any handling charges billed to the members of the buying group represent the revenue recognized for financial reporting purposes. The Company satisfies the performance obligation and recognizes revenue when the orders are shipped to members. The Company bases its estimates for sales returns and discounts on historical experience and has not experienced significant fluctuations between estimated and actual return activity and discounts given. The Company's optical laboratories manufacture and distribute corrective lenses and eyeglasses to ophthalmologists and optometrists. The Company satisfies the performance obligation and recognize revenue when the product is shipped, net of allowance for discounts.
Other revenues include management and administrative service fees derived from the non-consolidated facilities that the Company accounts for under the equity method, management of surgical facilities in which it does not own an interest, and management services provided to physician practices for which the Company is not required to provide capital or additional assets. These agreements typically require the Company to provide recurring management services over a multi-year period which are billed and collected on a monthly basis. The fees derived from these management arrangements are based on a predetermined percentage of the revenues of each facility or practice and are recognized in the period in which management services are rendered and billed.
Cash, Cash Equivalents and Restricted Cash
The following table reconciles cash, cash equivalents and restricted cash reported within the condensed consolidated balance sheets to the totals shown within the condensed consolidated statement of cash flows (in thousands):
 
 
Successor
 
 
September 30,
2018
 
December 31,
2017
 
 
 
 
 
Cash and cash equivalents
 
$
79,123

 
$
174,914

Restricted invested assets included in other long-term assets
 
315

 
315

Total cash, cash equivalents and restricted cash in the statement of cash flows
 
$
79,438

 
$
175,229


Restricted invested assets included in other long-term assets on the condensed consolidated balance sheet represents restricted cash held in accordance with the provisions of the operating lease agreement at the Company's Chesterfield, Missouri facility. The Company has a deposit with the landlord that shall be held as security for performance under the Company's covenants and obligations within the agreement through January 2024.
Accounts Receivable and Allowances for Contractual Adjustments and Doubtful Accounts
With the Company's adoption of ASC 2014-09 on January 1, 2018, for those accounts in which the Company has an unconditional right to payment, subject only to the passage of time, the right is recorded as a receivable. Accounts receivable are recorded net of contractual adjustments and allowances for doubtful accounts to reflect accounts receivable at net realizable value. Accounts receivable consists of receivables from federal and state agencies (under the Medicare and Medicaid programs), managed care health plans, commercial insurance companies, employers and patients. Management recognizes that revenues and receivables from government agencies are significant to the Company's operations, but it does not believe that there is significant credit risk associated with these government agencies. Concentration of credit risk with respect to other payors is limited because of the large number of such payors. The Company had a net third-party Medicaid settlements liability of $7.7 million and $1.0 million as of September 30, 2018 (Successor) and December 31, 2017 (Successor), respectively, included in other current liabilities in the condensed consolidated balance sheets.
The Company recognizes that final reimbursement of accounts receivable is subject to final approval by each third-party payor. However, because the Company has contracts with its third-party payors and also verifies insurance coverage of the patient before medical services are rendered, the amounts that are pending approval from third-party payors are not considered significant. The Company's policy is to collect co-payments and deductibles prior to providing medical services. It is also the Company's policy to verify a patient’s insurance prior to the patient’s procedure. Patient services of the Company are primarily non-emergency, which allows the surgical facilities to control the procedures for which third-party reimbursement is sought and obtained. The Company does not require collateral from self-pay patients.
The Company analyzes accounts receivable at each of its facilities to ensure the proper aged category and collection assessment. At a consolidated level, the Company's policy is to review accounts receivable aging, by facility, to determine the appropriate allowance for doubtful accounts. Patient account balances are reviewed for delinquency based on contractual terms. This review is supported by an analysis of the actual revenues, contractual adjustments and cash collections received. An account balance is written off only after the Company has pursued collection with legal or collection agency assistance or otherwise has deemed an account to be uncollectible.
The receivables related to the Company's optical products purchasing organization are recognized separately from patient accounts receivable, as discussed above, and are included in other current assets in the condensed consolidated balance sheets. Such receivables were $9.3 million and $7.6 million at September 30, 2018 (Successor) and December 31, 2017 (Successor), respectively.
Goodwill
Goodwill represents the fair value of the consideration provided in an acquisition over the fair value of net assets acquired and is not amortized. Additions to goodwill include amounts resulting from new business combinations and incremental ownership purchases in the Company's subsidiaries. A summary of the Company's acquisitions for the nine months ended September 30, 2018 is included in Note 2. Acquisitions and Developments.
A summary of activity related to goodwill for the nine months ended September 30, 2018 (Successor) follows (in thousands):
Successor
 
 
Balance at December 31, 2017
 
$
3,346,838

Acquisitions, including post acquisition adjustments
 
57,710

Divestitures and deconsolidations
 
(31,942
)
Balance at September 30, 2018
 
$
3,372,606


Other Current Liabilities
A summary of other current liabilities follows (in thousands):
 
 
Successor
 
 
September 30,
2018
 
December 31,
2017
 
 
 
 
 
Interest payable
 
$
28,322

 
$
20,537

Amounts due to patients and payors
 
22,400

 
18,096

Accrued expenses and other
 
72,216

 
71,311

Total
 
$
122,938

 
$
109,944


Other Long-Term Liabilities
A summary of other long-term liabilities follows (in thousands):
 
 
Successor
 
 
September 30,
2018
 
December 31,
2017
 
 
 
 
 
Facility lease obligations
 
$
138,116

 
$
121,627

Other
 
109,195

 
100,853

Total
 
$
247,311

 
$
222,480


At four of the Company's surgical facilities, the Company has financing obligations payable to the lessors of certain land, buildings and improvements. Payments are allocated to principal adjustments of the financing obligations and interest expense. The current portions of the financing obligations were $6.8 million and $6.3 million at September 30, 2018 (Successor) and December 31, 2017 (Successor), respectively, and were included in other current liabilities in the condensed consolidated balance sheets. The long-term portions of the financing obligations are included as facility lease obligations in the table above.
In 2017, one of the Company's surgical facilities entered into a development agreement to construct a new hospital. Due to certain provisions of the agreement, the surgical facility is deemed the owner during construction, and as such, the Company records the ongoing costs as incurred as a deferred financing obligation. As of September 30, 2018 (Successor), the Company has recorded a total of $36.7 million of costs for this project, of which $23.1 million was recorded during the nine months ended September 30, 2018 (Successor). These project costs are included as non-cash additions to property and equipment, net in the condensed consolidated balance sheet and as a component of facility lease obligations.
Derivative Instruments and Hedging Activities
In accordance with ASC 815, Derivatives and Hedging (“ASC 815”), the Company records all derivatives on the balance sheet at fair value. The accounting for changes in the fair value of derivatives depends on the intended use of the derivative, whether the Company has elected to designate a derivative in a hedging relationship and apply hedge accounting and whether the hedging relationship has satisfied the criteria necessary to apply hedge accounting. Hedge accounting generally provides for the matching of the timing of gain or loss recognition on the hedging instrument with the recognition of the changes in the fair value of the hedged asset or liability that are attributable to the hedged risk in a fair value hedge or the earnings effect of the hedged forecasted transactions in a cash flow hedge. The Company may enter into derivative contracts that are intended to economically hedge certain of its risk, even though hedge accounting does not apply or the Company elects not to apply hedge accounting.
In accordance with the FASB’s fair value measurement guidance in ASU 2011-04, the Company made an accounting policy election to measure the credit risk of its derivative financial instruments that are subject to master netting agreements on a net basis by counterparty portfolio.
Non-Controlling Interests—Redeemable
Each partnership and limited liability company through which the Company owns and operates its surgical facilities is governed by a partnership or operating agreement, respectively. In certain circumstances, the applicable partnership or operating agreements for the Company's surgical facilities provide that the facilities will purchase all of the physician limited partners’ or physician minority members’, as applicable, ownership if certain adverse regulatory events occur, such as it becoming illegal for the physician(s) to own an interest in a surgical facility, refer patients to a surgical facility or receive cash distributions from a surgical facility. The non-controlling interests—redeemable are reported outside of stockholders' equity in the condensed consolidated balance sheets.
A summary of activity related to the non-controlling interests—redeemable follows (in thousands):
Successor
 
 
Balance at December 31, 2017
 
$
299,316

Net income attributable to non-controlling interests—redeemable
 
20,528

Acquisition and disposal of shares of non-controlling interests, net—redeemable (1)
 
20,279

Distributions to non-controlling interest—redeemable holders
 
(22,582
)
Balance at September 30, 2018
 
$
317,541

(1)
Includes post acquisition date adjustments.
Recent Accounting Pronouncements
In May 2014, the FASB issued ASU 2014-09, "Revenue from Contracts with Customers," along with subsequent amendments, updates and an extension of the effective date (collectively the "New Revenue Standard"), which outlines a single comprehensive model for recognizing revenue and supersedes most existing revenue recognition guidance, including guidance specific to the healthcare industry. This five-step process requires significant management judgment in addition to changing the way many companies recognize revenue in their financial statements. The Company adopted this ASU on January 1, 2018 using the modified retrospective approach. The adoption of this standard did not have a significant impact on the recognition of net revenues for any period. Adoption of the standard resulted in the Company revising its related disclosures.
In February 2016, the FASB issued ASU 2016-02, "Leases," which will require, among other items, lessees to recognize most leases as assets and liabilities on the balance sheet. Qualitative and quantitative disclosures will be enhanced to better understand the amount, timing and uncertainty of cash flows arising from leases. This guidance is effective for financial statements issued for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years, with early adoption permitted. The guidance is required to be applied using a modified retrospective transition approach for leases existing at, or entered into after, the beginning of the earliest comparative periods presented in the financial statements. In preparation of adopting the new standard, the Company has engaged outside consultants to assist in the identification of the Company's population of leases, implementing a new software for lease accounting and assisting in evaluating new accounting policy elections. The Company will adopt this ASU on January 1, 2019 and believes the primary effect of adopting the new standard will be to record right-of-use assets and obligations for current operating leases with material increases in reported property and equipment and liabilities. The Company is still evaluating the effect of adoption on financial disclosures, policies, procedures and control framework.
In November 2016, the FASB issued ASU 2016-18, "Statement of Cash Flows – Restricted Cash," which requires that a statement of cash flows explain the change during the period in the total of cash, cash equivalents, and amounts generally described as restricted cash or restricted cash equivalents. ASU 2016-18 is effective for fiscal years beginning after December 15, 2017, including interim periods within those years. The Company adopted this ASU on January 1, 2018 and retrospectively applied the guidance to all periods presented in the condensed consolidated statement of cash flows. The retrospective application to prior periods had no impact on the Company's cash flows from operating, investing and financing activities as previously disclosed. The adoption of this ASU resulted in the modification of the Company's presentation of the reconciliation of beginning-of-period and end-of-period total amounts shown on the condensed consolidated statement of cash flows to include restricted cash as discussed under the heading "Cash and Cash Equivalents" above.
XML 20 R9.htm IDEA: XBRL DOCUMENT v3.10.0.1
Acquisitions and Developments
 9 Months Ended
Sep. 30, 2018
Business Combinations [Abstract]  
Acquisitions and Developments
Acquisitions and Developments
The Company accounts for its business combinations in accordance with the fundamental requirements of the acquisition method of accounting and under the premise that an acquirer can be identified for each business combination. The acquirer is the entity that obtains control of one or more businesses in the business combination and the acquisition date is the date the acquirer achieves control. The assets acquired, liabilities assumed and any non-controlling interests in the acquired business at the acquisition date are recognized at their fair values as of that date, and the direct costs incurred in connection with the business combination are recorded and expensed separately from the business combination. Any goodwill recognized is determined as the excess of the fair value of the consideration conveyed plus the fair value of any non-controlling interests in the acquisition over the fair value of the net assets acquired. Acquisitions in which the Company is able to exert significant influence but does not have control are accounted for using the equity method.
Acquired assets and assumed liabilities typically include, but are not limited to, fixed assets, intangible assets and professional liabilities. The valuations are based on appraisal reports, discounted cash flow analyses, actuarial analyses or other appropriate valuation techniques to determine the fair value of the assets acquired or liabilities assumed. Fair value attributable to non-controlling interests is based on a Level 3 computation using significant inputs that are not observable in the market. Key inputs used to determine the fair value include financial multiples used in the purchase of non-controlling interests, primarily from acquisitions of surgical facilities. Such multiples, based on earnings, are used as a benchmark for the discount to be applied for the lack of control or marketability. Fair value attributable to the property and equipment acquired is based on Level 3 computations using key inputs such as cost trend data and comparable asset sales. Fair value attributable to the intangible assets acquired is based on Level 3 computations using key inputs such as the Company's internally-prepared financial projections. Fair values assigned to acquired working capital are based on carrying amounts reported by the acquiree at the date of acquisition, which approximate their fair values. The preliminary estimated fair value assigned to goodwill is primarily attributable to the acquisitions favorable reputations in their markets, their market positions and their ability to deliver quality care with high patient satisfaction consistent with the Company's business model.
Acquisitions
During the nine months ended September 30, 2018 (Successor), the Company acquired a controlling interest in two surgical facilities in new markets, a surgical facility in an existing market, which was merged into an existing facility and a physician practice for a combined cash purchase price of $32.9 million, net of cash acquired. The Company also acquired a controlling interest in an integrated physician practice, including multiple practice and surgical facility locations, in an existing market for a purchase price of $21.1 million, net of cash acquired. The purchase price for the 2018 acquisitions was funded through cash from operations. The total consideration related to these acquisitions was allocated to the assets acquired and liabilities assumed based upon their respective acquisition date fair values.
The aggregate amounts preliminarily recognized for each major class of assets acquired and liabilities assumed for acquisitions completed in the nine months ended September 30, 2018 (Successor), including post acquisition date adjustments, are as follows (in thousands):
Cash consideration
 
$
54,308

Fair value of non-controlling interests
 
28,776

Aggregate acquisition date fair value
 
$
83,084

Net assets acquired:
 
 
Current Assets
 
$
4,708

Property and equipment
 
2,301

Goodwill
 
75,947

Other long-term assets
 
3,460

Current liabilities
 
(2,332
)
Long-term liabilities
 
(1,000
)
Aggregate acquisition date fair value
 
$
83,084


The fair values assigned to certain assets and liabilities assumed by the Company have been estimated on a preliminary basis and are subject to change as new facts and circumstances emerge that were present at the date of acquisition. The goodwill acquired in connection with the 2018 acquisitions was allocated to the Company's reportable segments as follows: $68.6 million to surgical facility services and $7.4 million to ancillary services. Approximately $49.9 million of goodwill recorded for the 2018 acquisitions is deductible for tax purposes. The results of operations of the acquisitions are included in the Company’s results of operations beginning on the dates of acquisitions, and were not considered significant for the nine months ended September 30, 2018 (Successor).
During the one month ended September 30, 2017 (Successor), the Company completed acquisitions in existing markets of one physician practice and the assets of an endoscopy practice for a combined purchase price of $1.2 million. During the eight months ended August 31, 2017 (Predecessor), the Company completed acquisitions (excluding the NSH Holdco, Inc. acquisition) in existing markets of three physician practices for a combined cash purchase price of $14.2 million. During the nine months ended September 30, 2018 (Successor), no significant changes were made to the purchase price allocation of assets and liabilities, existing at the date of acquisition, related to individual acquisitions completed in 2017, excluding the acquisition of NSH as discussed below.
2018 Disposals and Deconsolidation
During the nine months ended September 30, 2018 (Successor), the Company sold its interests in three surgery centers and its optical laboratory for net cash proceeds of $17.6 million, and recognized a net pretax loss of $9.5 million included in loss on disposals and deconsolidations, net in the condensed consolidated statement of operations for the three and nine months ended September 30, 2018 (Successor). This non-cash loss was primarily a result of the write-off of the net assets of the facility (net of proceeds received) and was primarily driven by the write-off of the associated goodwill.
During the nine months ended September 30, 2018 (Successor), the Company sold a portion of its interest in one surgery center for net cash proceeds of $0.5 million. As a result of this transaction, the Company lost control of the previously controlled entity but retains a noncontrolling interest, resulting in the deconsolidation of the previously consolidated entity. The remaining noncontrolling interest was accounted for as an equity method investment, and initially measured and recorded at fair value as of the date of the transaction.
The fair value measurement utilizes Level 3 inputs, which include unobservable data, to measure the fair value of the retained noncontrolling interest. The fair value determination was based on a combination of multiple valuation methods, which included discounted cash flow and market value approach, which incorporates estimates of future earnings and market valuation multiples for certain guideline companies. The fair value of the investment of $2.0 million was recorded as a component of investments in and advances to affiliates in the accompanying condensed consolidated balance sheets.
Further, the transaction resulted in a pretax gain on deconsolidation of $1.1 million, which is included in loss on disposals and deconsolidations, net, in the accompanying condensed consolidated statement of operations for the three and nine months ended September 30, 2018 (Successor). The gain was determined based on the difference between the fair value of the Company's retained interest in the entity and the carrying value of both the tangible and intangible assets of the entity immediately prior to the transaction less cash proceeds received.
Acquisition of NSH
On August 31, 2017 (Predecessor), the Company completed its acquisition of NSH Holdco, Inc. (“NSH”) for total cash consideration of $711.7 million, net of cash acquired, including $19.6 million funded to an escrow account. During the nine months ended September 30, 2018 (Successor), information existing at the acquisition date became known to the Company as part of its continuing evaluation of the assets and liabilities existing at the date of acquisition, resulting in a net increase to goodwill of $1.1 million. The corresponding changes to certain classes of assets and liabilities from the preliminary allocation recorded at August 31, 2017 (Predecessor), are reflected in the table below, which has been finalized as of September 30, 2018 (Successor). The increase to goodwill during the period includes a working capital settlement payment resulting in additional cash consideration of $1.2 million.
The acquisition date fair value for each major class of assets acquired and liabilities assumed, including post acquisition date adjustments, are as follows (in thousands):
Cash consideration
 
$
764,007

Fair value of non-controlling interests
 
325,965

Acquisition date fair value
 
$
1,089,972

Net assets acquired:
 
 
Cash and cash equivalents
 
$
51,159

Accounts receivable
 
71,639

Inventories
 
14,986

Prepaid expenses and other current assets
 
18,367

Property and equipment
 
174,100

Intangible assets
 
27,881

Goodwill
 
871,373

Investments in and advances to affiliates
 
29,737

Long-term deferred tax assets
 
20,212

Other long-term assets
 
26,988

Accounts payable
 
(29,652
)
Accrued payroll and benefits
 
(30,853
)
Other current liabilities
 
(23,937
)
Current maturities of long-term debt
 
(16,416
)
Long-term debt, less current maturities
 
(42,770
)
Other long-term liabilities
 
(72,842
)
Acquisition date fair value
 
$
1,089,972


Change of Control - Pushdown Accounting
On August 31, 2017, BCPE Seminole Holdings LP (“Bain”), a fund advised by an affiliate of Bain Capital Private Equity, completed its purchase of 26,455,651 shares of the Company's common stock at a purchase price of $19.00 per share in cash (the “Private Sale”). As a result of the Private Sale and the Preferred Private Placement (defined in Note 4. Redeemable Preferred Stock), Bain became the controlling stockholder of the Company, holding preferred and common stock that collectively represent approximately 65.7% of the voting power of all classes of capital stock of the Company as of August 31, 2017. In connection with this change of control, the Company elected to apply “pushdown” accounting by applying the guidance in ASC 805, Business Combinations. In accordance with ASC 805, all identifiable assets and liabilities of the Company were measured at and adjusted to fair value as of August 31, 2017, and similarly goodwill was recognized based on the terms of the transaction and the fair value of the new basis of the net assets of the Company.
During the nine months ended September 30, 2018 (Successor), information existing at the transaction date became known to the Company as part of its evaluation of the assets and liabilities existing at August 31, 2017, resulting in a net decrease to goodwill of $18.2 million and corresponding changes to certain classes of assets and liabilities from the preliminary allocation recorded, that are reflected in the table below, which has been finalized as of September 30, 2018 (Successor).
The transaction date fair value recognized in connection with the application of pushdown accounting for each major class of assets and liabilities as of August 31, 2017, including post transaction date adjustments, are as follows (in thousands):
Equity attributable to Surgery Partners, Inc.
$
721,764

Redeemable preferred stock
310,000

Fair value of non-controlling interests
939,083

Transaction date fair value
$
1,970,847

Net assets:
 
Cash and cash equivalents
214,206

Accounts receivable
252,911

Inventories
44,310

Prepaid expenses and other current assets
61,438

Property and equipment
379,685

Intangible assets
63,978

Goodwill
3,281,728

Investments in and advances to affiliates
75,113

Restricted invested assets
315

Long-term deferred tax asset
206,073

Other long-term assets
50,666

Accounts payable
(64,921
)
Accrued payroll and benefits
(56,535
)
Other current liabilities
(97,617
)
Current maturities of long-term debt
(49,942
)
Long-term debt, less current maturities
(2,142,375
)
Long-term tax receivable agreement liability
(78,498
)
Other long-term liabilities
(169,688
)
Transaction date fair value
$
1,970,847


The post transaction date adjustments for pushdown accounting during the period includes a net increase of $3.9 million to the preliminary amounts assigned to intangible assets. The remaining adjustments to goodwill are attributable to a $17.9 million decrease to the preliminary fair value assigned to non-controlling interests, a $1.1 million increase related to the Acquisition of NSH (discussed above), and a $2.5 million increase to other long-term liabilities.
XML 21 R10.htm IDEA: XBRL DOCUMENT v3.10.0.1
Long-Term Debt
 9 Months Ended
Sep. 30, 2018
Debt Disclosure [Abstract]  
Long-Term Debt
Long-Term Debt
A summary of long-term debt follows (in thousands):
 
 
Successor
 
 
September 30,
2018
 
December 31,
2017
 
 
 
 
 
2017 Senior Secured Credit Facilities:
 
 
 
 
Revolver
 
$
11,000

 
$
—

Term Loan (1)
 
1,271,397

 
1,280,532

Senior Unsecured Notes due 2021 (2)

407,372

 
409,235

Senior Unsecured Notes due 2025
 
370,000

 
370,000

Notes payable and secured loans
 
88,068

 
101,921

Capital lease obligations
 
24,836

 
27,594

Total debt
 
2,172,673

 
2,189,282

Less: Current maturities
 
54,106

 
58,726

Total long-term debt
 
$
2,118,567

 
$
2,130,556


(1)
In connection with the application of pushdown accounting, the Company remeasured and recorded the Term Loan at fair value using a measurement date of August 31, 2017. The fair value was based on a Level 2 input using quoted prices for identical liabilities in inactive markets. As a result, the Company recorded a fair value discount as of the measurement date, which is reported in the consolidated balance sheets as a direct rededuction from the face amount the Term Loan and amortized to interest expense over the life of the Term Loan. The unamortized fair value discount as of September 30, 2018 (Successor) and December 31, 2017 (Successor) was $5.7 million and $6.2 million, respectively.
(2)
In connection with the application of pushdown accounting, the Company remeasured and recorded the Senior Unsecured Notes due 2021 at fair value using a measurement date of August 31, 2017. The fair value was based on a Level 2 input using quoted prices for identical liabilities in inactive markets. As a result, the Company recorded a fair value premium as of the measurement date, which is reported in the consolidated balance sheets as a direct addition to the face amount the notes and amortized to interest expense over the life of the Senior Unsecured Notes due 2021. The unamortized fair value premium as of September 30, 2018 (Successor) and December 31, 2017 (Successor) was $7.4 million and $9.2 million, respectively.
XML 22 R11.htm IDEA: XBRL DOCUMENT v3.10.0.1
Derivatives and Hedging Activities
 9 Months Ended
Sep. 30, 2018
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivatives and Hedging Activities
Derivatives and Hedging Activities
Cash Flow Hedges of Interest Rate Risk
The Company’s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish this objective, the Company primarily uses interest rate swaps as part of its interest rate risk management strategy. During 2018, such derivatives were used to hedge the variable cash flows associated with existing variable-rate debt.
For derivatives designated and that qualify as cash flow hedges of interest rate risk, the gain or loss on the derivative is recorded in Accumulated Other Comprehensive Income and subsequently reclassified into interest expense in the same period(s) during which the hedged transaction affects earnings, as documented at hedge inception in accordance with the Company’s accounting policy election. The earnings recognition of excluded components is presented in interest expense. Amounts reported in accumulated other comprehensive income related to derivatives will be reclassified to interest expense as interest payments are made on the Company’s variable-rate debt. Over the next 12 months, the Company estimates that an additional $1.1 million will be reclassified as a reduction to interest expense.
As of September 30, 2018 (Successor), the Company had one interest rate swap with a current notional amount of $330.0 million and a termination date of November 30, 2023. The Company had no derivative instruments as of December 31, 2017 (Successor).
The Company classifies its derivative financial instruments of $1.4 million as a long-term liability on the Balance Sheet as of September 30, 2018 (Successor). The Company had no derivative financial instruments as of December 31, 2017 (Successor).
The table below presents the effect of fair value and cash flow hedge accounting on the Company's consolidated balance sheets.
 
 
Successor
 
 
 
Predecessor
 
Successor
 
 
 
Predecessor
 
 
Three Months Ended September 30,
 
September 1 to September 30,
 
 
 
July 1 to August 31,
 
Nine Months Ended September 30,
 
 
 
January 1 to August 31,
 
 
2018
 
2017
 
 
 
2017
 
2018
 
 
 
2017
Derivatives in Cash Flow Hedging Relationships
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Losses related to effective portion of derivatives recognized in accumulated OCI, gross of tax effect
 
$
(1,389
)
 
$
—

 
 
 
$
—

 
$
(1,389
)
 
 
 
$
—

Loss related to effective portion of derivatives reclassified from accumulated OCI to interest expense, gross of tax effect
 
—

 
—

 
 
 
—

 
—

 
 
 
—
XML 23 R12.htm IDEA: XBRL DOCUMENT v3.10.0.1
Redeemable Preferred Stock
 9 Months Ended
Sep. 30, 2018
Temporary Equity Disclosure [Abstract]  
Redeemable Preferred Stock
Redeemable Preferred Stock
On August 31, 2017 (Predecessor), the Company issued 310,000 shares of Series A Preferred Stock to Bain at a purchase price of $1,000 per share for an aggregate purchase price of $310.0 million (the "Preferred Private Placement"). The net proceeds from the issuance were used to finance a portion of the NSH acquisition.
A summary of activity related to the redeemable preferred stock follows (in thousands):
Successor
 
 
Balance at December 31, 2017
 
$
330,806

Dividends accrued
 
23,973

Cash dividends declared
 
(3,886
)
Balance at September 30, 2018
 
$
350,893


There were no unpaid cash dividends declared at September 30, 2018 (Successor). The cash dividends declared but unpaid at December 31, 2017 (Successor) was $3.9 million, and were included in other current liabilities in the condensed consolidated balance sheet. The aggregate and per share amounts of unpaid cumulative preferred dividends as of September 30, 2018 (Successor) were $25.3 million and $81.70, respectively.
XML 24 R13.htm IDEA: XBRL DOCUMENT v3.10.0.1
Earnings Per Share
 9 Months Ended
Sep. 30, 2018
Earnings Per Share [Abstract]  
Earnings Per Share
Earnings Per Share
Basic and diluted earnings per share are calculated in accordance with ASC 260, Earnings Per Share, based on the weighted-average number of shares outstanding in each period and dilutive stock options, unvested shares and warrants, to the extent such securities exist and have a dilutive effect on earnings per share. Beginning in the Successor period, in connection with the issuance of the Series A Preferred Stock, the Company began computing basic and diluted earnings per share using the two-class method. The two-class method of computing earnings per share is an earnings allocation method that determines earnings per share for common shares and participating securities according to their participation rights in dividends and undistributed earnings.
A reconciliation of the numerator and denominator of basic and diluted earnings per share follows (in thousands except share and per share amounts):
 
 
Successor
 
 
 
Predecessor
 
Successor
 
 
 
Predecessor
 
 
Three Months Ended September 30,
 
September 1 to September 30,
 
 
 
July 1 to August 31,
 
Nine Months Ended September 30,
 
 
 
January 1 to August 31,
 
 
2018
 
2017
 
 
 
2017
 
2018
 
 
 
2017
Numerator:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net loss attributable to Surgery Partners, Inc.
 
$
(20,981
)
 
$
(9,140
)
 
 
 
$
(4,444
)
 
$
(57,964
)
 
 
 
$
(11,669
)
Less: amounts allocated to participating securities (1)
 
8,245

 
2,633

 
 
 
—

 
23,973

 
 
 
—

Less: mark to redemption adjustment
 
—

 
15,566

 
 
 
—

 
—

 
 
 
—

Net loss attributable to common stockholders
 
$
(29,226
)
 
$
(27,339
)
 
 
 
$
(4,444
)
 
$
(81,937
)
 
 
 
$
(11,669
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Denominator:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Weighted average shares outstanding- basic
 
48,037,634

 
48,314,746

 
 
 
48,146,611

 
48,020,369

 
 
 
48,121,404

Effect of dilutive securities (2)
 
—

 
—

 
 
 
—

 
—

 
 
 
—

Weighted average shares outstanding- diluted
 
48,037,634

 
48,314,746

 
 
 
48,146,611

 
48,020,369

 
 
 
48,121,404

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Loss per share:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Basic
 
$
(0.61
)
 
$
(0.57
)
 
 
 
$
(0.09
)
 
$
(1.71
)
 
 
 
$
(0.24
)
Diluted (2)
 
$
(0.61
)
 
$
(0.57
)
 
 
 
$
(0.09
)
 
$
(1.71
)
 
 
 
$
(0.24
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dilutive securities outstanding not included in the computation of (loss) earnings per share as their effect is antidilutive:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Stock options
 
144,795

 
—

 
 
 
—

 
153,884

 
 
 
—

Restricted shares
 
134,054

 
112,529

 
 
 
34,506

 
140,552

 
 
 
105,944

Convertible preferred stock
 
—

 
—

 
 
 
N/A

 
—

 
 
 
N/A

(1) 
Includes dividends accrued during the Successor periods for the Series A Preferred Stock. The Series A Preferred Stock does not participate in undistributed losses. There were no participating securities during the Predecessor periods.
(2) 
The impact of potentially dilutive securities for all periods presented was not considered because the effect would be anti-dilutive in each period.
Share Repurchase Transactions
On December 15, 2017 (Successor), the Company's Board of Directors authorized a share repurchase program of up to $50.0 million of the Company's issued and outstanding common stock from time to time. The timing and size of repurchases will be determined based on market conditions and other factors. The authorization does not obligate the repurchase of any shares and the Company may repurchase shares of common stock at any time without prior notice. The share repurchases will be made in accordance with applicable securities laws in open market or privately negotiated transactions. The authorization does not have a specified expiration date, and the share repurchase program may be suspended, recommenced or discontinued at any time or from time to time without prior notice.
There were no share repurchases under the share repurchase program during the three months ended September 30, 2018 (Successor). During the nine months ended September 30, 2018 (Successor), the Company repurchased 156,818 shares of its common stock stock at an average price of $12.64 per share through market purchases. At September 30, 2018 (Successor), the Company had $46.0 million of repurchase authorization available under the December 2017 authorization.
XML 25 R14.htm IDEA: XBRL DOCUMENT v3.10.0.1
Income Taxes
 9 Months Ended
Sep. 30, 2018
Income Tax Disclosure [Abstract]  
Income Taxes
Income Taxes
The Company uses the asset and liability method to account for income taxes. Under this method, deferred income tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. If a net operating loss ("NOL") or Section 163(j) interest (“163(j)”) carryforward exists, the Company makes a determination as to whether the NOL or 163(j) carryforward will be utilized in the future. A valuation allowance is established for certain carryforwards when their recoverability is deemed to be uncertain. The carrying value of the net deferred tax assets assumes that the Company will be able to generate sufficient future taxable income in certain tax jurisdictions, based on estimates and assumptions. If these estimates and related assumptions change in the future, the Company may be required to adjust its deferred tax valuation allowances.
The Company and certain of its subsidiaries file a consolidated federal income tax return. The partnerships, limited liability companies, and certain non-consolidated physician practice corporations also file separate income tax returns. The Company's allocable portion of each partnership's and limited liability company's income or loss is included in taxable income of the Company. The remaining income or loss of each partnership and limited liability company is allocated to the other owners.
The Company, or one or more of its subsidiaries, files income tax returns in the U.S. federal jurisdiction and various state jurisdictions. With few exceptions, the Company is no longer subject to U.S. federal income tax examinations for years prior to 2015 or state income tax examinations for years prior to 2014.
Section 382 (“Section 382”) of the Internal Revenue Code of 1986, as amended (the “Code”) imposes an annual limit on the ability of a corporation that undergoes an “ownership change” to use its NOLs to reduce its tax liability. An “ownership change” is generally defined as any change in ownership of more than 50.0% of a corporation’s “stock” by its “5-percent shareholders” (as defined in Section 382) over a rolling three-year period based upon each of those shareholder’s lowest percentage of stock owned during such period. As a result of the Symbion acquisition, approximately $179.0 million in NOL carryforwards are subject to an annual Section 382 base limitation of $4.9 million, and, as a result of the NovaMed acquisition, approximately $17.0 million in NOL carryforwards are subject to an annual Section 382 base limitation of $4.9 million. As a result of the NSH acquisition, approximately $20.5 million in NOL carryforwards are subject to an annual Section 382 base limitation of $2.8 million. The Private Sale resulted in an ownership change as defined in Section 382. As a result, approximately $449.7 million in NOL carryforwards are subject to an annual Section 382 base limitation of $14.2 million. At this time, the Company does not believe this limitation, when combined with amounts allowable due to net unrecognized built in gains, will affect its ability to use any NOLs before they expire. However, no such assurances can be provided. If the Company's ability to utilize its NOLs to offset taxable income generated in the future is subject to this limitation, it could have an adverse effect on the Company's business, prospects, results of operations and financial condition.
The Tax Cuts and Jobs Act (the "Tax Act") was enacted on December 22, 2017. The Tax Act reduced the US federal corporate tax rate from 35% to 21%, allows for 100% expensing of qualified capital expenditures, and limits interest expense deductions beginning in 2018.
The Company's accounting for the Tax Act is incomplete. As of the year ended December 31, 2017 (Successor), the Company was able to reasonably estimate certain effects and, therefore, recorded a provisional adjustment associated with the tax rate change (as discussed further in the 2017 form 10-K). The Company has not made any additional measurement-period adjustments to this item during the nine months ended September 30, 2018. The Company completed its the accounting for its 2017 temporary book/tax differences when it filed its 2017 federal tax return during the third quarter. However, the Company requires additional time to complete the analysis of the tax impact of the deferred re-measurement and record the adjustment. The Company expects to complete the accounting within the prescribed measurement period.
For the following tax reform items, the Company was able to reasonably estimate certain effects of the Tax Act in the nine months ended September 30, 2018 and, therefore, recorded provisional adjustments as follows:
Interest Expense Limitation: Under the Tax Act, interest expense is limited to 30% of the Company’s adjusted taxable income beginning in 2018 resulting in a temporary book to tax difference. Any disallowed interest expense is carried forward indefinitely. The Company was able to reasonably estimate the interest limitation and recorded an estimate for the disallowed interest expense. The provisional amount of disallowed interest expense as of September 30, 2018 is $69.8 million. The Company has recorded a valuation allowance of $11.4 million on a tax-effected basis against the deferred tax asset resulting from the disallowed interest expense. However, the Company is continuing to gather additional information to more precisely compute the amount of the interest limitation, and the accounting for this item is not yet complete as the Company is waiting for additional guidance to be released around the application of the law. The Company expects to complete its accounting within the prescribed measurement period.
100% Bonus Depreciation: Qualified capital expenditures placed in service after September 27, 2017 are eligible for 100% expensing under the Tax Act. The Company was able to reasonably estimate the 100% bonus depreciation expense and made a provisional estimate. However, the Company is continuing to gather additional information to more precisely compute the amount of 100% bonus depreciation, and the accounting for this item is not yet complete because the Company needs additional time to complete an accurate and thorough analysis of its fixed assets. The Company expects to complete its accounting within the prescribed measurement period.
The Company's effective tax rate was 48.8% for the nine months ended September 30, 2018 (Successor), compared to 7.4% for the one month ended September 30, 2017 (Successor) and (146.7)% for the eight months ended August 31, 2018 (Predecessor). The increase in the effective tax rate was primarily due to the Tax Act, which implemented an interest expense limitation resulting in a deferred tax asset that required a valuation allowance to be reported at its net realizable value. The Company recorded additional tax expense in 2018 to account for the gain on divestitures and valuation allowances on state tax attributes resulting from legislative changes enacted during the second quarter. The effective tax rate was further impacted by the Tax Act due to the reduced the U.S. federal corporate income tax rate, as discussed above, effective January 1, 2018.
XML 26 R15.htm IDEA: XBRL DOCUMENT v3.10.0.1
Commitments and Contingencies
 9 Months Ended
Sep. 30, 2018
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies
Commitments and Contingencies
Professional, General and Workers' Compensation Liability Risks
The Company is subject to claims and legal actions in the ordinary course of business, including claims relating to patient treatment, employment practices and personal injuries. The Company maintains general liability and professional liability insurance in excess of self-insured retentions, on a claims-made basis through third party commercial insurance carriers. Although management believes the coverage is sufficient for the Company's operations, some claims may potentially exceed the scope of coverage in effect. The Company also maintains workers' compensation insurance, subject to a deductible. Plaintiffs in these matters may request punitive or other damages that may not be covered by insurance. The Company is not aware of any such proceedings that are reasonably possible to have a material adverse effect on the Company's business, financial position, results of operations or liquidity.
Insurance Reserves
The Company expenses the costs under the self-insured retention exposure for general and professional liability and workers' compensation claims which relate to (i) claims made during the policy period, which are offset by insurance recoveries and (ii) an estimate of claims incurred but not yet reported that are expected to be reported after the policy period expires. Reserves and provisions are based upon periodic actuarially determined estimates. The reserves are estimated using individual case-basis valuations and actuarial analysis. Reserves for professional, general and workers' compensation claim liabilities are determined with no regard for expected insurance recoveries and are presented gross on the condensed consolidated balance sheets. Total professional, general and workers' compensation claim liabilities as of September 30, 2018 (Successor) and December 31, 2017 (Successor) are $19.8 million and $21.0 million, respectively. The balances include expected insurance recoveries of $14.7 million and $12.8 million, respectively.
Laws and Regulations
Laws and regulations governing the Company's business, including those relating to the Medicare and Medicaid programs, are complex and subject to interpretation. These laws and regulations govern every aspect of how the Company's surgical facilities conduct their operations, from licensing requirements to how and whether the Company's facilities may receive payments pursuant to the Medicare and Medicaid programs. Compliance with such laws and regulations can be subject to future government agency review and interpretation as well as legislative changes to such laws. Noncompliance with such laws and regulations may subject the Company to significant regulatory action including fines, penalties, and exclusion from the Medicare, Medicaid and other federal healthcare programs. From time to time, governmental regulatory agencies will conduct inquiries of the Company's practices, including, but not limited to, the Company's compliance with federal and state fraud and abuse laws, billing practices and relationships with physicians. On October 23, 2017, the Company received a civil investigative demand (“CID”) from the federal government under the False Claims Act (“FCA”) for documents and information dating back to January 1, 2010 relating to the medical necessity of certain drug tests conducted by the Company’s physicians and submitted to laboratories owned and operated by the Company. The government’s investigation remains ongoing and the Company intends to continue to respond to the CID and engage in further discussions with the U.S. Attorney’s Office in connection with the FCA investigation. In addition, the Company has been informed by CMS that payments to its diagnostic laboratory, Logan Laboratories, have been suspended pending further investigation by CMS. The Company is unable to predict the duration, scope or outcome of these investigations. While it is possible that a loss related to these matters may be incurred, given the ongoing nature of these investigations, management cannot reasonably estimate the potential magnitude of any such loss or range of loss, or the cost of the ongoing investigation, the entirety of which has been recorded in our operating expenses to date. An adverse outcome in these matters or any related litigation, including a determination that we were not, or are not, in compliance with the existing laws or regulations could result in the imposition of fines, civil and criminal penalties, equitable remedies, including disgorgement, injunctive relief, and/or other sanctions against us, and remediation of any such findings could have an adverse effect on the Company’s financial condition and results of operations. See Item 1A “Risk Factors” in our Annual Report on Form 10-K for the period ended December 31, 2017 under the heading “Risk Factors - Risks Related to Government Regulation - Companies within the healthcare industry continue to be the subject of federal and state audits and investigations, and we may be subject to such audits and investigations, including actions for false and other improper claims.” 
Acquired Facilities
The Company, through its wholly-owned subsidiaries or controlled partnerships and limited liability companies, has acquired and will continue to acquire surgical facilities with prior operating histories. Such facilities may have unknown or contingent liabilities, including liabilities for failure to comply with healthcare laws and regulations, such as billing and reimbursement, fraud and abuse and similar anti-referral laws. Although the Company attempts to assure that no such liabilities exist, obtain indemnification from prospective sellers covering such matters and institute policies designed to conform centers to its standards following completion of acquisitions, there can be no assurance that the Company will not become liable for past activities that may later be asserted to be improper by private plaintiffs or government agencies. There can be no assurance that any such matter will be covered by indemnification or, if covered, that the liability sustained will not exceed contractual limits or the financial capacity of the indemnifying party.
The Company cannot predict whether federal or state statutory or regulatory provisions will be enacted that would prohibit or otherwise regulate relationships which the Company has established or may establish with other healthcare providers or have materially adverse effects on its business or revenues arising from such future actions. Management believes, however, that it will be able to adjust the Company's operations so as to be in compliance with any statutory or regulatory provision as may be applicable.
Potential Physician Investor Liability
A majority of the physician investors in the partnerships and limited liability companies which operate the Company's surgical facilities carry general and professional liability insurance on a claims-made basis. Each partnership or limited liability company may, however, be liable for damages to persons or property arising from occurrences at the surgical facilities. Although the various physician investors and other surgeons generally are required to obtain general and professional liability insurance with tail coverage that extends beyond the period of any claims-made policies, such individuals may not be able to obtain coverage in amounts sufficient to cover all potential liability. Since most insurance policies contain exclusions, the physician investors will not be insured against all possible occurrences. In the event of an uninsured or underinsured loss, the value of an investment in the partnership interests or limited liability company membership units and the amount of distributions could be adversely affected.
Tax Receivable Agreement
On May 9, 2017, the Company entered into an agreement to amend that certain Income Tax Receivable Agreement, dated September 30, 2015 (as amended, the “TRA”), by and between the Company, and the other parties referred to therein, which amendment became effective on August 31, 2017. Pursuant to the amendment to the TRA, the Company agreed to make payments to H.I.G., the Company's former controlling shareholder, in its capacity as the stockholders representative pursuant to a fixed payment schedule. The amounts payable under the TRA are calculated as the product of (i) an annual base amount and (ii) the maximum corporate federal income tax rate for the applicable year plus three percent. The amounts payable under the TRA are related to the Company’s projected realized tax savings over the next six years and are not dependent on the Company’s actual tax savings over such period. The calculation of amounts payable pursuant to the TRA is thus dependent on the maximum corporate federal income tax rate. To the extent that the Company is unable to make payments under the TRA and such inability is a result of the terms of credit agreements and other debt documents that are materially more restrictive than those existing as of September 30, 2015, such payments will be deferred and will accrue interest at a rate of LIBOR plus 500 basis points until paid. If the terms of such credit agreements and other debt documents cause the Company to be unable to make payments under the TRA and such terms are not materially more restrictive than those existing as of September 30, 2015, such payments will be deferred and will accrue interest at a rate of LIBOR plus 300 basis points until paid.
Assuming the Company’s effective tax rate is 24%, calculated as the maximum corporate federal tax rate plus three percent, throughout the remaining term of the TRA, the Company estimates that the total remaining amounts payable under the TRA was approximately $65.1 million as of both September 30, 2018 (Successor) and December 31, 2017 (Successor). As a result of the amendment to the TRA, the Company was required to value the liability under the TRA by discounting the fixed payment schedule using the Company’s incremental borrowing rate. The carrying value of the liability under the TRA, reflecting the discount, was $47.8 million as of September 30, 2018 (Successor) and $44.3 million as of December 31, 2017 (Successor).
Contingent Consideration
In connection with certain prior period acquisitions, pursuant to the applicable purchase agreements, the Company was required to pay consideration to the prior owners of the applicable facilities should the requirements for continuing employment agreed to in the purchase agreements be met. In accordance with ASC 805, Business Combinations, contingent consideration with a continuing employment provision is recognized ratably over the defined performance period as compensation expense. As disclosed in the footnotes to the condensed consolidated statements of operations, the Company recognized contingent acquisition compensation expense of $0.5 million and $1.5 million for the three and nine months ended September 30, 2018 (Successor), respectively, $0.6 million for the one month ended September 30, 2017 (Successor), and $1.2 million and $5.1 million for the two and eight months ended August 31, 2017 (Predecessor), respectively.
Other
In connection with the Company's integration of the corporate office functions related to the acquisition of NSH, the Company closed it's Chicago, Illinois office on September 30, 2018 (Successor). As a result, the Company recognized a cease-use liability of $1.4 million, representing the estimated costs that will continue to be incurred under the office lease for its remaining term. The estimated costs were included as transaction and integration costs in the condensed consolidated statement of operations for the three and nine months ended September 30, 2018 (Successor) and as a component of other current liabilities and other long-term liabilities in the condensed consolidated balance sheet as of September 30, 2018 (Successor). During the second quarter 2018, the Company recognized a liability of $4.5 million for estimated severance costs in connection with the corporate office integration. The estimated costs were included as transaction and integration costs in the condensed consolidated statement of operations for the nine months ended September 30, 2018 (Successor) and the unpaid severance was included as a component of accrued payroll and benefits in the condensed consolidated balance sheet as of September 30, 2018 (Successor).
XML 27 R16.htm IDEA: XBRL DOCUMENT v3.10.0.1
Segment Reporting
 9 Months Ended
Sep. 30, 2018
Segment Reporting [Abstract]  
Segment Reporting
Segment Reporting
The Company operates in three major lines of business that are also the Company's reportable operating segments - the operation of surgical facilities, the operation of ancillary services and the operation of optical services. "All other" primarily consists of the Company's corporate general and administrative functions.
The following tables present financial information for each reportable segment (in thousands):
 
 
Successor
 
 
 
Predecessor
 
Successor
 
 
 
Predecessor

 
Three Months Ended September 30,
 
September 1 to September 30,
 
 
 
July 1 to August 31,
 
Nine Months Ended September 30,
 
 
 
January 1 to August 31,

 
2018
 
2017
 
 
 
2017
 
2018
 
 
 
2017
Revenues:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Surgical facility services
 
$
420,514

 
$
125,595

 
 
 
$
167,765

 
$
1,234,984

 
 
 
$
688,725

Ancillary services
 
20,719

 
5,775

 
 
 
4,409

 
62,655

 
 
 
52,261

Optical services
 
2,699

 
888

 
 
 
1,905

 
8,437

 
 
 
7,629

Total
 
$
443,932

 
$
132,258

 
 
 
$
174,079

 
$
1,306,076

 
 
 
$
748,615

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adjusted EBITDA (1):
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Surgical facility services
 
$
74,525

 
$
20,947

 
 
 
$
27,726

 
$
216,540

 
 
 
$
125,912

Ancillary services
 
875

 
(1,265
)
 
 
 
(10,737
)
 
2,925

 
 
 
(6,526
)
Optical services
 
571

 
193

 
 
 
555

 
2,087

 
 
 
2,214

All other
 
(16,983
)
 
(5,033
)
 
 
 
(9,142
)
 
(60,087
)
 
 
 
(36,036
)
Total
 
$
58,988

 
$
14,842

 
 
 
$
8,402

 
$
161,465

 
 
 
$
85,564


(1)
When the Company uses the term “Adjusted EBITDA,” it is referring to income before income taxes adjusted for (a) net income attributable to non-controlling interests, (b) depreciation and amortization, (c) interest expense, net, (d) equity-based compensation, (e) contingent acquisition compensation expense, (f) transaction, integration and acquisition costs, (g) gain on litigation settlement, (h) gain on acquisition escrow release, (i) reserve adjustments, (j) loss on disposals and deconsolidations, net, (k) gain on amendment to tax receivable agreement and (l) loss on debt refinancing. Adjusted EBITDA is the primary profit/loss metric reviewed by the chief operating decision maker in making key business decisions and on allocation of resources. Adjusted EBITDA is not a measurement of financial performance under GAAP, and should not be considered in isolation or as a substitute for net income, operating income or any other measure calculated in accordance with generally accepted accounting principles. The items excluded from Adjusted EBITDA are significant components in understanding and evaluating the Company's financial performance. The Company's calculation of Adjusted EBITDA may not be comparable to similarly titled measures reported by other companies.
A reconciliation of Adjusted EBITDA to income before income taxes included in the condensed consolidated statement of operations is as follows:
 
 
Successor
 
 
 
Predecessor
 
Successor
 
 
 
Predecessor
 
 
Three Months Ended September 30,
 
September 1 to September 30,
 
 
 
July 1 to August 31,
 
Nine Months Ended September 30,
 
 
 
January 1 to August 31,
 
 
2018
 
2017
 
 
 
2017
 
2018
 
 
 
2017
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adjusted EBITDA
 
$
58,988

 
$
14,842

 
 
 
$
8,402

 
$
161,465

 
 
 
$
85,564

Net income attributable to non-controlling interests
 
23,000

 
6,492

 
 
 
8,813

 
69,418

 
 
 
42,087

Depreciation and amortization
 
(16,945
)
 
(3,330
)
 
 
 
(7,599
)
 
(49,379
)
 
 
 
(30,124
)
Interest expense, net
 
(37,159
)
 
(15,883
)
 
 
 
(18,147
)
 
(107,368
)
 
 
 
(68,929
)
Equity-based compensation
 
(1,526
)
 
(1,683
)
 
 
 
(1,628
)
 
(6,303
)
 
 
 
(3,697
)
Contingent acquisition compensation expense
 
(503
)
 
(605
)
 
 
 
(1,210
)
 
(1,510
)
 
 
 
(5,057
)
Transaction, integration and acquisition costs (1)
 
(7,489
)
 
(3,457
)
 
 
 
(2,949
)
 
(25,419
)
 
 
 
(7,677
)
Gain on litigation settlement
 
—

 
—

 
 
 
—

 
—

 
 
 
3,794

Gain on acquisition escrow release
 
—

 
—

 
 
 
1,000

 
—

 
 
 
1,000

Reserve adjustments (2)
 
2,109

 
—

 
 
 
—

 
(2,670
)
 
 
 
—

Loss on disposals and deconsolidations, net
 
(12,631
)
 
(333
)
 
 
 
(114
)
 
(15,875
)
 
 
 
(1,715
)
Gain on amendment to tax receivable agreement
 
—

 
1,098

 
 
 
15,294

 
—

 
 
 
15,294

Loss on debt refinancing
 
—

 
—

 
 
 
(18,211
)
 
—

 
 
 
(18,211
)
Income before income taxes
 
$
7,844

 
$
(2,859
)
 
 
 
$
(16,349
)
 
$
22,359

 
 
 
$
12,329


(1)
This amount includes transaction and integration costs of $7.1 million and $23.8 million for the three and nine months ended September 30, 2018 (Successor), respectively, $3.0 million for the one month ended September 30, 2017 (Successor), and $2.3 million and $5.6 million for the two and eight months ended August 31, 2017 (Predecessor), respectively. This amount includes acquisition costs of $0.4 million and $1.6 million for the three and nine months ended September 30, 2018 (Successor), respectively, $0.5 million for the one month ended September 30, 2017 (Successor), and $0.6 million and $2.1 million for the two and eight months ended August 31, 2017 (Predecessor), respectively.
(2)
This amount represents adjustments to revenue in connection with applying consistent policies across the combined company as a result of the integration of Surgery Partners and NSH.
 
 
Successor
 
 
September 30,
2018
 
December 31,
2017
Assets:
 
 
 
 
Surgical facility services
 
$
4,015,094

 
$
4,072,521

Ancillary services
 
110,588

 
104,274

Optical services
 
34,811

 
48,309

All other
 
398,171

 
397,669

Total assets
 
$
4,558,664

 
$
4,622,773


 
 
Successor
 
 
 
Predecessor
 
 
Nine Months Ended September 30,
 
September 1 to September 30,
 
 
 
January 1 to August 31,
 
 
2018
 
2017
 
 
 
2017
Cash purchases of property and equipment, net:
 
 
 
 
 
 
 
 
Surgical facility services
 
$
21,590

 
$
1,613

 
 
 
$
14,582

Ancillary services
 
334

 
2

 
 
 
1,875

Optical services
 
42

 
23

 
 
 
73

All other
 
4,652

 
202

 
 
 
2,243

Total cash purchases of property and equipment, net
 
$
26,618

 
$
1,840

 
 
 
$
18,773
XML 28 R17.htm IDEA: XBRL DOCUMENT v3.10.0.1
Subsequent Events (Notes)
 9 Months Ended
Sep. 30, 2018
Subsequent Events [Abstract]  
Subsequent Events
Subsequent Events
On October 23, 2018, Surgery Partners, Inc. (the “Company”) announced that SP Holdco I, Inc., a Delaware corporation (“Holdings”), and Surgery Center Holdings, Inc., a Delaware corporation (the “Borrower”), each a wholly-owned subsidiary of the Company, together with certain wholly-owned subsidiaries of the Borrower, entered into an incremental term loan amendment, dated as of October 23, 2018 (“the Amendment”), with Jefferies Finance LLC, as administrative agent and collateral agent, and the other financial institutions party thereto from time to time, which amended and supplemented the credit agreement, dated as of August 31, 2017, by and among the Borrower, Holdings, certain wholly-owned subsidiaries of the Borrower party thereto from time to time, Jefferies Finance LLC, as administrative agent and collateral agent, and the other financial institutions party thereto from time to time (the “Credit Agreement”) to provide for a $180.0 million senior secured incremental term loan (the “Incremental Term Loan”). The Incremental Term Loan was fully drawn on October 23, 2018 and bears interest at a rate per annum equal to (x) LIBOR plus a margin ranging from 3.00% to 3.25% per annum, depending on the Borrower's first lien net leverage ratio or (y) an alternate base rate (which will be the highest of (i) the prime rate, (ii) 0.5% per annum above the federal funds effective rate, (iii) one-month LIBOR plus 1.00% per annum and (iv) 2.00% per annum) plus a margin ranging from 2.00% to 2.25% per annum, depending on the Borrower's first lien net leverage ratio. The Incremental Term Loan is subject to maturity, amortization and other terms consistent with the existing term loans outstanding under the Credit Agreement on the date of the Amendment.
Subsequent to the balance sheet date, the Company entered into two interest rate swaps with notional amounts of $330 million and $240 million and termination dates of November 30, 2023.
On October 31, 2018, the Company purchased three surgery centers for a combined purchase price of $50.0 million. The Company funded the purchase price with the cash flow received from the proceeds received from the $180.0 million Incremental Term Loan borrowings. As of the date of this filing, the Company has not completed its preliminary estimation of the fair values assigned to the assets acquired and liabilities assumed.
XML 29 R18.htm IDEA: XBRL DOCUMENT v3.10.0.1
Organization, Basis of Presentation and Significant Accounting Policies (Policies)
 9 Months Ended
Sep. 30, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Basis of Presentation
Basis of Presentation
The accompanying condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for fair presentation of the Company's financial position and results of operations have been included. The Company’s fiscal year ends on December 31 and interim results are not necessarily indicative of results for a full year or any other interim period. The information contained in these condensed consolidated financial statements should be read in conjunction with the Company’s consolidated financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2017.
Principles of Consolidation
The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, as well as interests in partnerships and limited liability companies controlled by the Company through its ownership of a majority voting interest or other rights granted to the Company by contract to manage and control the affiliate's business. All significant intercompany balances and transactions are eliminated in consolidation.
Pushdown Accounting
In connection with the change of control effective August 31, 2017, the Company elected to apply “pushdown” accounting by applying the guidance in Accounting Standards Codification Topic ("ASC") 805, Business Combinations. Accordingly, the condensed consolidated financial statements of the Company for periods before and after August 31, 2017 reflect different bases of accounting, and the financial positions and results of operations of those periods are not comparable. Throughout the Company's condensed consolidated financial statements and the accompanying notes herein, periods prior to the change of control are identified as "Predecessor" and periods after the change of control are identified as "Successor." See Note 2. Acquisitions and Developments for further discussion of the change of control.
Use of Estimates
Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and footnotes. Examples include, but are not limited to, estimates of accounts receivable allowances, professional and general liabilities and the estimate of deferred tax assets or liabilities. Actual results could differ from those estimates.
Variable Interest Entities
Variable Interest Entities
The condensed consolidated financial statements include the accounts of variable interest entities ("VIEs") in which the Company is the primary beneficiary under the provisions of ASC 810, Consolidation. The Company has the power to direct the activities that most significantly impact a VIEs economic performance, and the Company would absorb the majority of the expected losses from any of these entities should such expected losses occur. As of September 30, 2018 (Successor), the consolidated VIEs include four surgical facilities, three anesthesia practices and four physician practices. During the nine months ended September 30, 2018 (Successor), the Company divested of one surgical facility and acquired a physician practice, which were classified as VIEs. As of December 31, 2017 (Successor), the consolidated VIEs included five surgical facilities, three anesthesia practices and three physician practices.
Fair Value of Financial Instruments
Fair Value of Financial Instruments
The fair value of a financial instrument is the amount at which the instrument could be exchanged in an orderly transaction between market participants to sell the asset or transfer the liability. The Company uses fair value measurements based on quoted prices in active markets for identical assets or liabilities (Level 1), inputs other than quoted prices in active markets that are either directly or indirectly observable (Level 2), or unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions (Level 3), depending on the nature of the item being valued.
The carrying amounts reported in the condensed consolidated balance sheets for cash and cash equivalents, accounts receivable, restricted invested assets and accounts payable approximate their fair values.
The fair value of the derivative financial instruments was based on a quoted market price, or a Level 2 computation. As of September 30, 2018 (Successor), the fair value of the derivative liabilities was included in other long-term liabilities in the condensed consolidated balance sheets. As of December 31, 2017 (Successor), the Company had no derivative financial instruments.
The Company maintains a supplemental executive retirement savings plan (the "SERP") for certain executives. The SERP is a non-qualified deferred compensation plan for eligible executive officers and other key employees of the Company that allows participants to defer portions of their compensation. The fair value of the SERP asset and liability was based on a quoted market price, or a Level 1 computation.
The fair values of the Term Loan, Senior Unsecured Notes due 2021 and the Senior Unsecured Notes due 2025 were based on a Level 2 inputs using quoted prices for identical liabilities in inactive markets at September 30, 2018 (Successor) and December 31, 2017 (Successor). The carrying amounts related to the Company's other long-term debt obligations, including the Revolver, approximate their fair values.
Revenues
Revenues
In May 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2014-09, Revenue from Contracts with Customers. The Company adopted the new standard effective January 1, 2018, using the modified retrospective method. The adoption of the new standard did not have an impact on our recognition of net revenues for any periods prior to adoption. The majority of the “Provision for doubtful accounts” will continue to be recognized as an operating expense rather than as a direct reduction to revenues, given the Company’s practice of assessing a patient’s ability to pay prior to or on the date of providing healthcare services. After initial recognition, the Company’s accounts receivables are subject to impairment assessments periodically based on changes in credit risks using historical trends of cash collections, write-offs, accounts receivable agings and other factors.
The Company's revenues generally relate to contracts with patients in which the performance obligations are to provide healthcare services. The Company recognizes revenues in the period in which our obligations to provide health care services are satisfied and reports the amount that reflects the consideration the Company expects to be entitled to. The Company's performance obligations are generally satisfied over a period of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payer (Medicare, Medicaid, managed care health plans, employers and commercial insurance companies, including plans offered through the health insurance exchanges) and the transaction prices for the services provided are dependent upon the terms provided by (Medicare and Medicaid) or negotiated with (managed care health plans, employers and commercial insurance companies) the third-party payers. The payment arrangements with third-party payers for the services provided to the related patients typically specify payments at amounts less than the Company's standard charges. Medicare generally pays for services at prospectively determined rates based on clinical, diagnostic and other factors. Services provided to patients having Medicaid coverage are generally paid at prospectively determined rates per discharge, per identified service or per covered member. Agreements with commercial insurance carriers, managed care and preferred provider organizations generally provide for payments based upon predetermined rates per diagnosis, per diem rates or discounted fee-for-service rates. The Company continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.
Patient service revenues.  This includes revenue related to charging facility fees in exchange for providing patient care. The fee charged for healthcare procedures performed in surgical facilities varies depending on the type of service provided, but usually includes all charges for usage of an operating room, a recovery room, special equipment, medical supplies, nursing staff and medications. The fee does not normally include professional fees charged by the patient’s surgeon, anesthesiologist or other attending physician, which are billed directly by such physicians to the patient or third-party payor. However, in several surgical facilities, the Company charges for anesthesia services. Ancillary service revenues include fees for patient visits to the Company's physician practices, pharmacy services and diagnostic tests ordered by physicians.
Patient service revenues are recognized as performance obligations are satisfied. Performance obligations are based on the nature of services provided. Typically, the Company recognizes revenue at a point in time in which services are rendered and the Company has no obligation to provide further patient services. As the Company primarily performs outpatient procedures, performance obligations are generally satisfied same day and revenue is recognized on the date of service.
The Company determines the transaction price based on gross charges for services provided, net of estimated contractual adjustments, discounts from third-party payors, including Medicare and Medicaid. The Company estimates its contractual adjustments and discounts based on contractual agreements, its discount policies and historical experience. Changes in estimated contractual adjustments and discounts are recorded in the period of change.
Other service revenues. Optical service revenues consist of product sales from the Company's optical laboratories as well as handling charges billed to the members of the Company's optical products purchasing organization. The Company's optical products purchasing organization negotiates volume buying discounts with optical products manufacturers. The buying discounts and any handling charges billed to the members of the buying group represent the revenue recognized for financial reporting purposes. The Company satisfies the performance obligation and recognizes revenue when the orders are shipped to members. The Company bases its estimates for sales returns and discounts on historical experience and has not experienced significant fluctuations between estimated and actual return activity and discounts given. The Company's optical laboratories manufacture and distribute corrective lenses and eyeglasses to ophthalmologists and optometrists. The Company satisfies the performance obligation and recognize revenue when the product is shipped, net of allowance for discounts.
Other revenues include management and administrative service fees derived from the non-consolidated facilities that the Company accounts for under the equity method, management of surgical facilities in which it does not own an interest, and management services provided to physician practices for which the Company is not required to provide capital or additional assets. These agreements typically require the Company to provide recurring management services over a multi-year period which are billed and collected on a monthly basis. The fees derived from these management arrangements are based on a predetermined percentage of the revenues of each facility or practice and are recognized in the period in which management services are rendered and billed.
Cash, Cash Equivalents and Restricted Cash
Restricted invested assets included in other long-term assets on the condensed consolidated balance sheet represents restricted cash held in accordance with the provisions of the operating lease agreement at the Company's Chesterfield, Missouri facility. The Company has a deposit with the landlord that shall be held as security for performance under the Company's covenants and obligations within the agreement through January 2024.
Accounts Receivable and Allowances for Contractual Adjustments and Doubtful Accounts
Accounts Receivable and Allowances for Contractual Adjustments and Doubtful Accounts
With the Company's adoption of ASC 2014-09 on January 1, 2018, for those accounts in which the Company has an unconditional right to payment, subject only to the passage of time, the right is recorded as a receivable. Accounts receivable are recorded net of contractual adjustments and allowances for doubtful accounts to reflect accounts receivable at net realizable value. Accounts receivable consists of receivables from federal and state agencies (under the Medicare and Medicaid programs), managed care health plans, commercial insurance companies, employers and patients. Management recognizes that revenues and receivables from government agencies are significant to the Company's operations, but it does not believe that there is significant credit risk associated with these government agencies. Concentration of credit risk with respect to other payors is limited because of the large number of such payors. The Company had a net third-party Medicaid settlements liability of $7.7 million and $1.0 million as of September 30, 2018 (Successor) and December 31, 2017 (Successor), respectively, included in other current liabilities in the condensed consolidated balance sheets.
The Company recognizes that final reimbursement of accounts receivable is subject to final approval by each third-party payor. However, because the Company has contracts with its third-party payors and also verifies insurance coverage of the patient before medical services are rendered, the amounts that are pending approval from third-party payors are not considered significant. The Company's policy is to collect co-payments and deductibles prior to providing medical services. It is also the Company's policy to verify a patient’s insurance prior to the patient’s procedure. Patient services of the Company are primarily non-emergency, which allows the surgical facilities to control the procedures for which third-party reimbursement is sought and obtained. The Company does not require collateral from self-pay patients.
The Company analyzes accounts receivable at each of its facilities to ensure the proper aged category and collection assessment. At a consolidated level, the Company's policy is to review accounts receivable aging, by facility, to determine the appropriate allowance for doubtful accounts. Patient account balances are reviewed for delinquency based on contractual terms. This review is supported by an analysis of the actual revenues, contractual adjustments and cash collections received. An account balance is written off only after the Company has pursued collection with legal or collection agency assistance or otherwise has deemed an account to be uncollectible.
The receivables related to the Company's optical products purchasing organization are recognized separately from patient accounts receivable, as discussed above, and are included in other current assets in the condensed consolidated balance sheets.
Goodwill
Goodwill
Goodwill represents the fair value of the consideration provided in an acquisition over the fair value of net assets acquired and is not amortized. Additions to goodwill include amounts resulting from new business combinations and incremental ownership purchases in the Company's subsidiaries.
Derivative Instruments and Hedging Activities
Derivative Instruments and Hedging Activities
In accordance with ASC 815, Derivatives and Hedging (“ASC 815”), the Company records all derivatives on the balance sheet at fair value. The accounting for changes in the fair value of derivatives depends on the intended use of the derivative, whether the Company has elected to designate a derivative in a hedging relationship and apply hedge accounting and whether the hedging relationship has satisfied the criteria necessary to apply hedge accounting. Hedge accounting generally provides for the matching of the timing of gain or loss recognition on the hedging instrument with the recognition of the changes in the fair value of the hedged asset or liability that are attributable to the hedged risk in a fair value hedge or the earnings effect of the hedged forecasted transactions in a cash flow hedge. The Company may enter into derivative contracts that are intended to economically hedge certain of its risk, even though hedge accounting does not apply or the Company elects not to apply hedge accounting.
In accordance with the FASB’s fair value measurement guidance in ASU 2011-04, the Company made an accounting policy election to measure the credit risk of its derivative financial instruments that are subject to master netting agreements on a net basis by counterparty portfolio.
Non-Controlling Interests—Redeemable
Non-Controlling Interests—Redeemable
Each partnership and limited liability company through which the Company owns and operates its surgical facilities is governed by a partnership or operating agreement, respectively. In certain circumstances, the applicable partnership or operating agreements for the Company's surgical facilities provide that the facilities will purchase all of the physician limited partners’ or physician minority members’, as applicable, ownership if certain adverse regulatory events occur, such as it becoming illegal for the physician(s) to own an interest in a surgical facility, refer patients to a surgical facility or receive cash distributions from a surgical facility. The non-controlling interests—redeemable are reported outside of stockholders' equity in the condensed consolidated balance sheets.
Recent Accounting Pronouncements
Recent Accounting Pronouncements
In May 2014, the FASB issued ASU 2014-09, "Revenue from Contracts with Customers," along with subsequent amendments, updates and an extension of the effective date (collectively the "New Revenue Standard"), which outlines a single comprehensive model for recognizing revenue and supersedes most existing revenue recognition guidance, including guidance specific to the healthcare industry. This five-step process requires significant management judgment in addition to changing the way many companies recognize revenue in their financial statements. The Company adopted this ASU on January 1, 2018 using the modified retrospective approach. The adoption of this standard did not have a significant impact on the recognition of net revenues for any period. Adoption of the standard resulted in the Company revising its related disclosures.
In February 2016, the FASB issued ASU 2016-02, "Leases," which will require, among other items, lessees to recognize most leases as assets and liabilities on the balance sheet. Qualitative and quantitative disclosures will be enhanced to better understand the amount, timing and uncertainty of cash flows arising from leases. This guidance is effective for financial statements issued for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years, with early adoption permitted. The guidance is required to be applied using a modified retrospective transition approach for leases existing at, or entered into after, the beginning of the earliest comparative periods presented in the financial statements. In preparation of adopting the new standard, the Company has engaged outside consultants to assist in the identification of the Company's population of leases, implementing a new software for lease accounting and assisting in evaluating new accounting policy elections. The Company will adopt this ASU on January 1, 2019 and believes the primary effect of adopting the new standard will be to record right-of-use assets and obligations for current operating leases with material increases in reported property and equipment and liabilities. The Company is still evaluating the effect of adoption on financial disclosures, policies, procedures and control framework.
In November 2016, the FASB issued ASU 2016-18, "Statement of Cash Flows – Restricted Cash," which requires that a statement of cash flows explain the change during the period in the total of cash, cash equivalents, and amounts generally described as restricted cash or restricted cash equivalents. ASU 2016-18 is effective for fiscal years beginning after December 15, 2017, including interim periods within those years. The Company adopted this ASU on January 1, 2018 and retrospectively applied the guidance to all periods presented in the condensed consolidated statement of cash flows. The retrospective application to prior periods had no impact on the Company's cash flows from operating, investing and financing activities as previously disclosed. The adoption of this ASU resulted in the modification of the Company's presentation of the reconciliation of beginning-of-period and end-of-period total amounts shown on the condensed consolidated statement of cash flows to include restricted cash as discussed under the heading "Cash and Cash Equivalents" above.
Business Combinations
The Company accounts for its business combinations in accordance with the fundamental requirements of the acquisition method of accounting and under the premise that an acquirer can be identified for each business combination. The acquirer is the entity that obtains control of one or more businesses in the business combination and the acquisition date is the date the acquirer achieves control. The assets acquired, liabilities assumed and any non-controlling interests in the acquired business at the acquisition date are recognized at their fair values as of that date, and the direct costs incurred in connection with the business combination are recorded and expensed separately from the business combination. Any goodwill recognized is determined as the excess of the fair value of the consideration conveyed plus the fair value of any non-controlling interests in the acquisition over the fair value of the net assets acquired. Acquisitions in which the Company is able to exert significant influence but does not have control are accounted for using the equity method.
Acquired assets and assumed liabilities typically include, but are not limited to, fixed assets, intangible assets and professional liabilities. The valuations are based on appraisal reports, discounted cash flow analyses, actuarial analyses or other appropriate valuation techniques to determine the fair value of the assets acquired or liabilities assumed. Fair value attributable to non-controlling interests is based on a Level 3 computation using significant inputs that are not observable in the market. Key inputs used to determine the fair value include financial multiples used in the purchase of non-controlling interests, primarily from acquisitions of surgical facilities. Such multiples, based on earnings, are used as a benchmark for the discount to be applied for the lack of control or marketability. Fair value attributable to the property and equipment acquired is based on Level 3 computations using key inputs such as cost trend data and comparable asset sales. Fair value attributable to the intangible assets acquired is based on Level 3 computations using key inputs such as the Company's internally-prepared financial projections. Fair values assigned to acquired working capital are based on carrying amounts reported by the acquiree at the date of acquisition, which approximate their fair values. The preliminary estimated fair value assigned to goodwill is primarily attributable to the acquisitions favorable reputations in their markets, their market positions and their ability to deliver quality care with high patient satisfaction consistent with the Company's business model.
Earnings Per Share
Earnings Per Share
Basic and diluted earnings per share are calculated in accordance with ASC 260, Earnings Per Share, based on the weighted-average number of shares outstanding in each period and dilutive stock options, unvested shares and warrants, to the extent such securities exist and have a dilutive effect on earnings per share. Beginning in the Successor period, in connection with the issuance of the Series A Preferred Stock, the Company began computing basic and diluted earnings per share using the two-class method. The two-class method of computing earnings per share is an earnings allocation method that determines earnings per share for common shares and participating securities according to their participation rights in dividends and undistributed earnings.
Income Taxes
Income Taxes
The Company uses the asset and liability method to account for income taxes. Under this method, deferred income tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. If a net operating loss ("NOL") or Section 163(j) interest (“163(j)”) carryforward exists, the Company makes a determination as to whether the NOL or 163(j) carryforward will be utilized in the future. A valuation allowance is established for certain carryforwards when their recoverability is deemed to be uncertain. The carrying value of the net deferred tax assets assumes that the Company will be able to generate sufficient future taxable income in certain tax jurisdictions, based on estimates and assumptions. If these estimates and related assumptions change in the future, the Company may be required to adjust its deferred tax valuation allowances.
The Company and certain of its subsidiaries file a consolidated federal income tax return. The partnerships, limited liability companies, and certain non-consolidated physician practice corporations also file separate income tax returns. The Company's allocable portion of each partnership's and limited liability company's income or loss is included in taxable income of the Company. The remaining income or loss of each partnership and limited liability company is allocated to the other owners.
The Company, or one or more of its subsidiaries, files income tax returns in the U.S. federal jurisdiction and various state jurisdictions. With few exceptions, the Company is no longer subject to U.S. federal income tax examinations for years prior to 2015 or state income tax examinations for years prior to 2014.
Section 382 (“Section 382”) of the Internal Revenue Code of 1986, as amended (the “Code”) imposes an annual limit on the ability of a corporation that undergoes an “ownership change” to use its NOLs to reduce its tax liability. An “ownership change” is generally defined as any change in ownership of more than 50.0% of a corporation’s “stock” by its “5-percent shareholders” (as defined in Section 382) over a rolling three-year period based upon each of those shareholder’s lowest percentage of stock owned during such period.
XML 30 R19.htm IDEA: XBRL DOCUMENT v3.10.0.1
Organization, Basis of Presentation and Significant Accounting Policies (Tables)
 9 Months Ended
Sep. 30, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Carrying Amounts and Fair Values of Long-Term Debt
A summary of the carrying amounts and fair values of the Company's long-term debt follows (in thousands):
 
 
Successor
 
 
Carrying Amount
 
Fair Value
 
 
September 30,
2018
 
December 31, 2017
 
September 30,
2018
 
December 31, 2017
2017 Senior Secured Credit Facilities:
 
 
 
 
 
 
 
 
Revolver
 
$
11,000

 
$
—

 
$
11,000

 
$
—

Term Loan
 
$
1,271,397

 
$
1,280,532

 
$
1,272,986

 
$
1,267,189

Senior Unsecured Notes due 2021
 
$
407,372

 
$
409,235

 
$
423,667

 
$
422,535

Senior Unsecured Notes due 2025
 
$
370,000

 
$
370,000

 
$
355,200

 
$
346,413
Summary of Fair Value of Derivative Liabilities
During the nine months ended September 30, 2018 (Successor), the Company entered into certain derivative financial instruments. A summary of the fair values of the Company's derivative financial instruments follows (in thousands):
 
 
Successor
 
 
Fair Value
 
 
September 30,
2018
 
December 31, 2017
Derivative liabilities
 
 
 
 
Interest rate swap agreement
 
$
1,389

 
$
—
Schedule of Revenues by Service Type
A summary of revenues by service type as a percentage of total revenues follows:
 
 
Successor
 
 
 
Predecessor
 
Successor
 
 
 
Predecessor
 
 
Three Months Ended September 30,
 
September 1 to September 30,
 
 
 
July 1 to August 31,
 
Nine Months Ended September 30,
 
 
 
January 1 to August 31,
 
 
2018
 
2017
 
 
 
2017
 
2018
 
 
 
2017
Patient service revenues:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   Surgical facilities revenues
 
93.2
%
 
94.0
%
 
 
 
95.5
%
 
93.2
%
 
 
 
91.4
%
   Ancillary services revenues
 
4.7
%
 
4.2
%
 
 
 
2.7
%
 
4.8
%
 
 
 
7.0
%
 
 
97.9
%
 
98.2
%
 
 
 
98.2
%
 
98.0
%
 
 
 
98.4
%
Other service revenues:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   Optical services revenues
 
0.6
%
 
0.7
%
 
 
 
1.1
%
 
0.6
%
 
 
 
1.0
%
   Other revenues
 
1.5
%
 
1.1
%
 
 
 
0.7
%
 
1.4
%
 
 
 
0.6
%
 
 
2.1
%
 
1.8
%
 
 
 
1.8
%
 
2.0
%
 
 
 
1.6
%
Total revenues
 
100.0
%
 
100.0
%
 
 
 
100.0
%
 
100.0
%
 
 
 
100.0
%
Schedule of Revenue Sources for Patient Service Revenues
The following table sets forth patient service revenues by type of payor and as a percentage of total patient service revenues for the Company's consolidated surgical facilities (dollars in thousands):
 
 
Successor
 
 
 
Predecessor
 
 
Three Months Ended September 30,
 
September 1 to September 30,
 
 
 
July 1 to August 31,
 
 
2018
 
2017
 
 
 
2017
 
 
Amount
 
%
 
Amount
 
%
 
 
 
Amount
 
%
Patient service revenues:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Private insurance
 
$
230,718

 
53.1
%
 
$
72,930

 
56.2
%
 
 
 
$
80,166

 
46.9
%
Government
 
166,880

 
38.4
%
 
46,162

 
35.5
%
 
 
 
73,734

 
43.1
%
Self-pay
 
12,742

 
2.9
%
 
3,861

 
3.0
%
 
 
 
4,119

 
2.4
%
Other (1)
 
24,345

 
5.6
%
 
6,883

 
5.3
%
 
 
 
12,909

 
7.6
%
Total patient service revenues
 
434,685

 
100.0
%
 
129,836

 
100.0
%
 
 
 
170,928

 
100.0
%
Other service revenues:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Optical services revenues
 
2,699

 
 
 
888

 
 
 
 
 
1,905

 
 
Other revenues
 
6,548

 
 
 
1,534

 
 
 
 
 
1,246

 
 
Total revenues
 
$
443,932

 
 
 
$
132,258

 
 
 
 
 
$
174,079

 
 
 
 
Successor
 
 
 
Predecessor
 
 
Nine Months Ended September 30,
 
September 1 to September 30,
 
 
 
January 1 to August 31,
 
 
2018
 
2017
 
 
 
2017
 
 
Amount
 
%
 
Amount
 
%
 
 
 
Amount
 
%
Patient service revenues:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Private insurance
 
$
682,479

 
53.3
%
 
$
72,930

 
56.2
%
 
 
 
$
360,092

 
48.9
%
Government
 
493,362

 
38.6
%
 
46,162

 
35.5
%
 
 
 
308,993

 
42.0
%
Self-pay
 
39,050

 
3.1
%
 
3,861

 
3.0
%
 
 
 
15,949

 
2.2
%
Other (1)
 
64,075

 
5.0
%
 
6,883

 
5.3
%
 
 
 
51,374

 
6.9
%
Total patient service revenues
 
1,278,966

 
100.0
%
 
129,836

 
100.0
%
 
 
 
736,408

 
100.0
%
Other service revenues:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Optical services revenues
 
8,437

 
 
 
888

 
 
 
 
 
7,629

 
 
Other revenues
 
18,673

 
 
 
1,534

 
 
 
 
 
4,578

 
 
Total revenues
 
$
1,306,076

 
 
 
$
132,258

 
 
 
 
 
$
748,615

 
 
(1)
Other is comprised of anesthesia service agreements, auto liability, letters of protection and other payor types.
Schedule of Cash, Cash Equivalents and Restricted Cash
The following table reconciles cash, cash equivalents and restricted cash reported within the condensed consolidated balance sheets to the totals shown within the condensed consolidated statement of cash flows (in thousands):
 
 
Successor
 
 
September 30,
2018
 
December 31,
2017
 
 
 
 
 
Cash and cash equivalents
 
$
79,123

 
$
174,914

Restricted invested assets included in other long-term assets
 
315

 
315

Total cash, cash equivalents and restricted cash in the statement of cash flows
 
$
79,438

 
$
175,229
Schedule of Rollforward of Goodwill
A summary of activity related to goodwill for the nine months ended September 30, 2018 (Successor) follows (in thousands):
Successor
 
 
Balance at December 31, 2017
 
$
3,346,838

Acquisitions, including post acquisition adjustments
 
57,710

Divestitures and deconsolidations
 
(31,942
)
Balance at September 30, 2018
 
$
3,372,606
Schedule of Other Current Liabilities
A summary of other current liabilities follows (in thousands):
 
 
Successor
 
 
September 30,
2018
 
December 31,
2017
 
 
 
 
 
Interest payable
 
$
28,322

 
$
20,537

Amounts due to patients and payors
 
22,400

 
18,096

Accrued expenses and other
 
72,216

 
71,311

Total
 
$
122,938

 
$
109,944
Schedule of Other Long-Term Liabilities
A summary of other long-term liabilities follows (in thousands):
 
 
Successor
 
 
September 30,
2018
 
December 31,
2017
 
 
 
 
 
Facility lease obligations
 
$
138,116

 
$
121,627

Other
 
109,195

 
100,853

Total
 
$
247,311

 
$
222,480
Schedule of Rollforward of Noncontrolling Interest - Redeemable
A summary of activity related to the non-controlling interests—redeemable follows (in thousands):
Successor
 
 
Balance at December 31, 2017
 
$
299,316

Net income attributable to non-controlling interests—redeemable
 
20,528

Acquisition and disposal of shares of non-controlling interests, net—redeemable (1)
 
20,279

Distributions to non-controlling interest—redeemable holders
 
(22,582
)
Balance at September 30, 2018
 
$
317,541

(1)
Includes post acquisition date adjustments.
XML 31 R20.htm IDEA: XBRL DOCUMENT v3.10.0.1
Acquisitions and Developments (Tables)
 9 Months Ended
Sep. 30, 2018
Business Combinations [Abstract]  
Schedule of Assets Acquired and Liabilities Assumed
The aggregate amounts preliminarily recognized for each major class of assets acquired and liabilities assumed for acquisitions completed in the nine months ended September 30, 2018 (Successor), including post acquisition date adjustments, are as follows (in thousands):
Cash consideration
 
$
54,308

Fair value of non-controlling interests
 
28,776

Aggregate acquisition date fair value
 
$
83,084

Net assets acquired:
 
 
Current Assets
 
$
4,708

Property and equipment
 
2,301

Goodwill
 
75,947

Other long-term assets
 
3,460

Current liabilities
 
(2,332
)
Long-term liabilities
 
(1,000
)
Aggregate acquisition date fair value
 
$
83,084

The acquisition date fair value for each major class of assets acquired and liabilities assumed, including post acquisition date adjustments, are as follows (in thousands):
Cash consideration
 
$
764,007

Fair value of non-controlling interests
 
325,965

Acquisition date fair value
 
$
1,089,972

Net assets acquired:
 
 
Cash and cash equivalents
 
$
51,159

Accounts receivable
 
71,639

Inventories
 
14,986

Prepaid expenses and other current assets
 
18,367

Property and equipment
 
174,100

Intangible assets
 
27,881

Goodwill
 
871,373

Investments in and advances to affiliates
 
29,737

Long-term deferred tax assets
 
20,212

Other long-term assets
 
26,988

Accounts payable
 
(29,652
)
Accrued payroll and benefits
 
(30,853
)
Other current liabilities
 
(23,937
)
Current maturities of long-term debt
 
(16,416
)
Long-term debt, less current maturities
 
(42,770
)
Other long-term liabilities
 
(72,842
)
Acquisition date fair value
 
$
1,089,972

The transaction date fair value recognized in connection with the application of pushdown accounting for each major class of assets and liabilities as of August 31, 2017, including post transaction date adjustments, are as follows (in thousands):
Equity attributable to Surgery Partners, Inc.
$
721,764

Redeemable preferred stock
310,000

Fair value of non-controlling interests
939,083

Transaction date fair value
$
1,970,847

Net assets:
 
Cash and cash equivalents
214,206

Accounts receivable
252,911

Inventories
44,310

Prepaid expenses and other current assets
61,438

Property and equipment
379,685

Intangible assets
63,978

Goodwill
3,281,728

Investments in and advances to affiliates
75,113

Restricted invested assets
315

Long-term deferred tax asset
206,073

Other long-term assets
50,666

Accounts payable
(64,921
)
Accrued payroll and benefits
(56,535
)
Other current liabilities
(97,617
)
Current maturities of long-term debt
(49,942
)
Long-term debt, less current maturities
(2,142,375
)
Long-term tax receivable agreement liability
(78,498
)
Other long-term liabilities
(169,688
)
Transaction date fair value
$
1,970,847
XML 32 R21.htm IDEA: XBRL DOCUMENT v3.10.0.1
Long-Term Debt (Tables)
 9 Months Ended
Sep. 30, 2018
Debt Disclosure [Abstract]  
Summary of long-term debt
A summary of long-term debt follows (in thousands):
 
 
Successor
 
 
September 30,
2018
 
December 31,
2017
 
 
 
 
 
2017 Senior Secured Credit Facilities:
 
 
 
 
Revolver
 
$
11,000

 
$
—

Term Loan (1)
 
1,271,397

 
1,280,532

Senior Unsecured Notes due 2021 (2)

407,372

 
409,235

Senior Unsecured Notes due 2025
 
370,000

 
370,000

Notes payable and secured loans
 
88,068

 
101,921

Capital lease obligations
 
24,836

 
27,594

Total debt
 
2,172,673

 
2,189,282

Less: Current maturities
 
54,106

 
58,726

Total long-term debt
 
$
2,118,567

 
$
2,130,556


(1)
In connection with the application of pushdown accounting, the Company remeasured and recorded the Term Loan at fair value using a measurement date of August 31, 2017. The fair value was based on a Level 2 input using quoted prices for identical liabilities in inactive markets. As a result, the Company recorded a fair value discount as of the measurement date, which is reported in the consolidated balance sheets as a direct rededuction from the face amount the Term Loan and amortized to interest expense over the life of the Term Loan. The unamortized fair value discount as of September 30, 2018 (Successor) and December 31, 2017 (Successor) was $5.7 million and $6.2 million, respectively.
(2)
In connection with the application of pushdown accounting, the Company remeasured and recorded the Senior Unsecured Notes due 2021 at fair value using a measurement date of August 31, 2017. The fair value was based on a Level 2 input using quoted prices for identical liabilities in inactive markets. As a result, the Company recorded a fair value premium as of the measurement date, which is reported in the consolidated balance sheets as a direct addition to the face amount the notes and amortized to interest expense over the life of the Senior Unsecured Notes due 2021. The unamortized fair value premium as of September 30, 2018 (Successor) and December 31, 2017 (Successor) was $7.4 million and $9.2 million, respectively.
XML 33 R22.htm IDEA: XBRL DOCUMENT v3.10.0.1
Derivatives and Hedging Activities (Tables)
 9 Months Ended
Sep. 30, 2018
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of the Effect of Fair Value and Cash Flow Hedge Accounting
The table below presents the effect of fair value and cash flow hedge accounting on the Company's consolidated balance sheets.
 
 
Successor
 
 
 
Predecessor
 
Successor
 
 
 
Predecessor
 
 
Three Months Ended September 30,
 
September 1 to September 30,
 
 
 
July 1 to August 31,
 
Nine Months Ended September 30,
 
 
 
January 1 to August 31,
 
 
2018
 
2017
 
 
 
2017
 
2018
 
 
 
2017
Derivatives in Cash Flow Hedging Relationships
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Losses related to effective portion of derivatives recognized in accumulated OCI, gross of tax effect
 
$
(1,389
)
 
$
—

 
 
 
$
—

 
$
(1,389
)
 
 
 
$
—

Loss related to effective portion of derivatives reclassified from accumulated OCI to interest expense, gross of tax effect
 
—

 
—

 
 
 
—

 
—

 
 
 
—
XML 34 R23.htm IDEA: XBRL DOCUMENT v3.10.0.1
Redeemable Preferred Stock (Tables)
 9 Months Ended
Sep. 30, 2018
Temporary Equity Disclosure [Abstract]  
Activity Related to Redeemable Preferred Stock
A summary of activity related to the redeemable preferred stock follows (in thousands):
Successor
 
 
Balance at December 31, 2017
 
$
330,806

Dividends accrued
 
23,973

Cash dividends declared
 
(3,886
)
Balance at September 30, 2018
 
$
350,893
XML 35 R24.htm IDEA: XBRL DOCUMENT v3.10.0.1
Earnings Per Share (Tables)
 9 Months Ended
Sep. 30, 2018
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted
A reconciliation of the numerator and denominator of basic and diluted earnings per share follows (in thousands except share and per share amounts):
 
 
Successor
 
 
 
Predecessor
 
Successor
 
 
 
Predecessor
 
 
Three Months Ended September 30,
 
September 1 to September 30,
 
 
 
July 1 to August 31,
 
Nine Months Ended September 30,
 
 
 
January 1 to August 31,
 
 
2018
 
2017
 
 
 
2017
 
2018
 
 
 
2017
Numerator:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net loss attributable to Surgery Partners, Inc.
 
$
(20,981
)
 
$
(9,140
)
 
 
 
$
(4,444
)
 
$
(57,964
)
 
 
 
$
(11,669
)
Less: amounts allocated to participating securities (1)
 
8,245

 
2,633

 
 
 
—

 
23,973

 
 
 
—

Less: mark to redemption adjustment
 
—

 
15,566

 
 
 
—

 
—

 
 
 
—

Net loss attributable to common stockholders
 
$
(29,226
)
 
$
(27,339
)
 
 
 
$
(4,444
)
 
$
(81,937
)
 
 
 
$
(11,669
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Denominator:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Weighted average shares outstanding- basic
 
48,037,634

 
48,314,746

 
 
 
48,146,611

 
48,020,369

 
 
 
48,121,404

Effect of dilutive securities (2)
 
—

 
—

 
 
 
—

 
—

 
 
 
—

Weighted average shares outstanding- diluted
 
48,037,634

 
48,314,746

 
 
 
48,146,611

 
48,020,369

 
 
 
48,121,404

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Loss per share:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Basic
 
$
(0.61
)
 
$
(0.57
)
 
 
 
$
(0.09
)
 
$
(1.71
)
 
 
 
$
(0.24
)
Diluted (2)
 
$
(0.61
)
 
$
(0.57
)
 
 
 
$
(0.09
)
 
$
(1.71
)
 
 
 
$
(0.24
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dilutive securities outstanding not included in the computation of (loss) earnings per share as their effect is antidilutive:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Stock options
 
144,795

 
—

 
 
 
—

 
153,884

 
 
 
—

Restricted shares
 
134,054

 
112,529

 
 
 
34,506

 
140,552

 
 
 
105,944

Convertible preferred stock
 
—

 
—

 
 
 
N/A

 
—

 
 
 
N/A

(1) 
Includes dividends accrued during the Successor periods for the Series A Preferred Stock. The Series A Preferred Stock does not participate in undistributed losses. There were no participating securities during the Predecessor periods.
(2) 
The impact of potentially dilutive securities for all periods presented was not considered because the effect would be anti-dilutive in each period.
XML 36 R25.htm IDEA: XBRL DOCUMENT v3.10.0.1
Segment Reporting (Tables)
 9 Months Ended
Sep. 30, 2018
Segment Reporting [Abstract]  
Reconciliation of Revenue from Segments to Consolidated
The following tables present financial information for each reportable segment (in thousands):
 
 
Successor
 
 
 
Predecessor
 
Successor
 
 
 
Predecessor

 
Three Months Ended September 30,
 
September 1 to September 30,
 
 
 
July 1 to August 31,
 
Nine Months Ended September 30,
 
 
 
January 1 to August 31,

 
2018
 
2017
 
 
 
2017
 
2018
 
 
 
2017
Revenues:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Surgical facility services
 
$
420,514

 
$
125,595

 
 
 
$
167,765

 
$
1,234,984

 
 
 
$
688,725

Ancillary services
 
20,719

 
5,775

 
 
 
4,409

 
62,655

 
 
 
52,261

Optical services
 
2,699

 
888

 
 
 
1,905

 
8,437

 
 
 
7,629

Total
 
$
443,932

 
$
132,258

 
 
 
$
174,079

 
$
1,306,076

 
 
 
$
748,615

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adjusted EBITDA (1):
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Surgical facility services
 
$
74,525

 
$
20,947

 
 
 
$
27,726

 
$
216,540

 
 
 
$
125,912

Ancillary services
 
875

 
(1,265
)
 
 
 
(10,737
)
 
2,925

 
 
 
(6,526
)
Optical services
 
571

 
193

 
 
 
555

 
2,087

 
 
 
2,214

All other
 
(16,983
)
 
(5,033
)
 
 
 
(9,142
)
 
(60,087
)
 
 
 
(36,036
)
Total
 
$
58,988

 
$
14,842

 
 
 
$
8,402

 
$
161,465

 
 
 
$
85,564


(1)
When the Company uses the term “Adjusted EBITDA,” it is referring to income before income taxes adjusted for (a) net income attributable to non-controlling interests, (b) depreciation and amortization, (c) interest expense, net, (d) equity-based compensation, (e) contingent acquisition compensation expense, (f) transaction, integration and acquisition costs, (g) gain on litigation settlement, (h) gain on acquisition escrow release, (i) reserve adjustments, (j) loss on disposals and deconsolidations, net, (k) gain on amendment to tax receivable agreement and (l) loss on debt refinancing. Adjusted EBITDA is the primary profit/loss metric reviewed by the chief operating decision maker in making key business decisions and on allocation of resources. Adjusted EBITDA is not a measurement of financial performance under GAAP, and should not be considered in isolation or as a substitute for net income, operating income or any other measure calculated in accordance with generally accepted accounting principles. The items excluded from Adjusted EBITDA are significant components in understanding and evaluating the Company's financial performance. The Company's calculation of Adjusted EBITDA may not be comparable to similarly titled measures reported by other companies.
Schedule of Segment Operating Income
A reconciliation of Adjusted EBITDA to income before income taxes included in the condensed consolidated statement of operations is as follows:
 
 
Successor
 
 
 
Predecessor
 
Successor
 
 
 
Predecessor
 
 
Three Months Ended September 30,
 
September 1 to September 30,
 
 
 
July 1 to August 31,
 
Nine Months Ended September 30,
 
 
 
January 1 to August 31,
 
 
2018
 
2017
 
 
 
2017
 
2018
 
 
 
2017
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adjusted EBITDA
 
$
58,988

 
$
14,842

 
 
 
$
8,402

 
$
161,465

 
 
 
$
85,564

Net income attributable to non-controlling interests
 
23,000

 
6,492

 
 
 
8,813

 
69,418

 
 
 
42,087

Depreciation and amortization
 
(16,945
)
 
(3,330
)
 
 
 
(7,599
)
 
(49,379
)
 
 
 
(30,124
)
Interest expense, net
 
(37,159
)
 
(15,883
)
 
 
 
(18,147
)
 
(107,368
)
 
 
 
(68,929
)
Equity-based compensation
 
(1,526
)
 
(1,683
)
 
 
 
(1,628
)
 
(6,303
)
 
 
 
(3,697
)
Contingent acquisition compensation expense
 
(503
)
 
(605
)
 
 
 
(1,210
)
 
(1,510
)
 
 
 
(5,057
)
Transaction, integration and acquisition costs (1)
 
(7,489
)
 
(3,457
)
 
 
 
(2,949
)
 
(25,419
)
 
 
 
(7,677
)
Gain on litigation settlement
 
—

 
—

 
 
 
—

 
—

 
 
 
3,794

Gain on acquisition escrow release
 
—

 
—

 
 
 
1,000

 
—

 
 
 
1,000

Reserve adjustments (2)
 
2,109

 
—

 
 
 
—

 
(2,670
)
 
 
 
—

Loss on disposals and deconsolidations, net
 
(12,631
)
 
(333
)
 
 
 
(114
)
 
(15,875
)
 
 
 
(1,715
)
Gain on amendment to tax receivable agreement
 
—

 
1,098

 
 
 
15,294

 
—

 
 
 
15,294

Loss on debt refinancing
 
—

 
—

 
 
 
(18,211
)
 
—

 
 
 
(18,211
)
Income before income taxes
 
$
7,844

 
$
(2,859
)
 
 
 
$
(16,349
)
 
$
22,359

 
 
 
$
12,329


(1)
This amount includes transaction and integration costs of $7.1 million and $23.8 million for the three and nine months ended September 30, 2018 (Successor), respectively, $3.0 million for the one month ended September 30, 2017 (Successor), and $2.3 million and $5.6 million for the two and eight months ended August 31, 2017 (Predecessor), respectively. This amount includes acquisition costs of $0.4 million and $1.6 million for the three and nine months ended September 30, 2018 (Successor), respectively, $0.5 million for the one month ended September 30, 2017 (Successor), and $0.6 million and $2.1 million for the two and eight months ended August 31, 2017 (Predecessor), respectively.
(2)
This amount represents adjustments to revenue in connection with applying consistent policies across the combined company as a result of the integration of Surgery Partners and NSH.
Reconciliation of Assets from Segment to Consolidated
 
 
Successor
 
 
September 30,
2018
 
December 31,
2017
Assets:
 
 
 
 
Surgical facility services
 
$
4,015,094

 
$
4,072,521

Ancillary services
 
110,588

 
104,274

Optical services
 
34,811

 
48,309

All other
 
398,171

 
397,669

Total assets
 
$
4,558,664

 
$
4,622,773
Schedule of Other Segment Reporting Information
 
 
Successor
 
 
 
Predecessor
 
 
Nine Months Ended September 30,
 
September 1 to September 30,
 
 
 
January 1 to August 31,
 
 
2018
 
2017
 
 
 
2017
Cash purchases of property and equipment, net:
 
 
 
 
 
 
 
 
Surgical facility services
 
$
21,590

 
$
1,613

 
 
 
$
14,582

Ancillary services
 
334

 
2

 
 
 
1,875

Optical services
 
42

 
23

 
 
 
73

All other
 
4,652

 
202

 
 
 
2,243

Total cash purchases of property and equipment, net
 
$
26,618

 
$
1,840

 
 
 
$
18,773
XML 37 R26.htm IDEA: XBRL DOCUMENT v3.10.0.1
Organization, Basis of Presentation and Significant Accounting Policies - Organization (Details)
Sep. 30, 2018
surgical_facility
state
Products And Services [Line Items]  
Number of surgical facilities owned 124
Number of states in which entity operates | state 32
Number of surgical facilities owned, majority interest 84
Number of surgical facilities owned, consolidated 105
Facilities, Ambulatory Surgery Centers  
Products And Services [Line Items]  
Number of surgical facilities owned 106
Facilities, Surgical Hospitals  
Products And Services [Line Items]  
Number of surgical facilities owned 18
XML 38 R27.htm IDEA: XBRL DOCUMENT v3.10.0.1
Organization, Basis of Presentation and Significant Accounting Policies - Variable Interest Entities (Details)
$ in Millions
 9 Months Ended
Sep. 30, 2018
Anesthesia_Practice
surgical_facility
physician_practice
Sep. 30, 2018
surgical_facility
Sep. 30, 2018
physician_practice
Sep. 30, 2018
USD ($)
Dec. 31, 2017
Anesthesia_Practice
Dec. 31, 2017
surgical_facility
Dec. 31, 2017
physician_practice
Dec. 31, 2017
USD ($)
Variable Interest Entity [Line Items]                
Number of facilities included in VIE 3 4 4   3 5 3  
Number of facilities divested | surgical_facility 1              
Variable Interest Entity, Primary Beneficiary, Aggregated Disclosure                
Variable Interest Entity [Line Items]                
Total assets related to VIE       $ 6.5       $ 13.1
Total liabilities related to VIE       $ 3.4       $ 5.8
Variable Interest Entity, Primary Beneficiary                
Variable Interest Entity [Line Items]                
Number of practices acquired, classified as VIE | physician_practice 1              
XML 39 R28.htm IDEA: XBRL DOCUMENT v3.10.0.1
Organization, Basis of Presentation and Significant Accounting Policies - Schedule of Carrying Amount and Fair Value of Long-Term Debt (Details) - Senior Notes - USD ($)
$ in Thousands
Sep. 30, 2018
Dec. 31, 2017
Senior Unsecured Notes Due 2021    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Long-term debt $ 407,372 $ 409,235
Senior Unsecured Notes Due 2021 | Carrying Amount    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Long-term debt 407,372 409,235
Senior Unsecured Notes Due 2021 | Fair Value | Fair Value, Inputs, Level 2    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Long-term debt 423,667 422,535
Senior Unsecured Notes Due 2025    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Long-term debt 370,000 370,000
Senior Unsecured Notes Due 2025 | Carrying Amount    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Long-term debt 370,000 370,000
Senior Unsecured Notes Due 2025 | Fair Value | Fair Value, Inputs, Level 2    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Long-term debt 355,200 346,413
Revolving Credit Facility | 2017 Senior Secured Credit Facility - Revolver | Carrying Amount    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Long-term debt 11,000 0
Revolving Credit Facility | 2017 Senior Secured Credit Facility - Revolver | Fair Value | Fair Value, Inputs, Level 2    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Long-term debt 11,000 0
Revolving Credit Facility | 2017 Senior Secured Credit Facility - Term Loan | Carrying Amount    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Long-term debt 1,271,397 1,280,532
Revolving Credit Facility | 2017 Senior Secured Credit Facility - Term Loan | Fair Value | Fair Value, Inputs, Level 2    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Long-term debt $ 1,272,986 $ 1,267,189
XML 40 R29.htm IDEA: XBRL DOCUMENT v3.10.0.1
Organization, Basis of Presentation and Significant Accounting Policies - Summary of the Fair Value of Derivative Liabilities (Details) - USD ($)
$ in Thousands
Sep. 30, 2018
Dec. 31, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Interest rate swap agreement $ 1,389 $ 0
XML 41 R30.htm IDEA: XBRL DOCUMENT v3.10.0.1
Organization, Basis of Presentation and Significant Accounting Policies - Fair Value of Financial Instruments, Narrative (Details) - USD ($)
$ in Millions
Sep. 30, 2018
Dec. 31, 2017
Fair Value, Inputs, Level 1    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Assets of SERP $ 1.6 $ 1.6
XML 42 R31.htm IDEA: XBRL DOCUMENT v3.10.0.1
Organization, Basis of Presentation and Significant Accounting Policies - Schedule of Revenues by Service Type (Details) - USD ($)
 1 Months Ended 2 Months Ended 3 Months Ended 8 Months Ended 9 Months Ended
Sep. 30, 2017
Aug. 31, 2017
Sep. 30, 2018
Aug. 31, 2017
Sep. 30, 2018
Revenue from External Customer [Line Items]          
Increase of revenue as result of changes in estimates to third-party settlements related to prior years $ 0   $ 1,400,000   $ 1,400,000
Revenue Source | Revenue          
Revenue from External Customer [Line Items]          
Service revenues as a percentage of total revenues 100.00%   100.00%   100.00%
Revenue Source | Revenue | Healthcare Organization, Patient Service          
Revenue from External Customer [Line Items]          
Service revenues as a percentage of total revenues 98.20%   97.90%   98.00%
Revenue Source | Revenue | Surgical Facility Services          
Revenue from External Customer [Line Items]          
Service revenues as a percentage of total revenues 94.00%   93.20%   93.20%
Revenue Source | Revenue | Ancillary Services          
Revenue from External Customer [Line Items]          
Service revenues as a percentage of total revenues 4.20%   4.70%   4.80%
Revenue Source | Revenue | Healthcare Organization, Other Service          
Revenue from External Customer [Line Items]          
Service revenues as a percentage of total revenues 1.80%   2.10%   2.00%
Revenue Source | Revenue | Optical Services          
Revenue from External Customer [Line Items]          
Service revenues as a percentage of total revenues 0.70%   0.60%   0.60%
Revenue Source | Revenue | Other          
Revenue from External Customer [Line Items]          
Service revenues as a percentage of total revenues 1.10%   1.50%   1.40%
Predecessor          
Revenue from External Customer [Line Items]          
Increase of revenue as result of changes in estimates to third-party settlements related to prior years   $ 600,000   $ 1,100,000  
Predecessor | Revenue Source | Revenue          
Revenue from External Customer [Line Items]          
Service revenues as a percentage of total revenues   100.00%   100.00%  
Predecessor | Revenue Source | Revenue | Healthcare Organization, Patient Service          
Revenue from External Customer [Line Items]          
Service revenues as a percentage of total revenues   98.20%   98.40%  
Predecessor | Revenue Source | Revenue | Surgical Facility Services          
Revenue from External Customer [Line Items]          
Service revenues as a percentage of total revenues   95.50%   91.40%  
Predecessor | Revenue Source | Revenue | Ancillary Services          
Revenue from External Customer [Line Items]          
Service revenues as a percentage of total revenues   2.70%   7.00%  
Predecessor | Revenue Source | Revenue | Healthcare Organization, Other Service          
Revenue from External Customer [Line Items]          
Service revenues as a percentage of total revenues   1.80%   1.60%  
Predecessor | Revenue Source | Revenue | Optical Services          
Revenue from External Customer [Line Items]          
Service revenues as a percentage of total revenues   1.10%   1.00%  
Predecessor | Revenue Source | Revenue | Other          
Revenue from External Customer [Line Items]          
Service revenues as a percentage of total revenues   0.70%   0.60%  
XML 43 R32.htm IDEA: XBRL DOCUMENT v3.10.0.1
Organization, Basis of Presentation and Significant Accounting Policies - Schedule of Revenues by Sources (Details) - USD ($)
$ in Thousands
 1 Months Ended 2 Months Ended 3 Months Ended 8 Months Ended 9 Months Ended
Sep. 30, 2017
Aug. 31, 2017
Sep. 30, 2018
Aug. 31, 2017
Sep. 30, 2018
Health Care Organization, Receivable and Revenue Disclosures [Line Items]          
Total revenues $ 132,258   $ 443,932   $ 1,306,076
Healthcare Organization, Patient Service          
Health Care Organization, Receivable and Revenue Disclosures [Line Items]          
Total revenues $ 129,836   $ 434,685   $ 1,278,966
Healthcare Organization, Patient Service | Customer | Revenue          
Health Care Organization, Receivable and Revenue Disclosures [Line Items]          
Service revenues as a percentage of total revenues 100.00%   100.00%   100.00%
Healthcare Organization, Patient Service | Private insurance          
Health Care Organization, Receivable and Revenue Disclosures [Line Items]          
Total revenues $ 72,930   $ 230,718   $ 682,479
Healthcare Organization, Patient Service | Private insurance | Customer | Revenue          
Health Care Organization, Receivable and Revenue Disclosures [Line Items]          
Service revenues as a percentage of total revenues 56.20%   53.10%   53.30%
Healthcare Organization, Patient Service | Government          
Health Care Organization, Receivable and Revenue Disclosures [Line Items]          
Total revenues $ 46,162   $ 166,880   $ 493,362
Healthcare Organization, Patient Service | Government | Customer | Revenue          
Health Care Organization, Receivable and Revenue Disclosures [Line Items]          
Service revenues as a percentage of total revenues 35.50%   38.40%   38.60%
Healthcare Organization, Patient Service | Self-pay          
Health Care Organization, Receivable and Revenue Disclosures [Line Items]          
Total revenues $ 3,861   $ 12,742   $ 39,050
Healthcare Organization, Patient Service | Self-pay | Customer | Revenue          
Health Care Organization, Receivable and Revenue Disclosures [Line Items]          
Service revenues as a percentage of total revenues 3.00%   2.90%   3.10%
Healthcare Organization, Patient Service | Other          
Health Care Organization, Receivable and Revenue Disclosures [Line Items]          
Total revenues $ 6,883   $ 24,345   $ 64,075
Healthcare Organization, Patient Service | Other | Customer | Revenue          
Health Care Organization, Receivable and Revenue Disclosures [Line Items]          
Service revenues as a percentage of total revenues 5.30%   5.60%   5.00%
Optical Services          
Health Care Organization, Receivable and Revenue Disclosures [Line Items]          
Total revenues $ 888   $ 2,699   $ 8,437
Other          
Health Care Organization, Receivable and Revenue Disclosures [Line Items]          
Total revenues $ 1,534   $ 6,548   $ 18,673
Predecessor          
Health Care Organization, Receivable and Revenue Disclosures [Line Items]          
Total revenues   $ 174,079   $ 748,615  
Predecessor | Healthcare Organization, Patient Service          
Health Care Organization, Receivable and Revenue Disclosures [Line Items]          
Total revenues   $ 170,928   $ 736,408  
Predecessor | Healthcare Organization, Patient Service | Customer | Revenue          
Health Care Organization, Receivable and Revenue Disclosures [Line Items]          
Service revenues as a percentage of total revenues   100.00%   100.00%  
Predecessor | Healthcare Organization, Patient Service | Private insurance          
Health Care Organization, Receivable and Revenue Disclosures [Line Items]          
Total revenues   $ 80,166   $ 360,092  
Predecessor | Healthcare Organization, Patient Service | Private insurance | Customer | Revenue          
Health Care Organization, Receivable and Revenue Disclosures [Line Items]          
Service revenues as a percentage of total revenues   46.90%   48.90%  
Predecessor | Healthcare Organization, Patient Service | Government          
Health Care Organization, Receivable and Revenue Disclosures [Line Items]          
Total revenues   $ 73,734   $ 308,993  
Predecessor | Healthcare Organization, Patient Service | Government | Customer | Revenue          
Health Care Organization, Receivable and Revenue Disclosures [Line Items]          
Service revenues as a percentage of total revenues   43.10%   42.00%  
Predecessor | Healthcare Organization, Patient Service | Self-pay          
Health Care Organization, Receivable and Revenue Disclosures [Line Items]          
Total revenues   $ 4,119   $ 15,949  
Predecessor | Healthcare Organization, Patient Service | Self-pay | Customer | Revenue          
Health Care Organization, Receivable and Revenue Disclosures [Line Items]          
Service revenues as a percentage of total revenues   2.40%   2.20%  
Predecessor | Healthcare Organization, Patient Service | Other          
Health Care Organization, Receivable and Revenue Disclosures [Line Items]          
Total revenues   $ 12,909   $ 51,374  
Predecessor | Healthcare Organization, Patient Service | Other | Customer | Revenue          
Health Care Organization, Receivable and Revenue Disclosures [Line Items]          
Service revenues as a percentage of total revenues   7.60%   6.90%  
Predecessor | Optical Services          
Health Care Organization, Receivable and Revenue Disclosures [Line Items]          
Total revenues   $ 1,905   $ 7,629  
Predecessor | Other          
Health Care Organization, Receivable and Revenue Disclosures [Line Items]          
Total revenues   $ 1,246   $ 4,578  
XML 44 R33.htm IDEA: XBRL DOCUMENT v3.10.0.1
Organization, Basis of Presentation and Significant Accounting Policies - Cash and Restricted Cash Balances (Details) - USD ($)
$ in Thousands
Sep. 30, 2018
Dec. 31, 2017
Sep. 30, 2017
Aug. 31, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]        
Cash and cash equivalents $ 79,123 $ 174,914    
Restricted invested assets included in other long-term assets 315 315    
Total cash, cash equivalents and restricted cash in the statement of cash flows $ 79,438 $ 175,229 $ 200,016 $ 214,521
XML 45 R34.htm IDEA: XBRL DOCUMENT v3.10.0.1
Organization, Basis of Presentation and Significant Accounting Policies - Accounts Receivable and Allowances for Contractual Adjustments and Doubtful Accounts (Details) - USD ($)
$ in Millions
Sep. 30, 2018
Dec. 31, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Third-Party Medicaid settlement liability $ 7.7 $ 1.0
Optical products receivable $ 9.3 $ 7.6
XML 46 R35.htm IDEA: XBRL DOCUMENT v3.10.0.1
Organization, Basis of Presentation and Significant Accounting Policies - Rollforward of Goodwill and Information on Impairments (Details)
$ in Thousands
 9 Months Ended
Sep. 30, 2018
USD ($)
Goodwill [Roll Forward]  
Goodwill, beginning of period $ 3,346,838
Acquisitions, including post acquisition adjustments 57,710
Divestitures and deconsolidations (31,942)
Goodwill, end of period $ 3,372,606
XML 47 R36.htm IDEA: XBRL DOCUMENT v3.10.0.1
Organization, Basis of Presentation and Significant Accounting Policies - Schedule of Other Current Liabilities (Details) - USD ($)
$ in Thousands
Sep. 30, 2018
Dec. 31, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Interest payable $ 28,322 $ 20,537
Amounts due to patients and payors 22,400 18,096
Accrued expenses and other 72,216 71,311
Total $ 122,938 $ 109,944
XML 48 R37.htm IDEA: XBRL DOCUMENT v3.10.0.1
Organization, Basis of Presentation and Significant Accounting Policies - Schedule of Other Long-Term Liabilities (Details) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2018
Dec. 31, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Facility lease obligations $ 138,116 $ 121,627
Other 109,195 100,853
Total 247,311 222,480
Current portions of the lease obligations 6,800 $ 6,300
Noncurrent deferred financing obligation, Noncurrent 36,700  
Payments of noncurrent deferred financing obligations $ 23,100  
XML 49 R38.htm IDEA: XBRL DOCUMENT v3.10.0.1
Organization, Basis of Presentation and Significant Accounting Policies - Schedule of Non-Controlling Interests - Redeemable (Details)
$ in Thousands
 9 Months Ended
Sep. 30, 2018
USD ($)
Non-Controlling Interests - Redeemable [Roll Forward]  
Beginning balance $ 299,316
Net income attributable to non-controlling interests—redeemable 20,528
Acquisition and disposal of shares of non-controlling interests, net—redeemable 20,279
Distributions to non-controlling interest—redeemable holders (22,582)
Ending balance $ 317,541
XML 50 R39.htm IDEA: XBRL DOCUMENT v3.10.0.1
Acquisitions and Developments - Additional Information (Details)
$ / shares in Units, $ in Thousands
 1 Months Ended 3 Months Ended 8 Months Ended 9 Months Ended
Aug. 31, 2017
USD ($)
$ / shares
shares
Sep. 30, 2017
USD ($)
physician_practice
Sep. 30, 2018
USD ($)
Aug. 31, 2017
USD ($)
physician_practice
endoscopy_practice
$ / shares
Sep. 30, 2018
USD ($)
surgical_facility
physician_practice
surgery_center
Dec. 31, 2017
USD ($)
Business Acquisition [Line Items]            
Goodwill     $ 3,372,606   $ 3,372,606 $ 3,346,838
Fair value of investment     2,000   2,000  
Gain on deconsolidation     1,100   1,100  
Payments for acquisitions, net of cash acquired   $ 1,163     55,213  
Bain Capital            
Business Acquisition [Line Items]            
Net increase (decrease) to goodwill         $ (18,200)  
Two Surgery Centers            
Business Acquisition [Line Items]            
Number of interests disposed (in surgery centers) | surgery_center         3  
Net proceeds from sale of interests         $ 17,600  
Loss sale of interests         $ 9,500  
Surgery Center            
Business Acquisition [Line Items]            
Number of interests disposed (in surgery centers) | surgery_center         1  
Net proceeds from sale of interests         $ 500  
Surgical Facility Acquisitions, New Market            
Business Acquisition [Line Items]            
Number of businesses acquired | surgical_facility         2  
Surgical Facility, Existing Market            
Business Acquisition [Line Items]            
Number of businesses acquired | surgical_facility         1,000  
Physician Practice            
Business Acquisition [Line Items]            
Number of businesses acquired | physician_practice         1,000  
Surgical Facility, Noncontrolling Interest, New Market            
Business Acquisition [Line Items]            
Number of businesses acquired | surgical_facility         1,000  
Surgical Facility and Physician Practice Acquisitions            
Business Acquisition [Line Items]            
Business acquisition total purchase price         $ 32,900  
Integrated Physician Practice Acquisitions            
Business Acquisition [Line Items]            
Number of businesses acquired | physician_practice         1,000  
Business acquisition total purchase price         $ 21,100  
Total Acquisitions            
Business Acquisition [Line Items]            
Number of businesses acquired | physician_practice   1        
Business acquisition total purchase price   $ 1,200        
Goodwill     75,947   75,947  
Tax deductible goodwill     49,900   49,900  
Endoscopy Practice            
Business Acquisition [Line Items]            
Number of businesses acquired | endoscopy_practice       1,000    
NSH            
Business Acquisition [Line Items]            
Additional cash consideration paid increasing goodwill         1,200  
Surgical Facility Services | Total Acquisitions            
Business Acquisition [Line Items]            
Goodwill     68,600   68,600  
Ancillary Services | Total Acquisitions            
Business Acquisition [Line Items]            
Goodwill     $ 7,400   $ 7,400  
Predecessor            
Business Acquisition [Line Items]            
Payments for acquisitions, net of cash acquired       $ 725,853    
Predecessor | Bain Capital            
Business Acquisition [Line Items]            
Business acquisition total purchase price $ 1,970,847          
Goodwill $ 3,281,728     $ 3,281,728    
Shares sold in acquisition (shares) | shares 26,455,651          
Share price (in USD per share) | $ / shares $ 19.00     $ 19.00    
Percentage of voting interests sold 65.70%     65.70%    
Pushdown accounting adjustments, increase (decrease) to intangibles $ 3,900          
Pushdown accounting adjustment increase to other long-term liabilities 2,500          
Predecessor | Total Acquisitions            
Business Acquisition [Line Items]            
Number of businesses acquired | physician_practice       3    
Business acquisition total purchase price       $ 14,200    
Predecessor | NSH            
Business Acquisition [Line Items]            
Goodwill 871,373     871,373    
Payments for acquisitions, net of cash acquired 711,700          
Acquisition escrow deposit 19,600     $ 19,600    
Net increase (decrease) to goodwill 1,100          
Pushdown accounting adjustments, decrease to preliminary fair value assigned to non-controlling interests $ 17,900          
XML 51 R40.htm IDEA: XBRL DOCUMENT v3.10.0.1
Acquisitions and Developments - Assets Acquired and Liabilities Assumed (Details) - USD ($)
$ in Thousands
 1 Months Ended 8 Months Ended 9 Months Ended
Aug. 31, 2017
Sep. 30, 2017
Aug. 31, 2017
Sep. 30, 2018
Dec. 31, 2017
Net assets acquired:          
Goodwill       $ 3,372,606 $ 3,346,838
2018 Acquisitions          
Business Acquisition [Line Items]          
Cash consideration       54,308  
Fair value of non-controlling interests       28,776  
Acquisition date fair value       83,084  
Transaction date fair value   $ 1,200      
Net assets acquired:          
Current Assets       4,708  
Property and equipment       2,301  
Goodwill       75,947  
Other long-term assets       3,460  
Current liabilities       (2,332)  
Long-term liabilities       (1,000)  
Acquisition date fair value       $ 83,084  
Predecessor | Bain Capital          
Business Acquisition [Line Items]          
Equity attributable to Surgery Partners, Inc. $ 721,764        
Redeemable preferred stock 310,000        
Fair value of non-controlling interests 939,083   $ 939,083    
Transaction date fair value 1,970,847        
Net assets acquired:          
Cash and cash equivalents 214,206   214,206    
Accounts receivable 252,911   252,911    
Inventories 44,310   44,310    
Prepaid expenses and other current assets 61,438   61,438    
Property and equipment 379,685   379,685    
Intangible assets 63,978   63,978    
Goodwill 3,281,728   3,281,728    
Investments in and advances to affiliates 75,113   75,113    
Restricted invested assets 315   315    
Long-term deferred tax assets 206,073   206,073    
Other long-term assets 50,666   50,666    
Accounts payable (64,921)   (64,921)    
Accrued payroll and benefits (56,535)   (56,535)    
Other current liabilities (97,617)   (97,617)    
Current maturities of long-term debt (49,942)   (49,942)    
Long-term debt, less current maturities (2,142,375)   (2,142,375)    
Long-term tax receivable agreement liability (78,498)   (78,498)    
Other long-term liabilities (169,688)   (169,688)    
Acquisition date fair value 1,970,847   1,970,847    
Predecessor | 2018 Acquisitions          
Business Acquisition [Line Items]          
Transaction date fair value     14,200    
Predecessor | NSH          
Business Acquisition [Line Items]          
Cash consideration 764,007        
Fair value of non-controlling interests 325,965   325,965    
Acquisition date fair value 1,089,972   1,089,972    
Net assets acquired:          
Cash and cash equivalents 51,159   51,159    
Accounts receivable 71,639   71,639    
Inventories 14,986   14,986    
Prepaid expenses and other current assets 18,367   18,367    
Property and equipment 174,100   174,100    
Intangible assets 27,881   27,881    
Goodwill 871,373   871,373    
Investments in and advances to affiliates 29,737   29,737    
Long-term deferred tax assets 20,212   20,212    
Other long-term assets 26,988   26,988    
Accounts payable (29,652)   (29,652)    
Accrued payroll and benefits (30,853)   (30,853)    
Other current liabilities (23,937)   (23,937)    
Current maturities of long-term debt (16,416)   (16,416)    
Long-term debt, less current maturities (42,770)   (42,770)    
Other long-term liabilities (72,842)   (72,842)    
Acquisition date fair value $ 1,089,972   $ 1,089,972    
XML 52 R41.htm IDEA: XBRL DOCUMENT v3.10.0.1
Long-Term Debt (Details) - USD ($)
$ in Thousands
Sep. 30, 2018
Dec. 31, 2017
Debt Instrument [Line Items]    
Capital lease obligations $ 24,836 $ 27,594
Debt and capital lease obligations 2,172,673 2,189,282
Less: Current maturities 54,106 58,726
Total long-term debt 2,118,567 2,130,556
Unamortized fair value discount (5,700) (6,200)
Unamortized fair value premium 7,400 9,200
Secured Debt | 2017 Senior Secured Credit Facility - Term Loan    
Debt Instrument [Line Items]    
Long-term debt 1,271,397 1,280,532
Secured Debt | Revolving Credit Facility | 2017 Senior Secured Credit Facility - Revolver    
Debt Instrument [Line Items]    
Long-term debt 11,000 0
Senior Notes | Senior Unsecured Notes Due 2021    
Debt Instrument [Line Items]    
Long-term debt 407,372 409,235
Senior Notes | Senior Unsecured Notes Due 2025    
Debt Instrument [Line Items]    
Long-term debt 370,000 370,000
Notes payable and secured loans    
Debt Instrument [Line Items]    
Long-term debt $ 88,068 $ 101,921
XML 53 R42.htm IDEA: XBRL DOCUMENT v3.10.0.1
Derivatives and Hedging Activities (Details)
$ in Thousands
 1 Months Ended 2 Months Ended 3 Months Ended 8 Months Ended 9 Months Ended
Sep. 30, 2017
USD ($)
Aug. 31, 2017
USD ($)
Sep. 30, 2018
USD ($)
swap
Aug. 31, 2017
USD ($)
Sep. 30, 2018
USD ($)
swap
Dec. 31, 2017
USD ($)
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]            
Estimated reduction to interest expense         $ 1,100  
Number of interest rate swaps | swap     1   1  
Derivative financial instruments, long-term liability     $ 1,389   $ 1,389 $ 0
Losses related to effective portion of derivatives recognized in accumulated OCI, gross of tax effect $ 0   (1,389)   (1,389)  
Loss related to effective portion of derivatives reclassified from accumulated OCI to interest expense, gross of tax effect $ 0   0   0  
Predecessor            
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]            
Losses related to effective portion of derivatives recognized in accumulated OCI, gross of tax effect   $ 0   $ 0    
Loss related to effective portion of derivatives reclassified from accumulated OCI to interest expense, gross of tax effect   $ 0   $ 0    
Interest Rate Swap One            
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]            
Derivative notional amount     $ 330,000   $ 330,000  
XML 54 R43.htm IDEA: XBRL DOCUMENT v3.10.0.1
Redeemable Preferred Stock - Additional Information (Details) - Series A Preferred Stock - USD ($)
 9 Months Ended
Aug. 31, 2017
Sep. 30, 2018
Dec. 31, 2017
Temporary Equity [Line Items]      
Dividends payable   $ 0 $ 3,900,000
Cumulative preferred dividends   $ 25,300,000  
Preferred dividends payable (in USD per share)   $ 81.70  
Majority Shareholder      
Temporary Equity [Line Items]      
Stock issued during period (shares) 310,000    
Purchase price per share (in USD per share) $ 1,000    
Proceeds from issuance of preferred shares $ 310,000,000    
XML 55 R44.htm IDEA: XBRL DOCUMENT v3.10.0.1
Redeemable Preferred Stock - Redeemable Preferred Stock Activity (Details) - Series A Preferred Stock
$ in Thousands
 9 Months Ended
Sep. 30, 2018
USD ($)
Increase (Decrease) in Temporary Equity [Roll Forward]  
12/31/2017 $ 330,806
Dividends accrued 23,973
Cash dividends declared (3,886)
September 30, 2018 $ 350,893
XML 56 R45.htm IDEA: XBRL DOCUMENT v3.10.0.1
Earnings Per Share (Details) - USD ($)
 1 Months Ended 2 Months Ended 3 Months Ended 8 Months Ended 9 Months Ended
Sep. 30, 2017
Aug. 31, 2017
Sep. 30, 2018
Aug. 31, 2017
Sep. 30, 2018
Dec. 15, 2017
Numerator:            
Net loss attributable to Surgery Partners, Inc. $ (9,140,000)   $ (20,981,000)   $ (57,964,000)  
Less: amounts allocated to participating securities 2,633,000   8,245,000   23,973,000  
Less: mark to redemption adjustment 15,566,000   0   0  
Net loss attributable to common stockholders $ (27,339,000)   $ (29,226,000)   $ (81,937,000)  
Denominator:            
Weighted average shares outstanding- basic (shares) 48,314,746   48,037,634   48,020,369  
Effect of dilutive securities (shares) 0   0   0  
Weighted average shares outstanding- diluted (shares) [1] 48,314,746   48,037,634   48,020,369  
Loss per share:            
Basic (in USD per share) $ (0.57)   $ (0.61)   $ (1.71)  
Diluted (in USD per share) [1] $ (0.57)   $ (0.61)   $ (1.71)  
Authorized share repurchase amount           $ 50,000,000.0
Stock repurchased (shares)     0   156,818  
Average repurchase cost (in USD per share)         $ 12.64  
Remaining repurchase authorization available     $ 46,000,000   $ 46,000,000  
Stock options            
Loss per share:            
Antidilutive securities excluded from computation of (loss) earnings per share (shares) 0   144,795   153,884  
Restricted shares            
Loss per share:            
Antidilutive securities excluded from computation of (loss) earnings per share (shares) 112,529   134,054   140,552  
Convertible preferred stock            
Loss per share:            
Antidilutive securities excluded from computation of (loss) earnings per share (shares) 0   0   0  
Predecessor            
Numerator:            
Net loss attributable to Surgery Partners, Inc.   $ (4,444,000)   $ (11,669,000)    
Less: amounts allocated to participating securities   0   0    
Less: mark to redemption adjustment   0   0    
Net loss attributable to common stockholders   $ (4,444,000)   $ (11,669,000)    
Denominator:            
Weighted average shares outstanding- basic (shares)   48,146,611   48,121,404    
Effect of dilutive securities (shares)   0   0    
Weighted average shares outstanding- diluted (shares) [1]   48,146,611   48,121,404    
Loss per share:            
Basic (in USD per share)   $ (0.09)   $ (0.24)    
Diluted (in USD per share) [1]   $ (0.09)   $ (0.24)    
Predecessor | Stock options            
Loss per share:            
Antidilutive securities excluded from computation of (loss) earnings per share (shares)   0   0    
Predecessor | Restricted shares            
Loss per share:            
Antidilutive securities excluded from computation of (loss) earnings per share (shares)   34,506   105,944    
[1] The impact of potentially dilutive securities for all periods presented was not considered because the effect would be anti-dilutive in those periods.
XML 57 R46.htm IDEA: XBRL DOCUMENT v3.10.0.1
Income Taxes (Details) - USD ($)
$ in Millions
 1 Months Ended 8 Months Ended 9 Months Ended
Sep. 30, 2017
Aug. 31, 2017
Sep. 30, 2018
Operating Loss Carryforwards [Line Items]      
Estimated disallowed interest expense     $ 69.8
Valuation allowance on deferred tax asset     $ 11.4
Effective tax rate 7.40%   48.80%
Symbion      
Operating Loss Carryforwards [Line Items]      
NOL carryforwards     $ 179.0
Annual base limitation     4.9
NovaMed      
Operating Loss Carryforwards [Line Items]      
NOL carryforwards     17.0
Annual base limitation     4.9
NSH      
Operating Loss Carryforwards [Line Items]      
NOL carryforwards     20.5
Annual base limitation     2.8
Bain Capital      
Operating Loss Carryforwards [Line Items]      
NOL carryforwards     449.7
Annual base limitation     $ 14.2
Predecessor      
Operating Loss Carryforwards [Line Items]      
Effective tax rate   (146.70%)  
XML 58 R47.htm IDEA: XBRL DOCUMENT v3.10.0.1
Commitments and Contingencies (Details) - USD ($)
$ in Thousands
 1 Months Ended 2 Months Ended 3 Months Ended 8 Months Ended 9 Months Ended
Sep. 30, 2017
Aug. 31, 2017
Sep. 30, 2018
Jun. 30, 2018
Aug. 31, 2017
Sep. 30, 2018
Dec. 31, 2017
Guarantor Obligations [Line Items]              
Professional, general and workers' compensation insurance reserve     $ 19,800     $ 19,800 $ 21,000
Expected insurance recoveries     14,700     $ 14,700 12,800
Federal effective tax rate           24.00%  
Long-term tax receivable agreement liability     65,100     $ 65,100 65,100
Net long-term tax receivable agreement liability     47,800     47,800 $ 44,300
Contingent acquisition expense $ 605   503     1,510  
Cease-use liability     $ 1,400     $ 1,400  
Estimated severance costs incurred       $ 4,500      
Predecessor              
Guarantor Obligations [Line Items]              
Contingent acquisition expense   $ 1,210     $ 5,057    
Materially More Restrictive | LIBOR              
Guarantor Obligations [Line Items]              
Debt instrument, basis spread on variable rate           5.00%  
Not Materially More Restrictive | LIBOR              
Guarantor Obligations [Line Items]              
Debt instrument, basis spread on variable rate           3.00%  
XML 59 R48.htm IDEA: XBRL DOCUMENT v3.10.0.1
Segment Reporting - Revenues by Reportable Segment (Details)
$ in Thousands
 1 Months Ended 2 Months Ended 3 Months Ended 8 Months Ended 9 Months Ended
Sep. 30, 2017
USD ($)
Aug. 31, 2017
USD ($)
Sep. 30, 2018
USD ($)
Aug. 31, 2017
USD ($)
Sep. 30, 2018
USD ($)
segment
Segment Reporting Information [Line Items]          
Number of operating segments | segment         3
Revenues $ 132,258   $ 443,932   $ 1,306,076
Total segment adjusted EBITDA 14,842   58,988   161,465
Predecessor          
Segment Reporting Information [Line Items]          
Revenues   $ 174,079   $ 748,615  
Total segment adjusted EBITDA   8,402   85,564  
Operating Segments | Surgical Facility Services          
Segment Reporting Information [Line Items]          
Revenues 125,595   420,514   1,234,984
Total segment adjusted EBITDA 20,947   74,525   216,540
Operating Segments | Ancillary Services          
Segment Reporting Information [Line Items]          
Revenues 5,775   20,719   62,655
Total segment adjusted EBITDA (1,265)   875   2,925
Operating Segments | Optical Services          
Segment Reporting Information [Line Items]          
Revenues 888   2,699   8,437
Total segment adjusted EBITDA 193   571   2,087
Operating Segments | Predecessor | Surgical Facility Services          
Segment Reporting Information [Line Items]          
Revenues   167,765   688,725  
Total segment adjusted EBITDA   27,726   125,912  
Operating Segments | Predecessor | Ancillary Services          
Segment Reporting Information [Line Items]          
Revenues   4,409   52,261  
Total segment adjusted EBITDA   (10,737)   (6,526)  
Operating Segments | Predecessor | Optical Services          
Segment Reporting Information [Line Items]          
Revenues   1,905   7,629  
Total segment adjusted EBITDA   555   2,214  
All Other          
Segment Reporting Information [Line Items]          
Total segment adjusted EBITDA $ (5,033)   $ (16,983)   $ (60,087)
All Other | Predecessor          
Segment Reporting Information [Line Items]          
Total segment adjusted EBITDA   $ (9,142)   $ (36,036)  
XML 60 R49.htm IDEA: XBRL DOCUMENT v3.10.0.1
Segment Reporting - Segment Operating Income (Details) - USD ($)
$ in Thousands
 1 Months Ended 2 Months Ended 3 Months Ended 8 Months Ended 9 Months Ended
Sep. 30, 2017
Aug. 31, 2017
Sep. 30, 2018
Aug. 31, 2017
Sep. 30, 2018
Segment Reporting Information [Line Items]          
Total segment adjusted EBITDA $ 14,842   $ 58,988   $ 161,465
Net income attributable to non-controlling interests 6,492   23,000   69,418
Depreciation and amortization (3,330)   (16,945)   (49,379)
Interest expense, net (15,883)   (37,159)   (107,368)
Equity-based compensation (1,683)   (1,526)   (6,303)
Contingent acquisition compensation expense (605)   (503)   (1,510)
Transaction, integration and practice acquisition costs (3,457)   (7,489)   (25,419)
Gain on litigation settlement 0   0   0
Gain on acquisition escrow release 0   0   0
Reserve adjustments 0   2,109   (2,670)
Loss on disposals and deconsolidations, net (333)   (12,631)   (15,875)
Gain on amendment to tax receivable agreement 1,098   0   0
Loss on debt refinancing 0   0   0
Income (loss) before income taxes (2,859)   7,844   22,359
Transaction and integration costs 2,983   7,099   23,771
Practice acquisition costs $ 500   $ 400   $ 1,600
Predecessor          
Segment Reporting Information [Line Items]          
Total segment adjusted EBITDA   $ 8,402   $ 85,564  
Net income attributable to non-controlling interests   8,813   42,087  
Depreciation and amortization   (7,599)   (30,124)  
Interest expense, net   (18,147)   (68,929)  
Equity-based compensation   (1,628)   (3,697)  
Contingent acquisition compensation expense   (1,210)   (5,057)  
Transaction, integration and practice acquisition costs   (2,949)   (7,677)  
Gain on litigation settlement   0   3,794  
Gain on acquisition escrow release   1,000   1,000  
Reserve adjustments   0   0  
Loss on disposals and deconsolidations, net   (114)   (1,715)  
Gain on amendment to tax receivable agreement   15,294   15,294  
Loss on debt refinancing   (18,211)   (18,211)  
Income (loss) before income taxes   (16,349)   12,329  
Transaction and integration costs   2,343   5,584  
Practice acquisition costs   $ 600   $ 2,100  
XML 61 R50.htm IDEA: XBRL DOCUMENT v3.10.0.1
Segment Reporting - Assets by Operating Segment (Details) - USD ($)
$ in Thousands
Sep. 30, 2018
Dec. 31, 2017
Segment Reporting Information [Line Items]    
Assets $ 4,558,664 $ 4,622,773
Operating Segments | Surgical Facility Services    
Segment Reporting Information [Line Items]    
Assets 4,015,094 4,072,521
Operating Segments | Ancillary Services    
Segment Reporting Information [Line Items]    
Assets 110,588 104,274
Operating Segments | Optical Services    
Segment Reporting Information [Line Items]    
Assets 34,811 48,309
All Other    
Segment Reporting Information [Line Items]    
Assets $ 398,171 $ 397,669
XML 62 R51.htm IDEA: XBRL DOCUMENT v3.10.0.1
Segment Reporting - Cash Purchases of Property and Equipment (Details) - USD ($)
$ in Thousands
 1 Months Ended 8 Months Ended 9 Months Ended
Sep. 30, 2017
Aug. 31, 2017
Sep. 30, 2018
Segment Reporting Information [Line Items]      
Purchases of property and equipment, net $ 1,840   $ 26,618
Operating Segments | Surgical Facility Services      
Segment Reporting Information [Line Items]      
Purchases of property and equipment, net 1,613   21,590
Operating Segments | Ancillary Services      
Segment Reporting Information [Line Items]      
Purchases of property and equipment, net 2   334
Operating Segments | Optical Services      
Segment Reporting Information [Line Items]      
Purchases of property and equipment, net 23   42
All Other      
Segment Reporting Information [Line Items]      
Purchases of property and equipment, net $ 202   $ 4,652
Predecessor      
Segment Reporting Information [Line Items]      
Purchases of property and equipment, net   $ 18,773  
Predecessor | Operating Segments | Surgical Facility Services      
Segment Reporting Information [Line Items]      
Purchases of property and equipment, net   14,582  
Predecessor | Operating Segments | Ancillary Services      
Segment Reporting Information [Line Items]      
Purchases of property and equipment, net   1,875  
Predecessor | Operating Segments | Optical Services      
Segment Reporting Information [Line Items]      
Purchases of property and equipment, net   73  
Predecessor | All Other      
Segment Reporting Information [Line Items]      
Purchases of property and equipment, net   $ 2,243  
XML 63 R52.htm IDEA: XBRL DOCUMENT v3.10.0.1
Subsequent Events (Details)
Oct. 31, 2018
USD ($)
surgery_center
Oct. 23, 2018
USD ($)
Nov. 09, 2018
USD ($)
swap
Sep. 30, 2018
USD ($)
swap
Subsequent Event [Line Items]        
Number of interest rate swaps | swap       1
Subsequent Event        
Subsequent Event [Line Items]        
Number of interest rate swaps | swap     2  
Senior Notes | Incremental Term Loan | Subsequent Event        
Subsequent Event [Line Items]        
Debt instrument face amount   $ 180,000,000.0    
Federal Funds Rate | Senior Notes | Incremental Term Loan | Subsequent Event        
Subsequent Event [Line Items]        
Debt instrument, basis spread on variable rate   0.50%    
One Month LIBOR | Senior Notes | Incremental Term Loan | Subsequent Event        
Subsequent Event [Line Items]        
Debt instrument, basis spread on variable rate   1.00%    
Base Rate | Senior Notes | Incremental Term Loan | Subsequent Event        
Subsequent Event [Line Items]        
Debt instrument, basis spread on variable rate   2.00%    
Interest Rate Swap One        
Subsequent Event [Line Items]        
Derivative notional amount       $ 330,000,000
Interest Rate Swap One | Subsequent Event        
Subsequent Event [Line Items]        
Derivative notional amount     $ 330,000,000  
Interest Rate Swap Two | Subsequent Event        
Subsequent Event [Line Items]        
Derivative notional amount     $ 240,000,000  
Three Surgery Centers | Subsequent Event        
Subsequent Event [Line Items]        
Number of businesses acquired | surgery_center 3      
Business acquisition total purchase price $ 50,000,000      
Minimum | LIBOR | Senior Notes | Incremental Term Loan | Subsequent Event        
Subsequent Event [Line Items]        
Debt instrument, basis spread on variable rate   3.00%    
Minimum | Margin Rate | Senior Notes | Incremental Term Loan | Subsequent Event        
Subsequent Event [Line Items]        
Debt instrument, basis spread on variable rate   2.00%    
Maximum | LIBOR | Senior Notes | Incremental Term Loan | Subsequent Event        
Subsequent Event [Line Items]        
Debt instrument, basis spread on variable rate   3.25%    
Maximum | Margin Rate | Senior Notes | Incremental Term Loan | Subsequent Event        
Subsequent Event [Line Items]        
Debt instrument, basis spread on variable rate   2.25%    
EXCEL 64 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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
  •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end XML 65 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 66 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 68 FilingSummary.xml IDEA: XBRL DOCUMENT 3.10.0.1 html 244 290 1 true 74 0 false 12 false false R1.htm 0001000 - Document - Document and Entity Information Sheet http://www.surgerypartners.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 1001000 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.surgerypartners.com/role/CondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 1001001 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://www.surgerypartners.com/role/CondensedConsolidatedBalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 1002000 - Statement - Condensed Consolidated Statements of Operations Sheet http://www.surgerypartners.com/role/CondensedConsolidatedStatementsOfOperations Condensed Consolidated Statements of Operations Statements 4 false false R5.htm 1004000 - Statement - Condensed Consolidated Statements of Comprehensive Income (Loss) Sheet http://www.surgerypartners.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeLoss Condensed Consolidated Statements of Comprehensive Income (Loss) Statements 5 false false R6.htm 1005000 - Statement - Condensed Consolidated Statements of Stockholders' Equity Sheet http://www.surgerypartners.com/role/CondensedConsolidatedStatementsOfStockholdersEquity Condensed Consolidated Statements of Stockholders' Equity Statements 6 false false R7.htm 1006000 - Statement - Condensed Consolidated Statements of Cash Flows Sheet http://www.surgerypartners.com/role/CondensedConsolidatedStatementsOfCashFlows Condensed Consolidated Statements of Cash Flows Statements 7 false false R8.htm 2101100 - Disclosure - Organization, Basis of Presentation and Significant Accounting Policies Sheet http://www.surgerypartners.com/role/OrganizationBasisOfPresentationAndSignificantAccountingPolicies Organization, Basis of Presentation and Significant Accounting Policies Notes 8 false false R9.htm 2102100 - Disclosure - Acquisitions and Developments Sheet http://www.surgerypartners.com/role/AcquisitionsAndDevelopments Acquisitions and Developments Notes 9 false false R10.htm 2103100 - Disclosure - Long-Term Debt Sheet http://www.surgerypartners.com/role/LongTermDebt Long-Term Debt Notes 10 false false R11.htm 2104100 - Disclosure - Derivatives and Hedging Activities Sheet http://www.surgerypartners.com/role/DerivativesAndHedgingActivities Derivatives and Hedging Activities Notes 11 false false R12.htm 2105100 - Disclosure - Redeemable Preferred Stock Sheet http://www.surgerypartners.com/role/RedeemablePreferredStock Redeemable Preferred Stock Notes 12 false false R13.htm 2106100 - Disclosure - Earnings Per Share Sheet http://www.surgerypartners.com/role/EarningsPerShare Earnings Per Share Notes 13 false false R14.htm 2107100 - Disclosure - Income Taxes Sheet http://www.surgerypartners.com/role/IncomeTaxes Income Taxes Notes 14 false false R15.htm 2108100 - Disclosure - Commitments and Contingencies Sheet http://www.surgerypartners.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 15 false false R16.htm 2109100 - Disclosure - Segment Reporting Sheet http://www.surgerypartners.com/role/SegmentReporting Segment Reporting Notes 16 false false R17.htm 2110100 - Disclosure - Subsequent Events (Notes) Notes http://www.surgerypartners.com/role/SubsequentEventsNotes Subsequent Events (Notes) Notes 17 false false R18.htm 2201201 - Disclosure - Organization, Basis of Presentation and Significant Accounting Policies (Policies) Sheet http://www.surgerypartners.com/role/OrganizationBasisOfPresentationAndSignificantAccountingPoliciesPolicies Organization, Basis of Presentation and Significant Accounting Policies (Policies) Policies http://www.surgerypartners.com/role/OrganizationBasisOfPresentationAndSignificantAccountingPolicies 18 false false R19.htm 2301302 - Disclosure - Organization, Basis of Presentation and Significant Accounting Policies (Tables) Sheet http://www.surgerypartners.com/role/OrganizationBasisOfPresentationAndSignificantAccountingPoliciesTables Organization, Basis of Presentation and Significant Accounting Policies (Tables) Tables http://www.surgerypartners.com/role/OrganizationBasisOfPresentationAndSignificantAccountingPolicies 19 false false R20.htm 2302301 - Disclosure - Acquisitions and Developments (Tables) Sheet http://www.surgerypartners.com/role/AcquisitionsAndDevelopmentsTables Acquisitions and Developments (Tables) Tables http://www.surgerypartners.com/role/AcquisitionsAndDevelopments 20 false false R21.htm 2303301 - Disclosure - Long-Term Debt (Tables) Sheet http://www.surgerypartners.com/role/LongTermDebtTables Long-Term Debt (Tables) Tables http://www.surgerypartners.com/role/LongTermDebt 21 false false R22.htm 2304301 - Disclosure - Derivatives and Hedging Activities (Tables) Sheet http://www.surgerypartners.com/role/DerivativesAndHedgingActivitiesTables Derivatives and Hedging Activities (Tables) Tables http://www.surgerypartners.com/role/DerivativesAndHedgingActivities 22 false false R23.htm 2305301 - Disclosure - Redeemable Preferred Stock (Tables) Sheet http://www.surgerypartners.com/role/RedeemablePreferredStockTables Redeemable Preferred Stock (Tables) Tables http://www.surgerypartners.com/role/RedeemablePreferredStock 23 false false R24.htm 2306301 - Disclosure - Earnings Per Share (Tables) Sheet http://www.surgerypartners.com/role/EarningsPerShareTables Earnings Per Share (Tables) Tables http://www.surgerypartners.com/role/EarningsPerShare 24 false false R25.htm 2309301 - Disclosure - Segment Reporting (Tables) Sheet http://www.surgerypartners.com/role/SegmentReportingTables Segment Reporting (Tables) Tables http://www.surgerypartners.com/role/SegmentReporting 25 false false R26.htm 2401403 - Disclosure - Organization, Basis of Presentation and Significant Accounting Policies - Organization (Details) Sheet http://www.surgerypartners.com/role/OrganizationBasisOfPresentationAndSignificantAccountingPoliciesOrganizationDetails Organization, Basis of Presentation and Significant Accounting Policies - Organization (Details) Details http://www.surgerypartners.com/role/OrganizationBasisOfPresentationAndSignificantAccountingPoliciesTables 26 false false R27.htm 2401404 - Disclosure - Organization, Basis of Presentation and Significant Accounting Policies - Variable Interest Entities (Details) Sheet http://www.surgerypartners.com/role/OrganizationBasisOfPresentationAndSignificantAccountingPoliciesVariableInterestEntitiesDetails Organization, Basis of Presentation and Significant Accounting Policies - Variable Interest Entities (Details) Details 27 false false R28.htm 2401405 - Disclosure - Organization, Basis of Presentation and Significant Accounting Policies - Schedule of Carrying Amount and Fair Value of Long-Term Debt (Details) Sheet http://www.surgerypartners.com/role/OrganizationBasisOfPresentationAndSignificantAccountingPoliciesScheduleOfCarryingAmountAndFairValueOfLongTermDebtDetails Organization, Basis of Presentation and Significant Accounting Policies - Schedule of Carrying Amount and Fair Value of Long-Term Debt (Details) Details 28 false false R29.htm 2401406 - Disclosure - Organization, Basis of Presentation and Significant Accounting Policies - Summary of the Fair Value of Derivative Liabilities (Details) Sheet http://www.surgerypartners.com/role/OrganizationBasisOfPresentationAndSignificantAccountingPoliciesSummaryOfFairValueOfDerivativeLiabilitiesDetails Organization, Basis of Presentation and Significant Accounting Policies - Summary of the Fair Value of Derivative Liabilities (Details) Details 29 false false R30.htm 2401407 - Disclosure - Organization, Basis of Presentation and Significant Accounting Policies - Fair Value of Financial Instruments, Narrative (Details) Sheet http://www.surgerypartners.com/role/OrganizationBasisOfPresentationAndSignificantAccountingPoliciesFairValueOfFinancialInstrumentsNarrativeDetails Organization, Basis of Presentation and Significant Accounting Policies - Fair Value of Financial Instruments, Narrative (Details) Details 30 false false R31.htm 2401408 - Disclosure - Organization, Basis of Presentation and Significant Accounting Policies - Schedule of Revenues by Service Type (Details) Sheet http://www.surgerypartners.com/role/OrganizationBasisOfPresentationAndSignificantAccountingPoliciesScheduleOfRevenuesByServiceTypeDetails Organization, Basis of Presentation and Significant Accounting Policies - Schedule of Revenues by Service Type (Details) Details 31 false false R32.htm 2401409 - Disclosure - Organization, Basis of Presentation and Significant Accounting Policies - Schedule of Revenues by Sources (Details) Sheet http://www.surgerypartners.com/role/OrganizationBasisOfPresentationAndSignificantAccountingPoliciesScheduleOfRevenuesBySourcesDetails Organization, Basis of Presentation and Significant Accounting Policies - Schedule of Revenues by Sources (Details) Details 32 false false R33.htm 2401410 - Disclosure - Organization, Basis of Presentation and Significant Accounting Policies - Cash and Restricted Cash Balances (Details) Sheet http://www.surgerypartners.com/role/OrganizationBasisOfPresentationAndSignificantAccountingPoliciesCashAndRestrictedCashBalancesDetails Organization, Basis of Presentation and Significant Accounting Policies - Cash and Restricted Cash Balances (Details) Details 33 false false R34.htm 2401411 - Disclosure - Organization, Basis of Presentation and Significant Accounting Policies - Accounts Receivable and Allowances for Contractual Adjustments and Doubtful Accounts (Details) Sheet http://www.surgerypartners.com/role/OrganizationBasisOfPresentationAndSignificantAccountingPoliciesAccountsReceivableAndAllowancesForContractualAdjustmentsAndDoubtfulAccountsDetails Organization, Basis of Presentation and Significant Accounting Policies - Accounts Receivable and Allowances for Contractual Adjustments and Doubtful Accounts (Details) Details 34 false false R35.htm 2401412 - Disclosure - Organization, Basis of Presentation and Significant Accounting Policies - Rollforward of Goodwill and Information on Impairments (Details) Sheet http://www.surgerypartners.com/role/OrganizationBasisOfPresentationAndSignificantAccountingPoliciesRollforwardOfGoodwillAndInformationOnImpairmentsDetails Organization, Basis of Presentation and Significant Accounting Policies - Rollforward of Goodwill and Information on Impairments (Details) Details 35 false false R36.htm 2401413 - Disclosure - Organization, Basis of Presentation and Significant Accounting Policies - Schedule of Other Current Liabilities (Details) Sheet http://www.surgerypartners.com/role/OrganizationBasisOfPresentationAndSignificantAccountingPoliciesScheduleOfOtherCurrentLiabilitiesDetails Organization, Basis of Presentation and Significant Accounting Policies - Schedule of Other Current Liabilities (Details) Details 36 false false R37.htm 2401414 - Disclosure - Organization, Basis of Presentation and Significant Accounting Policies - Schedule of Other Long-Term Liabilities (Details) Sheet http://www.surgerypartners.com/role/OrganizationBasisOfPresentationAndSignificantAccountingPoliciesScheduleOfOtherLongTermLiabilitiesDetails Organization, Basis of Presentation and Significant Accounting Policies - Schedule of Other Long-Term Liabilities (Details) Details 37 false false R38.htm 2401415 - Disclosure - Organization, Basis of Presentation and Significant Accounting Policies - Schedule of Non-Controlling Interests - Redeemable (Details) Sheet http://www.surgerypartners.com/role/OrganizationBasisOfPresentationAndSignificantAccountingPoliciesScheduleOfNonControllingInterestsRedeemableDetails Organization, Basis of Presentation and Significant Accounting Policies - Schedule of Non-Controlling Interests - Redeemable (Details) Details 38 false false R39.htm 2402402 - Disclosure - Acquisitions and Developments - Additional Information (Details) Sheet http://www.surgerypartners.com/role/AcquisitionsAndDevelopmentsAdditionalInformationDetails Acquisitions and Developments - Additional Information (Details) Details 39 false false R40.htm 2402403 - Disclosure - Acquisitions and Developments - Assets Acquired and Liabilities Assumed (Details) Sheet http://www.surgerypartners.com/role/AcquisitionsAndDevelopmentsAssetsAcquiredAndLiabilitiesAssumedDetails Acquisitions and Developments - Assets Acquired and Liabilities Assumed (Details) Details 40 false false R41.htm 2403402 - Disclosure - Long-Term Debt (Details) Sheet http://www.surgerypartners.com/role/LongTermDebtDetails Long-Term Debt (Details) Details http://www.surgerypartners.com/role/LongTermDebtTables 41 false false R42.htm 2404402 - Disclosure - Derivatives and Hedging Activities (Details) Sheet http://www.surgerypartners.com/role/DerivativesAndHedgingActivitiesDetails Derivatives and Hedging Activities (Details) Details http://www.surgerypartners.com/role/DerivativesAndHedgingActivitiesTables 42 false false R43.htm 2405402 - Disclosure - Redeemable Preferred Stock - Additional Information (Details) Sheet http://www.surgerypartners.com/role/RedeemablePreferredStockAdditionalInformationDetails Redeemable Preferred Stock - Additional Information (Details) Details 43 false false R44.htm 2405403 - Disclosure - Redeemable Preferred Stock - Redeemable Preferred Stock Activity (Details) Sheet http://www.surgerypartners.com/role/RedeemablePreferredStockRedeemablePreferredStockActivityDetails Redeemable Preferred Stock - Redeemable Preferred Stock Activity (Details) Details 44 false false R45.htm 2406402 - Disclosure - Earnings Per Share (Details) Sheet http://www.surgerypartners.com/role/EarningsPerShareDetails Earnings Per Share (Details) Details http://www.surgerypartners.com/role/EarningsPerShareTables 45 false false R46.htm 2407401 - Disclosure - Income Taxes (Details) Sheet http://www.surgerypartners.com/role/IncomeTaxesDetails Income Taxes (Details) Details http://www.surgerypartners.com/role/IncomeTaxes 46 false false R47.htm 2408401 - Disclosure - Commitments and Contingencies (Details) Sheet http://www.surgerypartners.com/role/CommitmentsAndContingenciesDetails Commitments and Contingencies (Details) Details http://www.surgerypartners.com/role/CommitmentsAndContingencies 47 false false R48.htm 2409402 - Disclosure - Segment Reporting - Revenues by Reportable Segment (Details) Sheet http://www.surgerypartners.com/role/SegmentReportingRevenuesByReportableSegmentDetails Segment Reporting - Revenues by Reportable Segment (Details) Details 48 false false R49.htm 2409403 - Disclosure - Segment Reporting - Segment Operating Income (Details) Sheet http://www.surgerypartners.com/role/SegmentReportingSegmentOperatingIncomeDetails Segment Reporting - Segment Operating Income (Details) Details 49 false false R50.htm 2409404 - Disclosure - Segment Reporting - Assets by Operating Segment (Details) Sheet http://www.surgerypartners.com/role/SegmentReportingAssetsByOperatingSegmentDetails Segment Reporting - Assets by Operating Segment (Details) Details 50 false false R51.htm 2409405 - Disclosure - Segment Reporting - Cash Purchases of Property and Equipment (Details) Sheet http://www.surgerypartners.com/role/SegmentReportingCashPurchasesOfPropertyAndEquipmentDetails Segment Reporting - Cash Purchases of Property and Equipment (Details) Details 51 false false R52.htm 2410401 - Disclosure - Subsequent Events (Details) Sheet http://www.surgerypartners.com/role/SubsequentEventsDetails Subsequent Events (Details) Details http://www.surgerypartners.com/role/SubsequentEventsNotes 52 false false All Reports Book All Reports sgry-20180930.xml sgry-20180930.xsd sgry-20180930_cal.xml sgry-20180930_def.xml sgry-20180930_lab.xml sgry-20180930_pre.xml http://fasb.org/us-gaap/2018-01-31 http://xbrl.sec.gov/invest/2013-01-31 http://xbrl.sec.gov/dei/2018-01-31 http://fasb.org/srt/2018-01-31 true true ZIP 70 0001638833-18-000020-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001638833-18-000020-xbrl.zip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

    KC2=5#;ELZ:3Y:9/+ZW(Z@['D\Y2 M7N/;8$/C__>N/_SCJ>5ZAO9/6C3%6NN?BJ<__O(__\=?TP]%E'/7^9A=_U \ M^/FV2-$D7^O-PI?ZR[=Q2C06CQ.-X''_[GX (_LIO6:VI:L[&DZR;Y,?^L#( MZ%/7W^D_/_OTH443D(;^Y"']8O&;?B_][KJ?Y3\4XUC-]BPPP;W]OS_^@A#" M@BI%Z5]_6N]=']ZMM0A&_:6 MFNLW%#U]K;=HO/C5X_<6OYA3III4;V>4>C_ZBE03:363PLELZLD=5(^OG#]Y M\=1CFKO\G35\VO(-)@ &^YTVL+SATUX3]+UQ^U]S5/_7IPDH3MJ$Z@:=\?CJ M^M-DU/W#?.N/'UM\S'H98-.70?:AR/+F6:]H]%MV]R7+CT:_1]B \".;D6#^ MNQY\^=O]H-_M3V9C^J'7AR:S?;CS6?Q<.\\??UDTV3S1O_Y4^:W9T'XJC:U9 M4MZRNY'LWK=V^T*YZ:?LGJ(F MN*R9=I\MN;?+EGD[_PCGX_#^](GM [FHL5 MJ$DOZV;C\2@OX\FG;C;LP$M7L&2IQYG"Q_*TGJ"C-*_#H<6ZRNSB)4-SM61- M]B4'9GI#,:A-*P2G$H)=P&#?0E#O4H1B:ZT;W=V/AO#7\8H4F&YW>C<=I-TR M5VG;1FJ69[>)YE^SM\/NZ"X[4^FHFO:3E&P][[-T..K#BE^1W)))PX>_9" MD_ QFW3ZPZP7.OFP/[P97Z1(5$_R/,'^Q7K?#%HM&Z @=W!1HE*"]S M&%L >2TNXOO1,+TH'PT&0(.W\W-K%\GO35-]16BPN^/8RL@9.Y$O,P MR\_8 M&+Q,R]MDP=GH\PO2P:W;?^Y,WQW$6XT^"[A^>2S?KO&<:HVG25[]VZ5EXG:- M^%AKQ"N(L++DNR^X;_I>27D(*R>JK%PKPP>78;%GJ[8,2LV7X_VJ[]-.MW^- M\PD(ZJ@W[4ZN\D]9_K7?S0HI3D<-_E58K_EOSR3'"A/ZN6I"/_Z29O1SQ8R. M9X1/N6=O!Z;?3_K=SN"RV%XUI]?!^.4]P,]P_M>L,YC<=CMY=I7?=(;]_RY* M$G^ /Y,QF+6>T6@IA!N"D9CD1[#%-1>NTG5S@S]YI*U)+JU-<;=JJ9NO%'=^+VU(L7Q6$/9Y8?4$F M]%)7?_:=03W+!:=&':P]0 C2NI>M>]GP>&I+;'Z!S+\NP#ZZD+)I*VF'4?3UBG>NN2O/NG;VLHV*WR. M6>'6>;B(&+#=6G06#L2KWTG3^A O<.A;-Z)U(\[$C=@E,FH]B19,F[$+IP78 M%F ;#K#[VKW3@N[QPK?V[.1%Q2X'S?J?O:EM4PFMA3R]A3QI;N72UV?V 0BM MJWTA.]KQ):X.;N<;3'L!Y M#2676D!I >62-Y*\QKB^73MN\:19>-*DZ*E-6#0Y:&LK/S8 E,ZZT&$;.#34 MVVAS&JW+\+IS&LV(A;8Z3M'>/_8*N=Y64&H^^K=@UX HI3EN6*L^K?/4AE-M MMN&,5?*LLPVME6MFLJ%5V-:&-C !T4 $:[> -1/!'H?6WO_10M4Y5"N]($QZ M6T0=[%$'_]')^YTO@^PMM,FS\22D^?2SL7UP@\YX#%K3+>AX=5T\>5A1X,K. M#Q_R/@AADL8,>O?A1W-SDV[X^[@]%XFI_)#NR%J+R$3$^"]OUT.IQT M]H<@@]"K<.$Q65I.7SSY/F$# _B,]8N=;G]04//3-+])=8%^'8WO^Y/.X#*\ MV&?G=Q3FKB')_IB[ (/8Z>?_Z RFF7UX_/%7(&PG[]X^O ,8'JQ@QV.;M\/[ MZ61<-,#GP>^%6F\WXR<8V##E\Q:!;?7;W'V9#CJ34?Z0-"'+'UR6$/'2U'SS M-,^;U:W?T/H-AQ:V>69\:1/B*<+>N:J_LJ/&9QA>;F;4Q6^8Q:>O+;"LJ=]S M_7&KW6=6EK4%E!90SNA:F\;@RYGC1)OL/@1X7,[:_8H6M\K7NN"O0>@O9;GW MO)6GM5SGK<2G7A_]3B5>/HO1JO 15;A,^%:!7Z,"?W< V6IPJ\&O6X,;XD?_ ML_6CSTV%6S^Z,4JL=LOCGM ,G\F2T)DK;+NTTQS=;(B!_;[K@EK%W)-B'NPB MHE8MSS%RW7XOQ3F[OZ]T@T7K-K>[+AJXZV+[D'MQ@F&^V?FA=0X.BA>;R=UB MQ&L,K7=PW]O(NHVL7YMJGL?JL1D"H \Z>6M #ZN<-71NU?,UJ^?S;FZKGJUZ MODKU/ _'MHU"VRBT5=8SL:7M(E*[B/2JU+(!^RXNXE*P=@6I74%J5Y"V7T%J MPLU96[@#;5*Z34HW'Q$NSB78?E_)V22_7JD+T";-6GM_ZATC^X@SSN&DU2N% MF/:$5HLYC8LQ]K1!MH6=%G9:V#DOV#D?5^*;RTJR0MDC0E2=HX3&BZ M;K\J5;NX[.,+;^9NU:0U@1>JE\THT?GHU39.T2[51WU5^M*ZC'O<$]LX%6U5 MK4&J=CE;2W=+N)S;7O!+M6OM'O+6IIZ'3=TA)#TW<&E!H@6)"PM4O[<X(^X<\L"OU(UO\\>M[]Z S1C;^.YGLXW]S"&AW8[> M)&/?L&6E"U'15VKM6]5N+7Y#LG7;;K\\C].EKQ1/VE.I+9HT DVV3T:3L< M3_)I(LU2^)0^-'M%EK\;=8:_=2;3'-Y&$"%K[XB=?OZ/SF":V8?''W\%E>SD MW=N'=R"I@Y6!/;9Y.[R?3L9%@PVO_"WKC*=Y(0NV,^Z/5]X5QI/^'9#TZOJQ MQ^,/OC_N#D:I[]K+WXV&-Y,LOTMS+T'@IVS8'^7O1Y.%@C<=O1YUMR0*3^JR M41;VI+%E25I$>L^+TIZ&L)T@/I%E@R3N?T154]CJU*#)3.SK@>' M0]@^2$T'>A6 B?!]@JM_ID0#S,Y!S3<)9"Y8M6.X(EO5BU )E"Y23 MBI7T_0#ELF=9AW.SZ?Y]"-H*=.X5\_;3#$24MTC70*2K19IG&=EB38LUQW'* M=L<:_$)@<)T\?P"+^C&['^63K&?N1M/AI,6&K;$!GT83=^3;!2MC PW_!F5L M#7^KW*WA/U>L.?-LS.[IZ]9WN) ,RK'3S:WW:]C49:=Z$1[D(;#[6 >7#OI46[UAMJL:;%FI-L'6QWPIP)5#7;,6MW MPK1 >8HD=9/W6+=9J0L!MS9)_4H1I=WOM-CT/97]1.?DJ,NY) MBK=EPG(-[.>Y<#AA/^_J[ALK-+ZNJF6'K(?8%N)SU(>]_A;F\'4+ W!DN M7M:*^4%1OIKH+:CO?$?6ZT+OP]U(U<+TJ?R/!@92KTNIVA#IU"%2"SYM^J9U M6ULH:@ 4M7Y\,_!I:S!XV@4PN/[0>6AAX+!2_[3?GN MBS>TZ9 LFC0.3=F'VE3E$%0<\SQP9=CRR>CGF\Y5X MP>V)C=;^7;C]:S%IDT"WFGM1(M)&?>U^\=;V7:KM:S?0GR@"7+\-8@\5V/%Y MH,>"\_LH-KY%^?/ODYE#EO%?\KT6;/T'*$CGRP"F.,GR;#P):83];&P?W* S M'@/INX4J7UT73U9O#:GL_ #*#3B8 #&#WGWX\;S$Y"4D>1*:W6CR.CRZ&?10 M,[VA^%%X['3<'P(,F^Z_I_UQ/U'TR;UY_^G77T>#7G?T=MC]RV7[-@O!J:'' MW&)6$.3BS.4*]*U8O^^&/M]*8"N!NSMLRS)X$H=M^=*=C>+Z>33I#):>C-\. M4_=+$L"-4SP**NW[KI,Y*GW*[BEJV7Q:-J^KOMXM5CN"$+UGT(G[*[_G TR!(R]X/B[-0!/:6J(!$L M_N@N>YR^[0Q2TN;3;99-S+!G>KU"43N#IVNO(%B"O]R/QIW!W_+1]!Z4N#N8 M)J:D-O"Y_G":]:Y@:$4HM938_#3-;[+\P64I?CH/H5P(P''(M+BAK4RGUQ%, M+@OHB["QZ>*T?XR[3.:? IT^_SE:4;PSV2%S$H2JH=7K$-2*1D]:.?!N/M/'(V>3-*ER$C9";C%0J++NX//U]]N=OG?R/Q6)]TT5P M._!\9I*OPRCO,:5:!K3%NS[-R+3D-)HAT'S0R1_.:UMU ZUR%8WGXZ@A\EGF MA;\;PL"9_W#[,$XKS<,/>:<[2?NEEGAT20+XLKFW@'= P%MG28M[A\.]S;1^ M'?!7L31]&4*VXYK[!0'7KB*0MEO=Y/#-UV/X=IIR*S;M>OKIUM//32Q*"G5) M E$SN584M@JM CR9](_SDHPR718VY3G"["F_5BV: M3]49UNAZ%&G<^Z&_=6ET0-'^Y#%;OBQ)'[.OH\%7,-NK;=:$L4Z<3?K0[!59 MGI3XM\YDFL/;@&]D-X$NV)Z>G9= ETG[)$T;:;LG>:Y5J"U8X MN)$P+2Z^7!K;$*P-P5Y7"';P'%N;2#U](O5D<79KQ5LK?G!IK"QB]3$;%!NP M.OGDX7,.ZI;6M$;#L7U8?K(B9;]U_FN4IXV:MYT\NQT->HOCV^4=MD6]L:OK M3Y-1=ZTJ*8P\&YL/>7:=Y<#8HL5YR>SVE'L2I%K2[4F,:PF_+,NUE#^25.^Y MW,.Z;_HJA.\,&'UPCZEE=#,8O6\[55GJKK53K9TZO%0W_1CPJQ#8LQ".4V_P M+.>'BXKD_:_94QR5BJ2O",=B,^-'^/:G/SOWYR47FZ;X)!K5. +\O M(8"!$?7Z@VDB0Y$E*2H[AV^IIDW6B_GHSHWN[J>318'G3CY,A1L^9'F!Y?:A M^@4K8A+N[@>CARPKM.KJ/KWIO"3E@$1Z$K1:*AT/@63#MI@?0SC=:/@URR?] M+X/LG(W<443T&5J]$E-Y(D%M4?1,4+0)PGEL$]^BZ!FBZ"G-?66E[U926TFM MS)N1T3AR G"KA6(E#K6!^ M#U*WB<96*"]<*%]E4K&5RB9+93,2B*<*U-K<1^-\TS9@V\M]H,QG7\\N+BE M1BY/Z16P\-/#W9>SR]<]4[IV>4KGR<)96H+\_MDWT2]8#Y;9;L&R.'1:\>_# MZ7C:&:1=\%?YWX?=+)]T^L/)@WUXGXHSK!81^ T^G_<[@\'#;Z,\6P1XX"NO MA1?_ +GBSN'FK+I=T<;<_ G%^KB;.DU#54&??N:#7O!:K0>!V[.^^[%\T"=2[QS\;A2FI8. M@("M<.Y?."M)>[XRN:5!;)'S+(2S N7">#CE/Z7.VH41K$-O, MQ:O*7!RRY%S:(?L]J'.IV[0.AE87L;NJ82?+FA!PO&9%.#T\OSQ0N0A]/.DE MJ4LKE$U0Q%:ASCGR;]+*XPO\I-;,M%IQN6;FE&[?\_*[WPZ[>0&LG<'G++][-^JL5^E_-QK> M3.!1>L/GA_O5*H*?LF%_E+\?3GY5R$OW5"&F0'EHW\'NW V2G/\QY_S'I9WAG$Z; W#M?765&L^].?G?LV M#'AU&KB7,& +@7H=L<$*;*2DT7@0\M?C1!/R8 M[6;:1:Y>(8A4N#_]8>O^-!M?JMR?9:ZU[L\%P%?K_M0E2U<7=3R\XFLGQ;)/ MLIHN1%M1^X)\V7B2R)9"WM>5_ZPGT).855.HL:IU!FM3KRBY,+^:,;_I#\\G M.]DF$5Z!%9W??;DJF:VUK+:6<\Q9-02?_QRUUG)A+>>*6T.AQJK0V5K+BXQ% M+\9:MC%G\U2]M9;;(]%TV)_!D!D"G-]FXW[G7Q_R3G?2[V;+^GB7=<;3/%M4 MBRBU77Q@T>[ID^D+%=\;@]6H_4!ZN/L;YV?<_G4]/^16__KUECM_*QWG&U6] M?TYW^''G=][?/HQ!MCK#?]T_QX!RTYV_-AWW/F3YI]M.OO*97O\K8.6RP*4> M[P&*8,JC9?UZ^E9_/&($RY___LF7A_$_5@:R^J*E+_AL.+KK#VN_,=>(--SQ M]?BT>/4GI.CXB/US*T;Q#.O!?4N)']6^AL!JY -TL.Y4:%?6JV^U=FT%S_^MGSY]_;R_H_&VC:2\WCH'/S MPQQ0/V;7*V>R?IR=S 'FO2&<64R##MI%KCFR7C/FG7 &46X%^O&7Z\Y@#-PH MO7SQ13?-\_2K_A@PZY]9)P\SI-_BXU)[HB0)1GO-%:86"22C5,A)I"TQ/_[R M9G$/V:8O+4;B1]W"*9DU^%!8EPB_&V\Q%..\(9@Q&QWBG@5#M9%1*<.PCL:' M'W_YGKFCF_BC/E =2//_2R;O\.= Y^_SXNC1%A1!P(!0$1Y3YJ);P2,%(, MPD&1IC_^D'"@>.'"1C"E-.8$K0QYPZA6QQ_ &(*?>?.W?/3GY!;ZW7>&VQ#3 M,A4]PUP'Z:0+5%G0(!<0"5%II?4*I&SXU.IH8G^0Y0Y$ZV:4;S,*H0P67%%/ ML>$ +H8R+@D2,4:'/<8__F*ZW6R0['W6^Z%X^_*(5CZW.I*/V4T?XA\(J]]W M[K:1:L2D\Z!$&%G$-7:@SZ!0A(8@K652_?C+?&__#Q_ I1YF^?A__0#1U%^6 MQ[/ZT=4!?0)Q&2Q.$&PQ'JH=1L)$BW'00"<#JI48Q*2PPEE2L9 Z 6Q2V=@[D;3X61U%(N[9O>P(K2L'V_XL@H')PQ"1A+%&%$"H!.! MP &4"I-@94D]"D^!4C3[WU]_>F8NNTZW86F]98*)905A7"$M5124&"\D,8:! M'^",LES O^L$(ZPY!#OHJF$MP216'A0D1AJ4!.'23L\(YBAG'GV?A!6NWD+# M &_I! !VJ0SQ?U>4:%E-/P, #"^SL -ZH5_3T$OS622][],)RE+\'E4G![* MLU5,6JX?^"_0Z'^]RVXZ@YE:/TF?=1_"IPSBDM$@^W4T2-9@_.[#.CUWK!^Q M3$FZK*L*.R/ SCN$. K,T C^7Q3@=T2/;%BGI 0'7K""DOLDTTO(_A'FF-VE M]\!T9[\J;&G322Z4C\DP.X$16$4%GD' 7 1PN"VEQI:$%S\*[[Y(] RY4P6B ME%%\.@$7OMUGPW&]-*>2 ONF$W,6:>2X0T1R')F.$KQ?P9GBX')1MDXG3/"S M5*J=V3XILEPL9A]$6;:MX"& EIE!<;@'AN-0OJ'8Z(".%9FG2@2.H %ZZ)@ MX$!9; A$@$Y*HM>G)0#!3SJKI0(C]08')@2^?U"1 &N@.5401G&(3IQ6$..5 M>46;,:E_;I@4ICYZ<'=!-S473N@@% >,,DYQ"*-E":KXJ:&J;E8K?CR8)P^A MD3/I)Q6594;XF- '4\M*;BGF!\*:OW7ZPW>C\?AJN-QOW(40]:@6B7B)"(L. M>2S!7P+O4X/C%""V02E=)DH$>9Q+$CB MN1),E8UT,TBR&7@I,U)BHX+65&%*&46LF!2$Y5&'4GAQNNEL@[B4$Z4$& PO MF D"K(%!G#JB**(" D>-(07,K!8BG5!:1I*ILWX MY1E$E,0KF1*;(7(0#%PXCIXSX47)'T[YV*9-=!MDX]9RB*0IP1'Q8+ F!DG M-14",>"-E!C*5./D?BOW$O#;*>PB1+[@7CH=M626%PH?;1G!"6?XP!-=;.=8 M0L[CX-ZR@ZHY]M;;P+T!8T"DB1(0+P: 0:)#F2[B&=^C;E+[(L0A$P/$*BR9 M@XD[PXF5ED;JD 8/7@840LDW)<\E!@Y-C#*$+4\G,"\4TA9IZ22'R3@4 ,*T M1%2#]UV*J)X+/0XVFSJ<6N&-#Y)$!MZC*4(J9<$&:1F-8CA D+\^&7;JR6R* M"JD!1Q)Y+82*B%KKA)>),Q1\9>%5"73Q(;3N8]8=W0S[_YWUWLXW;*8DIQF/ ML\EXGE/N 9B]@U^G?5O]; S/IG< <[.-"\L/NMU\FO4^=![RT6 G6PVS*[[ M:Y1YV[P\,E6 =LI!_,4)QQ8X0*C!%#0';* B)49PP>GF!-$QJ-I&'6_UJ\Y";/"J(O&CPT76\=P=(0 KRUA@?.-2+@USD1M8G1 M:%7R6A73ZC#L?0EY#\+GC]EXDO>[X(>^+=9GH5G1J>F\3&E0!TH)X17AAJFT M*FTA ^"&8IQ>:L#/A "UQ'PD5M^OOX7X4O#+A#EZLN@?U-\]$D**O>*U'H" MW@D5.(5 $QNN K(.@FKI8/(^((I):?)"+KL"6XVH-'[ W=%=!C*Z1(/WV>3J MVO?'W>K]+O)W5CL'KC1VP#,!<14'QU()"(5A3DX&'HDHI4X8HU5S>'94^YC' M)EX0:066%.)[< 9 '*UP&*!%ZA0[RO(6$B;5=\ZC/[X?C3N#O^6CZ?W[T:1H MD-+[8!SFU]@ 'Z=)>ZZN%YM#QK->6:_.ZUS:3I(&\G1C36< ,I)]NLVR"%7]_X9$B.Q/BWL M:,[ C3<&_&"F Z"XX7R9T.M[EO&"V-]%NDODP.<_1U4U=>NYP&/:#,N#94AR MHHC"\'^FM$V9$<3H!B[0_7(A=/)A,C$VNQ[EV:(=:% V]ME]#N,O7I1(=C?* M)_W_+OZZ,4URD@MF:M>\"-=..Z.9=UIQ)[0W%FN.L02A+R=-WVC,R!.PO(P\ M)Z;NX2XAWC][4" 6\"@E<'TP00*[@#T,4P:(%$NX_P8C267+G_U>JEN;H!8Z MN$BDMT2 C0"?']/$'6"8)=J6LUBPB&"D2;*($[4OB,K"RS5"%)I,)8 M(6.-9($55C8@'V5Y0\@;B,):#AW/SFK@A7#:.H0I5R)(&7'B#U6@7(J74FJ$ M8-:RY_BV%HM((&#FE#).$'>6!Y_XA+C!+I#20A@&;Q8WW9CLW2$1G&OJ(<[R MA"M)-0&;$+Q*NWN-825A5IR+)DKSYCTJ(7C)A5,>HGC!P/_BSA1[5!CQ5,7R M,B)3C8PK]W!+<.U"@:=&&Q2$QHA)CT$F8G(,D&7453A>;SBB])Q)=#B/H'Z/ M/9B-:$.T+B5_E>,DJ@*1 F4"T*H&$UI"6&BI+[ $Z95HU2N1U)= *KH0RXL9$1J2WV6%"F"E5CR'#+$"[M MT%"R43;C^ 3>S61 J&T77V("9#:6<4"]9 9.$@_/)JOL8'R":I*<'9&X&0:J3KL"6) M3F R0,$0)Q"@&6(D]DQ$46 :Z!FUH5P4A>C&JEHC;897EO*@G0-OT(&:\QA0 MD0*$T(-@6E[&>?42_$*CP86SDF(;).=!@?2J$ K?!U'O-"D3&@O.T-Y(O71H M;U$"[_.H>LOB45?)J+". MWSG>QXD7=Q]TQMD(7O U&T[AYX_9>#J8C*[=;;J3 5X3QA.8P@3 MN^_DR?V=3 8%\(SGGYZ,/@#\Y*F@[W'/-0 4!#[D>>F(D C,<.T4XU@+34DJH&:E V?=E7,>&%\HD4O69G6G MO8>@6BK$$(8X#H# 0-PL +D(CXY;6NMC70*%MCG;;50JR. 11#E,6R<,#L@" MZKE4CB#&IP; 9]X:K:'",CGDF M%(3 I83$&ZS1\D:$ \_GU'0KF]=9M=Y4_WTT?,P;+EH]G?[ZT.GWW@Y=Y[X_ MZ0R>RQQJ833F$>P(X591ZY'G8'&QHC$YB>7(A2]K1\N"918DG2M_YOFCYQ!H MD13^ N6UU$)$%2U DU!*D%*U/HA&N! G84&W,[Y=M)@=19P7BEPGX3'JRPI' MA7'*:.DY1*=*"$.LHR801+DH!W& KVR%:IMF\SVS?J8.F$6$*D, UV7DWFD> MH_'8:26=J5KZI.BPH]X&J:7W*C"G, J"6Q1L53?-?IB5>E#/NI-NY.K?+[8\[0:]/0*<_=E.DAW8CWL=B87 XKC :5 M:,$1)3#TL@@L/'/ M303QE9EL-<)M9_5;Y[]&.7QFH=V[SLQKX0.EW@;%B4>:>Z((\CX*1K13FV>F MV'836Q_DX^3FZ]ESZ1L_+3;L5K%">5)4C0$[Y+D!QCCLC9?*LI2Y,.7R,2O9 MH=I!O&28FPI2,"XPN!8D(J6YB* =3"K)10#_3Q!;VM^OZ6[#_-!Y*,*ZJ^NG MZ&-#19'=ZYPY+AU N8 8#NPF#1:E#:8.*,Z4!Z@OK7/3E0S1KN-[FMAT?-L; M_3DTW:+@!K0RO?^:CB?%VSY#])H-^NG2POQA=F/).';Z^3\Z@VDV^U39P:I/ M7IZVYM4RM1&GJ9I#L>N>.R,M8$XZ @GD%L3IBG/L4J^0>_]4>SE'X!6=X4W_ ML7)/$V\D62GDX[GU1D?+).',8Q4<85KHD*XF0:$4%M#O(_TZ>5Y.Z*O);9:G MVXB+:XZ?2M8TG> <(Q@54HJ O40VP;B6BJ74A <\+X$CX=]%\#HR/1+^Z9Z8 M:EWPV2S_%O/1G4^7GZ4;?!)J?1Y5=YC'=#L[_UQ!@*48D$-;+HFQX#PCQ9@$ M)S_R6D4ZU#RV)M0B4;G\H=3G[K[XS%7^89IW;U/R[+H:G;/6UQN=0K(E)O3Z27S.&10)\[WQRH07_B.GG^<#W* M_^SDO4_3+_^5=2>?1^] +B<5"ZD+[_Q%VEGO*8$#ZZA,Q?L9AV!,@871Z8R, MC2 VKISE+!8D'^FT[53V-/>7FN+:Z6/CB:'21NGA[@O\ MXCEQQY)J<)3F^9=YI="=/7'L4A%H5JR)\^BDI9S0M&'0,AR,+6V=%KHDR2\: MZ--4TWK2A[7U)'#P$X:Z;1>*5A:? [8L2JH\.%S8:+#_%.)1A0'1M=2E3/CJ MK2E;#.?[AKXIKM.((FHE&&:,N82P4[I@5<#2"P]Q40E4I7SIT/\^["U,=-9; M[!I.>V',8##JSO:&I%?UN_W[^59HB+,*Q\9VQOUN4;?P,YBM40ZNT/SVP2=' MZ= [.M!R<@@YP"/@,KC7E*3MT\%9#-1#J8:VK]UP>6 2G)+4>\[7+U.;8FY3 M)4S"2>#,4JJQF5%;1H'*.^1> ;4WKQ,DZQ!L (,@(?BSDHF(@& BL)BN9RNE MW(E8WE)XB63;9LLB$:GD"8?L'P$\R2HL(9Q:0+++S3RE?WY]5 M6]Y]1XP-B-(@(3A+1\,HT^"=*E]<9X,$UL^M&LXMYK@:*GCLX[-VG8Q M1'!0C&C#(#8-&-Q0^!$"UB# [CFW>59\BUDM#^[0LTD5>+!3-IW^X$)H*Z(S M8+ZC]#"U%6$UX+U/;K-QO_.OQ8463[5F&S,?0*! * (%U)Q29R,F((-,69H* M92WGM.]O'T!=^IWAO^Y/.9V-"SK&2U @;\&NR[151&N0-HL,,29R'TT#V;-Y M&=DJ,+J!H70)-V4 @SXHUQ @0H?_#/L80V;3G!@&J-G(0([C$LW]%$J+'B\ MD@+T/8,%+YG-W%7\>9X9W3E&6S%4!K3>4>\L^).1"0/!#;682LFUY+:41E!, MSB]UW3R*EXQSTUX^&K&74E,ON.1IK3E=)J&. D0W!)?ENWJNVXQKKU/: MQ,5 I5'.IDMVP'0*2JA/5_@2$J1%HGQ-[!M,50D57SRSZNVQNS&%>LV$A[B2 M8,J1T\H2! @4+($)856^W%!SO@XZU>-XT5 W$1M)*L -$\)(#;@N%1C)Z--_ M@HV%D]Z$N+7+6M(ZL2>.> @2J"H<68.8L->$P$Q_+..#0OAOZBL>UQ4AL=AD@1FZ5!*+>**<=A MFBIXP'L1?/DF-X;W-2D(:'O]P70"?L53MA*P:C#M9;VT^R))PG2V_'IUO0 M M$(%"5F9[?+9:S?K.+]F'ZA>LJ%:XNQ^,'K+LTV34_>.JV#*ROTU4:"623)-,Y@?/C8M5RYT6IHW&.11VTBP'SH)&BPB!, M,=,JW;!3Q"0WL8#QB;"G6 MD7.+G51.7( 5/Q4_=D:J$*BGQ'D.",4UIB85H*>.,2T]]L16J0>G2K7JL7>D M"HHA; UABAM@1328$G"O2'0F%7L+E48#<4X.R8KR\=GGBW 1+F1PG*=*HI1& MD"INK$,\@K=.<6F#*1.$R/5UI<=SJ5N,Y$"7OZ6MV"[M?0&&4!8M%T$*:K4D MC%24Z*):"J$/.XL37)O '<2^3ACX+^4$',JHA :""$N1%+Y?0&@AT!80]%EIF :>G8 M! -,$N*EPKFH7K-WI$GGD6R4'L)HRI%*QZ^=C9$Q;+G3Y6.R5"LLOX.>#44: MQ=.9 M3K]?M/".$9&&>&(4(DE:+>.$:.P\8PHTMGPOFJ!D?HM0Y==W&-8F' 33!%+" MM0!DX()$$RAU0+1@%;%!ELBG/1X"YVH57G)KNZ_L=HLERRI6B5 MKYW&>=N(^A\K6_NT0<@XL.D6<1^EMHZ"A5<$U$U[NUQ/,(G^",+/OP@NG\CU M,JH\1]=Y68:J)-CM.!;]>5&9/9Z-3*/&Y\\UGJ2I34<"E(MC9Z6C[Y]&D M,U@N(/EVF+H_>]2= 3YI%CE1W#$PP-J1=/N[YU%4[M%=G'4_R/RK" N1SI?^ M<':5T=,WKJ[?P;//MYTAH.:<9=55.![K$QV%N"L7]BJF+0W,@MO$TY73/AT# MM9$$YL"Y+I\&55**2N+NC0;'(W SP&+5,2$>*2:MI3CA/9AB2S"U*-UI@A M M[4S2-*V^7R1#MI+Z0Y4K6W']C:): S^T8.FJ*QN=38>=G)$2=*=D\BC8:\%/ MRI/D9O5[A2\U&G[..\/Q+%^*FU@L:^4"3^LYA';(._T4CBA%C,!);>6HR4Q,)YJ].2M2JU/U&FB98ODGYE]Z'Q1'=Q8'C91E\3C%34LL8 ME[(17#MI3%0<.XT8X1&5:TN0Q^MISH=2ZU&Y&7X7R;A3S.K@F04S(2F89P3A M@91<* I!:,E,4%(7$^R!9 LI*+;N%V?(W&A3(=9#W HH%" 5_ %Q)AA0PRW1 MUF,2@M.1,5UQ;HD]ZS76S*NAU%BI6T6Q5$9&ZQCB$*]H[:GE@.H0;Q,LRV=X MZ?/2<7!J'/("+ 43CPA9GF[.]*FNA>!.(HRC!MPEI>P6%Q=(D)6X%T0"_$K% M!(L )B+5BJ2:8VR(4;I<-S 5*CTY09XI["05\]I$&2%TIQ:<.QZ*NR*=DDBH MTL451#\?.)Y@2BN6T<=TU;2S#D =R4BEIA8;91S!7I!RAGH+%^)P4]JFCI2A M,2+B9;HWC"O#K(*H1AJ)J0K:E+VB5.>D>3-:YA%1CG)%0'DXN"O8JI"J[GOJ M>)!4L9+W(K=P7@X_HTTE*-.V4IKJ-07#.!4@;M)%37UR+@C2):DC5#5Q2BNK M&YPXKSA+1;BX%LH"3&@%+ /E$MJ74AB$RK55O[U-:7Z.\;^SWML>X'C_NBCX M,K_C=)Z\!N]PJ7(U/)O>PIEVVR"J<"GB)BGD?C:[ND<"-H%5C4GS82,E8RA"Y&^X(,%"7!&EP,1AG"IG ME5P"C/FSV'P.S)HMQ&U:N3W@ @1G,=!TS2@)G@,T:2&E!'T!IUT)%LJ%C"52 MAR/Z,BF.0F\0S_M.OS>O10SMB_(C%;QH(+Q%(D%G* 1;!',N.1@4I8R ^ *Y MZ&+)\@O,Z)%XMXFL#>9K8[ 0$#"J /BFP()1QI1R#EN3JCX;P40Y5ZRH>#8) M?R&L?3K?WW@-Y9P;PB&>18'Q5/4)H)5QJXG!Z7ZO*L\!",HQ;V2^&C*E=>QH =T1D[#N+I+?H[AER#B%)'"&!TT MMT;JR!$QC%@O!/.NM.N$4$H.3?^UVWR.\Z6U@I%-ASQF*=$60EPO#7?,6 >N M.T6<:>2UCZ43 8)IU>/OLR:;H^4HD#)Y8J3STWP:H8.4]UM-+2NJ$5%_1H=DPF M+M.R:1QLC"9*R9"WVEMD#5,.L2F5@$'DW7/^D@ M$I ZG3XZ(NL*(C:&9XW1.$\9D1"-11L%=TA: M@PVC6$,4#GYIN1 DH9I>#-L65^=^[GR;M7ZZ5;?IZI9J]PLN+ =WDW-&TJ42 MSE(O!8_2JO(]?$@@^>PR["$HV2CF-4;OG&*12(91<"F12;6A(F(,R(D#6+NR MSXD(/IR[<@+VS:^KAHCY+'+0RB#FK !HE)@[CU1*;C%$HF?I*H>29R(YQH=3 MMS7BG9Q'C5&K='D]L42B:#A'6EJL)?.$@74SD;A2T7"BY0'-V9'8M'[U=6$S MTR[_Q2FCIBN7!QX%!!SR:8N'M98)C9&,BB8=*]^*(JB6AUO@>9:<#>1C8Q20 M($F"L#B5LP=6>FN(=3%*HA4 *"WO,99*'2XM=D)6IIWKH_RAZ:H7B2?4,A*C MDYR*D*Y5BY$1I[QQQ)0NC6=@ 9_=@_3]9#LA7QJC2BI($1Q)M1TP!V_#H!"U M!R-&'8* K;2HEJKB'BX9O*@3!P. RM)>\32 M04GK Z@)5@%YC3B-02L=2,6A(72XE-%6%Z<>GP\-A#NL8P#O+A!;W%LA#:61 M(&(J> M/RI^0 (UA#7-U"]D/ =H3(?*&1>@7]1$02!PLMPB5#ZLC)'26NXE@FHH.]]G MQU0S0&W#[C9528 MIX@6&12CX"$ZI:(L:\AV!=C.GCN-@3!C17#4BW1U!M=(*9_B50B3P$Y1*4I; M*8X%86L,FM]P_"[KC+.K+X/^3?&5':]W\%Z#TXHB0T+RJ(PE&HQOVAF"+8KE M,MU$\K62S#7#>-%(-Y5%YEB!FI"@C'(<,6RE VQC@DNK>$3E?6-,4;'[2(LS MX>D_2^?"S<1U\OP!4*&FA.PF"E/P_'W *E)KN;/!X!"DLT)Z&;"(I2T>X'!J MO$[B+4:UAVEL(K_PFB-,7(P(<=$!!,RD.Z=L>8A:#(@IY[T4)@4 $"-%G,>U-FH\@.).6Z2#! "KP7()P4:0:GMA; M6]ZC)O5Z$8(&SGK9\]APE0?3(@9#4SU7H36.BB4YMY$H47$C"4D5I?$Y37W_ MN^!P ,H N;1'G AJ-)$6@#"=;@)L*!_J;2K)/F1 A!YXF7ER%WPV^R_\?3!- MX4'XUKWM#&^RCT"V<'V==;>^W7IO"?R8"NHY'"G7'/Q5JQC#E"*IK(\.E;U4 MQCB2^Z/TS@1J%FLV5_ISJ1@'4RH0YHA7@'\4%YH/B,>P*VT.? -BC'A+W&TJ MI1&MM;(A> @DN A*2TDT0=&;8#@5)4_RC>;@3#:(MG$P^O/7K'>3_:W3'[X; MC<>?1S:#Z&[0&8\AJLMZ_]F?W/:'G__,!E^SWX ZM[M7R$.:QF"-2ENXG('Y M6X(LIF"'.= IELO#K">I7SC0E;F.[NY&P^*NPP^=_"HOD*M7N.F+.P:?=:#> MOH_+56-Q2!=^*Y\VJ@E *BH5#6 N)&8&J;59+3Z2[FM!>&EJSX_KNZ>QYA"M M3D/ %"PB.&H5N4EW.85(/37$4@X8; X]C>+9V$PGMZ,\Y1-VY4)$"HPS3#)0 M+AQ1(9I@=1(S#:Q93D MKJ:'<4N$A*.!* >X%KBJ&S)10$E.Q8<2S MH;QHM!L)C*677K#@(*3AVE!-(H".)4RG"AZD>K1*8Q"E[QOMU70RGG2&"7UW M)+!*N[0"=0S%"#]9@Q@E7B!C)%ZK4KX#@9?&\UWC+OM\R0Q-'N!%]Z-AMKA4 M;=%JZ?UEWV]UWBYJE&H]P'P#]PX!'"F$/9'$&"\E.N&\-XH8@W#*2V*E,^GF M-Z2M"!!9$0UVS1!9S:]G16Q?XSXT7X":='&Y5L0[RW' '@BQXO/L M==Z%-=E%O58\-2TP,(@KP;SA+AV*0:GN,(G:$"K+-6V9DG58NSZ0%X]W4Z:" M46RQMY$&Q[A+F7L7-*A*&JZ0Y10Q4_J%X[W/L]ML..Y_37[CZ"Y[GTVNKC]W MOAWU1@*#L3,,@ !I[+1R!$(6XY%#A%-/RB7GWS#XW_J$ZV;R'1,^:-3+0@#W MEWOOL \$;!66\SD;YI!)%P%X) ;O'J7)GU'XV;$8# M-F56S98 #C?J[2JI&S J,@3K4IR6+HR>RQ<- 3"[-&A"J#S*J#>%EU90!FX+ M]TQ[HIC0@L8YJ1W$&Z6DW1NN*:=['K690.SY93I)*WR?1UMLYC@T5EC.D/<( M!P.XZ,#/#^! >Y2N/!5@CTKW=2B%MZ;)-I,],-T."3E:&:$MB)6'&!P\8PZV M>T:Z=)>M+5M!:%6R@PVFW7-W7G@L(D7.4&()8*RR<2XXR-)RN8Y4[>\<)K\- M $I&8]KV#$#B-?9,4$5G<\<<>5G* I+2[1@-G_PF'*44"\6T2/3-=#0K.P,FBP\49$IWBDWBDU(RU3C.B2@E*T@XR> 6TW M0[=A$>(#[J22 A%084[TG#K@.8?2-O4W1+"+H,XVV*X%X8A+CB"HC18SB,?] MC#A<8WG7R/U:O\.P,LO''[&LVG*8Y/_^:TB6@\T&6FNYO MM^-*0$V)TR:FHH>>$S!-6FE*"$.*>2G=XVO0P MH@*QG-#$4RPUYH8SS:G@43E;'"^,OE)4I&A%Y82B\B'O?P7FOQV.IWEG6)K? MGB1#*6\%F^O6@4XFGC#@LX%3@AE6)!<2L6IQ6+3]G@^D/GX4!&1&L= MJ8!($D7N(H,P@2&*N%'6)Q7PI.(9*5OIQ5I#"^O[B?] M;F?PVN)PI F7P@**FI""-D.TE5QJ ?\#FQNKH[?FJ.!RQ/UJF"9-2JU&1)UR MW"!A*,;P?VDLITPS7,DTU)SDR:=I?I.4#2:3CIJ^NN17<(8;[!$1@7#GF#+ M-1$4]THJ0RKYISD_(O\ND@5KNZFI,\J!QV&PYI8@HXH+H1VHD\=T99O)\1R/ MY56K-G-HS("><)0Q#8:8U<6J9?/T MZ<)#9Y$E,4H0KHP#V/!4:P*A4W36,N.BDY4> R-GX#%;FD5-2,&4AT-,>I0)6U>GD(ZSR;,_. M5YI1ML)B+L$[EY&!M<6:>8!40U/=$"]>5F1/.LV"U\(R;0+7!RE@Q@UK/-9"J'IRBYA%+)1SX:"HH1X1SP!-KTB%#L!2-!:>SYL=A M$^UU^@?NG,:$(.N-T-I1%4-(O-80$2MCJM?*.&WYW:Q4>>V>*R1 MV(+V)IK(C3O93L:M:'\.:<+ZU2]!F$0TW=4-98#_*QM]M M*']NB;Y:_]P3XJ3C1&ACD"(.SY@@(R,:;'XE]+"CV8)&TW$UJJ7,8P:"++GS M6C-)#.=%IH'3J+6J ))#BO)2)8A+S[A)B3W&R"%'"7?6*JD)=H(3@BTANC+G MC-@A$7Q[XE]>P@W[F X!>*12G5].M4#@SH J."L1D=7[*4DS5*'9ON6+\VTJ M:FNBU))HSR,X^B&5!A6*,:<-JZJ/T++C3--MTC$F181_<.":X72M-1,0KTLA ML4:H.MUVR"74EMW[R[:12*15S%"B0SJ#8"25SDALN/22NLID*C_H8?26NWM* MMHE485 HX83PG#AG!<7@UO#@=2KU5JFX]*"[C5K6[B/7ID(,4J&HN/<\1)M* MGU--#*-"AL!JMG@>ZI@ #!1P#+=-B166>B0_ ?':E%4HKJ5)ML M!C_./-/&4D&==,0*Y)][3:RPU'HP9(&JH'%UV8R#;N_:@?3GG&B+6DA.&&,$ M:4Z)T0H[XA0+(/H"L6JG$!]R(6=[PE]*GDU%JJ/#,@CPUC!3Q@:$(H,?H^;( M5Q>GH(=,\2_SH-%D7*O6PA7CZ;Z-$!R/.&WU#41Q*WFP""+=TP2S_[S\-!MB MQ"H+40(IPL?<;I!G%;X M-\U IK-FQVG2;)889&3:W.L9)RHJ1 5/FZVY(5C':NWCK?:=1YH-),]6;VN@A]RRVW-U3FJW8<4P]LNEZ-Q.#)MYH37TPA** M*\MY4G6,&+1E[?>DV:PC-!K,&0*514J )X2"-(P$YRWUU=N,CY(9/W>^OM ] M)9(CX;QS+JT!2\,EE](1'B5&M*JF9MK1U@P#>>9I-N^Y(TCQR%CD42/##,"< M93Q0AJ(ZP2G*'4A_SFDVJJE#B@H:TL9!1 RFV"G*G698*E6=WSSHV '.+_C (>W_ M9S$X'I)I#6%?:;;QY.IZ/K^C7DTFL/<0J"%F>.2!:0,1.]-*>,1=1.4+?C&C M4JY?[[[9;6J4D=(-RB\>V:8;J9RE.D9+<=I#%Z*S!GE&O.2I4$)0 MI5M_,4)8:+SET*9WTP'HZ-?,][_V>]FP-][R=G WZ(S'5]?%A=%KSGK>!_\= MY/4ZRT%H:^X(?\.7YX@)$Y1H;SCB-M6B-81% 6!C/6AI260)I^N7398GLCQ/ MGWV90.@_R:=I[+8S[H\_W>=9IWH6KJ ZR-,K+P-6?W.KKH30@OC^;$S MO)E;3/C;;YUO_;OIW1HBKW[IR;R^'7;S@G"=P>KX;#6\F\"B] MH03BG[)A?Y2_'TW*90VG7\;9OZ?PY@#LK>BY^GRM]_+LGP;[6P=\@6'ZW7-& M AA!;;IGCQ:G_Q UB 7M?92(.F>J2W<3LK2RN"UK6G:^A)U+H^F-AL6E(Y'@RQ3%#GJJQ?R2,O,L])9KTS$#CQON]Z!NC1S&&&(@3U#"'2)RA+Z;2 M1EJ=5F@YN5]U!!IDVX!K!-TBP"!B0.F"#Q1Q->,6L2BPZD.-)P?72^-6A' Y M[PSB%"*! /K63;'!IS\[]]NP$,)1IRFQVMD8";5!^+E7RTFTLKI\(#J%MU.5 M6_K[<#J>=@8IZW*5_WW8S?))IS^_SS5;^@&=NN> MJGZ=R:U,[)-D=VO_FM)(M,T]LN@E)6>\G_X"#R5;9%,/*8FD:">92>+H%4"C M@1_0>.'(-CJ&FIL?T;\Y,;/:O[2D@SQT:A\UH86*2H901Y538+EGVMQDCD7\7WL(C_[>KL@VP6_Y_)19DNSCM9#]F<\'_<@WD8#Y&2KR85/V3!4+?D MG$K9*>-]T.MT>[.6AME*SS.)YROX(/$M("CC")HOD&MC72\@.XVR#]:IV.<] M#T+\&];0ZILA SE500VTL^!OR7D>Z6-BUXF# MBUJR;MI#'9;E%JTK558?BK[3F>">13K3MIA=3B^&AX4_L\%]/?]QMEALL"P/ MI7UA)49B$4-H5$,$DY*, ,&JM#)\66.KW475'?&C!#V7]O7$,*P4/&A58[*> M:_(K&S MZ?S?SRYO)NGSES_^9#%^@M^2/K23N MG3$A\14RB16O*F,H6HJ@_,H4_:4H?">*,?Z>(XG[R?,C2((8L"IB1=;.@V:K M9RD8XW+0(<6XX;7@^9)@ISS[,/GU[!_U'_(=DS2YFKR=7A_[VR?SXTYBQ3$N)F=A92;P1@].QZ$P5 MM->Y.[A7?+['('Z7)RJ46EAY:C=L/Z-GJ^^\BXU\+.2+Z:X?^V2W-]I_9/ I M!0O3R>*GR2/Q#E\26UGB*DA'24PQ>4 J.7O?)'#O\ [T-G24G&=1/N9UC8[& MN61D.P&T C&AR]@JXWG!0/X@E/,7+;KD ME,!IQQ>5R0^ @6,_8W-GJRQC:MK(Q%;*]L3.^I&LL,,:Y$JQ346";%RLK%T@ M2"AIQD6]$V)([3>?R?/8$9\QV.UX>3G[38J='ZE;D I'Y,85#LN)C1)F*FR: M&G^,FNT9T3VDVTK2*@<<2IY/AR_@/U].AJ^\NHA+)#A\_*BU(=';#-IHJ?]F M=*BC1Q6"AA"U8U_2V84 M*Z7VSG:AP0.Z5!;D9!$U6SY>K;F"6-2C.]M"F!\ MZDLBE#;K9OTX4ACWK%X5*D%)G&+(G+K .%(;(Q!A>80:E8A%NFKJ F]"I8/ MHQF(D6WG.AN.;'CNU1HZ/Z:?)E^#S(5$.3]/SJ6&9?IV.KEH\]F'>'Z^+"*9 M7+S./_QP=3U;NL8OV>,W\@N.;(ET;NP:4]/L&(TQ+8!*E3*R56;A]153*X+: M,^-'E^HAK1M@\JT9':"2LZ45BVHIV"QS*#L3_UT)=MQ@8N68V9JB<@Q\/4UD MH+(4#5D$TYF:[T,TNQAARJJR!!)?1)6#E !Z7$H&^3:&+N7R?4EF- 0,;*EU M088')<@.>0/E5F=*+:6+1XXOF?M0^HD!"YO@AM&E0*;E$DEKJI6BSE'2S;2; M,=Y(Q[-('@M*$%,V1D5;)37($*VH>$LR!UJURXIHB^ON=G?"IXN/L\79Y9_G MLYN//\VNA[3YU?7TZH8/[.-D_B7+*(?[^NKNR[<^M"U/^8OA3V>7$D#\\GXR MN1:_?W$QE1]\=BF_[W*VN)E/%NGS"C$+_A&7-Q?3JW<;:;K7)OKK;S-IA)C, M/^>)O+5MZ )>B964+071>Z-9G@RY(M5<'"/-:H@@=BKQBF ]5GJ:U%8%?UOR M^N;LL[S$Y>79L'"V:/J!RWK1DZXF<@6/D3F,R=E*8&Q).57#\".'[)*O'>Q]A@SJV?R*%7WQ9C+_Y?W9 M?")OM>>'QJSF?C)>&EZ12@ZR5D>TG.N817HT[!*\=LENAMJID=2B& M R]+D=71D$3"4)IW+> (M1#V2NT#8.L^L:%8LBF7DCG@S3IBR2KK6H@*^UI% M(\1Z?1!B__-A8L7P9^\Y- O2*Y4(4L (7E7-H3KH!XG5?PK/(;9,+V\8#AWS M>G/(E$*,FG%%!(HFL2X%YCRX$AN5\,3K??R.7G.;Y46@6PC.M2=>\R=2O,-5 MKYY]AF5?*"NR6:;(5]Q%]A;$IA5IS"Z-7?5G$CQRW5MN13=54C (%5(L@5&? ME+&Q:NABGGC=-Q%\%]M\>::1,JN\!(C\O5\Q[!&NQ4JK MF*1#M=4EXH/K"\J8>>?OZ]?.K.U/(-V]N<]213(V-DS3^O?/%C+Z0IH8*NNJ'QP$8O*7#,L[4HL>]*FO0+IV;K MR3V*Y!4)?/AX.?L\X1\P9"ON1<[Y*7F'XKTV5(BMN&%P4:*WE ,&9K?58+IR M0D?>K.;^MQ+T3.I'4Q"J!$JA42QL*DFEPB#)^IADEODFZC4;E6=0_]\WT^O/ M?YUR0N\^%SL3ML+.XGP^^ZU,..B?]I6S=SCO:Y/"S6)ZQ>8[GO-O6PR)D7MU MR+_\Y2^SRXMSR9O]:;T"]AEY]94"I&(;.W =^1Y"3GSJRJD0JZLIUUR[5T-- MZQ5(*QROBN*:?^.UE"S<#O&2"_IIB,1"6P%%WQ@F)'XW)ML-F37S6[, MY$H=D08[(A^FY>DTC^F?R]$[!=5PM"EM\U'ES/:@5K36^=BE$+1;KV_=E>8V MO9)/_C@Y6WQ)^GW>V7#=IQD@U8*,CT)#8*2$E*-%<&RHK0S [:I4UMNZQTAY M.LFCUYQ-)T3(H'6 $ VKA]ZVQQ")3&!JPH8XM<(P7)8\OQ5VEV*X+_Q[3.S&S%^X/^29H MFJ0IDPF1G$S%X,BO&KYU*#56.7?5P#;0:L'#\<0P_H(7,"+YRE^;6G,V8F+- ME9*':CS6-O90<006=GEI,S&1(=E?XST8EZG&&!PPE. HB\5^&AR,O8A9;;-2 M68E] %0<*.K*1Q=,JZWXOA[UN1P,3V:3Q>NK^@]&Y^_8^[^7+WO]5NKKCVI' MK.5X./GJ*[J(F=% M3'+TF]C3A$!;*D!*"FHH+1VKK2$.I4JKYPU%AND[G2+]AZ(]%TL M1]"A1*,YM+ MN$))V3I0G@QI&\:>6HY ^9C%8#M7(3#XB$DWM2PP&-3&1*M\ MVF;S=J=\@U&% MF(=F,S'7CTM8-'S=;49=0"X^CPXNST]O/N9_TR>3>DPK:N2GDP M:H_47 O-6\P)@J\1O?742BVJ\A^[R*UK0CUU@8Q/9WTX&Y>);':6%+M7">=3 M#K6PT?8<6?''^VS&>C9N9\&LI",O)M.__3AY=W99KZZ9VJ]\I/RF_C)AHS.[ MG$@N4IZ_?GRSQUSDRH..\WP_FN2<-7C-_U:5?5."XIL/L>]@,*B#>:(9.IUT M[&HMKW7L4Q0'7X6C9QE"T++/49Z%K=%=F3/*2"&[LP0&OIB8DQ=]<:QRI!+#\E*E7MA2^TR8LGLZ9++&P:6!KU923>1LXGLY6>&:1)GBTF9 M+/_](/ ]G>QZJR$3@V3C@@.=6]*A*9ER@+8RD.P'J*YW_8U+X(FRNE^T^:2; M_W#2.S7K S@I)@8@G;PV)@"2,J7%T*F&1-+/Y_AF?OZ>/Q?/AZD/3&B\^*^; MV^>:K=6JC]61A_O[B_*A,A+)?#4* QB(J&2%M_3.6->_I#S(^1@_]P6P?,^4 M,%+*K3<]\Z;)V]G\ZR/I9%'X#XOKPQ<8KH8>@&PD.#9VZ(!:0A\=!-*!?(NZ M#QI?:6_=*@1^!JL'E-@AHTVV%HKQ> :.&\!6CZ"B] P[R\)3V+\?&6N^!9F- M1ZFY <3B.0**GM"DID(=:J%E11^&.5B\L95I:B+ (RQQSCH!Q[] MCVHN@RR;SBG&2.Q#DKQPI50# 0='#75W\Y'\B& >X&@O(CAH4E[IZFM(.B;@ M2^$H-)UL(J-KD@QK%PQHAR\DAG&31MX8EQ1C EV,*U%;R$/B+5)E,-C'NMH< MFX^=)NX3X[?*^,:["#IDU,H$[QI&P!"@S\&AUR_%QVCT$J)/UK()C0K8X%*N MI55 ISC>S/T[GS=HC\#'3Q/)_-_UCKR>%\GR3?]^H[ '30)UIS/+9/,]XF*L9@N MG;H;]00M>2D)[-0A6I$OO"N> QF03HG"%CBHU QA<-@A,8U/\$*/%,!.Y)-&!R:=R'@N2<.&%(D:(W(* M'JMF?B'E@ Q.^E(PCN351B.P+V:W75<*D974#9/D'%]2IX:X 4K)F+O7K5?K M#_A[(G873]KX'KE&%DJ.D!4C 2,3#=C8,-I)JA,MX%IU\)YI';4"WI!/!6UH M%EKAD"Q;9"BJ@JTM]KD^K4@]A=B5),\/5[>I#VDIGTP_21OEL?7?YI#DQ:YR M^ E--MU(06>-!E%*4/O+CBRC=<:W]9@\=6&O[&:AF_35Q=][V M)Y$MYKODXE$>28.GW"!P;#%HJ6G!ZMSER0WISM<1@K*0 IKBV6M+=V6%B6M2QP-XM7YG'LW#9,XP]W;DR=+W_32[FMT=WP/WY'#5XEII0B VF3(C#\C6 M%$J6V?+-JOYY@@&=[NS&=I[V(8.#CITE'UMK-GN4,>^*?3I[$@5> QM*[.^E MERF*+R*&<9/)=K]:Z0WT*E$SBNUG&!"OS2-U.IVR+F,T_[S29 M>"5Y)=,*I'YHI7,$ZP'HU]^].TUC$E/:L UOKL1@ M^$ C-:0FV^-*:QA-=[+.V;7YMF,TW69P&$>_?3NTW$X6LG5C>C$]&P;NL"T^ M'SX:KR[^O]GTZOK?^B8",[@ M^K$_@]@#J48HT,5*2AN/C4/P$I6:9Q$*Y_//O[;,Y? M<-O<\A)%YXPT36JZ)-6D*3$F&RN'!HSI6*MK+PV_'&Q[3QJ;F7@:FP?=!6T] MV]8,1H,"8FNG)!Q*D&T";*E[]#).Z[5*B7VRNB6UP,"QZE;(,I43.:+9:;^ M<4;:Y&93B+9HAM$ILV(HOJH,Y:#4K/OI]LX;Z?=9I7D+1<^C?LS8LA+'HJ46 M(0%8]C'6%U]LYO ]!9.[FDL'@'YM(\(3J7\28M,:H.'*# M%BA"B%HNSI MJT+HRT6L/$W!0^1N@$'/G2#!?DK)JQ$39J%:%ZNWCJ-.8AM&MO56C$2BCR%P M=O7NU]NM8>.#$C.;WNGU717VBE7^>?)I=OE)$BDK7[/CMY6?=3=#X/7;+]^Q88#%LY:R/0S= MV)?EIKT3=U8D^5R]V AD5:70QN82WS_@[^/@1T\IG\WGG_E'_#SY.)NSP5XN M=#K>064VW*U8([,$J")AU:Y)2$/&6MV%5M_?06T1Y/F-%*GSY[8-*>>XSTL# M=<0 $I:R7V2/$I4#U8SO<@#?D""_[&_\*D3WAYD;HA-K@AO>872#0HXPQERS MY^@T<+C=%T:Q(NBUI_+OZ_1/V=;9&H&T].#E" H3(Q4.L$.Q119/IKZLQ3#, MLF;/I_5<8>_)7J5(68=03&D<%J'&')3V[)XCQ]JFGSMR7&$L#_7?.'(9^!E. MM]Q,6!SZ#\NS'&OI:A65*?(R%Y&U.4D_F*DJ<#S6N1MG#%@XY=,[9:XY?NW=TI1D^G)^T]22/ZFJM-!K44_!2+A6.\6(#C M?_ VGJHTX _+,91U@:HD,_0<>,#2T.A:M,QORM7HW&75K?-.VU,^O5.V'-5Z M\F(FY'$(O(FNJM2RM=%)AW.7O[;+28"G)NT]2<-K#OX3*1VAR2IGHJ(C!:?8 M>?'_\2C2V,C+LN536+A](I14WE(L@L>V,5:4Y\.,Y!HZV2 ?C<\@CQ5%!V?Z MDG$IR#!Z#XS='V]P$N'T[]2J%IUBXZL=I .X1DI%ZA!+TX5%%/MYA+?=WM_U M^9^R76[:I\K18'.R 18=R419'5,UGF0(V>_FO/:5_LHUI VRL3;IG7R4EF2 MO7:0Y47[VY?G'UFP!VT?8#+D&SM "U8Y4C5&7;(E$[%L6%QF@J'U1Y_OZO1/ MV?+Y8FKQ(7@R\II),9%E4VBH><3J-PS4#MJN#;-[_FF=2!8L:!^\!LQL_ &Q M8;99VZ2A1!^3[]Y_CRN,/[)@V[RXY6,BDUB%+E.2$IC#F5XG)D:4!?8GD:TO@C"[8T_(UC,P4VQR!I2X,:A@"@(5N3U)<^ M6X#UF4TG=GJG;#F&Y2L@-;L- "(C1)LR:FJ-1>W[&KR]Y7WV*^U]Y02'C4X8 M,O@&)E9J$0W)E!!;6^ZG@AQ$&H?(@C$Z\C),(P47P%L@GTW"3+ZR FQ(=B*J MM2Z(7?ABFF[[WX;%':__?GD[6F4DGD&/ 9%GU$*H4A<:X1(G'XTCVA M&6V5-(<]1._#=.V#D_'-T3:"3=2L:Y +)H=)7KJ'+<>N=L&WT1IA! ?MDY.G ME3E:+%11VI8=E."3TZQ&QJN246&_P E0Q@ _GITM]85/X&KLF!@A:,,N1MOL MP,K.#.=K""K45!'Z)W=P6AV5JR^KMV]_PC+^NMYI9]/* V'DT%+7X*44U.@J MXX!"=GQPE4U"/T/&:*3UUHWG4GQ8[L>.V>>@DI=.]R># &I?;AX^SJRY#MNZ_:_#NVY2I-1>W9 MDYMHP=6:HFV$C$)"<]#ZV3;'D>Q/D^M\MGC_9CZ3<4@7Z?._+63UVW(_F0R! ME867O2DZ0E<2BL-2F",5OFF*_YV)O98..C)^Z&>(\-=;MUKKL3MS^Q/)>/=2 M*I@A!#O,N]J\BTRFFJIE<8@RVH]#$SAN)H#RK[[GZ&%?3F>=O)W)$LAI!?! M: 89LD@\R-B.*N/WUDQF\7QOBM5>>O@Q:>3G=-9ZC8[:[5M M' >6BO0 ME#?!YBAHO%=.[3WMB;'Q>^-3M6SS";/GF+) -AZ&>2^8DV>GUI'&.*"#*X^E M;)?>:E]":-8T(L?$1(O!6=U*98^4E.[;9U\91=C9[:=2-G8OG6-OXI36.@,4 M!=':TA@*9%NJX6/M9W %\D]1TWB]1/R2+7T(\1]WXX)OZ%TK6(JL*#3D&9"3 MPVC 1.PY1]0=.G@<>WN7S4$W^>5"K@;"!A8H:F)LGRWK)0"K@-GP9*PPG)A\ MQJU%:ZIQ3*-;TYIRHF31#=8BY"K+E3KDX*ASLB_%X"Y&)Q:9 Q1]\S%"K(%! M4LG>DLXEL /JLXMV_?7D!!@<'2]#LB"L M@WX'8?!GOF63#_+G/;&*#2FJP$") R_!$,$45E>&5#F'1AV8, K,SJQNH_9A MIC^=32^7/R///GR87=T?ZB"/J\?=H5.:Y"48.6=$B$E%FSGZJ3$H#O6-Z7W9 M..+:SMV>!7/0$%\6*2AKV;[)O F;DKP2F23-ZRFT7C9;4-O1A3-NRTL$WRP[ M<)1L3H[>E&&!!"07=*E]8,QPU9X$>[M80U9Z7X&VRMVVG8,:CR=NR\/ M16]F\V'+V;I+F._;L%?MR!=O3&:>*X?ZY&.A'(-#OIVM\V&O2(41F_5L!HXO MFF.\9D2MLK.U&HL?)]=GT:G)1S^97 MLM5PBWP=1P2-PT(;;8.<.=Y6D I5(*\L]D^YVZ+(_0KX1FA__?9NB^%D<;=3 MO.ZGD?RTWN?O;?/M[^<&F)6Q';@\P=402/7 G\>"BS*D#V\ZE8%J+T),EK M&T/AI -$!2U"O5^0]/']9[;WT[.K>P*TAY7> %3V(+>'^8>B9&@ZM88 &=A9 MM-!,:,F4RA&>V<*_/B#_^'_R-5=K.O,S=\7 MD_^^$7,E8U;[8L+5SV^3'#O6)B--^,HAFJ0(0JN,C(%!HF?3=4]RBR59?SL? MZ#J!X,Q.VE%E/''UD;)F:-CUR2S"&EEZ^SB]A?][>WM;SIM.?PT M^6TW$7@3C+?>1!,CH"])VY9;5 Q?;&TK=5L;1&!.EO^-L&AGJ5C,MBBOG/-$ M)7F2^?F-5/D\5?)I=K@MM0([CF$7*17D>5(%9RAH)IIC8,)4:; MZ/ MPQ>_G7W<2/,(-<\A?DF[^VGV2=&AL(%I)83BLG4U)E6"E[W*)$-C70V^E([] M#7?_D>Q_>;O^9?)NYTV=:Q=56@<49@\U >L:VH+!1:OY@_R/E8NZ_"4;H4Q' MR29R!P#/&/4_WD_/WR_OR?+[=JC\74.PLC;,NP0RX00K1X@MI*B:DD>GMO(> MNI!?RC1OD/8(/??)_\+;[8SGXY8!&)_9JUB&Y\Y ;8%(^>(Y,):1+B9W]2D: M@]12WC>@'0./YNZ@BU S5)<3&*D8"R9C<:KZJDJ.&$WK8G^/QJ_M=7@^@^/9 MX9I"!G"E*44YBU=7RXWIVD:K0C_:W"B[-L+O&23NDN'%C-)04U*R!0+;X A> M@EF#K#QATT#S;N7.'B@P_/\$+01T-A&;'1^U!M>/=M,RD=T]A<07 MJM=A=!,J!P-59I2BE.WGZN5]R!8^B'YYRBO-[/G-_&VNA]B1PX,NQD,^K$#! MR7*5@BW*!G4RQ00H4D36-P*LY^GVP^/X?87F6?6;48&3V.7*.O2$IM7"?X,M(597L2;MLBO&0F=4I-K;'H+(L5L;6O)L[HAC M>I9H4)%#7XYT4M'>YI@7WA250.33=W,^EW6"\ JXO3?9,4EI5W;J@Y M$R89@FY<#@6Z/HYEV=8F(E>I>)C0Q<^""V^W1QUYS9Q).DE/M?(Q %E&;5I6 MK#',MI14/P>&UA=GC[+R+)X/6E$4+30@L,YJ4(BI>%5<2C(1H&)_8:R'H_&] MI1ZW))2T(=FLB-#S_1DV)SN7D%3= '$ #TWX3F6'6PQ#LM18LV6Z6;X MQ=A;Y[YJ1/N'0,7^"1]MTM"UAEJ\-U4"FT(E3Z=]^G+P[N[R72Q@R,"F_J;],/DRO9I<3:5V2 M9[,?WVRX$_<-'_LXGQW'FXU!L7>0G ZQZ1*CYCU_"G+9S:8#!PB&H]'RG[28S>$C4CRT\4QPX;*IA.B-'9I[._ M3BZVL$C&,BJ63@P.]:(W*(:;<0E'Y4KJW#LO%M8+[EZ0Q5\^?_@[?V +BXP9 MLVXRMI$J!&EP#G\"A[?./Y^?QFAHF#8@#^+[N7:WMG5^5/$[$LB@UZ*:CWDX!-"*VS!92U;P[[>E 'TV@+R MC40\@.N9WJJ+3DU],Q.U$IA17SR7OV.--/ MDZ_065I8VN7LM[],+MY-_GPVO1HJEMY>3^8_3\Y7LM7QZN+7LW\<%9CZ"BY' M#=F"8M/5*N44B_*E &N6[@S8NE#VQ/,Q97E0P&N@2--A#I(J:'QW:UN*,QC= M7 >_O@-Q;EEAC]E9*J YSK,NZN236@J$(X)0OBO]V@6?)XXFV"V%$G)V!5A' M.#8?Y.&-2WE3RFEM*.%@Q(3C#48"I: +)6DIEHJ=HOG.Q/+)2 MC[W[S8>;88?E0]1M&_%F4O56+!04K8JLD/9++73 86Y?77QL<2]DM,MM]/8% M/1[5,6:3+,=IC5%N9##@J>FHLC2$R?B1OK. X>-:0^X8*\]A^;";=@E8'YHW MB<"FD"QA$S_6%$B'5 ?HK%D;EG4HKL?=3*ZY#4OEF<;(Y.:&0QLHA]?&Z]C1 MC5V(LF^R=W$&I"0]IL/08L?6+D&SNC59$NIJ*OWR=J_71O0?&@M'7F#T'*&SGP,06)0:QFFJ4I12Y MG[_.+MIM$/,.T=1SPS_V?L8&Z5S6#M!PB&(T&6N*9]U(?;Y4&T,6GTOJ4Z._ M+.NTQ"[Z6,&G'($M9DA&2F!8JSMJC3$.-RC"1E*>2O"8>$UKI*)-8M^ H;0K0YALAW<6BJL _CF#W99,&EALAP(K(QLXR!G.X*=EY9KS:8A=U) M_^7FZF+^>0\FF%TO,51#&PR SH3($1,0QU!-91_Z_+-2"!MN^ A!SR-^S!PK MOHN93:S7*4+2CN,\",YEE4)(7G4S;]@Q:]J0F-N1^-NYO8M?9_EF<,N;N8&M5:M<@&$AY-X9A$MF3<3J1+#5P%94,4L+<6?U5QA_#V9Z%,NX1'(6*-@:OI72M56]:"C7!8.X:@W@?.ES@#DGQ3KI%D>^#]CE+ M.UG-J51*6-GAU,(HN,L5/HO:J=#&)\VGI1*' M*GQNVG16"Y1U]J&3>HBI/4<[\3 M)Z#NHIC]\"BK75[$W3%I"MFL80])XW0K],Y3-5;]9F&869IMR;+FLL?,\O"6E7.U:-T' MH,#X!0\A@9\FUZ_?RJOYV)"1$]"?^V6A'(P'5VJUD*2X5]IF?;/%0F2-*GWE M*]_$]3+FQTADGY(\I-UF5<*J&VDP".*-HV; B"D@>0_]FU@PL)Z0?2FQ;#'U M\HID,+7(OLA*\PH-BR%B@&%H0%\/X5^8K9V@LX\Z*8Z'6R0PV:12R$JK!'LT M]K-='D."Y@.Q]68^^SB97W]^!W(K$:/5,30?DC9.:<7Q>Y))PF *MGY MJS$/!(7;Y?)BTNPZYQ^2Y9TJW'W=O5W.5^?3R\NS^>=?)O-/T_/)@S_BF[/"[_%FK$^U.?"99 8K,@L<0=62FW9\&,LS20UJO_1JJ,LY MJ6/9NP5W#8HX]5P]>)VEZX<% 555:GG#Y 0,)Z"H6Q[0=)7)*&UH@@1?"(T= MP(N/43G;OS2CVP)5C\72L[S[2'6,0@@L 02 ZB!JB-Z!0HT*3>L+#]7+Z_S. MXCB<>WX8'*N<8ZN@HU< TCGL2TN>3&V*FNL+RWY7TMSH74<"#5^#5,8B_R\2 M*)<5Y[2WIS-7\\')B_^_>SR9O)F,O_E_=E\ MK0IW0VWEZGS 8K*MBDU2I ZNQ0J1I<8GR?O75@+Q.Y^R3__;_4G=6\HY6ZD M[8.9\;F:UDB'00 P!@S#&6.HVFJ;LBV4Y([$S.U7Q ^SF^$MZ\NGO[R*_G 5 M^;_/'K-X>ABP*I,8Y1EU9?CF9#Z=+.(J#5MG4L?@8RDLFI0@>[:WJCK9E0>Z M1J7K0Y)"_:>@'A35(QA_6'S#CUC$F^OWL_GT?]:3RUL56O%ULZ&TZ%2#&EPR M?#FUSAQ_2G'0?9.W&'[3,BQ8NZ"C%#V']E']5>"L95Q8F^4 L?%-5*8$&[S, M_0O"2C*<2.RID M(]/8R+C0E)<^"2IL^T QY)[M#R+[%%!6YU:)[#2C^LPD!'$N285*Q8(&C$2L?\+.9105#\;ZD$RA]_]:-+&6@MR\DU)8;TL MI++51X4Z84@5+$H[Y;-(^W@VO>L#9=!Q;]K*DQH^34L<"1J3&,)#2S8B9"?C M:5F@SMDN@PE@UY9+[4#2LSD8G5AC'=O:T-@3RLQ.B]I5\,Y69Z-1?0X$[/H MX4=S\+5^ODR'TOGKF_GD_D3R8^>A3;".\9_G",R -AS>^XI(%6(V+NJ^RWC= M^VSE: \"V%+(K)OAOVNIO@0CPQ;J.3O5#X%I2&#$[+F;J_Q7\_;V]:.T%)L? M[8HZ)/$[*6&,%FV0Z<4%BDGDK6SKU>P/V9/W;L>; +1W^9]:=;-SFJ]AE&$0 M9)0+T18^39T5%B5%F[W/ MLGB9%5>'RJZ'F7*Z3ZJ_#!9]=W(B"3Y91V]8,[7+DQ-?GAK-+ M<06_O)],)),?+RZ&*O&SRS)=G%_.%@S$%^DS_\?'V>+L\L_SV)<9$R7G,_>RM:EVI?9CR"5 MS:+YA@7YZV^S3=LP'Q1F &04'T,B#&!EI65(&AJA3X9\GQG0P3]7G&_9M W\ MMLF1%RDY$VSUAGTA&8@AIP+95RN5QG9N##KR$C, PE7(AT+IR?.E\,(:A2TP;9MA9F2+V;(ZV MQ 18FT*CR69?,MN[J(?=(^"KJ29VT?TKX]TS:-KELAEEB8.3&*MQ4"V'J3E& M*3#R*DNO9U_@J)]Q[CLEAM@!2 N2SZH!FL9@,]ML4I6E5JIMF,_J-EBGC21M MKH#X:7)=_W'KU?/9Q^GUV>6P:.1B$ZK8.I,2E2Q2TSJSG7!L3Z5V*SE@(J5\ MM+M'EA!LEU=\$J&'879T[*+C$X+,=\SP=0,3=9)<%4I6#X+OCDJ*?]:K#_?# M[*>I6%..(\OLYN_7;V\NX_GY4")P5".:-.H6V)* +*<8EL@ZH%S!&F>L[2X3 M1QB=YC[(R7,X/FCL6VU#CGB'H=-.F530,;3#)B9-]5,-92_1^J/<8;C>,HVQ ME1"S*Y6/2X4@PT[:@(*(O49,G?(N'=XAR=X)'$DU%0<'[,;2,!#90Y2)O3%J MEG:_AT!K@"X!JM7LFE&QY:*[ MM+4AZ3Q=8>8I1.Z?R?&':E(8@PE:MLE30%=E_F^+M;'"J3[[HP,X_0),?LF' MRY=_^"A1^!/J,T"7A,AN.T($J1718:DX@,+BO"5:HGG*F#Y%[2,;'SIF- M6@+="GJC +V++GGI@TMH;8BA#[:&U7D'8_SCO?$\^[[_]=\OI^^6B9:C MCQWRJ*SDN)/1H+UL#FR,5(M,QJVU=N\X@=:U8V?6]BB1+>%(JHT,8^Q<8@X4 M+5$:,KP<$5CONBR,@?6#/RI/.RT;Y%A5MG$J F(K;=E1NE" 2M19VM;[7HFU MW0Y[Y.DEZAH$=0:+2$#=D6R9]G%?ABB]HQ,PU81K+^F/X;?<25, MF;R710(,D-G^&@\4AAH&CMLUA;X;PRLZ#+D[#92.A56&Y7T\NAB$35Q?+H:?#=SUUH#3?]% *%C;R"GPM M?-UEVU_54HM?^SXQV>NZ2O)E>1" EE'P,=1B;=.EI*H[ M^+LG+F[.KV]D^#=_P\^383^/3([Z8?GUPY\W:9)9!_*PDBB(R09@H]LR1*]) MMVS96K'=BJGE/E93BWHVOY*5IO?V#97)V^GY])$Z!2T' M*X4YR+A)R[!L8K28C93#>]=WZKURND?"VTAZ+@.C@\JEJ"9XC\@!"?ORV#@T MT9:_2[,92ITZ#;UXZ\?P. 8^3:YN)O)$DP4I,1'_,;U^?S>2^\OKDB0Y^/]; MMP9^7T--JFI)D<]06H48?9*R,$;A;/!EK4L7=#C7^8)'B_?;/YWCS#@)CD/V MG%MKN8')";,BXX"OOHV,-_J*25+KIO=W>#9''GIB&$!1E@/)!31"X@,KVJ7B MG&D--S2#A^!/_IANG[%?SV^E]U6\?YF<75Z_/S^;3U[/WYU=3?]G.,DW_$^1 MY?*KUT2]_):\]BVW9/\RNYFSH._=+2E+6OUYJU]Z*$O()V<*60;"LN%=)P(= M2T:PMGB+W4L1'_OIF\(7/,=M 9@0R)HUL+1N: M&F+*U165P/1KOE!IOXZ'_CBV%>'_>?9I,K_Z.B9A_XZ-5%-1%Y>(#Z_ZZ-&6 MI$M,DOG$?EZJ#6NO-G^P3Q59/T%TC9EA,8;215-#2OI( MP9RB>UT_J=]A#L1"M:;ZBC):+&M&G;5YQW;/V>!"7Z %FC_^QU&>0!J$:G0V M5^?):_94$2N9((7#'"&$V.\]E )86G^'_^/HCI\*J;%FZ;PNUH%/+68'43GO M/95836<]K4+JBH'^.+?CID-,29$/@L$(2FM*H9JS'!T"6\R<^W@2R'T+V.0D M4R* UFF0Y?, X#Q0HEACB<4J=E2V7^%NO5.GF!+97=I'6J%@2@L@L:%M*=KEW')HUG4Y;E_.MZ(P58:&S1!RR)14DQ6<; ]*7W;- M7V)/\0UBO_(Z;,+IX9+RJB+IU*RV'MG3^>R;G(9 ]5Q-O_H;\12#V),XB\T9 MHY&UB\93096UXC I*FOR(/I0&&78OJHY&++K];1_R/[AE,_# ,\ITAS7L[FQ MMOF")I(('GV546H;&E_8>?XA^-UR-@]WXU*(247MM-8-8THQF<'2*%D9%?IQ MC7B2KW:["/UQ2 UTKL56UXJ*'F1*G$F#0RP:+*.*;PVI/2J.?_@5L0&VS.%F MRRIX9TSQ0:22=(O08K^!#TZKTFR7!G6&Z!62"1AU@QPJL1]V,6GIFFZY+Z=S MSI(]*4MTC\L3#32;;APZ,D2W,8/ SL:J%!1&=KTQ^[YQ4X73*H$[OH@?9[ZB MS&Y$B]79 (ULQ*(K&)U=]2J7W*\@H]^Y?)\8: 8G8Z"IY%@)3"RRK!*"*@8X MY,REMQ92R72J-O'P<29DF>MM^6\VKJJFU KHX-A/%$VYW_KLK/-X4G'Y(<3U M0F%F@\IVU_N0,P!DS5X\.4BUFJ93Z LY#9_&'V>QES#3E>QUC24Y%V?XT\=I^TGS/1):U\02F@6(CF"I$%FJ7I,%OIG$@_N M)&WC^$ Q66?OLX?H /DO E=*RT9>X [A*ZM\BJ<5,K]]#?ENF2U*Q&I&@/L M<;&57!K+D/VI]_WU\L;#22*<4]V>JZPT4[5: WIVIQ"'1'G**;$]"]3U:[/? M79_5\SN3[Q/C3/05D]/$X3L']%7%D(.--D?BC]&&E5?&ROSC4Y;U00/-(4.I M2[%L =BP!ADD8)TE4$YM&F'.B /7]V-]A_)ZH4A3I5@J: YRHN16#17;JN3^ M5%&Z81=I>@F+_CB+?42:Z$S"PC&]E8D:#I.**+,2+50Q)MU#AD?C3JMW[C1D M_^A(4V-%G;7,NP76^49%X'TRME3MR76NT9&UI_6B>5J"WRW2K%:K0@0U:X1& M,95@HM):6TLFM&ZVK5TV)W^+0G\L4B,/5AK<$X$O0-EEIRL4%X-+T)G@4T=J M^XDT(T)%4ZW).@'C6$8+1F8+^J 9-J2^[@E]V&NIC6CU%U/^\V3!9.\P^??^ M'#YIL_7*<"A9/6 E5,!A3$Y!1XRF=7;&Z/6%BYMH>#R-ZV/J[M-HJPEL!)US MU4&ND0S3W#QA,#KH/NVO"1]+HVRO2C)>/\\^R&;AP9P<=P-)\XJ:*ZTH!45F MQUL*KKEL9.[8AHC>K\V:V,S#T[@\Z&826>TD:^'8J((+LC-8]L;83%K:P/M) MG'YM7OX^&1TO&\\8JJDU0O*.U8YC ::OZ$Q40@33%RSXM4JZO9"Z2]F!PR+K MI-E*M\*$ >K89&*_9]V!T ^8UW+K#T;I6.:JH"T^>2^#X\$KAS(M$Y&=+.J0 M5.=BO55/DBD#W?-5._/#O1O\MXO)]&\_3MZ=7=:K:XZCO]K_E-_47R8?IE>S MR\E?9I=B?!<_OME?A\H//[65E_;HG,^ .R;A M34S7+L\7B]=OE"M=5E#:?,G!;7?*Z38:V(LDP>LB,45K) M')AHDT/);%4(RL,R[-5JD[!6)"KT++^F#(-G^8NFLXOE]\;S_[Z9+J8/3B,_ M*<6KK41=C9'^%VBNH>RE\,VDALJH>-_=+ ;NY/7 7C0]V2VJSAVEN%/D]^& M3XT(\%M444S6VQQ=*"U#B1Z)0F+A YH4/- &:2]76^\HZR]BVUG07R=!+UG\ M[6Q^T6;SMY,I?VCK)LDO8KI=8L&&>';U)5-Y]U7\X0^SJYT$1(UC+&6,2^RO M3 LQZ\BXH*E:[^=N'E1;?S1U>"4*\"QAMP1"J;'LU$N%R MF-1D!#[R5=YA-?U.0MM5RB,:?3-_PE['F!6:K)QM.H!U3LK_$CO0@I6UK6W: MBAEVYFX+L0?F^9$7\>LBW#=GTXL?KF[W7VQM-G8F276WK@4 MI6+9.9*V9!,'<3:9Z)3W,A?(@+)=GN 5["RTYYG]EW..ZT^=60;[>6P,5QN2 M;2')G#^.@TMQW:#VO8OGY\G'F_GY>_ZZ-_/9N_G9AWAS_9Y=UO],+I9+OO2& M\,N5R;F&L3BQL$'A&$=;QCTQQ1J]J5+;RN&^Q:Z_"6Z=SY_6>=M.W7:&?IY\ M.)O*MH>OW_OU:S;QN#7#!]Y61>QMHJI058TAD*/H0'DJNE=JYS?ZUB=1.L+O MQ;!7Y'HZWP22C@_[*@=KWFA,+;"+:9JJBXYQ"'^$_VZ;8C;-]T"OP[X=&7R\ M8#8L8-L!>7!,Z6,)VB79P4;(0+8&THQN'3,)&U8KH!D[^S'B]LS342P^RGIT M&ZPL:@&5L"CR,@B@;1B&3SAZ-TY7/KM;>2\+ 91J41ZA;"*L1N9VI1 T MQ].E&XZW/X59AAR+)1^/W$&5/?N@IFRL"3(9-N'*8#*D F-%[.O)F"6[ ?.L MD/!8 L?V 15T55KQ=+0$B%)CB$#.(E/IG.X(A"#;W9]%X)<7KC>SN5R->,VX M[>\WU[)/\=?9YHV*CY-ZUAPB!V+7'PTP*$HC+)EBAX?.4_8> MLBJI&=D1+@_M8M=ZZ(,;PN[O5(J;?_*VRAE;366W2!@<6(BQV69UPZ3 MIY\F3-3LP[9:0^F@>N%,3]CE3S26ZZA&!K:QSZ8X%H4BQL1C/;U$*1(]A>,R%X6C R!)FG*RC%99XCOKSR[4^O4RZ%:&_ZZ1OTC&3MD!5TK)620 MJE-0'(*72![)58[7H^RWZ<)T3=:N[7E_'G/C57.A!&+E$].H(YO*0L')L%5V MY*[ZU)%G0:V7,CZ-NET*Y;1GD\/"DL09<$B:#+A:8L-@T>?2E_3QCS1VG]2- MI4)]9^;(26S&K6J0LN^VBMGTZS]): M(?4.O.TBBE]G/_,M_/!1_CSD_^+%?]TL%Z0?U7RI%G1T\MJC:["DM;1_Z("8 MC')!=7=H!TF,L'8 R1S2_AF9ZH>E,E9H%:PWKB01#JD@XQ>[Q["3$\ZX_2PE M*=^0754@^2=%:X>S1VNPV7[O()LQO]-E.!*7N]AA!8Y49?7.X#FPYIN.96"2 M0Q3+#NYTSW 7.RXURXR^Y)FFF,(X%Z0XA+DK,H+ =$F]@W&7S^;SS_+^.;QU MK@*X-V?SCK<'F4 AC>*'$Y?34Y3)&+0^J=RLKHQ\+5&IE5&& MH0R-?&>3#BRD+[!LNYD]M&!D_[4#,)[1)L<",3I58DE%L;B,[_RM92^A6\DXEZELX>Y80#F5' M5H5@HF<%$!^M+#@?H[?4 A\SGWPNX"1[9*78&V4M;:XI')CYUS?7B^NS M*TFXO9@1+0L4>@ MZE((P+JA2[--9E[N6PSSR=GB9OYYR8"T33&A\=-D?O9NDF>+ZXUM>P^$(6:E MI#^R-=/)*DFK>(5LU:PRR;>0#(. !QOCS)^\N\?*CN0]R-*]?K#Y \U%:Z'B MZG& 409*CEE7'8)C;,= 1HOI M^?3C[>RI\YOY])I14CI;3,^/FM5"#H15YJ"&L8: =(1(#+>T\9>M6)EY&R_ M[\NL#5@^>>['3!=_MZ[-_[% 2(S_HJ":X%FIL M0IJ1-9B((;(-KI1#KM)T%3J=6A'GP43P@I(^I.&.+;@&H%PHP!8L9F0Y+X4- MP<>(9 M^@O%5_TF8ZL60Y?*,+IJ+$1;5EW?V M=SE2Z>L4[LG%VA,5_Z#KQ7AR=>//E(C@\Y!FG+Z=GI\M"XON#7 :_>;/;^8L MQ/GG-+F:\'=/^8_QW;OYY)T06*:+\\O9XF:^J3H>5MZ"E3(,V%&A ZNE?(TM M1[0Z-A5PTPISK=9E_A1I'4+>][.XIRIO59*U8#PY8+"N6-)5Y59451G[#A!8G_/Y#(D= M3/#?@K+[$+V56MCD F,2BXXBVYBD)G.X)Y7BEF6IEOHA&RE6K86EIB%1"EA<)MLHFVFS''R.>R."!9+1G MN'M?3#8@7V!=O-3EQ-(8'M0:4QTN-\5-#\DG*Z8.ZMYG%+3,IQ5,1Z" ^'^: MD@Z^1OXWJF^#T0=@[GT^0PZIR=,X1(26/=6:8%D\E(->J4H]?3[_\V$^ 6). M[. =L!-R%I(D##(&TX)3N++ZXXA\2AG[YA]R3-L7*Y$ 3VUJ 0@*E4MV8S?U:[E2F=+\3?#@:N195T MYG^DPA&M211-50P^8R*HWNJ-["D;O'WYX]O!KB79&Y604L/5T2/:Z[SE*5<**44LY>]5JQM38F6O"XEQDT%N)D3!LJM78 MV:AMYFZO8CF@08M5V>A;JY@4%)DZQS;>ZN89V]GXD+G?S: =03*CQ@P9Q>38 M0C":M/3;Y58'8Z98$:R/SS%FA^1M!T/F7*V5+[OD7L$''67V4<)<$# SJ\\Q M9,=@;<2(M:J*\:X">#9DC#YK1-^<,I0:1Q;U.4;L8=9D//N_?*TEW-SX_(8# MW?//OS(SZ7)V_G\?YNRK1=:^.J-2B,Q/+CX1GUA1VN7+ MZ:=_6EQ_OIS\O__\EG_DJ[=G'Z:7G__EU^F'R>*??IK\]D\_SSZ<7?WK\+G% M]'\F_Z+5Q^M__>?_]>[Z7]>^G:F=O'H_,/\OK/+_S[]^/+L0/E_]?79]/?OP M+_CQ'U\^=#W[^/^S]ZY-;B,YNO#GYNWO15& < JS_VA_!,(X2@USYX M_MQ)O2R/12;G8>H SI1N*!<[)%VE6 NMT7JQ4LGGV=),9L[M_,0WLOGPKG6 MOR2WL:27$RHU"1P2YM*1NFBD,U55(]%-%4IG1K7(H(?)TO%JW2>9;@ 7P9ME M@I2)Z\!:I,+/PQL1+3MJ37H7W;>?8L<7&>8KMWV[#*'),;C_'@P_)E)Y)YTN)+K*X MI*T94,E?H[ V<:=!6E*^T'7\:0U.1>)K^<63DN"> $0&8:1B1D> M "?9TL&23S#1Q/>+S(79P1IZN%#.1, *(SE@ E@AHJ1%.9[7\HV3)]@3K+(3 MFGP3V,\:F9:X7E,!LU&%U"2^N>$QG' &]D"(99D\.7?*H"DJ9#'-DL6FUZSU M_PI#C$%T+50LQR;7I/0)0$%/_XCI;D)?"UH%",_L@)K+2E!Q,,XZ$VF2(7\D MH V0S8"!I)4>XR^.4-D5@?"X/C#Q "_;TTE:Z?%T)EZ$/7=@'7?9&YR^M MEWH7>U=,%5F=DJX.$?9XE-"OL0-;+.C'&?1@O0YQ0(L["&TS"F+V$-578BH^5_^?(/QZMJ#W76 MJ7*P(GH%:GB!IWTX5RR52@H) MIJ)\\V-3!.KU[Z:0+U![U0C4K=%GJXHPC49BJMY9;<,>&EALL'.LJPQ\IFR8 MKBB#A19%^AG:9.)GF8)UHS\_7KG!RLS"6 W2*_+$?)'1L.B;VS#(Y_ T$&^2 M9&!+@-$415XJQ8_F#YMBV)0U[JS\"RT-'&W\MU?GKYP,%I7^[I7/_I 'U9_9 MQA;T!-60QA??OZTU5'6PL='5]WLO^_I^N[^'HF#Q4VU=O8A*.M[6>'A54NS/ M6IKLKQ0'X3?W#M.2FE5&JMAU_#0@&F\WR+\4OK(3[K9R-RU!6\B%V^$IX../ M\S 8-F*2P^GE_5>N5EZ!'W*X0Y>[9U6K:?/DV1PXOE_S+*DB /$W23[\3^ M:\5TVBKA?*Z5\$YO.\' ?0_&._HM2I.^*>EL$2';Q9:[@+6MQ&X'OWVW-Z:Z M@T9/) 6Q7(.T& RZ[KA[L7.*-+/R#0@(O#?)'#\27O:W5W$2BU<_E//<%8K7 M9:A[V&A=I=[T?#\K1, &5/,&5'\'!M1]YM(.4:8_<"]'@Z88Y:2QY(&&S(&# MS+4ZUS%($P@_\K+FH(:MP08PJ%$BOB XO1ZXX_'N+:!U-MF=E=BP-+[9HW5T MV+AE;66_B#2GO6PEA6!KXZ9VS!;3?O:NVF.M9S](OSE!4J K_3]4-=:G;6Y5 MH^2EAQ;I]+QLL!ULNV!AUIEWOY )UB; MGM_;P [JW/3K'$^.Z?AX;5)/:"Y.FFC%*>+4 S[U-]OFJ/.:Z.8Q>O,ILWA= MGOSH0_QM\YD4N9GR)L^TW9!SZ\F&@ADZETV&,K@47$F,%%)Q))A7&#L))G5Q M_"*CW-Z1=1OX$0%BBGI5> ?V5$5_>'1MEB);#-^HE#(8ME>=\U=T]V13$2%[ MY*#F9/2[_GEGT&@4"ZY'(R,;]SJC1H*#5@-R[U0DV^(+M\0)VB']& @O?YU> M^3[R8(CUP##Z\/$1[]>C]]T!7AC],#X_'WVX?O?QZN/U5??\^GKP;GC5NWKI MR,+]1[P3:5%081DD@ ?=_C\JQ8MN;14SJ"^M;0)"%A&TKZ\N26?N ;1- MA(@1WU+2(1BV!\UE@8H'"_.Y\Z_.EXXS$['(O"A:XL\(5P$]I[@5X^.@\30" M]GEM H?[W;=_O[KZ7'[LO7U#$784MQPNK!&%\10#BBC$C- ?>Z6XM%CF6>&K M,.D\<3["8TZO>_;?]-@56K)@H_:ZN+R_J?!O;./+V?_?<:YH%C"X:$EQE4LP M:9TXR8U:LU7S[ZAY03-@P.**6(4H]1P M2%,OS' !2^XVTZH"_*O!IHD*VJ-YPCM%I%2>OBF A*ZXPFA@I3AUM2=67G3+6I=7!$S'6!U>":@#!TW%&YIGJ3(3&=: M1+HK"M1<:JO - LS"!,]5GM%$36ITJ.V%>16:V&CD,AY4D3 !!CWYU$;\,[O M14QL6?'J)NK_HU"YY'01AS^J[S&L+(<#84/ M;UK0+<$.3VC]H5KU<;IR@W:U% MX/W5Y?E5_VK\OG?YX7V_-\2KW%?CZY?6N=NB^>N^I.%*S.=9K2HTD6'U"L7[&&@.'&UN':H;A1/0 M]J&'5RS<#;<./2?V5+%RC.F_3;(_Z K5AHM\^!HJGBA"@P'3_H6@;E MX>_8UX-*YQZ8,C[]A;<4H4..#TP%1N_:.CN*V1:P FCNX*T& M>QAV[PLPM<(S0^JE=4Q+*H?B>')7KTXC!YI;R;B#I)M%4U#D25,SZO6'C?BB-@)B38X:&>V& M0,:GC!;AMS'W64-.QPWH"&+91-.#?C,#Q&V8K.UMM:(%R/]=74I7.VE9N_T. ML["OV=,.L,1*6@;448Y,%N2J1\:9"T#4.8&F7 +&+TJ_-:C%/X3>" )[+3"[ M!G62.RI#[XK.J0N3-5+[JGH3Y!DW(T?:%;'-,*GMD)N1J/,&QUU?>'*VE+MX M=86=O%\%V')2W'/_G+VF[=&@[#5EKRE[3=EK>JQ>TX,#X\>PEH&B7(.X.;6W M]QIFIW@[3P!]SY2U5/>IP ;Q5B"TR"J5SHIM)^],$V5RD6/B&(5W]@AL9TZ5 MMXCVWZ7-=I/D=B8?VAN1<%*XF'1FF1=;>0=,TY.EZAITP M!<3Q<.,GFEHL5H#*GWOQC-#5T%A,IRHP8#6I2WW7*R)X2JTAIK):.I:F3PLY M#X Y+&UOVP>8-0Q?4;Y!XN\^%-?5I[6*ZJ2""4YZ$RBWYW*14"N/6S)%'X<0*)"#:*V4'\B#@ MDQ(9;PH"L):7)Q-37#<'Z#D5%',TP9VCA&I9,<9A@S@OJ8\",I\A6%]A@2F/'5;%VE.96;S"W' ,8HJL-D"[?C$#'N M"<0O1"M64KH9D[KHE8FE4M,ADCZXG3(XJ?/*^2*$\PN,S^GCXI0UO9!*<@_0'L9N-1HE6 ).YR*-+<=WN9IZ1T]G MF:NO4:95@(Q#.9BR(Z)+P[(2 **P8?@F^ILFQ7K:IL:.I9IH&;:K8CW?\U.& M:)T$E^?&C9U--4;(#8?;'>=]D9F]5@P #E(8YW/9H$]H[VQM@ !4$ZQ*

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